concept_id	concept_synonym_name	language_concept_id
44802747	[D]Crossed laterality (situation)	4180186
44802748	[D]Clicking thumb (situation)	4180186
44802749	[D]Symptoms affecting skin and other integumentary tissue (situation)	4180186
44802751	[D]Anaesthesia of skin (situation)	4180186
44802752	[D]Burning of skin (situation)	4180186
44802753	[D]Pricking of skin (situation)	4180186
44802754	[D]Tingling of skin (situation)	4180186
44802757	[D]Numbness (situation)	4180186
44802758	[D]Paraesthesia (situation)	4180186
44802759	[D]Formication (situation)	4180186
44802762	[D]Local superficial swelling, mass or lump (situation)	4180186
44802765	[D]Nodule, subcutaneous (situation)	4180186
44802770	[D]Lump on leg (situation)	4180186
44802771	[D]Lump on thigh (situation)	4180186
44802772	[D]Wrist lump (situation)	4180186
44802775	[D]Oedema (situation)	4180186
44802776	[D]Oedema, generalised (situation)	4180186
44802777	[D]Dropsy (situation)	4180186
44802778	[D]Oedema, localised (situation)	4180186
44802779	Choice and booking telephone reminder to make initial hospital appointment (procedure)	4180186
44802780	Failed to make choice and booking hospital appointment (finding)	4180186
44802781	Advised to attend general practitioner out of hours service (situation)	4180186
44802783	Point of care D-dimer assay positive (finding)	4180186
44802784	Point of care D-dimer assay negative (finding)	4180186
44802785	Human immunodeficiency virus monitoring (regime/therapy)	4180186
44802786	Human immunodeficiency virus annual review (regime/therapy)	4180186
44802789	Measles mumps rubella catch-up vaccination (procedure)	4180186
44802789	MMR (measles mumps rubella) catch-up vaccination	4180186
44802790	Measles mumps rubella catch-up vaccination declined (situation)	4180186
44802791	Declined consent for notification of drug misuse (finding)	4180186
44802794	Referral to National Health Service stop smoking service (procedure)	4180186
44802794	Referral to NHS (National Health Service) stop smoking service	4180186
44802795	Helicobacter pylori stool test negative (finding)	4180186
44802796	Helicobacter pylori stool test equivocal (finding)	4180186
44802797	At low risk of meticillin resistant staphylococcus aureus infection (finding)	4180186
44802797	At low risk of MRSA (meticillin resistant staphylococcus aureus) infection	4180186
44802801	Preferred place of death: discussion not appropriate (finding)	4180186
44802802	At high risk of meticillin resistant staphylococcus aureus infection (finding)	4180186
44802802	At high risk of MRSA (meticillin resistant staphylococcus aureus) infection	4180186
44802803	Preferred place of death: patient undecided (finding)	4180186
44802805	Recently stopped smoking (finding)	4180186
44802806	Benzodiazepine dosage reduction declined (situation)	4180186
44802808	Assessment of mental capacity in accordance with Mental Capacity Act (2005) (procedure)	4180186
44802809	Assistance to stand for pressure area relief (regime/therapy)	4180186
44802809	Assist to stand for pressure relief	4180186
44802810	Central venous catheter care education (procedure)	4180186
44802811	Advance supply of steroid medication (procedure)	4180186
44802814	Sodium level setting on haemodialysis machine (observable entity)	4180186
44802817	Haemodialysis extracorporeal circuit volume (observable entity)	4180186
44802819	Haemodialysis pump speed (observable entity)	4180186
44802820	Ultrafiltration rate setting on haemodialysis machine (observable entity)	4180186
44802821	Haemodialysis ultrafiltration volume (observable entity)	4180186
44802822	Substitution flow rate (observable entity)	4180186
44802823	Substitution volume (observable entity)	4180186
44802827	[D]Pallor and flushing (situation)	4180186
44802831	[D]Spontaneous bruising	4180186
44802831	[D]Spontaneous ecchymoses (situation)	4180186
44802832	[D]Petechiae (situation)	4180186
44802835	[D]Thickening of skin (situation)	4180186
44802836	[D]Development symptoms	4180186
44802836	[D]Metabolism symptoms	4180186
44802836	[D]Nutrition, metabolic and developmental symptoms (situation)	4180186
44802839	[D]Abnormal weight gain (situation)	4180186
44802841	[D]Feeding difficulties and mismanagement (situation)	4180186
44802841	[D]Feeding problem	4180186
44802842	[D]Feeding problem in infant (situation)	4180186
44802844	[D]Delayed milestone (situation)	4180186
44802848	[D]Global retardation	4180186
44802848	[D]Other specified failure of physiological development (situation)	4180186
44802850	[D]Hyperalimentation (situation)	4180186
44802853	[D]Facial pain (situation)	4180186
44802856	[D]Lump in head or neck (situation)	4180186
44802857	[D]Localised swelling, mass and lump, head (situation)	4180186
44802858	[D]Localised swelling, mass and lump, neck (situation)	4180186
44802859	[D]Lump on head (situation)	4180186
44802861	Preferred place of care - home (finding)	4180186
44802862	Preferred place of care - hospice (finding)	4180186
44802863	Preferred place of care - community hospital (finding)	4180186
44802865	Preferred place of care - nursing home (finding)	4180186
44802870	GPCF1/2 - section 63 claim status (finding)	4180186
44802871	Health of the Nation Outcome Scale for working age adults score	4180186
44802871	Health of the Nation Outcome Scale for working age adults score (observable entity)	4180186
44802875	Haemodialysis sodium profile type (observable entity)	4180186
44802877	Ido language (qualifier value)	4180186
44802878	Limb oedema of sudden onset (finding)	4180186
44802880	Oedema of head (finding)	4180186
44802883	Haemodialysis anticoagulant bolus dose (observable entity)	4180186
44802884	Duration of haemodialysis (observable entity)	4180186
44802885	Haemodialysis blood circuit connection (observable entity)	4180186
44802886	Haemodialysis needle gauge (observable entity)	4180186
44802887	Haemodialysis pump head segment (observable entity)	4180186
44802888	Skin prick - method of drug administration (qualifier value)	4180186
44802890	Haemodialysis machine stroke volume (observable entity)	4180186
44802892	Pali language (qualifier value)	4180186
44802893	Volapuk language (qualifier value)	4180186
44802897	[D]Aphasia (situation)	4180186
44802898	[D]Voice disturbance (situation)	4180186
44802899	[D]Voice disturbance, unspecified (situation)	4180186
44802900	[D]Aphonia (situation)	4180186
44802901	[D]Loss of voice (situation)	4180186
44802903	[D]Dysphonia (situation)	4180186
44802904	[D]Hoarseness (situation)	4180186
44802905	[D]Hypernasality (situation)	4180186
44802906	[D]Hyponasality (situation)	4180186
44802909	[D]Dysphasia (situation)	4180186
44802910	[D]Slurred speech (situation)	4180186
44802915	[D]Dyslexia (situation)	4180186
44802919	[D]Throat haemorrhage (situation)	4180186
44802923	[D]Postural orthostatic tachycardia syndrome (POTS)	4180186
44802923	[D]Rapid heart beat	4180186
44802923	[D]Tachycardia, unspecified (situation)	4180186
44802929	[D]Precordial friction (situation)	4180186
44802930	[D]Gangrene (situation)	4180186
44802931	[D]Gangrene, spreading cutaneous (situation)	4180186
44802932	[D]Phagedaena (situation)	4180186
44802933	[D]Gangrene of toe in diabetic (situation)	4180186
44802936	Health of the nation outcome scale for secure services score (observable entity)	4180186
44802936	HoNOS-secure (health of the nation outcome scale - secure) score	4180186
44802941	Not a carer (finding)	4180186
44802942	Brief intervention for smoking cessation (procedure)	4180186
44802944	Meteorological health forecasting service declined (situation)	4180186
44802947	Slow induction of warfarin therapy (procedure)	4180186
44802948	QRISK2 cardiovascular disease 10 year risk score (assessment scale)	4180186
44802949	Patient health questionnaire 9 score (observable entity)	4180186
44802949	PHQ (patient health questionnaire) 9 score	4180186
44802951	Influenza A virus H1N1 subtype detected (finding)	4180186
44802953	Local flu response centre notified (finding)	4180186
44802953	Local FRC (Flu response centre) notified	4180186
44802954	Close contact with Influenza A virus subtype H1N1 (event)	4180186
44802954	Influenza A virus H1N1 subtype close contact	4180186
44802956	Hospital referral declined	4180186
44802956	Referral to secondary care declined (situation)	4180186
44802957	Patient record merged (finding)	4180186
44802959	Distorted limb shape (finding)	4180186
44802963	Suspected malignant mesothelioma (situation)	4180186
44802966	Preferred place of death: learning disability unit (finding)	4180186
44802967	Symptomatic relief on limb elevation (finding)	4180186
44802968	Preferred place of death: mental health unit (finding)	4180186
44802971	No papillomatosis (situation)	4180186
44802973	Preferred place of care - discussed with patient (finding)	4180186
44802974	Preferred place of care - discussed with family (finding)	4180186
44802977	Preferred place of care - patient unable to express preference (finding)	4180186
44802979	[D]Cardiogenic shock (situation)	4180186
44802979	[D]Heart shock	4180186
44802981	[D]Gram-negative shock (situation)	4180186
44802984	[D]Lymph node enlargement (situation)	4180186
44802985	[D]Lymphadenopathy (situation)	4180186
44802987	[D]Generalised enlarged lymph nodes (situation)	4180186
44802988	[D]Localised enlarged lymph nodes (situation)	4180186
44802992	[D]Respiratory system and chest symptoms (situation)	4180186
44802993	[D]Respiratory abnormalities (situation)	4180186
44802996	[D]Orthopnoea (situation)	4180186
44802998	[D]Apnoea (situation)	4180186
44803001	[D]Shortness of breath (situation)	4180186
44803003	[D]Cough syncope (situation)	4180186
44803014	[D]Non-cardiac chest pain (situation)	4180186
44803015	[D]Swelling, mass and lump of chest (situation)	4180186
44803016	[D]Chest lump (situation)	4180186
44803025	Referral to general surgery special interest general practitioner (procedure)	4180186
44803026	Unplanned transfer into unit (finding)	4180186
44803028	Referral to specialist health visitor (procedure)	4180186
44803029	Participant in Million Women Study (finding)	4180186
44803032	Requires assistance with all activities of daily living (finding)	4180186
44803035	Gold standards framework supportive care stage 3 - last days: category D - days prognosis (finding)	4180186
44803038	Referral for cognitive behavioural therapy (procedure)	4180186
44803039	Referral to tuberculosis screening service (procedure)	4180186
44803041	Wound of anterior tibia (disorder)	4180186
44803042	Electronic record notes summary verified (finding)	4180186
44803044	Assessment of own care needs (finding)	4180186
44803046	Renal dysplasia due to fetal ACE (angiotensin converting enzyme) inhibitor exposure	4180186
44803046	Renal dysplasia due to fetal angiotensin converting enzyme inhibitor exposure (disorder)	4180186
44803050	Acquired obstruction of urinary tract (disorder)	4180186
44803050	Acquired obstructive uropathy	4180186
44803053	Nephropathy induced by tacrolimus (disorder)	4180186
44803055	Nephropathy induced by lead (disorder)	4180186
44803056	American Sign Language (qualifier value)	4180186
44803057	Australian Sign Language (qualifier value)	4180186
44803060	Makaton language (qualifier value)	4180186
44803062	Assessment using clinical documentation (procedure)	4180186
44803066	CH7 claim status (finding)	4180186
44803069	Powered aircraft collision with aircraft while manoeuvering on ground (event)	4180186
44803070	Renewal of prosthesis in organ NOC (procedure)	4180186
44803073	Correction of displacement of prosthesis NOC (procedure)	4180186
44803075	Microvascular reattachment of organ NOC (procedure)	4180186
44803080	Secondary operation NOC (procedure)	4180186
44803082	Sheath used from other agency (finding)	4180186
44803083	Accounting status (finding)	4180186
44803085	Minor surgery claim status (finding)	4180186
44803087	Collision of spacecraft with other spacecraft (event)	4180186
44803089	Introduction of removable radioactive material into organ NOC (procedure)	4180186
44803091	PULHHEEMS - P1R (finding)	4180186
44803092	GP74 - cervical cytology claim (record artifact)	4180186
44803095	FP81 night visit claim status (finding)	4180186
44803097	GP19 - temporary resident claim (more than 15 days) (procedure)	4180186
44803098	Family history: Mental disorder NOS	4180186
44803098	Family history: Mental disorder NOS (situation)	4180186
44803101	PULHHEEMS - P3R (finding)	4180186
44803102	GP82 - arrest of dental haemorrhage (record artifact)	4180186
44803104	Temporary resident claim status (less than 15 days) (finding)	4180186
44803106	Home Office road traffic statistics - police venesection alcohol payment claim status (finding)	4180186
44803107	PULHHEEMS - P4R (finding)	4180186
44803109	FP19 temporary resident more than 15 days claim status (finding)	4180186
44803110	Mental Health Act payment claim status (finding)	4180186
44803116	PULHHEEMS - P6R (finding)	4180186
44803117	Mental Health Act form 3, section 18 payment claim status (finding)	4180186
44803118	Discussion about caesarean section wound	4180186
44803118	Discussion about caesarean section wound for maternal wellbeing (procedure)	4180186
44803119	Health promotion clinic claim status (finding)	4180186
44803120	Magnetic resonance imaging defaecating proctogram (procedure)	4180186
44803121	PULHHEEMS - P7R (finding)	4180186
44803125	Faeroese language interpreter needed	4180186
44803125	Faroese language interpreter needed (finding)	4180186
44803127	Contraception from other agency (finding)	4180186
44803130	PULHHEEMS - U3 (finding)	4180186
44803131	On examination - left red reflex present (finding)	4180186
44803133	General anaesthetic second general practitioner claim (procedure)	4180186
44803134	Equipment loan status (finding)	4180186
44803136	Congenital stenosis of anus without mention of fistula	4180186
44803136	Congenital stricture of anus without mention of fistula (disorder)	4180186
44803140	SD86 form general practitioner superannuated pay summary (record artifact)	4180186
44803140	SD86 - GP (general practitioner) superannuated pay summary	4180186
44803140	SD86 - GP superannuated pay summary (record artifact)	4180186
44803141	Arrest of dental haemorrhage claim status (finding)	4180186
44803143	HC1 health centre staff claim form (record artifact)	4180186
44803145	Aspiration of other lesion of organ NOC (procedure)	4180186
44803146	Signing of general practitioner maternity claim by doctor (procedure)	4180186
44803146	Signing of GP (general practitioner) maternity claim by doctor	4180186
44803150	Deroofing of cyst of organ NOC (procedure)	4180186
44803152	GP/PS3 form status (finding)	4180186
44803153	Attention to prosthesis NOC (procedure)	4180186
44803154	Replantation of organ NOC (procedure)	4180186
44803155	Cytology of organ NOC (procedure)	4180186
44803156	Brush cytology of organ NOC (procedure)	4180186
44803157	Continuous injection of therapeutic substance into organ NOC (procedure)	4180186
44803160	Excision of organ NOC (procedure)	4180186
44803165	Re-exploration of organ and packing of organ NOC (procedure)	4180186
44803166	PULHHEEMS - Eur2 (finding)	4180186
44803167	Immunisation claim (procedure)	4180186
44803167	Vaccination claim	4180186
44803168	PULHHEEMS - L2R (finding)	4180186
44803169	Placement of prosthesis in organ NOC (procedure)	4180186
44803172	Conversion to prosthesis in organ NOC (procedure)	4180186
44803174	Stereotactic biopsy of lesion of organ NOC (procedure)	4180186
44803175	Introduction of non-removable material into organ NOC (procedure)	4180186
44803176	Introduction of gold seeds into organ NOC (procedure)	4180186
44803178	PULHHEEMS - L3R (finding)	4180186
44803182	CH7 completed and signed (finding)	4180186
44803183	PULHHEEMS - L5R (finding)	4180186
44803185	Did not attend general practitioner anticoagulant clinic (finding)	4180186
44803188	Methods of operation NOC (procedure)	4180186
44803189	Replacement of organ NOC (procedure)	4180186
44803192	Other destruction of organ NOC (procedure)	4180186
44803193	Suture of laceration of organ NOC (procedure)	4180186
44803196	PULHHEEMS - Eul1 (finding)	4180186
44803197	Microvascular reconstruction of organ NOC (procedure)	4180186
44803198	PULHHEEMS - S5 (finding)	4180186
44803199	PULHHEEMS - Eul3 (finding)	4180186
44803200	Evacuation of contents of organ NOC (procedure)	4180186
44803204	Surgical intervention indicated (situation)	4180186
44803205	PULHHEEMS - L7R (finding)	4180186
44803207	PULHHEEMS - Eul5 (finding)	4180186
44803209	PULHHEEMS - S1 (finding)	4180186
44803210	Other non-operations (procedure)	4180186
44803211	PULHHEEMS - Eul7 (finding)	4180186
44803216	PULHHEEMS - S8 (finding)	4180186
44803217	PULHHEEMS - M2 (finding)	4180186
44803218	Laser destruction of organ NOC (procedure)	4180186
44803219	Other operations on unspecified organ (procedure)	4180186
44803222	PULHHEEMS - M4 (finding)	4180186
44803225	Obliteration of cavity of organ NOC (procedure)	4180186
44803226	Introduction of radioactive caesium into organ NOC (procedure)	4180186
44803227	Obliteration of diverticulum of organ NOC (procedure)	4180186
44803232	Early operations NOC (procedure)	4180186
44803233	PULHHEEMS - HR6 (finding)	4180186
44803234	Exploration of sinus track from organ NOC (procedure)	4180186
44803235	Dilation of stricture of organ NOC (procedure)	4180186
44803236	PULHHEEMS - U4 (finding)	4180186
44803238	Removal of other repair material from organ NOC (procedure)	4180186
44803239	Autograft to organ NOC (procedure)	4180186
44803240	PULHHEEMS - U5 (finding)	4180186
44803241	Javanese language interpreter needed (finding)	4180186
44803243	PULHHEEMS - HL3 (finding)	4180186
44803244	PULHHEEMS - U6 (finding)	4180186
44803245	PULHHEEMS - HL5 (finding)	4180186
44803246	Plastic repair of organ NOC (procedure)	4180186
44803247	Resuture of organ NOC (procedure)	4180186
44803252	Maternity booking 17-30 weeks (procedure)	4180186
44803253	Azerbaijani language interpreter needed (finding)	4180186
44803254	Care during confinement (procedure)	4180186
44803255	Other immunisation (Rate B) (procedure)	4180186
44803256	Complete postnatal care (procedure)	4180186
44803258	International cholera certificate fee paid (finding)	4180186
44803259	Partial postnatal care - two visits (procedure)	4180186
44803262	Excision of sinus tract from organ NOC (procedure)	4180186
44803263	Partial postnatal care - three visits (procedure)	4180186
44803265	Partial postnatal care - four visits (procedure)	4180186
44803267	Other destruction of organ NOC OS (procedure)	4180186
44803268	Manipulative removal of foreign body from organ NOC (procedure)	4180186
44803269	Bypass of organ NOC (procedure)	4180186
44803270	Incision of lesion of organ NOC (procedure)	4180186
44803271	Extirpation of unspecified organ (procedure)	4180186
44803275	Maternity anaesthetic service claim (procedure)	4180186
44803277	Introduction of therapeutic implant into organ NOC (procedure)	4180186
44803278	Date of next disease modifying antirheumatic drug monitoring clinic appointment (observable entity)	4180186
44803279	Upper urinary tract lavage sample (specimen)	4180186
44803282	Mat B1 - certificate of expected confinement (record artifact)	4180186
44803283	Autoreplacement of organ NOC (procedure)	4180186
44803285	Implantation of prosthesis into organ NOC (procedure)	4180186
44803286	Insertion of prosthesis into organ NOC (procedure)	4180186
44803287	Xenograft to organ NOC (procedure)	4180186
44803289	Maternity services claimed (finding)	4180186
44803292	Absent right sided atrioventricular connection - univentricular (disorder)	4180186
44803294	Absent right sided atrioventricular connection with straddling valve (disorder)	4180186
44803295	Absent left sided atrioventricular connection with straddling valve (disorder)	4180186
44803296	Lunchtime eating routine	4180186
44803296	Midday eating routine (observable entity)	4180186
44803297	Concordant ventriculoarterial connection (finding)	4180186
44803298	Mid-morning eating routine (observable entity)	4180186
44803300	Mid-afternoon eating routine (observable entity)	4180186
44803301	Dinner eating routine	4180186
44803301	Early evening eating routine (observable entity)	4180186
44803301	Evening meal eating routine	4180186
44803303	Late evening eating routine (observable entity)	4180186
44803303	Supper eating routine	4180186
44803305	Starting of telehealth monitoring (regime/therapy)	4180186
44803306	Ending of telehealth monitoring (regime/therapy)	4180186
44803307	Imperforate mitral valve	4180186
44803307	Mitral valve atresia (disorder)	4180186
44803307	MVA - mitral valve atretic	4180186
44803309	Malaligned atrial septum with flap valve to muscular rim of oval fossa (disorder)	4180186
44803311	Left superior vena cava persisting to coronary sinus and right atrium (disorder)	4180186
44803311	Left SVC (superior vena cava) persisting to coronary sinus and right atrium	4180186
44803312	Assessment using Westcotes individualised outcome measure (procedure)	4180186
44803313	Congenital tricuspid papillary muscle abnormality (disorder)	4180186
44803314	Bridging anticoagulant therapy with low molecular weight heparin (procedure)	4180186
44803316	Measurement of right anterior tibial doppler pressure (procedure)	4180186
44803325	Monitoring administration (record artifact)	4180186
44803326	Stress monitoring administration (record artifact)	4180186
44803327	Stress clinic administration (record artifact)	4180186
44803328	Hormone replacement clinic administration (record artifact)	4180186
44803330	Hypertension monitoring administration (record artifact)	4180186
44803333	Chronic obstructive pulmonary disease monitoring administration (record artifact)	4180186
44803334	Economic policy (qualifier value)	4180186
44803336	Educational system (qualifier value)	4180186
44803342	Health planning (qualifier value)	4180186
44803345	Human resource management (qualifier value)	4180186
44803348	Land use and fertility (qualifier value)	4180186
44803351	Mass media (qualifier value)	4180186
44803354	Mental and behavioural disorder (qualifier value)	4180186
44803355	Mental health (qualifier value)	4180186
44803357	Non profit organisation (qualifier value)	4180186
44803362	People with dementia (qualifier value)	4180186
44803364	People with visual disability (qualifier value)	4180186
44803365	Pharmaceutical industry (qualifier value)	4180186
44803366	Police (qualifier value)	4180186
44803367	Left superior vena cava persisting to right atrium (disorder)	4180186
44803367	Left SVC (superior vena cava) connecting to right atrium	4180186
44803368	Right inferior vena cava connecting to right sided atrium (disorder)	4180186
44803369	BD8 certificate of registration of death (record artifact)	4180186
44803370	Certificate of vision impairment (record artifact)	4180186
44803370	CVI - certificate of vision impairment	4180186
44803371	Does not wish to receive blood products (finding)	4180186
44803373	Separate hepatic vein and inferior vena cava connection to heart (disorder)	4180186
44803375	Certified sight impaired (finding)	4180186
44803378	Congenital pulmonary venous confluence in horizontal orientation (disorder)	4180186
44803381	Cancer monitoring administration (record artifact)	4180186
44803384	Left ventricular dysfunction monitoring administration (record artifact)	4180186
44803386	Atrial fibrillation monitoring administration (record artifact)	4180186
44803391	At high risk of cardiovascular disease monitoring administration (record artifact)	4180186
44803393	Obesity monitoring administration (record artifact)	4180186
44803394	Obesity clinic administration (record artifact)	4180186
44803395	Geriatric monitoring administration (record artifact)	4180186
44803396	Anti-smoking monitoring administration (record artifact)	4180186
44803396	Stop smoking monitoring administration	4180186
44803398	Well adult monitoring administration (record artifact)	4180186
44803400	Well man clinic administration (record artifact)	4180186
44803401	Well woman monitoring administration (record artifact)	4180186
44803405	Trainee contract administration (record artifact)	4180186
44803408	Seniority administration (record artifact)	4180186
44803410	Patient contact administration (record artifact)	4180186
44803412	Night visit administration (record artifact)	4180186
44803414	Pollutant (qualifier value)	4180186
44803415	Population structure (qualifier value)	4180186
44803416	Probation work (qualifier value)	4180186
44803418	Public and private partnership (qualifier value)	4180186
44803420	Qualitative research (qualifier value)	4180186
44803424	Resource management (qualifier value)	4180186
44803425	Road safety (qualifier value)	4180186
44803426	School health service (qualifier value)	4180186
44803427	Secondary and tertiary service (qualifier value)	4180186
44803428	Self employment (qualifier value)	4180186
44803430	Social capital (qualifier value)	4180186
44803435	Waste management (qualifier value)	4180186
44803439	Agricultural industry (qualifier value)	4180186
44803440	Health outcome (qualifier value)	4180186
44803441	Inpatient services (qualifier value)	4180186
44803442	Sickness absence (qualifier value)	4180186
44803444	Review (qualifier value)	4180186
44803446	General and acute services including accident and emergency (qualifier value)	4180186
44803451	Cor triatriatum with pulmonary veins to proximal chamber draining to left atrium with pulmonary venous chamber extracardiac communication	4180186
44803451	Divided left atrium with all pulmonary veins to proximal chamber draining to left atrium with pulmonary venous chamber extracardiac communication (disorder)	4180186
44803453	Fenestrated atrial septal defect within oval fossa (disorder)	4180186
44803454	Non-restrictive interatrial communication septal defect (disorder)	4180186
44803462	Malingerer administration (record artifact)	4180186
44803463	Advance directive administration (record artifact)	4180186
44803464	Maternity service administration (record artifact)	4180186
44803465	Certificates administration (record artifact)	4180186
44803466	SC1 self-certificate administration (record artifact)	4180186
44803467	SC2 self-certificate administration (record artifact)	4180186
44803469	Practice supplies administration (record artifact)	4180186
44803471	Drug stock control administration (record artifact)	4180186
44803471	Stock control - drugs	4180186
44803473	Accounting administration (record artifact)	4180186
44803475	Chronic disease administration (record artifact)	4180186
44803476	Research administration (record artifact)	4180186
44803477	Clinical trial administration (record artifact)	4180186
44803479	Bill/fee administration (record artifact)	4180186
44803480	Item of service administration (record artifact)	4180186
44803481	Paediatric surveillance administration (record artifact)	4180186
44803482	FP/RF new registration check administration (record artifact)	4180186
44803483	FP/CHS paediatric surveillance form administration (record artifact)	4180186
44803484	Prevention/screening administration (record artifact)	4180186
44803485	Child development check administration (record artifact)	4180186
44803489	Flu vaccination administration	4180186
44803489	Influenza vaccination administration (record artifact)	4180186
44803492	Cap follow-up administration	4180186
44803492	Diaphragm check follow-up administration (record artifact)	4180186
44803493	Diaphragm follow-up administration (record artifact)	4180186
44803494	Oral contraceptive check administration (record artifact)	4180186
44803496	GP/RF new patient check administration (record artifact)	4180186
44803497	Access to service (qualifier value)	4180186
44803499	Catering (qualifier value)	4180186
44803503	Community information and advice service (qualifier value)	4180186
44803504	Community social work (qualifier value)	4180186
44803505	Contact allergy (qualifier value)	4180186
44803507	Dancing (qualifier value)	4180186
44803512	European Union (qualifier value)	4180186
44803513	Evidence based medicine (qualifier value)	4180186
44803514	Expenditure (qualifier value)	4180186
44803515	Finance (qualifier value)	4180186
44803518	Growth (qualifier value)	4180186
44803520	Health belief model (qualifier value)	4180186
44803522	Health ethic (qualifier value)	4180186
44803528	Job description (qualifier value)	4180186
44803532	Azygos continuation of inferior vena cava to left superior vena cava (disorder)	4180186
44803533	Referral to virtual ward (procedure)	4180186
44803538	Assessment using school function assessment (procedure)	4180186
44803542	Patient unsuitable for foot pulse check (finding)	4180186
44803543	Screening administration (record artifact)	4180186
44803546	Breast screening administration (record artifact)	4180186
44803547	New patient screening administration (record artifact)	4180186
44803548	Hypertension screening administration (record artifact)	4180186
44803549	Geriatric screening administration (record artifact)	4180186
44803550	Epilepsy screening administration (record artifact)	4180186
44803551	Bowel cancer screening programme administration (record artifact)	4180186
44803552	Diabetes screening administration (record artifact)	4180186
44803554	Falls risk assessment administration (record artifact)	4180186
44803560	Medical examinations administration (record artifact)	4180186
44803561	Forces recruitment medical administration (record artifact)	4180186
44803562	Examination administration (record artifact)	4180186
44803564	Mobility allowance examination administration (record artifact)	4180186
44803570	Taxi driver examination administration (record artifact)	4180186
44803571	Heavy goods vehicle driver administration (record artifact)	4180186
44803575	Payment administration (record artifact)	4180186
44803576	British United Provident Association claim administration (record artifact)	4180186
44803576	BUPA (British United Provident Association) claim administration	4180186
44803577	Leave payment administration (record artifact)	4180186
44803579	Disability living allowance representative claim administration (record artifact)	4180186
44803580	Record transfer administration (record artifact)	4180186
44803583	Men's health (qualifier value)	4180186
44803584	Meta analysis (qualifier value)	4180186
44803587	Performance and assessment framework (qualifier value)	4180186
44803589	Pre-school setting (qualifier value)	4180186
44803593	Professional competence (qualifier value)	4180186
44803594	Psychological determinant (qualifier value)	4180186
44803595	Randomised controlled trial (qualifier value)	4180186
44803597	Sea transport (qualifier value)	4180186
44803599	Sexual practice (qualifier value)	4180186
44803603	Taxation (qualifier value)	4180186
44803605	Electoral ward (qualifier value)	4180186
44803606	Weaning (qualifier value)	4180186
44803607	Weight training (qualifier value)	4180186
44803608	Women's health (qualifier value)	4180186
44803610	Alcohol policy (qualifier value)	4180186
44803611	Business (qualifier value)	4180186
44803616	Asylum seeker with discretionary leave to remain (person)	4180186
44803617	Childhood nephrotic syndrome (disorder)	4180186
44803618	Patient rated wrist evaluation score (observable entity)	4180186
44803618	PRWE (patient rated wrist evaluation) score	4180186
44803621	Post hospital discharge medication reconciliation with patient (procedure)	4180186
44803628	Assessment Notification Reject Response Under Section 2 of the Community Care (Delayed Discharges etc) Act 2003 (record artifact)	4180186
44803629	Discharge Notification Under Section 5 of the Community Care (Delayed Discharges etc) Act 2003 (record artifact)	4180186
44803630	Discharge Notification Agreement Under Section 5 of the Community Care (Delayed Discharges etc) Act 2003 (record artifact)	4180186
44803631	Discharge Notification Disagreement Under Section 5 of the Community Care (Delayed Discharges etc) Act 2003 (record artifact)	4180186
44803636	Assessment using SEDS (Stirling eating disorders scale)	4180186
44803636	Assessment using Stirling eating disorders scale (procedure)	4180186
44803637	Entire record available to originator (record artifact)	4180186
44803639	Miscellaneous certificate signed (finding)	4180186
44803640	Epilepsy screening second invitation (procedure)	4180186
44803643	Dementia monitoring first letter (procedure)	4180186
44803649	Diagnostic imaging request summary (record artifact)	4180186
44803650	Abstract problem node (record artifact)	4180186
44803652	Excepted from atrial fibrillation quality indicators - patient unsuitable (finding)	4180186
44803653	Exception reporting - heart failure quality indicators (finding)	4180186
44803654	Excepted from myocardial infarction quality indicators - informed dissent (finding)	4180186
44803655	Excepted from myocardial infarction quality indicators - patient unsuitable (finding)	4180186
44803657	Pharmaceutical service (qualifier value)	4180186
44803659	Screening (qualifier value)	4180186
44803661	Ambulatory service (qualifier value)	4180186
44803663	Capacity building (qualifier value)	4180186
44803664	Club (qualifier value)	4180186
44803666	Cycling (qualifier value)	4180186
44803667	Database (qualifier value)	4180186
44803668	Demography (qualifier value)	4180186
44803674	Expectant parent (qualifier value)	4180186
44803675	Food access (qualifier value)	4180186
44803677	Food poverty (qualifier value)	4180186
44803679	General practitioner practice area (qualifier value)	4180186
44803683	Health promotion professional (qualifier value)	4180186
44803685	Information (qualifier value)	4180186
44803686	Lipid disorder monitoring first letter (procedure)	4180186
44803688	Excepted from stroke quality indicators - informed dissent (finding)	4180186
44803691	Diagnostic imaging procedure report (record artifact)	4180186
44803693	Social circumstances (record artifact)	4180186
44803695	Reason for referral (record artifact)	4180186
44803701	Acute medication (record artifact)	4180186
44803705	Excepted from cardiovascular disease quality indicators - informed dissent (finding)	4180186
44803706	Dementia monitoring verbal invitation (procedure)	4180186
44803708	Chronic obstructive pulmonary disease monitoring first letter (procedure)	4180186
44803709	Did not attend community disease modifying antirheumatic drug monitoring (finding)	4180186
44803709	Did not attend community DMARD (disease modifying antirheumatic drug) monitoring	4180186
44803711	Chronic obstructive pulmonary disease monitoring verbal invitation (procedure)	4180186
44803713	Excepted from mental health quality indicators - patient unsuitable (finding)	4180186
44803714	Excepted from chronic obstructive pulmonary disease quality indicators - patient unsuitable (finding)	4180186
44803718	Time modifiers (record artifact)	4180186
44803720	Letter with patient (record artifact)	4180186
44803722	Left ventricular dysfunction monitoring telephone invitation (procedure)	4180186
44803724	Phone contact only	4180186
44803724	Telephone contact only (record artifact)	4180186
44803726	Information technology (qualifier value)	4180186
44803728	Laboratory service (qualifier value)	4180186
44803729	Local authority area (qualifier value)	4180186
44803730	Local government (qualifier value)	4180186
44803731	Marketing (qualifier value)	4180186
44803732	National organisation (qualifier value)	4180186
44803735	Needle use (qualifier value)	4180186
44803737	Organisational psychology (qualifier value)	4180186
44803739	Passive smoking (qualifier value)	4180186
44803741	Primary care service (qualifier value)	4180186
44803742	Private finance initiative (qualifier value)	4180186
44803746	Public health methods, theory and research (qualifier value)	4180186
44803747	Quality standard (qualifier value)	4180186
44803748	Race relations (qualifier value)	4180186
44803750	Rural development (qualifier value)	4180186
44803752	Sexual health promotion (qualifier value)	4180186
44803759	Trade union (qualifier value)	4180186
44803760	Excepted from learning disability quality indicators - patient unsuitable (finding)	4180186
44803762	Amended pathology report (record artifact)	4180186
44803765	Exception reporting - mental health quality indicators (finding)	4180186
44803770	Exception reporting - left ventricular disease quality indicators (finding)	4180186
44803778	Entries to the record made between specified dates (record artifact)	4180186
44803780	Risk to patient (record artifact)	4180186
44803781	Dementia monitoring third letter (procedure)	4180186
44803784	Excepted from sexual health quality indicators - informed dissent (finding)	4180186
44803787	Lipid disorder monitoring 3rd letter	4180186
44803787	Lipid disorder monitoring third letter (procedure)	4180186
44803788	Lipid disorder monitoring telephone invitation (procedure)	4180186
44803792	Excepted from epilepsy quality indicators - informed dissent (finding)	4180186
44803796	Excepted from hypertension quality indicators - patient unsuitable (finding)	4180186
44803797	Excepted from depression quality indicators - patient unsuitable (finding)	4180186
44803798	Excepted from palliative care quality indicators - informed dissent (finding)	4180186
44803800	Exception reporting - atrial fibrillation quality indicators (finding)	4180186
44803801	Excepted from chronic kidney disease quality indicators - informed dissent (finding)	4180186
44803802	Voluntary sector (qualifier value)	4180186
44803805	Employment policy (qualifier value)	4180186
44803806	Growth disorder (qualifier value)	4180186
44803807	National Institute for Clinical Excellence (qualifier value)	4180186
44803807	NICE	4180186
44803810	Custodial care (qualifier value)	4180186
44803811	Patients' Association (qualifier value)	4180186
44803812	Retirement (qualifier value)	4180186
44803816	Line (qualifier value)	4180186
44803819	Anatomy (qualifier value)	4180186
44803820	Area based initiative (qualifier value)	4180186
44803822	Health care (qualifier value)	4180186
44803828	Constituency (qualifier value)	4180186
44803829	Costing (qualifier value)	4180186
44803830	Culture (qualifier value)	4180186
44803832	Death, disease and disability (qualifier value)	4180186
44803834	Excepted from chronic kidney disease quality indicators - patient unsuitable (finding)	4180186
44803837	Fulfiller request (record artifact)	4180186
44803837	Service order request	4180186
44803840	Depression monitoring third letter (procedure)	4180186
44803846	Chronic obstructive pulmonary disease monitoring second letter (procedure)	4180186
44803848	Excepted from mental health quality indicators - informed dissent (finding)	4180186
44803850	Address instruction (record artifact)	4180186
44803851	Exception reporting - general practitioner contract quality indicators (finding)	4180186
44803854	Excepted from coronary heart disease quality indicators - patient unsuitable (finding)	4180186
44803859	Exception reporting - coronary heart disease quality indicators (finding)	4180186
44803860	Excepted from left ventricular disease quality indicators - patient unsuitable (finding)	4180186
44803864	Chronic kidney disease monitoring verbal invitation (procedure)	4180186
44803864	Chronic kidney disease monitoring verbal invite	4180186
44803866	Depression monitoring verbal invitation (procedure)	4180186
44803867	Exception reporting - learning disability quality indicators (finding)	4180186
44803869	Electronic health record content specifications (record artifact)	4180186
44803870	Exception reporting - hypertension quality indicators (finding)	4180186
44803871	Diagnostic imaging report (record artifact)	4180186
44803872	Alerts (record artifact)	4180186
44803873	Present - time (record artifact)	4180186
44803874	Exception reporting - chronic kidney disease quality indicators (finding)	4180186
44803875	Plan (record artifact)	4180186
44803877	Economics, finance and industry (qualifier value)	4180186
44803878	Emergency planning (qualifier value)	4180186
44803879	Evaluation (qualifier value)	4180186
44803880	Evidence based health care (qualifier value)	4180186
44803881	Farmers market (qualifier value)	4180186
44803884	Grid reference (qualifier value)	4180186
44803886	Health, public health and health promotion (qualifier value)	4180186
44803887	Helpline (qualifier value)	4180186
44803888	Intermediate service (qualifier value)	4180186
44803889	International policy (qualifier value)	4180186
44803890	Key stage (qualifier value)	4180186
44803891	Knowledge management (qualifier value)	4180186
44803893	National service framework (qualifier value)	4180186
44803894	National Health Service (qualifier value)	4180186
44803895	National statistics socioeconomic classification (qualifier value)	4180186
44803896	Nomenclature of units for territorial statistics (qualifier value)	4180186
44803899	Post code sector (qualifier value)	4180186
44803900	Prevalence (qualifier value)	4180186
44803903	Public transport (qualifier value)	4180186
44803904	Purchaser (qualifier value)	4180186
44803906	Rail transport (qualifier value)	4180186
44803908	GPC claim - arrest dental haemorrhage paid (finding)	4180186
44803909	Excepted from atrial fibrillation quality indicators - informed dissent (finding)	4180186
44803910	Confidential patient data (record artifact)	4180186
44803911	Excepted from diabetes quality indicators - patient unsuitable (finding)	4180186
44803913	Diagnosis (record artifact)	4180186
44803914	Chronic kidney disease monitoring third letter (procedure)	4180186
44803915	Dementia monitoring second letter (procedure)	4180186
44803917	Excepted from heart failure quality indicators - informed dissent (finding)	4180186
44803920	Chronic obstructive pulmonary disease monitoring third letter (procedure)	4180186
44803923	Reason for no laboratory result (observable entity)	4180186
44803925	Exception reporting - chronic obstructive pulmonary disease quality indicators (finding)	4180186
44803926	Excepted from cancer quality indicators - informed dissent (finding)	4180186
44803928	Reason for encounter (record artifact)	4180186
44803931	Outcome (record artifact)	4180186
44803936	Aim/goal (record artifact)	4180186
44803939	Does not wish to register at alternative local practice (finding)	4180186
44803940	Abnormal morphology of thoracoabdominal organ (finding)	4180186
44803941	Sex tourism (qualifier value)	4180186
44803942	Sexual health (qualifier value)	4180186
44803943	Social policy (qualifier value)	4180186
44803944	Socioenvironmental factor (qualifier value)	4180186
44803945	Sociology (qualifier value)	4180186
44803946	Sports medicine (qualifier value)	4180186
44803947	Standard region (qualifier value)	4180186
44803948	Summary health (qualifier value)	4180186
44803949	Sustainable development (qualifier value)	4180186
44803951	Transport plan (qualifier value)	4180186
44803952	Voluntary agencies local policy (qualifier value)	4180186
44803954	Waste disposal (qualifier value)	4180186
44803955	Youth unemployment (qualifier value)	4180186
44803960	Air quality (qualifier value)	4180186
44803962	Health education (qualifier value)	4180186
44803963	Organic nutrition (qualifier value)	4180186
44803964	Vulnerable group (qualifier value)	4180186
44803966	Communication (qualifier value)	4180186
44803968	Ethnicity (qualifier value)	4180186
44803971	Anthropology (qualifier value)	4180186
44803975	Bilateral bilobed lung (disorder)	4180186
44803978	Dysphagia screening not indicated (situation)	4180186
44803979	Issue of chronic obstructive pulmonary disease rescue pack (procedure)	4180186
44803979	Issue of COPD (chronic obstructive pulmonary disease) rescue pack	4180186
44803981	Staff reimbursement administration (record artifact)	4180186
44803982	Intrauterine contraceptive device follow-up administration (record artifact)	4180186
44803982	IUCD (intrauterine contraceptive device) follow-up administration	4180186
44803983	Activity data (qualifier value)	4180186
44803984	Relative wealth (qualifier value)	4180186
44803986	Behavioural science (qualifier value)	4180186
44803989	Census district (qualifier value)	4180186
44803990	Clinical governance (qualifier value)	4180186
44803993	Consumer (qualifier value)	4180186
44803995	Charity (qualifier value)	4180186
44803996	Chemical (qualifier value)	4180186
44803999	Community project (qualifier value)	4180186
44804002	Disability measure (qualifier value)	4180186
44804006	Emergency plan (qualifier value)	4180186
44804007	Employment trends (qualifier value)	4180186
44804009	Funding (qualifier value)	4180186
44804010	General medical (qualifier value)	4180186
44804011	Guideline (qualifier value)	4180186
44804013	Health equity audit (qualifier value)	4180186
44804015	Holistic approach (qualifier value)	4180186
44804016	Household (qualifier value)	4180186
44804020	Interview (qualifier value)	4180186
44804022	Local policy (qualifier value)	4180186
44804025	Mobile phone (qualifier value)	4180186
44804032	Department of Health or National Health Service regional policy (qualifier value)	4180186
44804033	Economic indicator (qualifier value)	4180186
44804035	Exhibition (qualifier value)	4180186
44804038	Food safety (qualifier value)	4180186
44804040	Governance (qualifier value)	4180186
44804046	Health promotion unit (qualifier value)	4180186
44804050	Information system (qualifier value)	4180186
44804053	Local community (qualifier value)	4180186
44804057	Needle exchange (qualifier value)	4180186
44804059	Office of National Statistics area classification (qualifier value)	4180186
44804062	Post code district (qualifier value)	4180186
44804066	Religious group (qualifier value)	4180186
44804070	Self help group (qualifier value)	4180186
44804071	Service planning (qualifier value)	4180186
44804079	Teaching method (qualifier value)	4180186
44804080	Telecommunication (qualifier value)	4180186
44804081	Transport (qualifier value)	4180186
44804083	Workshop (qualifier value)	4180186
44804084	Paedophile (qualifier value)	4180186
44804086	Informatics (qualifier value)	4180186
44804091	Seen in L.A. clinic-school (finding)	4180186
44804092	Seen in L.A. clinic-child (finding)	4180186
44804093	Provision of work lamp (procedure)	4180186
44804095	Occupational health and safety (qualifier value)	4180186
44804097	Partnership working (qualifier value)	4180186
44804099	Patient charter (qualifier value)	4180186
44804100	People with disability (qualifier value)	4180186
44804101	People with mental health problem (qualifier value)	4180186
44804103	Primary care organisation (qualifier value)	4180186
44804105	Professional education and development (qualifier value)	4180186
44804106	Provider (qualifier value)	4180186
44804107	Public health organisation (qualifier value)	4180186
44804108	Public health worker (qualifier value)	4180186
44804109	Public information (qualifier value)	4180186
44804111	Quality improvement (qualifier value)	4180186
44804115	School heath promotion (qualifier value)	4180186
44804117	Sickness and absence policy (qualifier value)	4180186
44804118	Social mobility (qualifier value)	4180186
44804119	Social planning (qualifier value)	4180186
44804121	Sports injury (qualifier value)	4180186
44804125	Travel plan (qualifier value)	4180186
44804126	Pre-retirement (qualifier value)	4180186
44804127	Spinal cord disease and disorder (qualifier value)	4180186
44804128	Vehicle related air pollution (qualifier value)	4180186
44804129	Equipment (qualifier value)	4180186
44804131	National Public Health Classification data (qualifier value)	4180186
44804132	Air transport (qualifier value)	4180186
44804133	Belief (qualifier value)	4180186
44804134	Buildings, constructions and points (qualifier value)	4180186
44804135	Child health service (qualifier value)	4180186
44804138	Climate change (qualifier value)	4180186
44804139	Communicable bacterial disease	4180186
44804139	Communicable bacterial disease (qualifier value)	4180186
44804140	Comparative study (qualifier value)	4180186
44804142	Crime prevention (qualifier value)	4180186
44804143	Cross sectional survey (qualifier value)	4180186
44804144	Deaf and blind (qualifier value)	4180186
44804147	Drama therapy (qualifier value)	4180186
44804148	Environmental determinant (qualifier value)	4180186
44804149	Epidemiology (qualifier value)	4180186
44804150	Equal opportunity (qualifier value)	4180186
44804152	Fire safety (qualifier value)	4180186
44804153	Fire service (qualifier value)	4180186
44804156	Food production and quality (qualifier value)	4180186
44804157	Food standard (qualifier value)	4180186
44804160	Cancer chemotherapy management plan (qualifier value)	4180186
44804163	Did not attend influenza A virus subtype H1N1 vaccination (finding)	4180186
44804163	Did not attend swine flu vaccination	4180186
44804164	Participant in Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy trial (finding)	4180186
44804164	Participant in REEACT (Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy) trial	4180186
44804168	Providing hand washing facility (procedure)	4180186
44804172	Referral to Princess Royal Trust carers centre declined (situation)	4180186
44804176	Infant feeding review (regime/therapy)	4180186
44804177	Preferred place of death: care home (finding)	4180186
44804178	Prostate specific antigen monitoring invitation (procedure)	4180186
44804178	PSA (prostate specific antigen) monitoring invitation	4180186
44804180	Prostate specific antigen monitoring second letter (procedure)	4180186
44804180	PSA (prostate specific antigen) monitoring second letter	4180186
44804182	Assessment using NDI (neck disability index)	4180186
44804182	Assessment using neck disability index (procedure)	4180186
44804186	User choice (qualifier value)	4180186
44804188	Homophobic (qualifier value)	4180186
44804189	Career development (qualifier value)	4180186
44804190	Cyclist (qualifier value)	4180186
44804195	Agricultural pollution (qualifier value)	4180186
44804196	Healthcare and health services (qualifier value)	4180186
44804197	Personal development (qualifier value)	4180186
44804202	Pension (qualifier value)	4180186
44804203	Plastic surgery (qualifier value)	4180186
44804204	Family planning (qualifier value)	4180186
44804209	Assertiveness (qualifier value)	4180186
44804210	Birth rate (qualifier value)	4180186
44804211	Budget (qualifier value)	4180186
44804214	Communal establishment (qualifier value)	4180186
44804215	Health development (qualifier value)	4180186
44804216	Health insurance (qualifier value)	4180186
44804218	Household waste (qualifier value)	4180186
44804219	Housing (qualifier value)	4180186
44804220	Housing standard (qualifier value)	4180186
44804221	Health and safety commission region (qualifier value)	4180186
44804223	Incidence (qualifier value)	4180186
44804224	Income inequality (qualifier value)	4180186
44804225	Information media (qualifier value)	4180186
44804231	Lifelong learning (qualifier value)	4180186
44804232	Local education authority (qualifier value)	4180186
44804234	Neighbourhood (qualifier value)	4180186
44804235	Network (qualifier value)	4180186
44804236	Nuclear energy (qualifier value)	4180186
44804237	Nursing (qualifier value)	4180186
44804243	Physical education (qualifier value)	4180186
44804246	Pre-school children (qualifier value)	4180186
44804247	Basque language interpreter needed (finding)	4180186
44804249	Advice given about breast screening programme (situation)	4180186
44804252	Infant feeding antenatal checklist completed (finding)	4180186
44804253	Assessment using KELS (Kohlman evaluation of living skills)	4180186
44804253	Assessment using Kohlman evaluation of living skills (procedure)	4180186
44804256	Assessment using Melbourne assessment of unilateral upper limb function (procedure)	4180186
44804257	Assessment using FAB (frontal assessment battery)	4180186
44804257	Assessment using frontal assessment battery (procedure)	4180186
44804258	Assessment using BaFPE (Bay Area Functional Performance Evaluation)	4180186
44804258	Assessment using Bay area functional assessment (procedure)	4180186
44804259	ACE-R (Addenbrooke's cognitive examination - revised) score	4180186
44804259	Addenbrooke's cognitive examination revised - score (observable entity)	4180186
44804260	ACE-R (Addenbrooke's cognitive examination - revised) visuospatial subscore	4180186
44804260	Addenbrooke's cognitive examination revised - visuospatial subscore (observable entity)	4180186
44804261	ACE-R (Addenbrooke's cognitive examination - revised) language subscore	4180186
44804261	Addenbrooke's cognitive examination revised - language subscore (observable entity)	4180186
44804264	ACE-R (Addenbrooke's cognitive examination - revised) fluency subscore	4180186
44804264	Addenbrooke's cognitive examination revised - fluency subscore (observable entity)	4180186
44804265	ACE-R (Addenbrooke's cognitive examination - revised) attention and orientation subscore	4180186
44804265	Addenbrooke's cognitive examination revised - attention and orientation subscore (observable entity)	4180186
44804267	Osteoporosis medication prophylaxis (procedure)	4180186
44804269	No wound odour (situation)	4180186
44804275	Dermatological communicable diseases	4180186
44804275	Dermatological communicable diseases (qualifier value)	4180186
44804277	Crime reduction (qualifier value)	4180186
44804279	Data analysis (qualifier value)	4180186
44804280	Department of Health or National Health Service national policy (qualifier value)	4180186
44804283	Discussion technique (qualifier value)	4180186
44804286	Environmental health (qualifier value)	4180186
44804289	Focus group (qualifier value)	4180186
44804291	Food supply (qualifier value)	4180186
44804293	Fuel poverty (qualifier value)	4180186
44804294	Government initiative (qualifier value)	4180186
44804295	Government policy (qualifier value)	4180186
44804296	Harm reduction (qualifier value)	4180186
44804297	Health legislation (qualifier value)	4180186
44804300	Information dissemination and exchange (qualifier value)	4180186
44804301	Law (qualifier value)	4180186
44804303	Literature review (qualifier value)	4180186
44804304	Management (qualifier value)	4180186
44804305	Medical examination (qualifier value)	4180186
44804307	Music (qualifier value)	4180186
44804310	Science and technology (qualifier value)	4180186
44804313	Service utilisation (qualifier value)	4180186
44804317	Survey (qualifier value)	4180186
44804318	Technology (qualifier value)	4180186
44804319	Time factor (qualifier value)	4180186
44804321	Vertical transmission (qualifier value)	4180186
44804324	Built environment (qualifier value)	4180186
44804325	Communication and knowledge (qualifier value)	4180186
44804326	Employment terms (qualifier value)	4180186
44804329	Unplanned service (qualifier value)	4180186
44804333	People and populations (qualifier value)	4180186
44804334	Paediatrics (qualifier value)	4180186
44804335	Assessment using interest checklist UK (United Kingdom)	4180186
44804335	Assessment using interest checklist United Kingdom (procedure)	4180186
44804336	Atrial fibrillation monitoring invitation (procedure)	4180186
44804337	Chronic kidney disease monitoring invitation (procedure)	4180186
44804338	Chronic obstructive pulmonary disease monitoring invitation (procedure)	4180186
44804339	Dementia monitoring invitation (procedure)	4180186
44804346	Administration section (record artifact)	4180186
44804347	Cervical smear screening appointment reminder (procedure)	4180186
44804348	Cervical smear screening first letter (procedure)	4180186
44804350	Cervical smear screening telephone invitation (procedure)	4180186
44804353	Discontinued repeat medication (record artifact)	4180186
44804354	Repeat medication discontinued (situation)	4180186
44804356	AMH (anti-Mullerian hormone) measurement	4180186
44804356	Anti-Mullerian hormone level	4180186
44804356	Anti-Mullerian hormone measurement (procedure)	4180186
44804357	Anti-Mullerian hormone (substance)	4180186
44804358	Superficial leg ulcer	4180186
44804358	Superficial ulcer of lower limb (disorder)	4180186
44804359	High priority for influenza A subtype H1N1 vaccination (finding)	4180186
44804361	Neighbourhood renewal (qualifier value)	4180186
44804363	Offender (qualifier value)	4180186
44804364	Oral health (qualifier value)	4180186
44804368	Physical disability (qualifier value)	4180186
44804369	Policy formulation (qualifier value)	4180186
44804370	Policy maker (qualifier value)	4180186
44804372	Prisoner (qualifier value)	4180186
44804374	Project management (qualifier value)	4180186
44804376	Public place (qualifier value)	4180186
44804379	Regional variation (qualifier value)	4180186
44804380	Regulation (qualifier value)	4180186
44804381	Road safety education (qualifier value)	4180186
44804388	Traffic regulation (qualifier value)	4180186
44804390	Vitamin supplement (qualifier value)	4180186
44804396	GMS4 claim - contraception (non intrauterine contraceptive device) not claimed (finding)	4180186
44804396	GMS4 claim - contraception (non IUCD - intrauterine contraceptive device) not claimed	4180186
44804397	GMS4 claim - contraception (non intrauterine contraceptive device) paid (finding)	4180186
44804397	GMS4 claim - contraception (non IUCD - intrauterine contraceptive device) paid	4180186
44804398	GMS4 claim - contraception (non intrauterine contraceptive device) returned unpaid (finding)	4180186
44804398	GMS4 claim - contraception (non IUCD - intrauterine contraceptive device) returned unpaid	4180186
44804399	GMS4 claim - contraception (non intrauterine contraceptive device) sent to health authority (finding)	4180186
44804399	GMS4 claim - contraception (non IUCD - intrauterine contraceptive device) sent to health authority	4180186
44804400	GMS4 claim - contraception (non intrauterine contraceptive device) signed (finding)	4180186
44804400	GMS4 claim - contraception (non IUCD - intrauterine contraceptive device) signed	4180186
44804401	GMS4 claim - contraception (non intrauterine contraceptive device) up to date (finding)	4180186
44804401	GMS4 claim - contraception (non IUCD - intrauterine contraceptive device) up to date	4180186
44804402	GMS4 claim - contraception (intrauterine contraceptive device) due with new intrauterine contraceptive device (finding)	4180186
44804402	GMS4 claim - contraception (IUCD - intrauterine contraceptive device) due with new intrauterine contraceptive device	4180186
44804403	GMS4 claim - anaesthetic sent to health authority (finding)	4180186
44804405	GMS4 claim - immunisation (Rate B) sent to health authority (finding)	4180186
44804407	GMS4 claim - night consultation sent to health authority (finding)	4180186
44804408	GMS4 claim - registration examination sent to health authority (finding)	4180186
44804409	GMS4 claim - arrest of dental haemorrhage to Health Authority (finding)	4180186
44804410	GOS18 form received - no referral made (finding)	4180186
44804412	GP/PS1 form completed (finding)	4180186
44804415	Lives in flat with elevator access (finding)	4180186
44804415	Lives in flat with lift access	4180186
44804416	GP/PS2 form approved by health board (finding)	4180186
44804416	GP/PS2 form approved by Health Board (finding)	4180186
44804418	GP/PS2 form requested from Health Board (finding)	4180186
44804421	Lives in flat without elevator access (finding)	4180186
44804421	Lives in flat without lift access	4180186
44804422	GP/PS3 form approved by health board (finding)	4180186
44804422	GP/PS3 form approved by Health Board (finding)	4180186
44804423	GP/PS3 form requested from Health Board (finding)	4180186
44804424	GP/RF registration claim form (record artifact)	4180186
44804425	GP/RF new registration check form sent to health board (finding)	4180186
44804426	GP/CHS paediatric surveillance form administration (record artifact)	4180186
44804427	Face arm speech test (assessment scale)	4180186
44804427	FAST - face arm speech test	4180186
44804429	Discharged from community hospital (finding)	4180186
44804430	Concordance and compliance level 2 medication review (procedure)	4180186
44804431	Learning disability annual health check invitation first letter (procedure)	4180186
44804432	Learning disability annual health check invitation second letter (procedure)	4180186
44804437	Registered sight impaired (finding)	4180186
44804438	Young worker (qualifier value)	4180186
44804439	Commissioning (qualifier value)	4180186
44804441	Migrant worker (qualifier value)	4180186
44804442	Programme (qualifier value)	4180186
44804446	Salary (qualifier value)	4180186
44804447	Population based and preventive services (qualifier value)	4180186
44804450	Smoking cessation (qualifier value)	4180186
44804451	Workplace (qualifier value)	4180186
44804452	Age group (qualifier value)	4180186
44804453	Arts (qualifier value)	4180186
44804454	Assisted conception (qualifier value)	4180186
44804455	Biotechnology (qualifier value)	4180186
44804456	Caldicott (qualifier value)	4180186
44804457	Mass media campaign (qualifier value)	4180186
44804459	Community cafe (qualifier value)	4180186
44804464	Cost benefit analysis (qualifier value)	4180186
44804465	Cost (qualifier value)	4180186
44804470	GP/CHS form - paediatric surveillance (record artifact)	4180186
44804474	GP22 deregistration - enlisted	4180186
44804474	GP22 deregistration - enlisted in Her Majesty's forces (finding)	4180186
44804475	GP24 maternity claim - general practitioner on obstetric list (procedure)	4180186
44804476	Standing-start 180 degree turn test time (observable entity)	4180186
44804479	GP22 deregistration - moved, change of address in area (finding)	4180186
44804482	GP22 deregistration - transfer to Her Majesty's forces medical officer (finding)	4180186
44804483	GP22 deregistration - returned undelivered (finding)	4180186
44804484	GP22 deregistration - removed at patient's request (finding)	4180186
44804486	GP22 deregistration - registered twice (finding)	4180186
44804487	GP22 deregistration - practice changed and moved (finding)	4180186
44804488	GP22 deregistration - practice advise outside of their area (finding)	4180186
44804490	GP22 deregistration - practice advise removal via screening system (finding)	4180186
44804491	GP22 deregistration - practice advise patient no longer resident (finding)	4180186
44804493	GP22 deregistration - internal transfer within partnership (finding)	4180186
44804496	GP22 deregistration - emigration (finding)	4180186
44804498	Adjuvant drug therapy (regime/therapy)	4180186
44804498	Adjuvant therapy	4180186
44804499	Urine pH = 5.5 (finding)	4180186
44804500	Glycolate/creatinine ratio (procedure)	4180186
44804500	Glycollate/creatinine ratio	4180186
44804502	Specimen received in laboratory (situation)	4180186
44804503	Express dissent for Summary Care Record dataset upload (finding)	4180186
44804505	No family history of mitochondrial cytopathy (situation)	4180186
44804505	No family history of mitochondrial disease	4180186
44804508	No family history of hearing impairment	4180186
44804508	No family history of hearing loss (situation)	4180186
44804511	Quadrivalent human papillomavirus vaccination (procedure)	4180186
44804512	Increasing risk alcohol drinking (finding)	4180186
44804513	Higher risk alcohol drinking (finding)	4180186
44804519	HPV (human papillomavirus) vaccination invitation second SMS (short message service) text message sent	4180186
44804519	Human papillomavirus vaccination invitation second short message service text message sent (situation)	4180186
44804521	HPV (human papillomavirus) vaccination invitation third SMS (short message service) text message sent	4180186
44804521	Human papillomavirus vaccination invitation third short message service text message sent (situation)	4180186
44804522	Influenza vaccination invitation third short message service text message sent (finding)	4180186
44804522	Influenza vaccination invitation third SMS (short message service) text message sent	4180186
44804522	Influenza vaccination invitation third text message sent	4180186
44804523	On examination - epididymis (finding)	4180186
44804525	Patient not informed of test result (finding)	4180186
44804526	GPC claim - child health surveillance sent to Health Board (finding)	4180186
44804530	Well-being assessment for long term conditions reviewed (finding)	4180186
44804531	Suture removal requested by accident and emergency service (situation)	4180186
44804533	On examination - Left diabetic foot at increased risk (finding)	4180186
44804540	General practitioner assessment of cognition score (observable entity)	4180186
44804540	GPCOG (general practitioner assessment of cognition) score	4180186
44804541	FP7B male patient clinical notes card to follow from Family Practitioner Committee (finding)	4180186
44804541	FP7B male patient clinical notes card to follow from FPC (Family Practitioner Committee)	4180186
44804542	FP8B female patient clinical notes card to follow from Family Practitioner Committee (finding)	4180186
44804542	FP8B female patient clinical notes card to follow from FPC (Family Practitioner Committee)	4180186
44804543	Mental Health Act 1983 (England and Wales) form 5 section 4 nearest relative recommendation form (record artifact)	4180186
44804544	PBCL flag true: report, request, battery, test, ratio, text, boolean (qualifier value)	4180186
44804545	Cremation form 5 completed (finding)	4180186
44804546	Unsuccessful subcutaneous contraceptive insertion (situation)	4180186
44804548	Health education - sibling rivalry	4180186
44804548	Parent education about sibling rivalry (procedure)	4180186
44804549	Incretin mimetic dose changed (situation)	4180186
44804551	Multiple pressure ulcers (disorder)	4180186
44804552	Psychological therapy started (situation)	4180186
44804553	Adult safeguarding concern (finding)	4180186
44804554	Adult no longer safeguarding concern (finding)	4180186
44804555	Referral for medication compliance assessment offered (finding)	4180186
44804556	Smoker in household (finding)	4180186
44804557	Lithium therapy record book issued (finding)	4180186
44804560	National Health Service Continuing Healthcare Fast Track Pathway Tool Acceptance (record artifact)	4180186
44804561	National Health Service Continuing Healthcare Checklist Assessment (record artifact)	4180186
44804564	National Health Service Continuing Healthcare Decision Support Tool (record artifact)	4180186
44804565	National Health Service Continuing Healthcare Cancellation Notification (record artifact)	4180186
44804566	Consultation with patient encounter type (record artifact)	4180186
44804567	Consultation with representative of patient encounter type (record artifact)	4180186
44804568	Patient not present encounter type (record artifact)	4180186
44804569	Hepatitis B vaccination not indicated (situation)	4180186
44804571	Postgraduate training allowance refused (finding)	4180186
44804572	GPC claim - minor surgery signed (finding)	4180186
44804574	Imminent expected death (finding)	4180186
44804575	Parent education about child health (procedure)	4180186
44804576	Unmet need identified from care plan (finding)	4180186
44804577	Limited capability for work on work capability assessment criteria (finding)	4180186
44804583	Walk in centre administration (record artifact)	4180186
44804584	Assessment for post-laryngectomy rehabilitation (procedure)	4180186
44804585	Contraception method not decided (finding)	4180186
44804586	Method of drug administration (qualifier value)	4180186
44804588	GPC claim - minor surgery sent to Health Board (finding)	4180186
44804593	Lower limb distal segment volume (observable entity)	4180186
44804594	Lower limb proximal segment volume (observable entity)	4180186
44804597	Shape segment ratio difference between lower limbs (observable entity)	4180186
44804598	Ratio of lower limb proximal segment shape to distal segment shape (observable entity)	4180186
44804599	Upper limb distal segment volume (observable entity)	4180186
44804602	Percentage volume difference between upper limbs (observable entity)	4180186
44804603	Shape segment ratio difference between upper limbs (observable entity)	4180186
44804604	Ratio of upper limb proximal segment shape to distal segment shape (observable entity)	4180186
44804605	Precipitative diagnosis to lymphoedema onset time (observable entity)	4180186
44804606	Surgery to lymphoedema onset time (observable entity)	4180186
44804607	Treatment to lymphoedema onset time (observable entity)	4180186
44804609	Adolescent health screening (procedure)	4180186
44804610	Patient health questionnaire 9	4180186
44804610	Patient health questionnaire 9 (assessment scale)	4180186
44804614	Quercus petraea (organism)	4180186
44804614	Sessile oak	4180186
44804615	Referral under section 47 of Children Act 1989 rejected by child protection service (finding)	4180186
44804616	Assessment using BODE (body mass, airflow obstruction, dyspnoea and exercise capacity) index	4180186
44804616	Assessment using body mass, airflow obstruction, dyspnoea and exercise capacity index (procedure)	4180186
44804617	Education for intrauterine system (procedure)	4180186
44804617	Education for IUS (intrauterine system)	4180186
44804618	Education for condom use	4180186
44804618	Education for contraceptive sheath (procedure)	4180186
44804619	Education for female condom (procedure)	4180186
44804620	Education for withdrawal contraception (procedure)	4180186
44804621	Education for spermicidal contraceptive (procedure)	4180186
44804623	Contraceptive sheath problem (finding)	4180186
44804624	Problem with contraception (finding)	4180186
44804625	Finding of capacity to give consent (finding)	4180186
44804627	Declined consent for examination of central nervous system (finding)	4180186
44804629	Declined consent for examination of genitourinary system (finding)	4180186
44804630	Declined consent for examination of musculoskeletal system (finding)	4180186
44804631	Declined consent for examination of respiratory system (finding)	4180186
44804633	National Health Service Continuing Healthcare Fast Track Pathway Tool Rejection (record artifact)	4180186
44804634	National Health Service Continuing Healthcare Checklist Assessment Rejection (record artifact)	4180186
44804635	National Health Service Continuing Healthcare Request for Assessment Rejection (record artifact)	4180186
44804637	Insulin sensitivity factor - lunch (observable entity)	4180186
44804638	Insulin sensitivity factor - evening meal (observable entity)	4180186
44804638	Insulin sensitivity factor - tea	4180186
44804643	Anti-diabetic drug therapy observation (observable entity)	4180186
44804644	Consent given to share clinical information with general practitioner (finding)	4180186
44804647	Chronic idiopathic pain syndrome (disorder)	4180186
44804649	Worsening balance (finding)	4180186
44804652	Synovial fluid sample sent to laboratory (situation)	4180186
44804654	Reduction in peripheral oedema (finding)	4180186
44804655	GPC claim - minor surgery paid (finding)	4180186
44804660	Family history of fragile X syndrome in first degree relative (situation)	4180186
44804665	TAG (threshold assessment grid)	4180186
44804665	Threshold assessment grid (assessment scale)	4180186
44804668	Height and weight measurement for National Child Measurement Programme (finding)	4180186
44804669	Subject of MARAC (multi-agency risk assessment conference)	4180186
44804669	Subject of multi-agency risk assessment conference (finding)	4180186
44804670	Adult no longer vulnerable (finding)	4180186
44804672	Multiple sclerosis monitoring invitation (procedure)	4180186
44804674	Multiple sclerosis monitoring second letter (procedure)	4180186
44804675	Sigmoidoscopy abnormal (finding)	4180186
44804678	Lipid disorder treatment stopped (situation)	4180186
44804679	Referral for CAF (common assessment framework) for children and young people	4180186
44804679	Referral for common assessment framework for children and young people (procedure)	4180186
44804681	Housebound patient review (procedure)	4180186
44804683	TB (tuberculosis) screening chest X-ray abnormal	4180186
44804683	Tuberculosis screening chest X-ray abnormal (finding)	4180186
44804685	Abdominal aortic aneurysm screening offered (finding)	4180186
44804686	History of foot ulcer (situation)	4180186
44804688	Seen in bariatric surgery clinic (finding)	4180186
44804689	Organ donation information leaflet given (situation)	4180186
44804690	Blood donor information leaflet given (situation)	4180186
44804695	Born in Aruba (finding)	4180186
44804697	HIV (human immunodeficiency virus) test not appropriate	4180186
44804697	Human immunodeficiency virus test not appropriate (finding)	4180186
44804698	Medically fit for court appearance (finding)	4180186
44804699	PEPSE - post exposure prophylaxis after sexual exposure	4180186
44804699	Post exposure prophylaxis after sexual exposure (procedure)	4180186
44804700	PPC (preferred priorities for care) discussed	4180186
44804700	Preferred priorities for care discussed (situation)	4180186
44804702	Immunosuppressant drug therapy (procedure)	4180186
44804703	Lost to smoking cessation follow-up (finding)	4180186
44804707	Endurance shuttle walk test level (finding)	4180186
44804708	Closed fracture of one or more tarsal and metatarsal bones (disorder)	4180186
44804709	Advice given about risks of unprotected sexual intercourse (situation)	4180186
44804711	Independent in cooking (finding)	4180186
44804713	Dihydrocodeine screen (procedure)	4180186
44804714	Chitotriosidase level	4180186
44804714	Chitotriosidase measurement (procedure)	4180186
44804716	Declined consent for communication by telephone (finding)	4180186
44804718	Liver function monitoring (regime/therapy)	4180186
44804719	Unsuitable for weight management programme (finding)	4180186
44804722	Batch prescription cancelled (finding)	4180186
44804725	Education about child immunisation (procedure)	4180186
44804728	Education about home heating (procedure)	4180186
44804729	Education about child benefit (procedure)	4180186
44804730	Education about prevention of cot death (procedure)	4180186
44804732	Left peroneal doppler pressure (procedure)	4180186
44804734	Interstitial lung disease due to connective tissue disease (disorder)	4180186
44804735	Referral for multidisciplinary stroke function improvement declined (situation)	4180186
44804737	Major surgery care management (procedure)	4180186
44804739	Inpatient care management (procedure)	4180186
44804742	Replaces meals with drinks (finding)	4180186
44804746	At risk of domestic violence (finding)	4180186
44804748	Referral for multi-agency assessment (procedure)	4180186
44804750	Congenital abnormality of mitral papillary muscle (disorder)	4180186
44804752	Shortened mitral papillary muscle (disorder)	4180186
44804753	Atrioventricular septal defect with balanced ventricles (disorder)	4180186
44804757	Flail of right atrioventricular valve leaflet (disorder)	4180186
44804758	Associated mass of right atrioventricular valve leaflet (disorder)	4180186
44804759	Associated mass of left atrioventricular valve leaflet (disorder)	4180186
44804760	Gelatinous left atrioventricular valve leaflet (disorder)	4180186
44804762	Flail of left atrioventricular valve leaflet (disorder)	4180186
44804764	Direct current cardioversion planned (situation)	4180186
44804764	Electrical cardioversion planned	4180186
44804765	Interpreter declined (situation)	4180186
44804767	Anomalous false tendon of muscle bands of left ventricle (disorder)	4180186
44804768	Left ventricular outflow tract obstruction due to septal hypertrophy (disorder)	4180186
44804772	Generalised left ventricular dysfunction (disorder)	4180186
44804773	Regional left ventricular dysfunction (disorder)	4180186
44804776	Double chambered right ventricle with VSD (ventricular septal defect) above obstruction	4180186
44804776	Two chambered right ventricle with ventricular septal defect above obstruction (disorder)	4180186
44804777	Double chambered right ventricle with VSD (ventricular septal defect) below obstruction	4180186
44804777	Two chambered right ventricle with ventricular septal defect below obstruction (disorder)	4180186
44804778	Endurance shuttle walk test distance (observable entity)	4180186
44804779	Suspected cerebrovascular accident (situation)	4180186
44804779	Suspected stroke	4180186
44804780	National Health Service continuing healthcare status (finding)	4180186
44804782	National Health Service continuing healthcare fast track funding applied for (finding)	4180186
44804783	National Health Service continuing healthcare fast track funding granted (finding)	4180186
44804785	National Health Service continuing healthcare funding applied for (finding)	4180186
44804786	National Health Service continuing healthcare funding granted (finding)	4180186
44804788	Self referral to termination of pregnancy service (procedure)	4180186
44804790	Incremental shuttle walk test distance (observable entity)	4180186
44804791	Incremental shuttle walk test time taken (observable entity)	4180186
44804792	Advice given about wound care (situation)	4180186
44804793	Fire safety equipment fitted in home (finding)	4180186
44804794	Mean total daily insulin dose (observable entity)	4180186
44804796	Lumbar sympathetic plexus block using fluoroscopic guidance (procedure)	4180186
44804798	Ganglion impar block using fluoroscopic guidance (procedure)	4180186
44804799	Obturator nerve block using fluoroscopic guidance (procedure)	4180186
44804800	Stellate ganglion block using fluoroscopic guidance (procedure)	4180186
44804801	Intrathecal block using fluoroscopic guidance (procedure)	4180186
44804802	Checking accuracy of blood glucose meter (procedure)	4180186
44804803	Abnormality of myotome (finding)	4180186
44804807	Leave payment received (finding)	4180186
44804809	Administration of intravenous antiarrhythmic drug (procedure)	4180186
44804810	Administration of intravenous vasoactive drug (procedure)	4180186
44804815	Critical care surgery care management (procedure)	4180186
44804817	Critical care major complex surgery care management (procedure)	4180186
44804818	Critical care medicine care management (procedure)	4180186
44804819	Aggression control care management (procedure)	4180186
44804828	Nickel output measurement (procedure)	4180186
44804831	Patient identity verified (finding)	4180186
44804834	Unaccompanied child asylum seeker (person)	4180186
44804835	Drinks real ale (finding)	4180186
44804839	CE1B - employment contract	4180186
44804839	Staff employment contract (record artifact)	4180186
44804840	History of antiplatelet therapy (situation)	4180186
44804840	H/O: antiplatelet therapy	4180186
44804842	Emergency appointment (record artifact)	4180186
44804843	Appointment (record artifact)	4180186
44804844	Allowance (record artifact)	4180186
44804848	Congenital subvalvar mitral stenosis (disorder)	4180186
44804849	Obstruction of left ventricular inflow tract due to left superior vena cava connecting to coronary sinus (disorder)	4180186
44804851	Accessory mitral leaflet (disorder)	4180186
44804854	Flail of mitral leaflet (disorder)	4180186
44804855	Congenital abnormality of mitral chordae tendinae (disorder)	4180186
44804856	Physiotherapy self-referral (procedure)	4180186
44804857	Relative unaware of prognosis (situation)	4180186
44804859	Medication review done by medicines management technician (procedure)	4180186
44804864	Repair of recurrent ventral hernia using insert of prosthetic material (procedure)	4180186
44804866	Place of occurrence of accident or poisoning, canal (environment)	4180186
44804869	Special screening examination for neoplasm of intestinal tract (procedure)	4180186
44804870	Motor developmental delay (disorder)	4180186
44804873	Assessment using TOP (treatment outcomes profile)	4180186
44804873	Assessment using treatment outcomes profile (procedure)	4180186
44804875	TOP (treatment outcomes profile) score	4180186
44804875	Treatment outcomes profile score (observable entity)	4180186
44804877	General practice physical activity questionnaire (assessment scale)	4180186
44804877	GPPAQ - general practice physical activity questionnaire	4180186
44804880	Revision of internal cardiac defibrillator lead using fluoroscopic guidance (procedure)	4180186
44804881	Revision of cardiac biventricular permanent pacemaker lead using fluoroscopic guidance (procedure)	4180186
44804882	Revision of cardiac biventricular implantable cardioverter defibrillator lead using fluoroscopic guidance (procedure)	4180186
44804883	Referral to paediatric nephrologist (procedure)	4180186
44804887	Measurement of 24 hour urine manganese output (procedure)	4180186
44804889	Immunoreactive trypsinogen measurement (procedure)	4180186
44804892	C24/C22 very long chain fatty acid ratio measurement (procedure)	4180186
44804894	Referral for cryopreservation (procedure)	4180186
44804899	Supply of discharge medication (procedure)	4180186
44804899	Supply of TTO (to take out) medication	4180186
44804900	Variance from goal (finding)	4180186
44804901	Goal agreed (finding)	4180186
44804906	CD25 count (procedure)	4180186
44804907	Cytoplasmic CD25 count (procedure)	4180186
44804909	Smith immunoglobulin G antibody measurement (procedure)	4180186
44804913	Reticulin R1 immunoglobulin G antibody measurement (procedure)	4180186
44804914	Skin IgG antibody measurement	4180186
44804914	Skin immunoglobulin G antibody measurement (procedure)	4180186
44804916	Stop smoking service opportunity signposted (situation)	4180186
44804918	Discharge from virtual ward (procedure)	4180186
44804919	Purkinje cell immunoglobulin G antibody measurement (procedure)	4180186
44804920	Skeletal muscle immunoglobulin G antibody measurement (procedure)	4180186
44804921	Thioguanine level	4180186
44804921	Thioguanine measurement (procedure)	4180186
44804922	Free kappa light chain measurement (procedure)	4180186
44804923	Referral for semen analysis (procedure)	4180186
44804924	Free lambda light chain measurement (procedure)	4180186
44804925	Training grant (record artifact)	4180186
44804926	Review appointment (record artifact)	4180186
44804927	Postgraduate training allowance (record artifact)	4180186
44804929	GPC claim - anaesthetic paid (finding)	4180186
44804932	Administrative information (record artifact)	4180186
44804933	Grant (record artifact)	4180186
44804935	Bill paid (finding)	4180186
44804936	Fee paid (finding)	4180186
44804937	Fee sent (finding)	4180186
44804939	NHS Sickle Cell and Thalassaemia Screening Programme family origin (finding)	4180186
44804940	NHS Sickle Cell and Thalassaemia Screening Programme family origin African or African-Caribbean (black) (finding)	4180186
44804941	NHS Sickle Cell and Thalassaemia Screening Programme family origin South Asia (Asian) (finding)	4180186
44804943	NHS Sickle Cell and Thalassaemia Screening Programme family origin other non-European excluding African or African-Caribbean, South or South East Asian (other) (finding)	4180186
44804945	NHS Sickle Cell and Thalassaemia Screening Programme family origin United Kingdom (white) (finding)	4180186
44804946	NHS Sickle Cell and Thalassaemia Screening Programme family origin Northern European (white) (finding)	4180186
44804947	NHS Sickle Cell and Thalassaemia Screening Programme Caribbean Islands family origin (finding)	4180186
44804948	NHS Sickle Cell and Thalassaemia Screening Programme African family origin (finding)	4180186
44804950	NHS Sickle Cell and Thalassaemia Screening Programme Pakistan family origin (finding)	4180186
44804951	NHS Sickle Cell and Thalassaemia Screening Programme Bangladesh family origin (finding)	4180186
44804952	NHS Sickle Cell and Thalassaemia Screening Programme Chinese family origin (finding)	4180186
44804954	NHS Sickle Cell and Thalassaemia Screening Programme Malaysia, Vietnam, Philippines, Cambodia, Laos family origin (finding)	4180186
44804958	Chronic obstructive pulmonary disease 3 monthly review (regime/therapy)	4180186
44804958	COPD (chronic obstructive pulmonary disease) 3 monthly review	4180186
44804961	Mixed bipolar affective disorder, in partial remission (disorder)	4180186
44804962	Insertion of orthodontic anchorage (procedure)	4180186
44804963	Removal of orthodontic anchorage (procedure)	4180186
44804964	Prolapsing internal haemorrhoids with spontaneous retraction (disorder)	4180186
44804964	Second degree internal haemorrhoids	4180186
44804965	Prolapsing internal haemorrhoids requiring manual reduction (disorder)	4180186
44804965	Third degree internal haemorrhoids	4180186
44804966	Fourth degree internal haemorrhoids	4180186
44804966	Prolapsed non-reducible internal haemorrhoids (disorder)	4180186
44804968	Night visit claimable - higher (finding)	4180186
44804969	Reconstruction of breast using pedicled omental flap (procedure)	4180186
44804973	Endoscopic bilateral placement of intrafallopian implants (procedure)	4180186
44804974	On examination - visual acuity right eye = 6/48 (finding)	4180186
44804975	Patient requests copy of clinical correspondence (finding)	4180186
44804981	Referral to local authority weight management programme (procedure)	4180186
44804982	Fluoroscopic venogram of axillary vein using contrast with insertion of metallic stent graft	4180186
44804982	Fluoroscopic venography of axillary vein using contrast with insertion of metallic stent graft (procedure)	4180186
44804984	History of secondary diabetes mellitus (situation)	4180186
44804985	Consent given for observational study participation (finding)	4180186
44804988	Declined to give substance misuse history (finding)	4180186
44804989	Piperacillin and tazobactam desensitisation therapy (regime/therapy)	4180186
44804991	Advised to maintain back up supply of insulin for subcutaneous injection (situation)	4180186
44804994	Assessment for minor surgery (procedure)	4180186
44804996	Stop smoking invitation first short message service text message (procedure)	4180186
44804996	Stop smoking invitation first text message	4180186
44805000	Second tick-borne encephalitis vaccination (procedure)	4180186
44805001	Third tick-borne encephalitis vaccination (procedure)	4180186
44805002	Deterioration in ability to walk (finding)	4180186
44805004	General practitioner out of hours service notified of chronic obstructive pulmonary disease care plan (finding)	4180186
44805004	GP (general practitioner) OOH (out of hours) service notified of COPD (chronic obstructive pulmonary disease) care plan	4180186
44805007	Depot contraception leaflet given (situation)	4180186
44805009	Infant feeding postnatal checklist completed (finding)	4180186
44805010	CD41a count (procedure)	4180186
44805013	NHS Sickle Cell and Thalassaemia Screening Programme South America family origin (finding)	4180186
44805014	NHS Sickle Cell and Thalassaemia Screening Programme Middle East family origin (finding)	4180186
44805016	NHS Sickle Cell and Thalassaemia Screening Programme Greece, Turkey, Cyprus family origin (finding)	4180186
44805017	NHS Sickle Cell and Thalassaemia Screening Programme Italy, Portugal, Spain family origin (finding)	4180186
44805018	NHS Sickle Cell and Thalassaemia Screening Programme Austria, Belgium, Ireland, France, Germany, Netherlands family origin (finding)	4180186
44805020	Incomplete medical abortion	4180186
44805020	Incomplete termination of pregnancy (disorder)	4180186
44805022	Upper limb percentage excess volume (observable entity)	4180186
44805030	Integrated Care and Support Plan - Local Authority Only Funded (record artifact)	4180186
44805031	Lithium patient information booklet given (situation)	4180186
44805035	Pressure ulcer acquired in own home (disorder)	4180186
44805036	Frequent changes of address (finding)	4180186
44805037	Influenza vaccination verbal invitation (procedure)	4180186
44805038	Patient initiated encounter with mental health crisis team (procedure)	4180186
44805039	Prescription cancelled (finding)	4180186
44805044	Able to dress appropriately (finding)	4180186
44805045	Able to heat home (finding)	4180186
44805046	Able to manage payment of bill (finding)	4180186
44805047	Able to mobilise using mobility scooter (finding)	4180186
44805048	Able to perform work based activity (finding)	4180186
44805049	Able to prepare snack (finding)	4180186
44805055	Uses alternative communication skill (finding)	4180186
44805057	Requires assistance to change stoma bag (finding)	4180186
44805061	Carbon monoxide monitor in home (finding)	4180186
44805062	Contributes to own care plan	4180186
44805062	Contributes to own support plan (finding)	4180186
44805064	Difficulty changing stoma bag (finding)	4180186
44805065	Difficulty dressing appropriately (finding)	4180186
44805066	Difficulty managing payment of bill (finding)	4180186
44805068	Difficulty using audiovisual appliance (finding)	4180186
44805070	Blue Badge permit applied for	4180186
44805070	Has applied for disabled parking permit (finding)	4180186
44805072	Fluoroscopic venogram of cephalic vein using contrast with insertion of metallic stent graft	4180186
44805072	Fluoroscopic venography of cephalic vein using contrast with insertion of metallic stent graft (procedure)	4180186
44805074	Fluoroscopic venogram of superficial forearm vein using contrast with insertion of metallic stent graft	4180186
44805074	Fluoroscopic venography of superficial forearm vein using contrast with insertion of metallic stent graft (procedure)	4180186
44805075	Fluoroscopic venogram of iliac vein using contrast with insertion of metallic stent graft	4180186
44805075	Fluoroscopic venography of iliac vein using contrast with insertion of metallic stent graft (procedure)	4180186
44805076	Fluoroscopic venography of brachiocephalic vein using contrast with insertion of metallic stent graft	4180186
44805076	Fluoroscopic venography of innominate vein using contrast with insertion of metallic stent graft (procedure)	4180186
44805077	Needs assistance with shopping (finding)	4180186
44805077	Needs help with shopping	4180186
44805078	Fluoroscopic venogram of mesenteric vein using contrast with insertion of metallic stent graft	4180186
44805078	Fluoroscopic venography of mesenteric vein using contrast with insertion of metallic stent graft (procedure)	4180186
44805080	Fluoroscopic venogram of renal vein using contrast with insertion of metallic stent graft	4180186
44805080	Fluoroscopic venography of renal vein using contrast with insertion of metallic stent graft (procedure)	4180186
44805082	Fluoroscopic venogram of superficial femoral vein using contrast with insertion of metallic stent graft	4180186
44805082	Fluoroscopic venography of superficial femoral vein using contrast with insertion of metallic stent graft (procedure)	4180186
44805083	Current medication as reported by general practitioner (observable entity)	4180186
44805084	Primary intra-articular fixation of intra-articular fracture of bone (procedure)	4180186
44805088	Child on progressive care pathway (finding)	4180186
44805090	Child no longer on progressive care pathway (finding)	4180186
44805093	Asthma limits activities most days (finding)	4180186
44805096	Cytoplasmic CD45 count (procedure)	4180186
44805097	CD45RA count (procedure)	4180186
44805100	Cytoplasmic CD5 count (procedure)	4180186
44805102	Cockatiel serum protein specific immunoglobulin G antibody measurement (procedure)	4180186
44805106	Liverpool care pathway for the dying patient declined (situation)	4180186
44805107	Poultry serum protein specific immunoglobulin G antibody measurement (procedure)	4180186
44805108	Cytoplasmic CD61 count (procedure)	4180186
44805111	CD56 count (procedure)	4180186
44805112	CD55 count (procedure)	4180186
44805113	Tobramycin desensitisation therapy (regime/therapy)	4180186
44805117	Ceftazidime desensitisation therapy (regime/therapy)	4180186
44805119	Cytoplasmic CD10 count (procedure)	4180186
44805121	Soluble liver antigen immunoglobulin G antibody measurement (procedure)	4180186
44805122	Factor VIII related antigen IgE antibody measurement (procedure)	4180186
44805122	Factor VIII related antigen immunoglobulin E antibody measurement (procedure)	4180186
44805128	Age of sexual partner (observable entity)	4180186
44805131	O/E left dysplastic hip	4180186
44805131	On examination left dysplastic hip (disorder)	4180186
44805135	Born in Democratic Republic of Congo (finding)	4180186
44805138	Mental health in-reach team review (procedure)	4180186
44805138	MHIT (mental health in-reach team) review	4180186
44805139	Antenatal screening shows non significant haemoglobinopathy carrier (finding)	4180186
44805140	Antenatal screening shows carrier of significant haemoglobinopathy including sickle cell or thalassaemia (finding)	4180186
44805141	Patient declined to answer family origin questionnaire (situation)	4180186
44805142	No known disability (situation)	4180186
44805143	Excepted from diabetes quality indicators: service unavailable (finding)	4180186
44805144	Dari as a second language (finding)	4180186
44805147	Percutaneous transluminal coil embolisation of aneurysm of coronary artery using fluoroscopic guidance (procedure)	4180186
44805148	Consent given for smoking cessation data sharing (finding)	4180186
44805151	Coeliac disease annual review declined (situation)	4180186
44805152	Intravenous bisphosphonate prophylaxis (procedure)	4180186
44805154	Does adjust stoma bag (finding)	4180186
44805155	Does change stoma bag (finding)	4180186
44805157	Does dress appropriately (finding)	4180186
44805159	Does manage payment of bill (finding)	4180186
44805160	Does not adjust stoma bag (finding)	4180186
44805161	Does not attend dentist (finding)	4180186
44805163	Does not cool home (finding)	4180186
44805166	Does not feel safe in own home (finding)	4180186
44805168	Does not heat home (finding)	4180186
44805177	Financial assessment (finding)	4180186
44805182	Individual budget applied for (finding)	4180186
44805190	Regular attendance at dentist (finding)	4180186
44805191	Smoke alarm in home (finding)	4180186
44805194	Unable to cool home (finding)	4180186
44805196	Unable to heat home (finding)	4180186
44805197	Seen in sickle cell and thalassaemia clinic (finding)	4180186
44805199	Magnetic resonance imaging of pathology specimen (procedure)	4180186
44805200	Reopening of chest and re-exploration of intra-abdominal operation site (procedure)	4180186
44805204	Transluminal intracardiac echocardiography for complex congenital heart disease (procedure)	4180186
44805205	Advised to abstain from alcohol consumption (situation)	4180186
44805207	Gated computed tomography for cardiac function with contrast (procedure)	4180186
44805209	Declined to give details of registered general practitioner (finding)	4180186
44805211	Never had mammogram (situation)	4180186
44805214	Parrot specific immunoglobulin G antibody measurement (procedure)	4180186
44805216	Acetylcholine receptor immunoglobulin G antibody measurement (procedure)	4180186
44805219	Issue of nicotine replacement therapy voucher (procedure)	4180186
44805222	Insertion of programmable cystoperitoneal shunt of brain (procedure)	4180186
44805223	Infrequent episodic tension-type headache (disorder)	4180186
44805225	Adrenal cortex immunoglobulin G antibody level (procedure)	4180186
44805226	Neutrophil opsonisation study	4180186
44805226	Neutrophil opsonisation test (procedure)	4180186
44805227	Striated muscle immunoglobulin G antibody measurement (procedure)	4180186
44805229	Pituitary gland immunoglobulin G antibody measurement (procedure)	4180186
44805230	Immunoglobulin G/transferrin clearance ratio measurement (procedure)	4180186
44805232	T-cell receptor genotype determination (procedure)	4180186
44805233	Injury consistent with history given (finding)	4180186
44805235	Islet cell immunoglobulin G antibody measurement (procedure)	4180186
44805236	Community specialist palliative care not required (situation)	4180186
44805237	Sending of 24 hour ECG (electrocardiogram) for interpretation	4180186
44805237	Sending of 24 hour electrocardiogram for interpretation (procedure)	4180186
44805239	Deterioration in ability to walk up stairs (finding)	4180186
44805240	Referral to domestic abuse agency (procedure)	4180186
44805245	Patient accompanied by relative (finding)	4180186
44805246	Patient accompanied by care professional (finding)	4180186
44805248	Left ABPI (ankle brachial pressure index)	4180186
44805248	Left ankle brachial pressure index (procedure)	4180186
44805250	IG (improvement grant) 2 agreement signed	4180186
44805250	Improvement grant 2 agreement signed (finding)	4180186
44805252	Inhaler device used (finding)	4180186
44805257	Carer self assessment form given (situation)	4180186
44805258	Percutaneous removal of calculus from renal pelvis by incision using fluoroscopic guidance (procedure)	4180186
44805259	Personal history of transient ischaemic attack (situation)	4180186
44805260	Neurodevelopmental delay (disorder)	4180186
44805263	Automated oto-acoustic emission test not done (situation)	4180186
44805264	Automated auditory brainstem response test clear response (finding)	4180186
44805265	eMED3 (2010) new statement issued, may be fit for work (finding)	4180186
44805271	Unable to sense change in temperature (finding)	4180186
44805272	Unable to swim (finding)	4180186
44805274	Unable to use personal computer (finding)	4180186
44805276	Uses voice output communication aid (finding)	4180186
44805278	Cancer multidisciplinary team report (record artifact)	4180186
44805280	Referral for cardiac pacemaker check (procedure)	4180186
44805281	Seen by psychological wellbeing practitioner (finding)	4180186
44805285	Common assessment framework for children and young people process not initiated (finding)	4180186
44805286	Discussion about bariatric operative procedure (procedure)	4180186
44805288	Referral for medication compliance assessment declined (situation)	4180186
44805290	Written advice about long acting reversible contraception (situation)	4180186
44805295	RCA (root cause analysis) investigation of incident	4180186
44805295	Root cause analysis investigation of incident (procedure)	4180186
44805297	Carrier of haemochromatosis HFE gene mutation (finding)	4180186
44805298	Express consent for core Summary Care Record dataset upload (finding)	4180186
44805299	Express consent for core and additional Summary Care Record dataset upload (finding)	4180186
44805301	Gynaecology inpatient care (regime/therapy)	4180186
44805304	Gynaecology unplanned inpatient care (regime/therapy)	4180186
44805307	Monitoring of discharge per vagina (regime/therapy)	4180186
44805307	Monitoring of vaginal discharge	4180186
44805308	Monitoring of drainage of amniotic fluid per vagina (regime/therapy)	4180186
44805308	Monitoring of vaginal drainage of liquor	4180186
44805309	Nausea and vomiting care management (procedure)	4180186
44805310	Fever care management (procedure)	4180186
44805311	Complaining of scrotal swelling (finding)	4180186
44805314	Autonomy, dignity and human rights protected (finding)	4180186
44805315	Blood glucose range overnight (observable entity)	4180186
44805317	Combined synchronous retrograde and percutaneous antegrade endoscopic bypass of ureteric occlusion and insertion of ureteric stent using fluoroscopic guidance (procedure)	4180186
44805319	Preferred priorities for care document completed (situation)	4180186
44805323	Inner ear protein immunoglobulin G antibody measurement (procedure)	4180186
44805325	Thyroid peroxidase immunoglobulin G antibody measurement (procedure)	4180186
44805326	Elastase immunoglobulin G antibody measurement (procedure)	4180186
44805327	Healthy relationship with food (finding)	4180186
44805328	Lloyd George record received without problem summary (finding)	4180186
44805331	Myeloperoxidase immunoglobulin G antibody measurement (procedure)	4180186
44805332	Thyroglobulin immunoglobulin G antibody measurement (procedure)	4180186
44805339	Declines to reveal benefit status (finding)	4180186
44805341	Influenza vaccination requested (situation)	4180186
44805342	Referral to community gastroenterology service (procedure)	4180186
44805343	Referral to community urology service (procedure)	4180186
44805345	Declined consent for smoking cessation data sharing (finding)	4180186
44805346	Automated auditory brainstem response test incomplete (finding)	4180186
44805349	MED3 (2010) issued by hand, not fit for work (finding)	4180186
44805351	Home visit request by residential institution (procedure)	4180186
44805354	Consent declined by person with parental responsibility (finding)	4180186
44805355	Coeliac disease monitoring invitation second letter (procedure)	4180186
44805359	Cardiovascular disease risk assessment by third party (procedure)	4180186
44805359	CVD (cardiovascular disease) risk assessment by third party	4180186
44805363	Multi-agency action plan (qualifier value)	4180186
44805364	Child protection strategy meeting (procedure)	4180186
44805365	Common assessment framework declined by person with parental responsibility (situation)	4180186
44805366	Visual analogue mood scale (assessment scale)	4180186
44805367	Advice about artificial sweetener (procedure)	4180186
44805368	Advice about food product label (procedure)	4180186
44805376	Usually has lunch (finding)	4180186
44805380	Finding related to ability to heat home (finding)	4180186
44805381	Admission to nursing home (procedure)	4180186
44805383	History of progestogen only oral contraceptive usage (situation)	4180186
44805383	H/O: POP (progestogen only pill) usage	4180186
44805385	History of spermicidal contraceptive usage (situation)	4180186
44805386	History of subcutaneous contraceptive usage (situation)	4180186
44805388	History of transdermal contraceptive usage (situation)	4180186
44805389	H/O: coitus interruptus	4180186
44805389	History of withdrawal contraception method usage (situation)	4180186
44805390	Worsening peripheral oedema (finding)	4180186
44805394	Gynaecology inpatient care management (procedure)	4180186
44805396	Gynaecology major surgery inpatient care management (procedure)	4180186
44805397	Gynaecology major surgery inpatient care plan (record artifact)	4180186
44805398	On examination - visual acuity left eye = 6/48 (finding)	4180186
44805400	Gynaecology unplanned inpatient care plan (record artifact)	4180186
44805401	Gynaecology minor surgery inpatient care management (procedure)	4180186
44805403	On examination - visual acuity left eye = 6/7.5 (finding)	4180186
44805406	Major surgery inpatient care plan (record artifact)	4180186
44805414	Education for postcoital contraceptive (procedure)	4180186
44805415	Blood glucose range before breakfast (observable entity)	4180186
44805416	Blood glucose range after lunch (observable entity)	4180186
44805417	Blood glucose range after breakfast (observable entity)	4180186
44805419	Does not attend regular retinal screening (finding)	4180186
44805420	Referral to community vasectomy service (procedure)	4180186
44805421	Referral to community cardiology service (procedure)	4180186
44805422	Referral to community gynaecology service (procedure)	4180186
44805423	Referral to prostate assessment clinic (procedure)	4180186
44805424	Referral to community multiple sclerosis team (procedure)	4180186
44805426	Insulin infusion rate (observable entity)	4180186
44805427	Destruction of lesion of mouth (procedure)	4180186
44805429	In-house genitourinary medicine (procedure)	4180186
44805430	Injection therapy to lesion of upper gastrointestinal tract using fibreoptic endoscope (procedure)	4180186
44805431	In-house genitourinary medicine first appointment (procedure)	4180186
44805432	Perineal repair of rectal prolapse (procedure)	4180186
44805433	Intraocular pressure of left eye (observable entity)	4180186
44805435	Optic cup disc ratio of right eye (observable entity)	4180186
44805437	Grip strength of left hand (observable entity)	4180186
44805438	Grip strength of right hand (observable entity)	4180186
44805440	Right straight leg raise test response (observable entity)	4180186
44805441	Right mid upper arm circumference (observable entity)	4180186
44805442	Percutaneous cryotherapy ablation of tumour using computed tomography guidance (procedure)	4180186
44805443	Declined consent for student to access clinical record (finding)	4180186
44805444	Percutaneous cryotherapy ablation of tumour of lung using computed tomography guidance (procedure)	4180186
44805445	Declined consent for researcher to access clinical record (finding)	4180186
44805447	Percutaneous cryotherapy ablation of tumour of liver using computed tomography guidance (procedure)	4180186
44805448	Percutaneous cryotherapy ablation of tumour of kidney using computed tomography guidance (procedure)	4180186
44805449	Preferred place of care - discussion not appropriate (finding)	4180186
44805450	Advice about intrauterine contraceptive device, checking for threads (situation)	4180186
44805451	Automated auditory brainstem response test no clear response (finding)	4180186
44805452	Improvement grant received (finding)	4180186
44805453	Descending aorta anterior and same side as azygos vein with absent inferior vena cava (disorder)	4180186
44805455	Fax sent to outside agency (finding)	4180186
44805456	Discharge letter faxed to general practitioner (finding)	4180186
44805457	Discharge letter given to patient (finding)	4180186
44805459	History of female condom usage (situation)	4180186
44805460	Referral to heart failure education group declined (situation)	4180186
44805464	Insertion of male retropubic continence device (procedure)	4180186
44805466	Plastic operation on uterus (procedure)	4180186
44805469	Osteotomy of multiple metatarsals and fixation (procedure)	4180186
44805470	Osteotomy of bone of foot and fixation (procedure)	4180186
44805474	Tattooing of organ (procedure)	4180186
44805477	Introduction of photodynamic substance into organ (procedure)	4180186
44805480	Vasopressin antagonist drugs Band 1 (procedure)	4180186
44805481	Allergic emergency drugs Band 1 (procedure)	4180186
44805486	History of laser eye surgery (situation)	4180186
44805491	Antidepressant drug treatment started (situation)	4180186
44805492	Discussion about changing insulin requirement in pregnancy (procedure)	4180186
44805493	Did not attend fast track suspected cancer clinic (finding)	4180186
44805494	Did not attend fast track suspected gynaecological cancer clinic (finding)	4180186
44805495	Measles, mumps and rubella vaccination invitation (procedure)	4180186
44805495	MMR (measles, mumps and rubella) vaccination invitation	4180186
44805496	Wears medical alert identification (finding)	4180186
44805498	Uses contraception (finding)	4180186
44805500	Fitness for work statement issued (finding)	4180186
44805501	Fitness for work statement not issued (finding)	4180186
44805504	Target serum HDL (high density lipoprotein) cholesterol level	4180186
44805504	Target serum high density lipoprotein cholesterol level (observable entity)	4180186
44805508	Methicillin resistant staphylococcus aureus negative (finding)	4180186
44805508	MRSA (methicillin resistant staphylococcus aureus) negative	4180186
44805509	Blood glucose range before lunch (observable entity)	4180186
44805510	HPV (human papillomavirus) vaccination invitation SMS (short message service) text message sent	4180186
44805510	Human papillomavirus vaccination invitation short message service text message sent (situation)	4180186
44805511	Post bronchodilator spirometry (procedure)	4180186
44805512	GPC claim - immunisation signed (finding)	4180186
44805514	Military veteran (finding)	4180186
44805516	Exception reporting - obesity quality indicators (finding)	4180186
44805522	On psychotropic medication (finding)	4180186
44805523	Solicitors report completed (finding)	4180186
44805524	Discussion about chronic obstructive pulmonary disease exacerbation plan (procedure)	4180186
44805526	Asthma review using Royal College of Physicians three questions (regime/therapy)	4180186
44805527	Type 1 diabetic dietary review	4180186
44805527	Type I diabetic dietary review (regime/therapy)	4180186
44805528	Type 2 diabetic dietary review	4180186
44805528	Type II diabetic dietary review (regime/therapy)	4180186
44805529	Diabetic dietary review declined (situation)	4180186
44805531	Looked after child health assessment 6 month review (regime/therapy)	4180186
44805532	Looked after child health assessment annual review (regime/therapy)	4180186
44805533	Looked after child sexual health risk assessment completed (situation)	4180186
44805534	Looked after child health action plan completed (situation)	4180186
44805539	Does not wish to discuss prognosis (finding)	4180186
44805540	Mixed bipolar affective disorder, severe (disorder)	4180186
44805541	Open operation on outlet of male bladder (procedure)	4180186
44805542	Recurrent major depressive episodes, severe (disorder)	4180186
44805543	Recurrent manic episodes, severe (disorder)	4180186
44805545	Single manic episode, severe (disorder)	4180186
44805547	Recurrent manic episodes, in partial remission (disorder)	4180186
44805548	Recurrent manic episodes, in remission (disorder)	4180186
44805550	Single major depressive episode, in remission (disorder)	4180186
44805551	Single major depressive episode, in partial remission (disorder)	4180186
44805552	Single manic episode in partial remission (disorder)	4180186
44805553	Single manic episode in remission (disorder)	4180186
44805556	Worsening pulmonary oedema (finding)	4180186
44805557	Oedema information leaflet given (situation)	4180186
44805560	Measles, mumps and rubella vaccination invitation short message service text message sent (situation)	4180186
44805560	MMR (measles, mumps and rubella) vaccination invitation SMS (short message service) text message sent	4180186
44805560	MMR (measles, mumps and rubella) vaccination invitation text message sent	4180186
44805561	Cardiovascular disease risk assessment invitation short message service text message sent (procedure)	4180186
44805561	Cardiovascular disease risk assessment invitation SMS (short message service) text message sent	4180186
44805561	Cardiovascular disease risk assessment invitation text message sent	4180186
44805562	MED3 (2010) certificate not issued to patient (finding)	4180186
44805566	MED3 (2010) certificate issued - recommend altered hours (finding)	4180186
44805567	MED3 (2010) certificate issued - recommend amended duties (finding)	4180186
44805569	Review of patient goals (procedure)	4180186
44805570	Insulin dose (observable entity)	4180186
44805572	United Kingdom medical eligibility criteria for contraceptive use 2009 risk category (finding)	4180186
44805577	General practitioner assessment of cognition patient examination (assessment scale)	4180186
44805577	GPCOG (general practitioner assessment of cognition) patient examination	4180186
44805578	General practitioner assessment of cognition informant interview (assessment scale)	4180186
44805578	GPCOG (general practitioner assessment of cognition) informant interview	4180186
44805580	45 minute plasma growth hormone measurement (procedure)	4180186
44805581	Grade 1 (Stage pTa) papillary urothelial/transitional cell carcinoma (morphologic abnormality)	4180186
44805582	Grade 2 (Stage pTa) papillary urothelial/transitional cell carcinoma (morphologic abnormality)	4180186
44805592	Soft tissue technique (regime/therapy)	4180186
44805593	20 minute follicle stimulating hormone level	4180186
44805593	20 minute follicle stimulating hormone measurement (procedure)	4180186
44805594	20 minute luteinising hormone level	4180186
44805594	20 minute luteinising hormone measurement (procedure)	4180186
44805595	Not Gillick competent to give consent (finding)	4180186
44805597	Low risk of malnutrition (finding)	4180186
44805598	Medium risk of malnutrition (finding)	4180186
44805599	High risk of malnutrition (finding)	4180186
44805600	Gestational diabetes information leaflet given (situation)	4180186
44805601	No longer subject of looked after child arrangement (finding)	4180186
44805603	Care of syringe driver (regime/therapy)	4180186
44805604	Unknown severity (qualifier value)	4180186
44805605	Discussed with clinical supervisor (situation)	4180186
44805606	Discussed with clinical supervisor for safeguarding (situation)	4180186
44805611	Best interest decision made on behalf of patient (Mental Capacity Act 2005) (finding)	4180186
44805614	Consent given by Court of Protection appointed welfare deputy (finding)	4180186
44805617	Normal peripheral sensation (finding)	4180186
44805618	Education about conservation of hearing (procedure)	4180186
44805621	Vaginal care management (procedure)	4180186
44805623	Penile care management (procedure)	4180186
44805624	Tobacco use cessation case management (procedure)	4180186
44805629	Disposal of blunt disposable instruments (procedure)	4180186
44805630	Disposal of domestic waste (procedure)	4180186
44805631	Disposal of infectious waste (procedure)	4180186
44805639	Referral to cardiac rehabilitation programme not indicated (situation)	4180186
44805640	Referral to cardiac rehabilitation programme (procedure)	4180186
44805642	Phosphodiesterase-5 inhibitor not tolerated (situation)	4180186
44805644	Eats at night (finding)	4180186
44805645	Phosphodiesterase-5 inhibitor contraindicated (situation)	4180186
44805648	Night visit unspecified - claimable (finding)	4180186
44805649	GPC claim - immunisation paid (finding)	4180186
44805651	Cortisol measurement after overnight dexamethasone (procedure)	4180186
44805651	Post overnight dexamethasone cortisol level	4180186
44805651	Post overnight dexamethasone cortisol measurement	4180186
44805653	45 minute serum cortisol level	4180186
44805653	45 minute serum cortisol measurement (procedure)	4180186
44805655	Health visitor new birth visit (procedure)	4180186
44805656	Partner contraception (observable entity)	4180186
44805657	Referral to injection clinic (procedure)	4180186
44805658	Not appropriate to ask about informal carer (finding)	4180186
44805659	Clinical photograph taken by general practitioner (procedure)	4180186
44805662	Carer self assessment form not given (situation)	4180186
44805663	Personal health plan not appropriate (finding)	4180186
44805664	Vaginal vault smear repeat at 12 months (situation)	4180186
44805666	Vaginal vault smear repeat at 24 months (situation)	4180186
44805668	Single major depressive episode, severe, with psychosis, psychosis in remission (disorder)	4180186
44805669	Recurrent major depressive episodes, severe, with psychosis, psychosis in remission (disorder)	4180186
44805670	Chronic post traumatic stress disorder following military combat (disorder)	4180186
44805671	Lithium level checked at 3 monthly intervals (finding)	4180186
44805672	Has an older carer (finding)	4180186
44805673	Bariatric risk assessment (procedure)	4180186
44805676	Advice given about weight management (situation)	4180186
44805678	Beta blocker target dose not achieved (finding)	4180186
44805680	Complies with infection control regime (finding)	4180186
44805683	Discharge from heart failure nurse service (procedure)	4180186
44805695	Basic respiratory support management (procedure)	4180186
44805696	Administration of antipruritic (procedure)	4180186
44805696	Giving antipruritic	4180186
44805697	Referral to walk in centre doctor (procedure)	4180186
44805699	Buteyko breathing exercises (regime/therapy)	4180186
44805700	Hypertension 9 month review (regime/therapy)	4180186
44805701	Cremation form 4 completed (finding)	4180186
44805702	Discharge letter emailed to general practitioner (finding)	4180186
44805703	Partial oesophagectomy and anastomosis of oesophagus to jejunum (procedure)	4180186
44805704	On examination - amputated left midfoot (finding)	4180186
44805705	Target serum triglyceride level (observable entity)	4180186
44805707	Assessment for bariatric surgery (procedure)	4180186
44805711	Lives in non-institutional accommodation (finding)	4180186
44805712	Discussion about weight management programme (procedure)	4180186
44805713	Cirrhosis associated with cystic fibrosis (disorder)	4180186
44805713	Cystic fibrosis related cirrhosis	4180186
44805716	Mental health assessment declined (situation)	4180186
44805718	Postgraduate training allowance received (finding)	4180186
44805720	Mental health assessment - no abnormalities detected (finding)	4180186
44805721	Physical health assessment - no abnormalities detected (finding)	4180186
44805724	Insertion of intrathecal catheter using fluoroscopic guidance (procedure)	4180186
44805725	Radionuclide study of leakage of isolated limb perfusion using technetium 99m labelled red blood cells (procedure)	4180186
44805726	Subject not contactable, reasonable efforts made (finding)	4180186
44805727	GPC claim - child health surveillance signed (finding)	4180186
44805727	GPC claim - CHS (child health surveillance) signed	4180186
44805729	Moderate wheeze (finding)	4180186
44805730	Severe wheeze (finding)	4180186
44805732	Reinsertion of subcutaneous contraceptive (procedure)	4180186
44805733	Preferred priorities of care document offered (finding)	4180186
44805734	Health education regarding age of consent for sexual activity (procedure)	4180186
44805736	Consent given for follow-up by smoking cessation team (finding)	4180186
44805737	Declined consent for follow-up by smoking cessation team (finding)	4180186
44805738	Risk to health associated with overweight and obesity, at no increased risk (finding)	4180186
44805740	Risk to health associated with overweight and obesity, at high risk (finding)	4180186
44805742	Not receiving SSP (statutory sick pay)	4180186
44805742	Not receiving statutory sick pay (finding)	4180186
44805743	Intervention for risk to health associated with overweight and obesity, general advice on healthy weight and lifestyle (regime/therapy)	4180186
44805744	Intervention for risk to health associated with overweight and obesity, advice about diet and physical activity (regime/therapy)	4180186
44805746	Wheeze clinical management plan (qualifier value)	4180186
44805751	HSV (herpes simplex virus) type 1 DNA (deoxyribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44805751	Measurement of Herpes simplex virus type 1 deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44805753	Akin osteotomy	4180186
44805753	Medial closing wedge osteotomy of proximal phalanx of first toe (procedure)	4180186
44805756	Arthroscopy and biopsy of ankle joint (procedure)	4180186
44805757	Arthroscopic debridement of ankle joint (procedure)	4180186
44805760	Education about missed dose of oral contraceptive (procedure)	4180186
44805761	Immunosuppression resolved (finding)	4180186
44805762	Ostium secundum atrial septal defect resolved (finding)	4180186
44805764	ULTT (upper limb tension test) 2a	4180186
44805764	ULTT (upper limb tension test) with median, musculocutaneous and axillary nerve bias	4180186
44805764	Upper limb tension test with median, musculocutaneous and axillary nerve bias (procedure)	4180186
44805764	Upper limb tension test with median nerve bias	4180186
44805765	ULTT (upper limb tension test) with median and anterior interosseous nerve bias	4180186
44805765	Upper limb tension test with median and anterior interosseous nerve bias (procedure)	4180186
44805765	Upper limb tension test with median nerve bias	4180186
44805766	Detection of Treponema pallidum by nucleic acid amplification test (procedure)	4180186
44805766	Treponema pallidum detection by NAAT (nucleic acid amplification test)	4180186
44805767	Referral to ear, nose and throat triage service (procedure)	4180186
44805768	Referral to older people rapid assessment service (procedure)	4180186
44805769	Referral to cardiac rehabilitation service by secondary care (procedure)	4180186
44805771	Influenza A virus antiviral resistance measurement by RNA (ribonucleic acid) analysis	4180186
44805771	Measurement of Influenza A virus antiviral resistance by ribonucleic acid analysis (procedure)	4180186
44805772	Patient died in residential institution (finding)	4180186
44805773	HIV (human immunodeficiency virus) type 2 antiviral resistance measurement by RNA (ribonucleic acid) analysis	4180186
44805773	Measurement of human immunodeficiency virus type 2 antiviral resistance by ribonucleic acid analysis (procedure)	4180186
44805774	Hepatitis B virus antiviral resistance measurement by DNA (deoxyribonucleic acid) analysis	4180186
44805774	Measurement of hepatitis B virus antiviral resistance by deoxyribonucleic acid analysis (procedure)	4180186
44805776	Bethesda inhibitor assay (procedure)	4180186
44805776	Bethesda inhibitor test	4180186
44805779	Measurement of 3-aminobutyrate (procedure)	4180186
44805781	Haemoglobin separation study (procedure)	4180186
44805785	Gaucher disease genotype determination (procedure)	4180186
44805788	Phenylalanine/creatinine ratio measurement (procedure)	4180186
44805790	Tryptophan/creatinine ratio measurement (procedure)	4180186
44805793	Glutamate/creatinine ratio measurement	4180186
44805793	Glutamic acid/creatinine ratio measurement (procedure)	4180186
44805797	Lead/creatinine ratio measurement (procedure)	4180186
44805798	Red blood cell membrane protein study (procedure)	4180186
44805799	Thallium/creatinine ratio measurement (procedure)	4180186
44805800	Isopropanol precipitation test (procedure)	4180186
44805802	Methionine/creatinine ratio measurement (procedure)	4180186
44805806	Purine screening test (procedure)	4180186
44805808	Pig blood specific immunoglobulin E antibody measurement (procedure)	4180186
44805809	Pig blood specific immunoglobulin (substance)	4180186
44805810	Human leucocyte antigen B3 antigen typing (procedure)	4180186
44805812	Immunoglobulin A deficiency study (procedure)	4180186
44805813	Count of cells positive for both CD27 antigen and immunoglobulin D (procedure)	4180186
44805815	Human leucocyte antigen B8 antigen typing (procedure)	4180186
44805816	Human leucocyte antigen HLA-B8 antigen (substance)	4180186
44805817	Human leucocyte antigen D antigen related typing (procedure)	4180186
44805825	Ganglioside GM2 immunoglobulin M antibody measurement (procedure)	4180186
44805830	CD65L count (procedure)	4180186
44805832	Glycophagus domesticus specific immunoglobulin E antibody measurement (procedure)	4180186
44805832	Storage mite specific IgE antibody measurement	4180186
44805835	Tuberculosis lymphocyte activation study (procedure)	4180186
44805836	Nasogastric tube care management (procedure)	4180186
44805837	Complement alternative pathway AP100 measurement (procedure)	4180186
44805838	Referral to dementia care advisor (procedure)	4180186
44805841	Monitoring of venous pressure (regime/therapy)	4180186
44805842	Provision of transport by volunteer car service (procedure)	4180186
44805844	CAT - comprehensive aphasia test	4180186
44805844	Comprehensive aphasia test (assessment scale)	4180186
44805845	Assessment using CAT (comprehensive aphasia test)	4180186
44805845	Assessment using comprehensive aphasia test (procedure)	4180186
44805852	Referral to diabetes clinic (procedure)	4180186
44805853	Referral to alcohol misuse clinic (procedure)	4180186
44805855	Referral to community multidisciplinary care team (procedure)	4180186
44805856	Cardiac rehabilitation programme completed (situation)	4180186
44805857	Eplerenone contraindicated (situation)	4180186
44805859	Referral to older person clinic (procedure)	4180186
44805862	Referral to pain management clinic (procedure)	4180186
44805863	Spironolactone not indicated (situation)	4180186
44805866	Referral to neighbourhood early years service (procedure)	4180186
44805867	Referral to postnatal support group (procedure)	4180186
44805871	FRAX 10 year osteoporotic fracture probability score with bone mineral density	4180186
44805871	Ten year osteoporotic fracture probability score using World Health Organisation FRAX fracture risk assessment tool with bone mineral density (observable entity)	4180186
44805872	Suspected concealment of medication (situation)	4180186
44805875	Psychogenic cardiovascular symptom (finding)	4180186
44805876	Psychogenic gastrointestinal tract symptom (finding)	4180186
44805877	Out of hours care management plan discussed with carer (situation)	4180186
44805878	Psychogenic genitourinary tract symptom (finding)	4180186
44805879	BAAF (British Association for Adoption and Fostering) adult 1 fee unpaid	4180186
44805879	British Association for Adoption and Fostering adult 1 fee unpaid (finding)	4180186
44805880	Psychogenic respiratory symptom (finding)	4180186
44805882	Appointment cancelled by parent (finding)	4180186
44805883	Case management follow-up assessment declined (situation)	4180186
44805886	Resolution of significant event (procedure)	4180186
44805888	War injury due to explosion (disorder)	4180186
44805889	Diabetes monitoring injection site check declined (situation)	4180186
44805890	Weight management plan completed (situation)	4180186
44805892	Diabetes monitoring injection site not checked (situation)	4180186
44805894	JEV (Japanese encephalitis virus) IgG antibody measurement	4180186
44805894	Measurement of Japanese encephalitis virus immunoglobulin G antibody (procedure)	4180186
44805895	Measurement of lymphocytic choriomeningitis virus immunoglobulin G antibody (procedure)	4180186
44805896	HTLV (human T-cell lymphotropic virus) type 2 IgG antibody measurement	4180186
44805896	Measurement of human T-cell lymphotropic virus type 2 immunoglobulin G antibody (procedure)	4180186
44805897	Measurement of Marburg virus immunoglobulin G antibody (procedure)	4180186
44805901	Referral to slimming club (procedure)	4180186
44805902	Measurement of JC virus immunoglobulin G antibody (procedure)	4180186
44805904	Measurement of Human T-lymphotropic virus types 1 and 2 immunoglobulin G antibody (procedure)	4180186
44805905	Bronchoscopic radiofrequency cauterisation of upper lobe bronchus (procedure)	4180186
44805905	Endoscopic radiofrequency cauterisation of upper lobe bronchus	4180186
44805907	Metachromatic granules screening test (procedure)	4180186
44805912	Glycogen debrancher enzyme measurement	4180186
44805912	Glycogen debranching enzyme measurement (procedure)	4180186
44805921	Medication optimisation (procedure)	4180186
44805924	Eosinophilic leukaemia genotype determination (procedure)	4180186
44805924	FIP1L1-PDGFRA genotype determination	4180186
44805925	Receiving attendance allowance (finding)	4180186
44805935	Difference in leg length (observable entity)	4180186
44805936	Citrate output measurement (procedure)	4180186
44805937	Cystine output measurement (procedure)	4180186
44805940	5-hydroxyhistamine measurement (procedure)	4180186
44805941	Open biopsy of lesion of peritoneum (procedure)	4180186
44805942	Advice about risk of hormone replacement therapy (procedure)	4180186
44805947	Able to sleep with sedation (finding)	4180186
44805948	Able to sleep without sedation (finding)	4180186
44805949	Primary hybrid total replacement of shoulder joint using cement (procedure)	4180186
44805950	Primary prosthetic replacement of head of radius (procedure)	4180186
44805954	Re-excision of ganglion of hand (procedure)	4180186
44805955	Remanipulation of fracture of long bone and rigid internal fixation (procedure)	4180186
44805956	LOC4 application for additional payments during confinement form (record artifact)	4180186
44805957	Remanipulation of fracture of long bone and flexible internal fixation (procedure)	4180186
44805958	Transplantation of fascia (procedure)	4180186
44805960	Critical care medical care plan (record artifact)	4180186
44805962	Removal of retropubic device (procedure)	4180186
44805963	Critical care medical care plan for surgery (record artifact)	4180186
44805968	Prison first reception health assessment completed (situation)	4180186
44805974	Excision of pituitary gland using fluoroscopic guidance (procedure)	4180186
44805974	Fluoroscopy guided hypophysectomy	4180186
44805976	Magnetic resonance imaging of submandibular gland (procedure)	4180186
44805977	Magnetic resonance imaging of submandibular gland with contrast (procedure)	4180186
44805978	Magnetic resonance imaging of tongue (procedure)	4180186
44805980	Magnetic resonance imaging of tongue with contrast (procedure)	4180186
44805981	Magnetic resonance imaging of facial nerve (procedure)	4180186
44805982	Radiofrequency ablation of lesion of liver using fluoroscopic guidance (procedure)	4180186
44805985	Insertion of deep brain stimulator using fluoroscopic guidance (procedure)	4180186
44805987	On examination visual acuity right eye = 6/20 (finding)	4180186
44805990	Type of clinical document (attribute)	4180186
44805991	Care setting of clinical document (attribute)	4180186
44805993	Second stage osseointegrated implantation into jaw (procedure)	4180186
44805998	Measurement of hepatitis A virus immunoglobulin G antibody (procedure)	4180186
44806000	HHV (human herpes virus) 6 IgG antibody measurement	4180186
44806000	Measurement of human herpes virus 6 immunoglobulin G antibody (procedure)	4180186
44806001	Seen in leg club (finding)	4180186
44806002	HHV (human herpes virus) 8 IgG antibody measurement	4180186
44806002	Measurement of human herpes virus 8 immunoglobulin G antibody (procedure)	4180186
44806003	Impaired glucose tolerance resolved (finding)	4180186
44806004	HIV (human immunodeficiency virus) 1 and 2 IgG antibody measurement	4180186
44806004	Measurement of human immunodeficiency viruses 1 and 2 immunoglobulin G antibody (procedure)	4180186
44806005	Percutaneous balloon valvuloplasty of aortic valve of fetus using ultrasound guidance (procedure)	4180186
44806007	HBV (hepatitis B virus) core antigen IgG antibody measurement	4180186
44806007	Measurement of hepatitis B virus core antigen immunoglobulin G antibody (procedure)	4180186
44806010	X-ray of soft tissue specimen (procedure)	4180186
44806012	HSV (herpes simplex virus) type 1 IgG antibody measurement	4180186
44806012	Measurement of herpes simplex virus type 1 immunoglobulin G antibody (procedure)	4180186
44806014	Percutaneous microwave ablation of lesion of liver using computed tomography guidance (procedure)	4180186
44806015	Percutaneous microwave ablation of lesion of lung using computed tomography guidance (procedure)	4180186
44806018	Insertion of bypass stent through trabecular meshwork (procedure)	4180186
44806020	Fitting of external aortic root support (procedure)	4180186
44806021	Discussion about lipid lowering therapy (procedure)	4180186
44806025	Nursing assessment record (record artifact)	4180186
44806026	Examination of vagina using Sims speculum (procedure)	4180186
44806028	Care programme approach assessment record (record artifact)	4180186
44806029	Measurement of rubella virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44806029	Rubella virus RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44806030	Measurement of sandfly fever virus immunoglobulin G antibody (procedure)	4180186
44806031	5-hydroxyhistamine (substance)	4180186
44806032	Referral for general practice carer assessment (procedure)	4180186
44806033	Referral for social services carer assessment (procedure)	4180186
44806035	Nicotine replacement therapy using nicotine patch (procedure)	4180186
44806037	Under care of community care team (finding)	4180186
44806039	Discussion about laboratory finding at multidisciplinary case conference (procedure)	4180186
44806042	Referral to drug therapist (procedure)	4180186
44806044	Discharge from care following non-attendance (procedure)	4180186
44806046	Mental Health Act 1983 (England and Wales) procedure (procedure)	4180186
44806047	Maternity service procedure (procedure)	4180186
44806048	G6PD (glucose-6-phosphate dehydrogenase) genotype determination	4180186
44806048	Glucose-6-phosphate dehydrogenase genotype determination (procedure)	4180186
44806050	Referral to chronic obstructive pulmonary disease community nursing team (procedure)	4180186
44806050	Referral to COPD (chronic obstructive pulmonary disease) community nursing team	4180186
44806051	Factor VIII binding level	4180186
44806051	Factor VIII binding measurement (procedure)	4180186
44806054	Urine/blood osmolality ratio measurement (procedure)	4180186
44806055	Lactulose measurement (procedure)	4180186
44806056	Co-codamol measurement (procedure)	4180186
44806061	Total homocysteine measurement (procedure)	4180186
44806062	Aspartate transaminase/alanine transaminase ratio measurement (procedure)	4180186
44806063	Asparaginase measurement (procedure)	4180186
44806066	von Willebrand inhibitor study (procedure)	4180186
44806067	BCR-ABL gene ribonucleic acid transcript measurement (procedure)	4180186
44806068	A disintegrin and metalloproteinase with thrombospondin type 1 motif 13 protease antigen measurement (procedure)	4180186
44806070	Cardiolipin immunoglobulin G antibody measurement (procedure)	4180186
44806073	Repair of rupture of urethra (procedure)	4180186
44806074	Alpha cortolone output measurement (procedure)	4180186
44806075	Androsterone output measurement (procedure)	4180186
44806079	Pregnanetriol output measurement (procedure)	4180186
44806082	Immunoglobulin heavy chain gene study (procedure)	4180186
44806085	Rabbit blood specific immunoglobulin E (substance)	4180186
44806086	Voltage-gated potassium channel immunoglobulin G antibody measurement (procedure)	4180186
44806088	Intrinsic factor immunoglobulin G antibody measurement (procedure)	4180186
44806091	O/E - holosystolic murmur	4180186
44806091	On examination - pansystolic murmur (finding)	4180186
44806093	Androstenediol output measurement (procedure)	4180186
44806095	Free cortisol output measurement (procedure)	4180186
44806097	Tape closure of skin of head (procedure)	4180186
44806098	Toilet to skin of head (procedure)	4180186
44806099	Toilet to skin of neck (procedure)	4180186
44806101	Admission by out of hours service doctor (procedure)	4180186
44806102	Vocalised yawn-sigh exercise (regime/therapy)	4180186
44806103	Pescetarian (finding)	4180186
44806107	Police report received - action required (situation)	4180186
44806110	No cardiorespiratory activity (situation)	4180186
44806111	Immunisation information leaflet given (situation)	4180186
44806117	Parechovirus ribonucleic acid detection (procedure)	4180186
44806118	Parainfluenza type 4 nucleic acid detection (procedure)	4180186
44806120	Asthma self-management plan review (procedure)	4180186
44806122	QRISK2 calculated heart age (observable entity)	4180186
44806123	Difference between actual and QRISK2 calculated heart age (observable entity)	4180186
44806126	Hypertension self-management plan review (procedure)	4180186
44806129	Chronic kidney disease self-management plan review (procedure)	4180186
44806136	BAAF (British Association for Adoption and Fostering) adult 2 fee to patient	4180186
44806136	British Association for Adoption and Fostering adult 2 fee to patient (finding)	4180186
44806139	Discharge care plan (record artifact)	4180186
44806140	Measurement of Varicella zoster virus deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44806140	VZV (Varicella zoster virus) DNA (deoxyribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44806141	Record of fundal height measurement (record artifact)	4180186
44806142	Measurement of rhinovirus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44806142	Rhinovirus RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44806146	Partogram (record artifact)	4180186
44806147	Measurement of Rift Valley fever virus immunoglobulin G antibody (procedure)	4180186
44806148	Patient safety checklist (record artifact)	4180186
44806150	Medical photograph (record artifact)	4180186
44806151	Interventional radiology record (record artifact)	4180186
44806152	Controlled drug dispensing record (record artifact)	4180186
44806154	Infectious disease notification (record artifact)	4180186
44806155	Adoption report (record artifact)	4180186
44806158	Depression intensity scale circles score (observable entity)	4180186
44806158	DISCs (depression intensity scale circles) score	4180186
44806159	Chronic obstructive pulmonary disease rescue pack not indicated (situation)	4180186
44806159	COPD (chronic obstructive pulmonary disease) rescue pack not indicated	4180186
44806160	Allotransplantation of lobe of lung from live donor (procedure)	4180186
44806161	Referral to community treatment room (procedure)	4180186
44806163	Weight chart (record artifact)	4180186
44806164	Medical note (record artifact)	4180186
44806166	Outpatient nursing note (record artifact)	4180186
44806168	Phosphorylase measurement (procedure)	4180186
44806170	Galactose-6-sulphatase measurement (procedure)	4180186
44806171	Fructose-1,6-bisphosphatase measurement (procedure)	4180186
44806172	Removal of slough from skin using pressurised fluid jet (procedure)	4180186
44806173	Referral to disablement service (procedure)	4180186
44806174	Respite care available (finding)	4180186
44806175	Letter sent to relative (finding)	4180186
44806177	Did not attend expert patient programme (finding)	4180186
44806181	FP78 payment started (finding)	4180186
44806185	Rehabilitation for acute cardiac disorder (regime/therapy)	4180186
44806186	Rehabilitation for burn (regime/therapy)	4180186
44806188	Alpha globin genotype determination (procedure)	4180186
44806190	Beta globin genotype determination (procedure)	4180186
44806192	Androstenedione/creatinine ratio measurement (procedure)	4180186
44806193	Antenatal depression (disorder)	4180186
44806194	11-beta hydroxyandrosterone measurement (procedure)	4180186
44806199	16 alpha hydroxy dehydroepiandrosterone measurement (procedure)	4180186
44806201	Glucagon-like peptide 1 measurement (procedure)	4180186
44806202	Alcohol and glycol screening test (procedure)	4180186
44806204	Vitamin K1 epoxide measurement (procedure)	4180186
44806205	Reconstruction of intra-articular ligament (procedure)	4180186
44806206	Reconstruction of extra-articular ligament (procedure)	4180186
44806208	Plastic repair of intra-articular ligament (procedure)	4180186
44806212	Reimplantation of coeliac artery (procedure)	4180186
44806215	Reimplantation of suprarenal artery (procedure)	4180186
44806218	Education for lymphoedema care (procedure)	4180186
44806222	Antineutrophil cytoplasmic immunoglobulin G antibody measurement (procedure)	4180186
44806223	CD11b count (procedure)	4180186
44806225	Alpha-2 antiplasmin antigen specific immunoglobulin E antibody measurement (procedure)	4180186
44806227	Carbonate measurement (procedure)	4180186
44806229	Benzodiazepine screening test (procedure)	4180186
44806230	Growth hormone releasing hormone measurement (procedure)	4180186
44806231	Vaginal hysterectomy and pelvic floor repair (procedure)	4180186
44806233	Has UK (United Kingdom) general visitor visa	4180186
44806233	Has United Kingdom general visitor visa (finding)	4180186
44806234	Biopsy of soft tissue of thigh using ultrasonographic guidance (procedure)	4180186
44806234	Ultrasound guided biopsy of soft tissue of thigh	4180186
44806235	Computed tomography of cochlea (procedure)	4180186
44806236	Number of days absent from school due to asthma in past 6 months (observable entity)	4180186
44806237	Possible squint (situation)	4180186
44806237	Possible strabismus	4180186
44806238	Surgical biopsy of glans penis (procedure)	4180186
44806240	Incision of Peyronie plaque and insertion of graft (procedure)	4180186
44806240	Incision of Peyronie's plaque and insertion of graft	4180186
44806240	Lue procedure	4180186
44806242	Computed tomography sinogram of upper limb (procedure)	4180186
44806243	Computed tomography sinogram of lower limb with contrast (procedure)	4180186
44806243	Computed tomography sinogram of lower limb with contrast	4180186
44806244	Radiofrequency ablation using fluoroscopic guidance (procedure)	4180186
44806245	Number of urinary voids in 24 hours (observable entity)	4180186
44806246	On Care Of Next Infant programme (finding)	4180186
44806248	Referral to community diabetes service (procedure)	4180186
44806249	Under care of epilepsy specialist nurse (finding)	4180186
44806250	Advice about sickle cell disease and thalassaemia	4180186
44806250	Education about sickle cell disease and thalassaemia (procedure)	4180186
44806254	Renal function monitoring invitation first letter (procedure)	4180186
44806255	Renal function monitoring invitation second letter (procedure)	4180186
44806256	Renal function monitoring invitation third letter (procedure)	4180186
44806257	Inhaler technique not checked (situation)	4180186
44806260	Quantitative ultrasonography (procedure)	4180186
44806260	Quantitative ultrasound scan	4180186
44806263	Angina self-management plan review (procedure)	4180186
44806269	Marking of skin of spine using fluoroscopic guidance (procedure)	4180186
44806271	Choose and book advice and guidance request (procedure)	4180186
44806272	Measurement of rabies virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44806272	Rabies virus RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44806273	Lateral interbody fusion of lumbar spine (procedure)	4180186
44806274	Measurement of tick borne encephalitis virus immunoglobulin G antibody (procedure)	4180186
44806275	Measurement of yellow fever virus immunoglobulin G antibody (procedure)	4180186
44806279	Measurement of mass ratio of catecholamine to creatinine	4180186
44806279	Measurement of mass ratio of catecholamine to creatinine (procedure)	4180186
44806280	Measurement of Sindbis virus immunoglobulin G antibody (procedure)	4180186
44806281	Detection of severe acute respiratory syndrome virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44806281	SARS (severe acute respiratory syndrome) virus RNA (ribonucleic acid) detection by NAAT (nucleic acid amplification test)	4180186
44806282	Measurement of Ross river virus immunoglobulin G antibody (procedure)	4180186
44806284	Measurement of rotavirus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44806284	Rotavirus RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44806287	Referral to community sigmoidoscopy service (procedure)	4180186
44806290	Detection of West Nile virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44806290	West Nile virus RNA (ribonucleic acid) detection by NAAT (nucleic acid amplification test)	4180186
44806291	Endoscopic submucosal dissection of lesion of duodenum (procedure)	4180186
44806292	Endoscopic mucosal resection of lesion of duodenum (procedure)	4180186
44806294	Alpha heavy chain screening test (procedure)	4180186
44806295	Creatine kinase-MM isoenzyme measurement (procedure)	4180186
44806296	Creatine kinase-BB isoenzyme measurement (procedure)	4180186
44806298	Serine/creatinine ratio measurement (procedure)	4180186
44806300	Leucine/creatinine ratio measurement (procedure)	4180186
44806302	Valine/creatinine ratio measurement (procedure)	4180186
44806304	Glutamine/creatinine ratio measurement (procedure)	4180186
44806307	Lysine/creatinine ratio measurement (procedure)	4180186
44806309	Total coproporphyrin/creatinine ratio measurement (procedure)	4180186
44806310	Total coproporphyrin measurement (procedure)	4180186
44806312	Porphobilinogen screening test (procedure)	4180186
44806313	Seen in school asthma clinic (finding)	4180186
44806315	Dicarboxylate porphyrin measurement (procedure)	4180186
44806317	5-aminolaevulinic acid measurement (procedure)	4180186
44806318	Porphyrin/creatinine ratio measurement (procedure)	4180186
44806322	Rockall acute upper gastrointestinal haemorrhage risk score (assessment scale)	4180186
44806323	Under care of service (finding)	4180186
44806325	Under care of probation service (finding)	4180186
44806330	Dihydropyrimidine dehydrogenase measurement (procedure)	4180186
44806331	N-acetylglucosamine measurement (procedure)	4180186
44806338	Zinc output measurement (procedure)	4180186
44806341	History of cruise vacation (finding)	4180186
44806343	Minimal vaginal blood loss (finding)	4180186
44806344	Gastrostomy tube care management (procedure)	4180186
44806345	General practitioner confinement claim agreed (finding)	4180186
44806346	No bleeding symptom on anticoagulation therapy (situation)	4180186
44806350	Conversion to arthrodesis (procedure)	4180186
44806353	Continuous subcutaneous infusion of therapeutic substance (procedure)	4180186
44806357	Carrier of fragile X gene mutation (finding)	4180186
44806359	Severity of strain in voice (observable entity)	4180186
44806361	Severity of breathiness of voice (observable entity)	4180186
44806364	Multiple sclerosis care plan agreed (finding)	4180186
44806367	Asthma self-management plan agreed (finding)	4180186
44806368	Chronic kidney disease self-management plan agreed (finding)	4180186
44806369	Chronic obstructive pulmonary disease self-management plan agreed (finding)	4180186
44806370	Diabetes self-management plan agreed (finding)	4180186
44806373	Stroke self-management plan agreed (finding)	4180186
44806376	Percutaneous transluminal balloon assisted coil embolisation of aneurysm (procedure)	4180186
44806378	Has firearm certificate (finding)	4180186
44806379	Hepatitis C antigen positive (finding)	4180186
44806380	Cervical smear pus cells present (finding)	4180186
44806381	Cervical smear red blood cells present (finding)	4180186
44806382	Forward trunk flexion gait (finding)	4180186
44806383	Name changed by deed poll (finding)	4180186
44806384	Hip circumduction gait (finding)	4180186
44806386	Cryotherapy to prostate using transrectal ultrasound guidance (procedure)	4180186
44806387	Diuretic target dose achieved (finding)	4180186
44806390	Liaison with social services (procedure)	4180186
44806392	Liaison with anaesthetist (procedure)	4180186
44806396	Liaison with general medical practitioner (procedure)	4180186
44806397	Liaison with dentist (procedure)	4180186
44806398	Active range of right elbow pronation (observable entity)	4180186
44806402	Liaison with psychiatrist (procedure)	4180186
44806403	Liaison with Health Protection Agency (procedure)	4180186
44806406	Hypodermic needle injury (disorder)	4180186
44806407	Infectious bloody diarrhoea	4180186
44806407	Infectious haemorrhagic diarrhoea (disorder)	4180186
44806409	Radiofrequency ablation of soft palate (procedure)	4180186
44806410	EQ-5D-5L (EuroQol five dimension five level) scale	4180186
44806410	EuroQol five dimension five level scale (assessment scale)	4180186
44806411	Assessment using EQ-5D-5L (EuroQol five dimension five level) health outcome measure	4180186
44806411	Assessment using EuroQol five dimension five level health outcome measure (procedure)	4180186
44806412	EQ-5D-5L (EuroQol five dimension five level) mobility score	4180186
44806412	EuroQol five dimension five level mobility score (observable entity)	4180186
44806417	Referral to National Health Service treatment centre (procedure)	4180186
44806418	Suspended from last days of life pathway (finding)	4180186
44806420	Estimation of glomerular filtration rate (procedure)	4180186
44806424	Methadone screening test (procedure)	4180186
44806425	Methadone metabolite screening test (procedure)	4180186
44806426	Transfer to neonatal unit (procedure)	4180186
44806427	Umbilical cord blood gas (observable entity)	4180186
44806428	pH in umbilical cord venous blood (observable entity)	4180186
44806429	Cord venous blood pO2 (partial pressure of oxygen)	4180186
44806429	Partial pressure of oxygen in umbilical cord venous blood (observable entity)	4180186
44806431	Cord venous blood pCO2 (partial pressure of carbon dioxide)	4180186
44806431	Partial pressure of carbon dioxide in umbilical cord venous blood (observable entity)	4180186
44806432	Atazanavir measurement (procedure)	4180186
44806434	pH in umbilical cord arterial blood (observable entity)	4180186
44806436	Cord arterial blood pCO2 (partial pressure of carbon dioxide)	4180186
44806436	Partial pressure of carbon dioxide in umbilical cord arterial blood (observable entity)	4180186
44806438	Zonisamide measurement (procedure)	4180186
44806440	Rifabutin measurement (procedure)	4180186
44806441	Varanic acid measurement (procedure)	4180186
44806442	Screening test for diuretic drug (procedure)	4180186
44806443	Tricyclic drug screening test (procedure)	4180186
44806444	Phenothiazine screening test (procedure)	4180186
44806447	Sodium output measurement (procedure)	4180186
44806448	Bile acid subfraction measurement (procedure)	4180186
44806452	Free dopamine measurement (procedure)	4180186
44806453	Free dopamine output measurement (procedure)	4180186
44806454	Primary reverse polarity total prosthetic replacement of shoulder joint (procedure)	4180186
44806457	Factor VIII antigen level	4180186
44806457	Factor VIII antigen measurement (procedure)	4180186
44806459	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog gene D816V variant screening test (procedure)	4180186
44806460	Outpatient Clinic Attendance - Consultant Referral Letter (record artifact)	4180186
44806462	Outpatient Clinic Attendance - Patient Letter (record artifact)	4180186
44806470	Influenza A nucleic acid detection (procedure)	4180186
44806471	Paroxysmal nocturnal haemoglobinuria glycosyl-phosphatidylinositol measurement (procedure)	4180186
44806471	PNH (paroxysmal nocturnal haemoglobinuria) GPI (glycosyl-PI) level	4180186
44806473	EMA (eosin-5-maleimide) binding site assay	4180186
44806473	Eosin-5-maleimide cell binding study (procedure)	4180186
44806476	Factor VIII deficiency study (procedure)	4180186
44806477	Factor IX deficiency study (procedure)	4180186
44806478	Chromosome fragility study (procedure)	4180186
44806479	Cycle of change stage, alcohol (qualifier value)	4180186
44806481	Complement CH50 measurement (procedure)	4180186
44806482	Specimen collection by aspiration (procedure)	4180186
44806485	Specimen collection by clipping (procedure)	4180186
44806490	Injury of muscle of shoulder (disorder)	4180186
44806491	Dead on arrival in accident and emergency department (finding)	4180186
44806491	DOA (dead on arrival) in accident and emergency department	4180186
44806494	Injury of muscle of upper arm (disorder)	4180186
44806495	Injury of muscle of forearm (disorder)	4180186
44806496	Referral to psychological wellbeing practitioner (procedure)	4180186
44806498	Gastrostomy tube care assessment (procedure)	4180186
44806500	Gastrostomy tube irrigation assessment (procedure)	4180186
44806501	Informing patient of test result (procedure)	4180186
44806502	Peripheral oxygen saturation within target range (finding)	4180186
44806504	Request for telephone language interpreter service (procedure)	4180186
44806505	Securing tracheostomy tube (procedure)	4180186
44806506	Fork mashable dysphagia diet (finding)	4180186
44806508	Thick puree dysphagia diet (finding)	4180186
44806510	Minimal nausea (finding)	4180186
44806511	Verification of patient demographic information (procedure)	4180186
44806513	Normal neurovascular function (finding)	4180186
44806514	Injury of muscle of thigh (disorder)	4180186
44806515	Injury of muscle of lower leg (disorder)	4180186
44806520	Replacement of cylinder of inflatable penile prosthesis (procedure)	4180186
44806525	Extended hours appointment declined (situation)	4180186
44806527	Interstitial laser destruction of lesion of breast using ultrasonographic guidance (procedure)	4180186
44806527	Ultrasound guided interstitial laser destruction of lesion of breast	4180186
44806528	Pathological fracture of humerus (disorder)	4180186
44806530	Tendinosis (disorder)	4180186
44806531	Referral to patient advice and liaison service (procedure)	4180186
44806538	Percutaneous photodynamic therapy of lesion of bile duct using fluoroscopic guidance (procedure)	4180186
44806540	Automated percutaneous lumbar discectomy using fluoroscopic guidance (procedure)	4180186
44806542	Determination of varicella zoster virus genotype by deoxyribonucleic acid analysis (procedure)	4180186
44806542	VZV (Varicella zoster virus) genotype determination by DNA (deoxyribonucleic acid) analysis	4180186
44806543	Measurement of Venezuelan equine encephalitis virus immunoglobulin G antibody (procedure)	4180186
44806543	VEE (Venezuelan equine encephalitis) virus IgG antibody measurement	4180186
44806544	Magnetic resonance imaging of cervix for radiotherapy planning (procedure)	4180186
44806545	Measurement of Saint Louis encephalitis virus immunoglobulin G antibody (procedure)	4180186
44806546	Magnetic resonance imaging of rectum for radiotherapy planning (procedure)	4180186
44806547	Determination of torovirus genotype by ribonucleic acid analysis (procedure)	4180186
44806547	Torovirus genotype determination by RNA (ribonucleic acid) analysis	4180186
44806552	Acute viral meningitis (disorder)	4180186
44806554	Liaison with clinical microbiologist (procedure)	4180186
44806555	BAAF (British Association for Adoption and Fostering) adult 2 fee paid	4180186
44806555	British Association for Adoption and Fostering adult 2 fee paid (finding)	4180186
44806556	Liaison with clinical haematologist (procedure)	4180186
44806558	Liaison with clinical biochemist (procedure)	4180186
44806560	Liaison with clinical virologist (procedure)	4180186
44806565	Butyrylcholinesterase genotype determination (procedure)	4180186
44806568	Screen for zeta associated protein 70 (procedure)	4180186
44806568	Zeta associated protein 70 screen	4180186
44806569	von Willebrand glycoprotein Ib binding measurement (procedure)	4180186
44806569	von Willebrand GPIb (Glycoprotein Ib) binding level	4180186
44806570	Tissue plasminogen activator inhibitor level	4180186
44806570	Tissue plasminogen activator inhibitor measurement (procedure)	4180186
44806572	Primary anterior excision of body of cervical vertebra with reconstruction (procedure)	4180186
44806573	Primary decompression of posterior fossa and upper cervical spinal cord (procedure)	4180186
44806574	Revision anterior excision of body of cervical vertebra with reconstruction (procedure)	4180186
44806575	Revision decompression of posterior fossa and upper cervical spinal cord (procedure)	4180186
44806579	Assessment using Whooley depression screen (procedure)	4180186
44806580	Primary anterior excision of body of lumbar vertebra with reconstruction (procedure)	4180186
44806581	Revision of anterolateral excision of thoracic intervertebral disc and graft (procedure)	4180186
44806588	C29 dicarboxylic acid measurement (procedure)	4180186
44806589	Glucose output measurement (procedure)	4180186
44806591	Metadrenaline output measurement (procedure)	4180186
44806592	Measurement of calculated bicarbonate (procedure)	4180186
44806593	Operation on mitral subvalvar apparatus (procedure)	4180186
44806597	Cycle of change stage, weight management (qualifier value)	4180186
44806598	Specimen collection by resection (procedure)	4180186
44806600	European pressure ulcer advisory panel grade 1 ulcer right foot (disorder)	4180186
44806601	European pressure ulcer advisory panel grade 2 ulcer left foot (disorder)	4180186
44806603	European pressure ulcer advisory panel grade 2 ulcer right foot (disorder)	4180186
44806604	Functional communication therapy management (procedure)	4180186
44806605	Management of vaginal blood loss (procedure)	4180186
44806610	Provision of patient questionnaire (procedure)	4180186
44806611	Child protection category (finding)	4180186
44806613	Child protection category sexual (finding)	4180186
44806614	Child protection category emotional (finding)	4180186
44806615	Child protection category physical (finding)	4180186
44806616	Care plan agreed (finding)	4180186
44806619	Requires telephone language interpreter service (finding)	4180186
44806624	Fitting ureterostomy bag (procedure)	4180186
44806626	Simple orchidectomy with placement of testicular prosthesis by inguinal approach (procedure)	4180186
44806628	Advice on foreign travel - diarrhoea (procedure)	4180186
44806632	Injury of tendon of wrist joint (disorder)	4180186
44806634	Traumatic amputation of tongue (disorder)	4180186
44806635	Injury of tendon of thumb (disorder)	4180186
44806636	Foreign travel advice leaflet given (situation)	4180186
44806637	Pathological fracture dislocation (disorder)	4180186
44806640	Injury of tendon of shoulder joint (disorder)	4180186
44806641	Infection associated with wound (disorder)	4180186
44806642	Infection associated with burn (disorder)	4180186
44806643	Rhabdomyolysis associated with wound (disorder)	4180186
44806645	Foreign body associated with wound (disorder)	4180186
44806649	Digitally guided transrectal biopsy of prostate	4180186
44806649	Transrectal biopsy of prostate using finger guidance (procedure)	4180186
44806653	Cystoscopy and bladder washout (procedure)	4180186
44806656	Neurological injury associated with fracture dislocation (disorder)	4180186
44806657	Vascular injury associated with fracture dislocation (disorder)	4180186
44806658	Pregnancy resulting from assisted conception (finding)	4180186
44806659	Delayed discharge from critical care (finding)	4180186
44806663	Liaison with pathologist (procedure)	4180186
44806664	Laparoscopic laser myomectomy (procedure)	4180186
44806670	Endoscopic laser foraminoplasty of lumbar spine (procedure)	4180186
44806671	Radiofrequency volumetric tissue cauterisation of nasal turbinate	4180186
44806671	Radiofrequency volumetric tissue reduction of nasal turbinate (procedure)	4180186
44806675	Infection resistant to vancomycin (disorder)	4180186
44806677	Liaison with safeguarding children team (procedure)	4180186
44806678	Liaison with histopathologist (procedure)	4180186
44806682	Infection resistant to multiple antibiotics (disorder)	4180186
44806684	Closure of patent foramen ovale using doppler ultrasonographic guidance (procedure)	4180186
44806684	Doppler ultrasound guided closure of patent foramen ovale	4180186
44806685	Proteinuria resolved (finding)	4180186
44806686	Returning patient belongings (procedure)	4180186
44806688	Percutaneous endoscopic laser excision of thoracic intervertebral disc (procedure)	4180186
44806689	Returning patient records (procedure)	4180186
44806690	Endoscopic robot assisted coronary artery bypass (procedure)	4180186
44806691	Falloposcopy with coaxial catheter (procedure)	4180186
44806692	Radiofrequency subthalamotomy (procedure)	4180186
44806694	Guide wire recanalisation of fallopian tube using fluoroscopic guidance (procedure)	4180186
44806696	Smoking cessation drug therapy declined (situation)	4180186
44806697	Exception reporting - peripheral arterial disease quality indicators (finding)	4180186
44806698	Percutaneous transluminal balloon angioplasty of pulmonary vein using fluoroscopy guidance with contrast (procedure)	4180186
44806700	Operation on microvascular vessel (procedure)	4180186
44806702	Operation following glaucoma surgery (procedure)	4180186
44806704	Therapeutic operation on ileoanal pouch (procedure)	4180186
44806706	Histamine H2 receptor antagonist prophylaxis (procedure)	4180186
44806708	Discussion about organ transplantation (procedure)	4180186
44806710	Has anticipatory care plan (finding)	4180186
44806711	Inbound referral (record artifact)	4180186
44806712	Has children and young people acute deterioration management plan (finding)	4180186
44806712	Has CYPADM (children and young people acute deterioration management) plan	4180186
44806713	Outbound referral (record artifact)	4180186
44806714	Dispensing review of use of warfarin (procedure)	4180186
44806715	Children and young people acute deterioration management form (record artifact)	4180186
44806716	Surgery inpatient care management (procedure)	4180186
44806721	Education for visual impairment (procedure)	4180186
44806722	Assessment of vulnerable adult (procedure)	4180186
44806724	Education for long term care (procedure)	4180186
44806725	Child no longer cause for concern (finding)	4180186
44806728	Open repair of strangulated ventral hernia (procedure)	4180186
44806729	Open repair of strangulated ventral hernia with prosthesis (procedure)	4180186
44806730	Open repair of incisional hernia (procedure)	4180186
44806731	Open repair of obstructed incisional hernia (procedure)	4180186
44806732	Open repair of strangulated incisional hernia (procedure)	4180186
44806733	Mental health risk indicator assessment (procedure)	4180186
44806734	Management of anxiety (procedure)	4180186
44806736	Coordination of perioperative care (procedure)	4180186
44806738	Completion of post-resuscitation audit (procedure)	4180186
44806740	Education for ureterostomy care (procedure)	4180186
44806741	Summoning emergency assistance (procedure)	4180186
44806742	Assessment for admission to critical care unit (procedure)	4180186
44806745	Oxygen administration by mask at 60 percent concentration (procedure)	4180186
44806746	Management of body temperature (procedure)	4180186
44806747	Management of fall prevention (procedure)	4180186
44806748	Management of isolation for infection control (procedure)	4180186
44806750	Registered with dentist (finding)	4180186
44806751	Personal care (regime/therapy)	4180186
44806752	Education for bladder voiding technique (procedure)	4180186
44806755	Open rhinoseptoplasty (procedure)	4180186
44806762	Methyltetrahydrofolate measurement (procedure)	4180186
44806763	Immunoreactive lipase measurement (procedure)	4180186
44806764	Lambda light chain output measurement (procedure)	4180186
44806765	Division of tension free vaginal tape (procedure)	4180186
44806765	Division of TVT (tension free vaginal tape)	4180186
44806766	Division of transobturator tape (procedure)	4180186
44806767	Transurethral subtrigonal injection of polydimethylsiloxane bulking agent (procedure)	4180186
44806768	Flexible ureteroscopy (procedure)	4180186
44806769	Rigid ureteroscopy (procedure)	4180186
44806771	Rigid ureteroscopy and collection of ureteral washings (procedure)	4180186
44806772	Flexible ureteroscopy with biopsy of ureter (procedure)	4180186
44806774	Laser endopyelotomy (procedure)	4180186
44806775	Ascending ureterogram of upper moiety of duplex kidney (procedure)	4180186
44806778	Social environment (environment)	4180186
44806782	Extravesical reimplantation of ureter (procedure)	4180186
44806783	Discussion about ectopic pregnancy risk (procedure)	4180186
44806789	Severe monocular visual impairment (disorder)	4180186
44806792	Gastrostomy tube care	4180186
44806792	Maintenance of gastrostomy tube (procedure)	4180186
44806794	Victim of forced marriage (finding)	4180186
44806796	Education about deteriorating heart failure (procedure)	4180186
44806798	Inspiratory positive airway pressure (observable entity)	4180186
44806799	Issue of international yellow fever vaccination certificate (procedure)	4180186
44806802	Laser photocoagulation of subcutaneous congenital vascular malformation (procedure)	4180186
44806805	Anti-obesity drug therapy (procedure)	4180186
44806806	Organ donor card (record artifact)	4180186
44806815	Seasonal influenza vaccination (procedure)	4180186
44806817	Carrier of MCADD (medium chain acyl-coenzyme A dehydrogenase deficiency) gene mutation	4180186
44806817	Carrier of medium chain acyl-coenzyme A dehydrogenase deficiency gene mutation (finding)	4180186
44806818	Endoscopic submucosal dissection of lesion of stomach (procedure)	4180186
44806818	ESD (endoscopic submucosal dissection) of lesion of stomach	4180186
44806819	Endoscopic submucosal dissection of lesion of lower gastrointestinal tract (procedure)	4180186
44806819	ESD (endoscopic submucosal dissection) of lesion of lower gastrointestinal tract	4180186
44806822	Seasonal influenza vaccination not indicated (situation)	4180186
44806826	Infectious systemic inflammatory response syndrome with organ failure (disorder)	4180186
44806827	Systemic inflammatory response syndrome of non-infectious origin without organ failure (disorder)	4180186
44806828	WHO (World Health Organisation) (five) well being-index	4180186
44806828	World Health Organisation (five) well-being index (assessment scale)	4180186
44806830	Maltreatment (event)	4180186
44806832	WHO (World Health Organisation) (five) well being-index score	4180186
44806832	World Health Organisation (five) well-being index score (observable entity)	4180186
44806833	Open repair of obstructed incisional hernia with prosthesis (procedure)	4180186
44806834	Open repair of strangulated incisional hernia with prosthesis (procedure)	4180186
44806835	Open reduction and internal fixation of fractured mandible (procedure)	4180186
44806838	Congestive heart failure, hypertension, age 2, diabetes mellitus, stroke 2, vascular disease, age, sex category score	4180186
44806838	Congestive heart failure, hypertension, age 2, diabetes mellitus, stroke 2, vascular disease, age, sex category score (assessment scale)	4180186
44806839	Dissent for emergency care summary upload (finding)	4180186
44806840	Congestive heart failure, hypertension, age 2, diabetes mellitus, stroke 2 - vascular disease, age, sex category stroke risk score (observable entity)	4180186
44806842	Referral to IMHA (independent mental health advocate)	4180186
44806842	Referral to independent mental health advocate (procedure)	4180186
44806843	Coronary heart disease care plan (record artifact)	4180186
44806845	Breastfeeding support offered (situation)	4180186
44806847	HAS-BLED (hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile INR, elderly over 65, and drugs/alcohol concomitantly) score	4180186
44806847	Hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile international normalised ratio, elderly over 65, and drugs/alcohol concomitantly score	4180186
44806847	Hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile international normalised ratio, elderly over 65, and drugs/alcohol concomitantly score (assessment scale)	4180186
44806848	Intravenous feeding regime (finding)	4180186
44806849	Pholcodine screening test (procedure)	4180186
44806851	Iodine output measurement (procedure)	4180186
44806852	Iron output measurement (procedure)	4180186
44806854	Porphyrin output measurement (procedure)	4180186
44806859	Collection of specimen by syringe (procedure)	4180186
44806862	Breath sample (specimen)	4180186
44806867	Collection of foreign material (procedure)	4180186
44806868	Whooley depression screen score (observable entity)	4180186
44806869	Medication review by practice nurse (procedure)	4180186
44806871	Immature platelet fraction	4180186
44806871	Immature platelet fraction count (procedure)	4180186
44806873	Sensory modality assessment and rehabilitation technique (regime/therapy)	4180186
44806873	SMART - sensory modality assessment and rehabilitation technique	4180186
44806875	No bruising (situation)	4180186
44806876	Worsening exercise tolerance (finding)	4180186
44806877	Colonoscopy planned (situation)	4180186
44806880	Community disease modifying antirheumatic drug monitoring call	4180186
44806880	Community disease modifying antirheumatic drug monitoring call (procedure)	4180186
44806881	Community disease modifying antirheumatic drug monitoring first letter (procedure)	4180186
44806883	Follower of Free Christian Church (person)	4180186
44806883	Free Church	4180186
44806884	Moravian	4180186
44806884	Follower of Moravian Church (person)	4180186
44806885	Referral to support group (procedure)	4180186
44806886	Diastolic blood pressure centile (observable entity)	4180186
44806887	Systolic blood pressure centile (observable entity)	4180186
44806889	Ambulatory care (regime/therapy)	4180186
44806890	F213 report of injury to inmate completed (finding)	4180186
44806892	Epidural infusion care assessment (procedure)	4180186
44806893	Epidural anaesthesia care assessment (procedure)	4180186
44806894	Epidural analgesia care assessment (procedure)	4180186
44806899	Patient door access key code (observable entity)	4180186
44806900	Assessment declined (situation)	4180186
44806902	Intraoperative fluorescence angiography of coronary artery bypass graft (procedure)	4180186
44806904	Percutaneous perineal insertion of extraurethral retropubic adjustable compression device using fluoroscopic guidance (procedure)	4180186
44806905	Review declined (situation)	4180186
44806907	Fibreoptic endoscopic radiofrequency ablation of oesophageal lesion (procedure)	4180186
44806908	Repair of long gap oesophageal atresia by oesophageal lengthening using traction sutures (procedure)	4180186
44806910	Knee replacement planned (situation)	4180186
44806912	Administration of vaccine under patient specific direction (procedure)	4180186
44806915	Provision of patient decision aid (procedure)	4180186
44806917	Referral to British Lung Foundation breathe easy support group (procedure)	4180186
44806919	Antidepressant drug treatment changed (situation)	4180186
44806922	Multidisciplinary care plan (record artifact)	4180186
44806923	Critical care chart (record artifact)	4180186
44806924	Vital signs chart (record artifact)	4180186
44806929	Operation note (record artifact)	4180186
44806931	Clinical letter (record artifact)	4180186
44806932	Under care of vulnerable women service (finding)	4180186
44806933	Under care of safeguarding adult team (finding)	4180186
44806934	LOC1 application for additional payments during sickness form (record artifact)	4180186
44806935	Dizziness on neck extension (finding)	4180186
44806936	Receiving carer allowance (finding)	4180186
44806936	Receiving carer's allowance	4180186
44806937	Oxygen nasal cannula in situ (finding)	4180186
44806939	Chlamydia trachomatis (LGV - lymphogranuloma venereum) serovar DNA (deoxyribonucleic acid) detection	4180186
44806939	Chlamydia trachomatis (lymphogranuloma venereum serovar) deoxyribonucleic acid detection (procedure)	4180186
44806940	Detection of Clostridium difficile antigen (procedure)	4180186
44806941	Verification of expected death (procedure)	4180186
44806944	Range of great toe dorsiflexion	4180186
44806944	Range of hallux dorsiflexion (observable entity)	4180186
44806947	Urostomy aid education (procedure)	4180186
44806948	Consent for key information summary upload (finding)	4180186
44806949	Dissent for key information summary upload (finding)	4180186
44806951	Allograft of skin to head (procedure)	4180186
44806952	Attention to dressing of skin of head (procedure)	4180186
44806953	Dissent for key information summary upload overridden, patient aware (finding)	4180186
44806957	Request received for letter (finding)	4180186
44806959	Community disease modifying antirheumatic drug monitoring second letter (procedure)	4180186
44806960	Community disease modifying antirheumatic drug monitoring third letter (procedure)	4180186
44806961	Repeat prescription for appliance (procedure)	4180186
44806965	Congenital amblyopia (disorder)	4180186
44806970	Urine test due date (observable entity)	4180186
44806971	Faeces test due date (observable entity)	4180186
44806972	Semen analysis due date (observable entity)	4180186
44806973	Community disease modifying antirheumatic drug monitoring verbal invitation	4180186
44806973	Community disease modifying antirheumatic drug monitoring verbal invitation (procedure)	4180186
44806974	Cow milk intolerance (disorder)	4180186
44806976	Community disease modifying antirheumatic drug monitoring telephone invitation (procedure)	4180186
44806978	Contraceptive IUD (intrauterine device) change due date	4180186
44806978	Intrauterine contraceptive device change due date (observable entity)	4180186
44806978	IUCD (intrauterine contraceptive device) change due date	4180186
44806979	Weight screening (procedure)	4180186
44806980	Contraceptive IUD (intrauterine device) check due date	4180186
44806980	Intrauterine contraceptive device check due date (observable entity)	4180186
44806980	IUCD (intrauterine contraceptive device) check due date	4180186
44806981	Diagnostic laparoscopy with diathermy to endometriosis (procedure)	4180186
44806982	Referral for overseas medical treatment (procedure)	4180186
44806983	Bone density scan due date (observable entity)	4180186
44806985	Mild binocular visual impairment (disorder)	4180186
44806989	Patient participation group invitation letter (procedure)	4180186
44806991	Follicular lymphoma grade 3b (morphologic abnormality)	4180186
44806992	Fluid intake volume in 24 hours (observable entity)	4180186
44806994	Measurement of Nipah virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44806994	Nipah virus RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44806996	Measurement of poliovirus 1, 2, and 3 immunoglobulin G antibody/total antibody (procedure)	4180186
44807000	Measurement of Polyomavirus BK deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807000	Polyomavirus BK deoxyribonucleic acid measurement by nucleic acid amplification test	4180186
44807001	Measurement of poliovirus type 1 immunoglobulin G antibody/total antibody (procedure)	4180186
44807003	Measurement of Parainfluenza virus type 1 ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807003	Parainfluenza virus type 1 ribonucleic acid measurement by nucleic acid amplification test	4180186
44807009	Acute myeloid leukaemia with 11q23 abnormality (disorder)	4180186
44807011	Measurement of mumps virus S antigen immunoglobulin G antibody (procedure)	4180186
44807017	Admission letter (record artifact)	4180186
44807018	Letter (record artifact)	4180186
44807020	Unscheduled care letter (record artifact)	4180186
44807023	Under care of hospital admission prevention service (finding)	4180186
44807024	Endoscopic repair of hallux valgus (procedure)	4180186
44807025	Allied health professional therapy record (record artifact)	4180186
44807026	Radiotherapy record (record artifact)	4180186
44807029	Do not attempt cardiopulmonary resuscitation order (record artifact)	4180186
44807031	Non-statutory provider document (record artifact)	4180186
44807032	Letter sent about missed general practitioner appointment (finding)	4180186
44807032	Letter sent about missed GP (general practitioner) appointment	4180186
44807034	Third party document (record artifact)	4180186
44807037	Acute stroke care management (procedure)	4180186
44807039	Delirium care (regime/therapy)	4180186
44807040	Misuses anabolic steroids (finding)	4180186
44807041	History of anabolic steroid misuse (situation)	4180186
44807041	H/O anabolic steroid misuse	4180186
44807042	Detached PEG (percutaneous endoscopic gastrostomy) tube	4180186
44807042	Detachment of PEG (percutaneous endoscopic gastrostomy) tube	4180186
44807042	Detachment of percutaneous endoscopic gastrostomy tube (disorder)	4180186
44807042	Dislodged PEG (percutaneous endoscopic gastrostomy) tube	4180186
44807043	Leaking thoracic aortic aneurysm (disorder)	4180186
44807045	Endoscopic radiofrequency ablation of anal sphincter (procedure)	4180186
44807046	Traumatic amputation above knee (disorder)	4180186
44807050	Single kidney	4180186
44807050	Solitary kidney (finding)	4180186
44807054	Liaison with play therapist (procedure)	4180186
44807055	Liaison with counsellor (procedure)	4180186
44807062	Attention to total prosthetic replacement of shoulder joint (procedure)	4180186
44807063	Revisional excision of intervertebral disc (procedure)	4180186
44807064	Revisional intertransverse fusion of lumbar spine (procedure)	4180186
44807067	Attention to total hip replacement (procedure)	4180186
44807070	Attention to prosthetic hemiarthroplasty of hip (procedure)	4180186
44807072	Revisional posterior fusion of atlantoaxial joint (procedure)	4180186
44807077	Attention to endoprosthesis of bone (procedure)	4180186
44807078	Conversion from previous prosthetic replacement of head of radius (procedure)	4180186
44807079	LOC2 sickness notification form (record artifact)	4180186
44807084	Asthma monitoring due date (observable entity)	4180186
44807086	Dietary surveillance in hypercholesterolaemia (regime/therapy)	4180186
44807087	Screening due date (observable entity)	4180186
44807088	Cervical smear test due date (observable entity)	4180186
44807091	Vaginal vault smear test due date (observable entity)	4180186
44807094	NB-UVB (narrow band ultraviolet B) phototherapy	4180186
44807094	nUVB (narrow band ultraviolet B) phototherapy	4180186
44807094	Phototherapy using 311 nanometres narrowband ultraviolet B lamp (procedure)	4180186
44807096	Medication review due date (observable entity)	4180186
44807097	Insulin passport given (finding)	4180186
44807098	Date eligible for Mat B1 certificate (observable entity)	4180186
44807099	Unilateral gynaecomastia (situation)	4180186
44807100	Insulin alert patient information booklet information discussed (situation)	4180186
44807103	Informed dissent not to carry insulin passport (finding)	4180186
44807107	Dressing of leg ulcer (procedure)	4180186
44807108	Plucking of hair for microscopy and culture (procedure)	4180186
44807111	Determination of Norovirus genotype by ribonucleic acid analysis (procedure)	4180186
44807111	Norovirus genotype determination by ribonucleic acid analysis	4180186
44807112	Measurement of polyomavirus BK immunoglobulin M antibody (procedure)	4180186
44807114	Measurement of Parainfluenza virus type 3 ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807114	Parainfluenza virus type 3 ribonucleic acid measurement by nucleic acid amplification test	4180186
44807116	Measurement of Parainfluenza virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807116	Parainfluenza virus ribonucleic acid measurement by nucleic acid amplification test	4180186
44807118	Night time faecal incontinence (finding)	4180186
44807119	Measurement of Phlebovirus immunoglobulin G antibody/total antibody (procedure)	4180186
44807121	Cardiothoracic ratio (observable entity)	4180186
44807125	Seen by member of family nurse partnership team (finding)	4180186
44807126	Measurement of Poliovirus type 3 ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807126	Poliovirus type 3 RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44807128	Measurement of Parainfluenza virus type 4 ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807128	Parainfluenza virus type 4 ribonucleic acid measurement by nucleic acid amplification test	4180186
44807131	Shared decision making (procedure)	4180186
44807133	Shared decision making without patient decision aid (procedure)	4180186
44807134	Shared decision making with decision support (procedure)	4180186
44807136	Advice about speech (procedure)	4180186
44807137	Cluster of differentiation 56 immunophenotyping (procedure)	4180186
44807141	Variable rate intravenous infusion of insulin (procedure)	4180186
44807142	Liaison with psychotherapist (procedure)	4180186
44807144	Temperature chart (record artifact)	4180186
44807145	Liaison with community psychiatric nurse (procedure)	4180186
44807148	Liaison with person with personal welfare lasting power of attorney (procedure)	4180186
44807149	Liaison with clinical histologist (procedure)	4180186
44807152	Summary record (record artifact)	4180186
44807156	Registered patient lives outside practice area (finding)	4180186
44807160	Ambulatory blood pressure monitoring not indicated (situation)	4180186
44807161	Confusion assessment method short version (assessment scale)	4180186
44807161	Short CAM (confusion assessment method)	4180186
44807163	Name of informal carer (observable entity)	4180186
44807165	Assessment using confusion assessment method short version (procedure)	4180186
44807165	Assessment using short CAM (confusion assessment method)	4180186
44807169	Assessment of needs of carer (procedure)	4180186
44807170	Virology interpretation (observable entity)	4180186
44807171	Influenza H5 virus detected (finding)	4180186
44807173	Cystoscopic removal of ureteric calculus (procedure)	4180186
44807174	Debridement of skin (procedure)	4180186
44807175	Pneumococcal serotype 2 antibody measurement (procedure)	4180186
44807176	Pneumococcal serotype 3 antibody measurement (procedure)	4180186
44807177	Pneumococcal serotype 4 antibody measurement (procedure)	4180186
44807178	Pneumococcal serotype 5 antibody measurement (procedure)	4180186
44807183	Pneumococcal serotype 9V antibody measurement (procedure)	4180186
44807184	Diagnostic endoscopic examination of bladder and biopsy of lesion of prostate (procedure)	4180186
44807186	Transfer of distant skin flap to head (procedure)	4180186
44807192	Pneumococcal serotype 12F antibody measurement (procedure)	4180186
44807195	Pneumococcal serotype 17F antibody measurement (procedure)	4180186
44807199	Pneumococcal serotype 22F antibody measurement (procedure)	4180186
44807200	Pneumococcal serotype 23F antibody measurement (procedure)	4180186
44807201	Pneumococcal serotype 33F antibody measurement (procedure)	4180186
44807202	Canary droppings specific IgE antibody measurement	4180186
44807202	Canary faecal specific immunoglobulin E antibody measurement (procedure)	4180186
44807204	Mixed weed pollen specific immunoglobulin E antibody measurement (procedure)	4180186
44807206	Endovascular insertion of stent graft for aneurysm of aortic bifurcation (procedure)	4180186
44807207	Requires information on digital versatile disc (finding)	4180186
44807207	Requires information on DVD (digital versatile disc)	4180186
44807212	Percutaneous embolisation of splenic vein using fluoroscopic guidance (procedure)	4180186
44807213	Percutaneous embolisation of gastric vein using fluoroscopic guidance (procedure)	4180186
44807222	Post anaesthesia care management (procedure)	4180186
44807224	Professional judgement not to engage patient with insulin alert requirements (finding)	4180186
44807226	NEC - necrotising enterocolitis	4180186
44807226	Necrotising enterocolitis (disorder)	4180186
44807230	End of life advance care plan declined (situation)	4180186
44807233	Informed of international normalised ratio result (situation)	4180186
44807235	Exception reporting - osteoarthritis quality indicators (finding)	4180186
44807236	Excepted from osteoarthritis quality indicators - patient unsuitable (finding)	4180186
44807238	Measurement of plasma unconjugated oestriol multiple of median (procedure)	4180186
44807245	Measurement of pregnancy associated plasma protein A multiple of median (procedure)	4180186
44807245	PAPP-A MoM - pregnancy associated plasma protein A multiple of median	4180186
44807247	Measurement of serum pregnancy associated plasma protein A multiple of median (procedure)	4180186
44807247	Serum PAPP-A MoM (pregnancy associated plasma protein A multiple of median) measurement	4180186
44807250	Laparoscopic nephroureterectomy with pluck lower ureterectomy (procedure)	4180186
44807252	Laparoscopic nephroureterectomy with open lower ureterectomy (procedure)	4180186
44807253	Laparoscopic nephroureterectomy with cystoscopically assisted ureterectomy (procedure)	4180186
44807254	Injection of LHRH (luteinising hormone releasing hormone) agonist	4180186
44807254	Injection of luteinising hormone releasing hormone agonist (procedure)	4180186
44807255	Progressive shortening of uterine cervix (finding)	4180186
44807258	Measurement of blood pressure using non-invasive blood pressure monitor (procedure)	4180186
44807259	Tilapia RAST	4180186
44807259	Tilapia spp. specific IgE antibody measurement	4180186
44807259	Tilapia spp. specific immunoglobulin E antibody measurement (procedure)	4180186
44807260	Violence between family members of subject (finding)	4180186
44807261	Oral fluid buprenorphine level	4180186
44807261	Oral fluid buprenorphine measurement (procedure)	4180186
44807263	Oral fluid amphetamine level	4180186
44807263	Oral fluid amphetamine measurement (procedure)	4180186
44807265	Management of stroke rehabilitation (procedure)	4180186
44807266	Management of diabetes insipidus (procedure)	4180186
44807268	Number of urinary incontinence episodes in 24 hours (observable entity)	4180186
44807269	Has advance statement (Mental Capacity Act 2005) (finding)	4180186
44807271	Has advance decision to refuse life sustaining treatment (Mental Capacity Act 2005)	4180186
44807271	Has advance decision to refuse life sustaining treatment (Mental Capacity Act 2005) (finding)	4180186
44807272	Has appointed person with property and affairs lasting power of attorney (Mental Capacity Act 2005) (finding)	4180186
44807272	Has appointed person with property and affairs LPA (lasting power of attorney) (Mental Capacity Act 2005)	4180186
44807273	Has appointed person with health and welfare lasting power of attorney	4180186
44807273	Has appointed person with personal welfare lasting power of attorney (Mental Capacity Act 2005) (finding)	4180186
44807273	Has appointed person with personal welfare LPA (lasting power of attorney) (Mental Capacity Act 2005)	4180186
44807274	Active range of left hip flexion (observable entity)	4180186
44807277	Passive range of right hip flexion (observable entity)	4180186
44807278	Active range of left hip extension (observable entity)	4180186
44807280	Passive range of left hip extension (observable entity)	4180186
44807282	Active range of left hip abduction (observable entity)	4180186
44807283	Active range of right hip abduction (observable entity)	4180186
44807285	Passive range of right hip abduction (observable entity)	4180186
44807286	Active range of left hip adduction (observable entity)	4180186
44807288	Active range of left hip internal rotation (observable entity)	4180186
44807289	Active range of right hip internal rotation (observable entity)	4180186
44807293	Passive range of left hip adduction (observable entity)	4180186
44807294	Passive range of right hip adduction (observable entity)	4180186
44807299	Active range of left knee flexion (observable entity)	4180186
44807300	Active range of right knee flexion (observable entity)	4180186
44807301	Passive range of left knee flexion (observable entity)	4180186
44807302	Passive range of right knee flexion (observable entity)	4180186
44807304	Active range of right knee extension (observable entity)	4180186
44807305	Passive range of right knee extension (observable entity)	4180186
44807306	Active range of right ankle dorsiflexion	4180186
44807306	Active range of right ankle flexion (observable entity)	4180186
44807310	Passive range of right ankle eversion (observable entity)	4180186
44807312	Requires information on CD (compact disc)	4180186
44807312	Requires information on compact disc (finding)	4180186
44807313	Endovascular insertion of branched stent graft (procedure)	4180186
44807314	Endovascular insertion of fenestrated stent graft (procedure)	4180186
44807315	Endovascular insertion of coated stent	4180186
44807315	Endovascular insertion of drug coated stent (procedure)	4180186
44807317	Requires information on audio cassette tape (finding)	4180186
44807318	Endovascular insertion of metallic stent (procedure)	4180186
44807320	Glycophorin A positive cell count (procedure)	4180186
44807322	Testis specific immunoglobulin G antibody measurement (procedure)	4180186
44807323	Factor IX related antigen immunoglobulin E antibody measurement (procedure)	4180186
44807324	Nasogastric tube insertion management (procedure)	4180186
44807325	Gastrostomy tube insertion management (procedure)	4180186
44807326	Burn care management (procedure)	4180186
44807327	Glomerular basement membrane immunoglobulin G antibody measurement (procedure)	4180186
44807331	Education for constipation care (procedure)	4180186
44807332	Assessment for nasogastric tube insertion (procedure)	4180186
44807333	Assessment for gastrostomy tube insertion (procedure)	4180186
44807334	Education for gastrostomy tube insertion (procedure)	4180186
44807337	Intercellular cement immunoglobulin G antibody measurement (procedure)	4180186
44807340	Requires contact by text relay (finding)	4180186
44807341	LOC3 sickness payment record (record artifact)	4180186
44807342	Double stranded deoxyribonucleic acid immunoglobulin G antibody measurement (procedure)	4180186
44807347	Requires deafblind communicator guide (finding)	4180186
44807348	Haemophilus influenza B immunoglobulin G antibody measurement (procedure)	4180186
44807349	Mixed cereal pollen specific immunoglobulin E antibody measurement (procedure)	4180186
44807351	Exception reporting - rheumatoid arthritis quality indicators (finding)	4180186
44807356	Provision of advice about taking paracetamol (procedure)	4180186
44807357	Raloxifene contraindicated (situation)	4180186
44807358	Teriparatide contraindicated (situation)	4180186
44807359	GP/UMS not okayed by Health Board (finding)	4180186
44807360	Raloxifene not indicated (situation)	4180186
44807361	Teriparatide not indicated (situation)	4180186
44807363	Teriparatide not tolerated (situation)	4180186
44807364	Raloxifene declined (situation)	4180186
44807365	Teriparatide declined (situation)	4180186
44807367	Amylase/creatinine ratio	4180186
44807367	Amylase/creatinine ratio measurement (procedure)	4180186
44807369	Zinc/creatinine ratio	4180186
44807369	Zinc/creatinine ratio measurement (procedure)	4180186
44807374	Atrial fibrillation excluded (situation)	4180186
44807376	Complex skin ulcer care enhanced services administration (procedure)	4180186
44807378	Referral for cardiac event recording (procedure)	4180186
44807379	Complies with dietary regimen (finding)	4180186
44807381	Removal of subcutaneous contraceptive claim (procedure)	4180186
44807382	Stroke initial post discharge review (regime/therapy)	4180186
44807383	Reconstruction of posterolateral corner of knee (procedure)	4180186
44807385	Blood spot free carnitine (procedure)	4180186
44807389	Workplace ergonomics (record artifact)	4180186
44807390	Employment and support allowance (qualifier value)	4180186
44807392	Vital capacity after bronchodilation (observable entity)	4180186
44807393	Care of patient following epidural infusion (regime/therapy)	4180186
44807395	Care of patient following epidural analgesia (regime/therapy)	4180186
44807396	Measurement of Chikungunya virus immunoglobulin M antibody (procedure)	4180186
44807397	Chikungunya virus ribonucleic acid measurement by nucleic acid amplification test	4180186
44807397	Measurement of Chikungunya virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807400	Measurement of Coxiella burnetii phase 1 immunoglobulin G antibody/total antibody (procedure)	4180186
44807403	Reconstruction of ligament of carpometacarpal joint of thumb (procedure)	4180186
44807406	Passive range of right ankle inversion (observable entity)	4180186
44807409	Passive range of left ankle extension (observable entity)	4180186
44807410	Passive range of right ankle extension (observable entity)	4180186
44807412	Capillary filling time of right extremity (observable entity)	4180186
44807412	Capillary refill time of right extremity	4180186
44807416	Horizontal cup disc ratio of left eye (observable entity)	4180186
44807417	Horizontal cup disc ratio of right eye (observable entity)	4180186
44807418	Vertical cup disc ratio of left eye (observable entity)	4180186
44807419	Vertical cup disc ratio of right eye (observable entity)	4180186
44807420	Temperature of left foot (observable entity)	4180186
44807421	Temperature of right foot (observable entity)	4180186
44807424	Superior neuroretinal rim width of left eye (observable entity)	4180186
44807425	Superior neuroretinal rim width of right eye (observable entity)	4180186
44807426	Nasal neuroretinal rim width of left eye (observable entity)	4180186
44807432	Holistic needs assessment (procedure)	4180186
44807433	Provision of copy of discharge letter to patient (procedure)	4180186
44807435	Provision of toileting aid (procedure)	4180186
44807436	Venous thromboembolism prevention management (procedure)	4180186
44807438	Provision of night time positioning aid (procedure)	4180186
44807440	Referral for employment support (procedure)	4180186
44807441	Ganglioside D1b immunoglobulin G antibody measurement (procedure)	4180186
44807443	Lysozyme immunoglobulin G antibody measurement (procedure)	4180186
44807444	Erythropoietin immunoglobulin G antibody measurement (procedure)	4180186
44807446	Acute asthma control management (regime/therapy)	4180186
44807447	Education for artificial airway (procedure)	4180186
44807450	Mixed cereal grain specific immunoglobulin E antibody measurement (procedure)	4180186
44807452	Endovascular insertion of stent into aortic bifurcation (procedure)	4180186
44807455	Education for nasogastric tube care (procedure)	4180186
44807457	Referral to chronic pain management service (procedure)	4180186
44807458	Right dorsalis pedis pulse monophasic (finding)	4180186
44807461	Amputation stump suitable for prosthesis (finding)	4180186
44807463	Right dorsalis pedis pulse biphasic (finding)	4180186
44807464	Urinary elimination care management (procedure)	4180186
44807466	Education for vaginal care (procedure)	4180186
44807466	Vaginal care education	4180186
44807468	Right dorsalis pedis pulse triphasic (finding)	4180186
44807469	Left dorsalis pedis pulse absent (finding)	4180186
44807470	Right dorsalis pedis pulse absent (finding)	4180186
44807473	Left posterior tibial pulse biphasic (finding)	4180186
44807475	Left posterior tibial pulse triphasic (finding)	4180186
44807478	Extra-amniotic injection of abortifacient (procedure)	4180186
44807479	Intra-amniotic injection of abortifacient (procedure)	4180186
44807480	Impaired light touch sensation left foot (finding)	4180186
44807481	Peripheral pulse of left leg, function (observable entity)	4180186
44807482	Peripheral pulse of right leg, function (observable entity)	4180186
44807483	Gynaecology bladder training inpatient care plan (record artifact)	4180186
44807485	Hyperemesis in pregnancy inpatient care plan (record artifact)	4180186
44807488	Hyperemesis in pregnancy care management (procedure)	4180186
44807490	Monitoring of drainage fluid (regime/therapy)	4180186
44807491	Management of patient controlled analgesia (procedure)	4180186
44807494	Blood product transfusion adverse reaction detected (finding)	4180186
44807495	Improved bladder control (finding)	4180186
44807498	Obtaining consent for disposal of fetal tissue (procedure)	4180186
44807499	Obtaining consent for disposal of human tissue (procedure)	4180186
44807500	Management of counselling for change in body image (procedure)	4180186
44807503	Object - subject of information (qualifier value)	4180186
44807504	Referral to pregnancy loss counselling service (procedure)	4180186
44807506	Self management of diabetes (procedure)	4180186
44807510	Checking position of nasogastric tube using pH indicator testing strip (procedure)	4180186
44807512	Assessment of risk prior to nasogastric feeding (procedure)	4180186
44807512	Nasogastric feeding risk assessment	4180186
44807513	Nasogastric tube care assessment (procedure)	4180186
44807515	Measurement of etravirine (procedure)	4180186
44807518	Measurement of Babesia immunoglobulin G antibody/total antibody (procedure)	4180186
44807519	Measurement of human coxsackie B virus immunoglobulin M antibody (procedure)	4180186
44807521	Measurement of human coxsackie B virus immunoglobulin G antibody (procedure)	4180186
44807523	Recurrent ganglion of hand (disorder)	4180186
44807524	Measurement of arbovirus immunoglobulin G antibody/total antibody (procedure)	4180186
44807525	Measurement of enterovirus immunoglobulin G antibody/total antibody (procedure)	4180186
44807527	Determination of enterovirus genotype by ribonucleic acid analysis (procedure)	4180186
44807527	Enterovirus genotype determination by ribonucleic acid analysis	4180186
44807528	Excision of recurrent ganglion of hand (procedure)	4180186
44807529	Enterovirus ribonucleic acid measurement by nucleic acid amplification test	4180186
44807529	Measurement of enterovirus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807531	Primary arthroscopic excision of ganglion of wrist (procedure)	4180186
44807533	Measurement of alphavirus immunoglobulin G antibody/total antibody (procedure)	4180186
44807535	Dengue virus ribonucleic acid measurement by nucleic acid amplification test	4180186
44807535	Measurement of Dengue virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807536	Coronavirus ribonucleic acid measurement by nucleic acid amplification test	4180186
44807536	Measurement of coronavirus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807537	Measurement of Dengue virus immunoglobulin G antibody/total antibody (procedure)	4180186
44807538	Arbovirus ribonucleic acid measurement by nucleic acid amplification test	4180186
44807538	Measurement of arbovirus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807541	Measurement of arbovirus immunoglobulin M antibody (procedure)	4180186
44807542	Astrovirus antigen screening test (procedure)	4180186
44807543	Astrovirus genotype determination by ribonucleic acid analysis	4180186
44807543	Determination of astrovirus genotype by ribonucleic acid analysis (procedure)	4180186
44807544	Adenovirus genotype determination by deoxyribonucleic acid analysis	4180186
44807544	Determination of adenovirus genotype by deoxyribonucleic acid analysis (procedure)	4180186
44807546	Coronavirus genotype determination by ribonucleic acid analysis	4180186
44807546	Determination of coronavirus genotype by ribonucleic acid analysis (procedure)	4180186
44807547	Coxiella burnetii deoxyribonucleic acid detection by nucleic acid amplification test	4180186
44807547	Detection of Coxiella burnetii deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807552	Stabilisation of distal radioulnar joint (procedure)	4180186
44807553	Transfer of extensor indicis proprius tendon to extensor pollicis longus (procedure)	4180186
44807553	Transfer of extensor indicis proprius to extensor pollicis longus (procedure)	4180186
44807557	Medication monitoring administration (procedure)	4180186
44807564	Assessment using LDSQ (learning disability screening questionnaire)	4180186
44807564	Assessment using learning disability screening questionnaire (procedure)	4180186
44807565	LDSQ (learning disability screening questionnaire) score	4180186
44807565	Learning disability screening questionnaire score (observable entity)	4180186
44807566	In-house genitourinary medicine follow-up appointment (procedure)	4180186
44807567	In-house genitourinary medicine discharge (procedure)	4180186
44807570	Sialendoscopically assisted extra-oral removal of stone from parotid duct (procedure)	4180186
44807571	Sialendoscopically assisted intra-oral removal of stone from submandibular duct (procedure)	4180186
44807572	Subtotal cholecystectomy (procedure)	4180186
44807574	Citalopram measurement (procedure)	4180186
44807575	Pyridinoline/creatinine ratio measurement (procedure)	4180186
44807581	Absent light touch sensation left foot (finding)	4180186
44807584	Right ankle reflex normal (finding)	4180186
44807585	Education for internal cardiac defibrillator (procedure)	4180186
44807588	Left ankle reflex absent (finding)	4180186
44807589	Right ankle reflex absent (finding)	4180186
44807590	CD71 transferrin receptor count (procedure)	4180186
44807591	HLA (human leucocyte antigen) B8 serotyping	4180186
44807591	Human leucocyte antigen B8 serotyping (procedure)	4180186
44807593	Allograft of skin to neck (procedure)	4180186
44807596	Admission avoidance care started (situation)	4180186
44807597	Admission avoidance care ended (situation)	4180186
44807598	Aetiocholanolone/androsterone ratio measurement (procedure)	4180186
44807600	MDMA (methylenedioxymethamphetamine) screening test	4180186
44807600	Methylenedioxymethamphetamine screening test (procedure)	4180186
44807605	Clinical management plan updated (finding)	4180186
44807607	Letter written to housing (finding)	4180186
44807609	On waiting list for part 3 (finding)	4180186
44807610	Referred for part 4 accommodation (finding)	4180186
44807611	On waiting list for part 4 (finding)	4180186
44807612	Arthroscopic drilling of lesion of articular cartilage of knee (procedure)	4180186
44807613	Referral to community HIV (human immunodeficiency virus) nurse specialist	4180186
44807613	Referral to community human immunodeficiency virus nurse specialist (procedure)	4180186
44807616	Hip hitching gait (finding)	4180186
44807617	Copy of clinical record requested by insurance company (finding)	4180186
44807619	Copy of clinical record given to patient (finding)	4180186
44807621	Copy of clinical record sent to solicitor (finding)	4180186
44807622	Information prescription declined (finding)	4180186
44807624	Not smiling by 8 weeks old (finding)	4180186
44807625	Acute stroke care (regime/therapy)	4180186
44807626	Management of acute stroke (procedure)	4180186
44807627	Reason for suspension of care plan (observable entity)	4180186
44807629	Measles virus RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44807629	Measurement of measles virus ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807636	Determination of Influenza A virus genotype by ribonucleic acid analysis (procedure)	4180186
44807636	Influenza A virus genotype determination by RNA (ribonucleic acid) analysis	4180186
44807637	Determination of Influenza B virus genotype by ribonucleic acid analysis (procedure)	4180186
44807637	Influenza B virus genotype determination by RNA (ribonucleic acid) analysis	4180186
44807638	HTLV (human T cell lymphotropic virus) type 1 RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44807638	Measurement of human T cell lymphotropic virus type 1 ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807639	Release of collateral ligament of MCP (metacarpophalangeal) joint	4180186
44807639	Release of collateral ligament of metacarpophalangeal joint (procedure)	4180186
44807639	Release of collateral ligament of MPJ (metacarpophalangeal joint)	4180186
44807640	Release of collateral ligament of PIPJ (proximal interphalangeal joint)	4180186
44807640	Release of collateral ligament of proximal interphalangeal joint (procedure)	4180186
44807642	Family no longer cause for concern (finding)	4180186
44807643	OK (Outerbridge-Kashiwagi) procedure	4180186
44807643	Open excision of intra-articular osteophyte of elbow (procedure)	4180186
44807645	Laparoscopic repair of incisional hernia with prosthesis (procedure)	4180186
44807647	Laparoscopic repair of recurrent incisional hernia with prosthesis (procedure)	4180186
44807650	Laparoscopic repair of strangulated ventral hernia (procedure)	4180186
44807651	Laparoscopic repair of strangulated ventral hernia with prosthesis (procedure)	4180186
44807652	Laparoscopic repair of strangulated incisional hernia with prosthesis (procedure)	4180186
44807653	Laparoscopic repair of obstructed ventral hernia (procedure)	4180186
44807654	Laparoscopic repair of obstructed ventral hernia with prosthesis (procedure)	4180186
44807655	Laparoscopic repair of obstructed incisional hernia with prosthesis (procedure)	4180186
44807656	Laparoscopic repair of ventral hernia (procedure)	4180186
44807657	Diagnostic endoscopic examination of ileoanal pouch using colonoscope (procedure)	4180186
44807658	Diagnostic endoscopic examination of ileoanal pouch using fibreoptic sigmoidoscope (procedure)	4180186
44807659	Diagnostic endoscopic examination of colonic pouch using rigid sigmoidoscope (procedure)	4180186
44807662	Excision of pilonidal sinus and closure with skin flap (procedure)	4180186
44807662	Karydakis procedure	4180186
44807663	Fibrinogen level, Klauss	4180186
44807663	Fibrinogen measurement, von Clauss (procedure)	4180186
44807665	Victim of sexual activity without consent (finding)	4180186
44807666	Glycolate output measurement (procedure)	4180186
44807667	Fat globules screening test (procedure)	4180186
44807669	Myelin immunoglobulin G antibody measurement (procedure)	4180186
44807670	Faenia rectivirgula immunoglobulin G antibody measurement (procedure)	4180186
44807671	Immunoglobulin G antibody to PM-1 measurement (procedure)	4180186
44807673	Mushroom specific immunoglobulin G antibody measurement (procedure)	4180186
44807675	Pemphigoid immunoglobulin G antibody measurement (procedure)	4180186
44807677	Thyroid stimulating immunoglobulin G antibody measurement (procedure)	4180186
44807678	Neutrophil oxidative burst study (procedure)	4180186
44807681	Tau protein measurement (procedure)	4180186
44807682	Hyocholic acid measurement (procedure)	4180186
44807686	Cytoplasmic immunoglobulin M mu chain measurement (procedure)	4180186
44807687	Cytoplasmic CD33 count (procedure)	4180186
44807689	Count of cells negative for CD33 antigen and positive for CD34 antigen (procedure)	4180186
44807690	Cytoplasmic CD34 count (procedure)	4180186
44807691	Cytoplasmic CD4 count (procedure)	4180186
44807692	Cytoplasmic CD41 count (procedure)	4180186
44807694	Cytoplasmic CD22 count (procedure)	4180186
44807695	Cytoplasmic CD79 count (procedure)	4180186
44807696	Cytoplasmic myeloperoxidase measurement (procedure)	4180186
44807699	Cytoplasmic lambda light chain measurement (procedure)	4180186
44807701	Cytoplasmic CD7 count (procedure)	4180186
44807706	CD138 count (procedure)	4180186
44807708	Abdominal aortic aneurysm screen ultrasound scan normal (finding)	4180186
44807709	Abdominal aortic aneurysm screen ultrasound scan abnormal (finding)	4180186
44807712	Parent of child in care (finding)	4180186
44807713	Pre-surgery evaluation of lung recipient (procedure)	4180186
44807713	Pretransplant evaluation of lung recipient	4180186
44807714	HIV (human immunodeficiency virus) 1 RNA (ribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44807714	Measurement of human immunodeficiency virus 1 ribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807716	Determination of human papilloma virus genotype by deoxyribonucleic acid analysis (procedure)	4180186
44807716	HPV (human papilloma virus) genotype determination by DNA (deoxyribonucleic acid) analysis	4180186
44807719	Determination of Herpes simplex virus type 1 and 2 deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807719	HSV (herpes simplex virus) type 1 and 2 DNA (deoxyribonucleic acid) determination by NAAT (nucleic acid amplification test)	4180186
44807720	HSV (herpes simplex virus) 1 and 2 IgM antibody measurement	4180186
44807720	Measurement of Herpes simplex virus 1 and 2 immunoglobulin M antibody (procedure)	4180186
44807721	Detection of human herpes virus 8 deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44807721	HHV (human herpes virus) 8 DNA (deoxyribonucleic acid) detection by NAAT (nucleic acid amplification test)	4180186
44807726	Noncompliance with physiotherapy regimen (finding)	4180186
44807729	Determination of hepatitis D virus genotype by ribonucleic acid analysis (procedure)	4180186
44807729	HDV (hepatitis D virus) genotype determination by RNA (ribonucleic acid) analysis	4180186
44807740	Advice to carer regarding child safety around domestic animals (procedure)	4180186
44807743	Advance supply of controlled medication (procedure)	4180186
44807744	Discharge from community specialist palliative care (procedure)	4180186
44807747	Delayed reconstruction of breast with local muscle flap (procedure)	4180186
44807748	Immediate reconstruction of breast with local muscle flap (procedure)	4180186
44807750	Delayed reconstruction of breast with pedicled TRAM (transverse rectus abdominis myocutaneous) flap	4180186
44807750	Delayed reconstruction of breast with pedicled transverse rectus abdominis myocutaneous flap (procedure)	4180186
44807755	Immediate reconstruction of breast with TRAM (transverse rectus abdominis myocutaneous) flap	4180186
44807755	Immediate reconstruction of breast with transverse rectus abdominis myocutaneous flap (procedure)	4180186
44807756	Delayed reconstruction of breast with TRAM (transverse rectus abdominis myocutaneous) flap	4180186
44807756	Delayed reconstruction of breast with transverse rectus abdominis myocutaneous flap (procedure)	4180186
44807758	Delayed reconstruction of breast with free flap (procedure)	4180186
44807759	Immediate reconstruction of breast with deep inferior epigastric perforator skin flap (procedure)	4180186
44807759	Immediate reconstruction of breast with DIEP (deep inferior epigastric perforator) skin flap	4180186
44807760	Delayed reconstruction of breast with deep inferior epigastric perforator skin flap (procedure)	4180186
44807760	Delayed reconstruction of breast with DIEP (deep inferior epigastric perforator) skin flap	4180186
44807762	Immediate reconstruction of breast with submuscular implant (procedure)	4180186
44807763	Delayed reconstruction of breast with submuscular implant (procedure)	4180186
44807764	Reconstruction of breast with submuscular implant and reconstructive tissue matrix (procedure)	4180186
44807766	Delayed reconstruction of breast with submuscular implant and reconstructive tissue matrix (procedure)	4180186
44807768	Measurement of prothrombin immunoglobulin G antibody (procedure)	4180186
44807771	Coagulation factor II antigen level	4180186
44807771	Measurement of coagulation factor II antigen (procedure)	4180186
44807773	Coagulation factor VII antigen level	4180186
44807773	Measurement of coagulation factor VII antigen (procedure)	4180186
44807774	Coagulation factor IX antigen level	4180186
44807774	Measurement of coagulation factor IX antigen (procedure)	4180186
44807776	Coagulation factor XI antigen level	4180186
44807776	Measurement of coagulation factor XI antigen (procedure)	4180186
44807780	Photography of face (procedure)	4180186
44807781	Analysis of gait (procedure)	4180186
44807782	Inflation of breast tissue expander (procedure)	4180186
44807784	Laparoscopically assisted left hemicolectomy (procedure)	4180186
44807785	Open extended left hemicolectomy (procedure)	4180186
44807791	Active range of left shoulder abduction (observable entity)	4180186
44807794	Laparoscopically assisted transverse colectomy (procedure)	4180186
44807796	Open sigmoid colectomy (procedure)	4180186
44807797	Laparoscopic sigmoid colectomy (procedure)	4180186
44807798	Laparoscopic sigmoid colectomy converted to open (procedure)	4180186
44807799	Has involved healthcare professional in discussion about advance care planning (finding)	4180186
44807801	Laparoscopically assisted subtotal colectomy (procedure)	4180186
44807802	Laparoscopic subtotal colectomy (procedure)	4180186
44807803	Laparoscopic subtotal colectomy converted to open (procedure)	4180186
44807804	Open total colectomy (procedure)	4180186
44807805	Laparoscopically assisted total colectomy (procedure)	4180186
44807806	Laparoscopic total colectomy (procedure)	4180186
44807808	Combined hepatitis A and B vaccination declined (situation)	4180186
44807811	Open panproctocolectomy (procedure)	4180186
44807812	Laparoscopically assisted panproctocolectomy (procedure)	4180186
44807813	Laparoscopic panproctocolectomy (procedure)	4180186
44807815	Testosterone replacement therapy (procedure)	4180186
44807816	Ageing males' symptoms scale (assessment scale)	4180186
44807820	Initiation of suicide risk management document (procedure)	4180186
44807822	Provision of written information about diet and nutrition (procedure)	4180186
44807828	Provision of written information about intrauterine contraceptive device (procedure)	4180186
44807828	Provision of written information about IUCD (intrauterine contraceptive device)	4180186
44807834	Provision of written information about intramuscular contraceptive injection (procedure)	4180186
44807836	Provision of written information about cervical smear test (procedure)	4180186
44807839	Provision of written information about progestogen only oral contraception (procedure)	4180186
44807842	Provision of written information about male and female condoms (procedure)	4180186
44807843	BAAF (British Association for Adoption and Fostering) form C/D fee paid	4180186
44807843	British Association for Adoption and Fostering form C/D fee paid (finding)	4180186
44807844	Provision of written information about disease modifying antirheumatic drug (procedure)	4180186
44807848	Provision of written information about contraceptive cap	4180186
44807848	Provision of written information about diaphragm contraception (procedure)	4180186
44807849	Provision of written information about ear care (procedure)	4180186
44807851	Provision of written information about organ donation (procedure)	4180186
44807852	Provision of written information about blood donation (procedure)	4180186
44807854	Provision of written information about immunisation (procedure)	4180186
44807857	Assessment using diabetes quality of life questionnaire (procedure)	4180186
44807858	Consent given for Electronic Prescription Service (finding)	4180186
44807858	Consent given for EPS (Electronic Prescription Service)	4180186
44807860	Influenza B nucleic acid detection (procedure)	4180186
44807861	Clarke hypoglycaemia awareness questionnaire (assessment scale)	4180186
44807864	Seen in ear care clinic (finding)	4180186
44807866	Major urological surgery inpatient care plan (record artifact)	4180186
44807868	Education about ketoacidosis (procedure)	4180186
44807871	Education about diabetic nephropathy (procedure)	4180186
44807872	Kamath and Stothard carpal tunnel syndrome questionnaire (assessment scale)	4180186
44807873	Education about diabetic retinopathy (procedure)	4180186
44807875	Aneurysm of needle site of dialysis arteriovenous fistula (disorder)	4180186
44807876	Moving and handling equipment available at home (finding)	4180186
44807878	Referral to health psychologist (procedure)	4180186
44807879	Current palliative oncology treatment (record artifact)	4180186
44807881	Baseline waist circumference (observable entity)	4180186
44807882	Baseline BMI (body mass index) centile	4180186
44807882	Baseline body mass index centile (observable entity)	4180186
44807884	General Practitioner Referral (record artifact)	4180186
44807886	General Practitioner Referral Accept Response (record artifact)	4180186
44807889	Insertion of oesophageal pH monitoring device using fluoroscopic guidance (procedure)	4180186
44807891	Insertion of oesophageal manometry catheter using fluoroscopic guidance (procedure)	4180186
44807892	Amyloid cardiomyopathy (disorder)	4180186
44807893	Endoscopic balloon dilatation of bronchus (procedure)	4180186
44807895	Acute non-infective exacerbation of chronic obstructive pulmonary disease (disorder)	4180186
44807895	Acute non-infective exacerbation of COPD (chronic obstructive pulmonary disease)	4180186
44807897	Fitting of mandibular advancement device (procedure)	4180186
44807898	Loosening of tension free vaginal tape (procedure)	4180186
44807898	Loosening of TVT (tension free vaginal tape)	4180186
44807899	Referral to post-amputation rehabilitation service (procedure)	4180186
44807900	Medically induced evacuation of retained products of conception using prostaglandin (procedure)	4180186
44807903	Education about intraosseous device care (procedure)	4180186
44807906	Therapeutic percutaneous aspiration of spinal cyst using computed tomography guidance (procedure)	4180186
44807907	Therapeutic percutaneous aspiration of spinal cyst using magnetic resonance imaging guidance (procedure)	4180186
44807908	Telehealth encounter type (record artifact)	4180186
44807910	Percutaneous insertion of left atrial appendage closure device using fluoroscopic guidance (procedure)	4180186
44807910	Percutaneous occlusion of left atrial appendage	4180186
44807913	Insertion of permanent biventricular pacemaker lead using fluoroscopic guidance (procedure)	4180186
44807915	Provision of written information about anger management (procedure)	4180186
44807917	Dilatation of urethra using urethral sound (procedure)	4180186
44807918	Ultrasonography of multiple pregnancy (procedure)	4180186
44807918	Ultrasound scan of multiple pregnancy	4180186
44807920	Suicide risk unchanged from previous level (finding)	4180186
44807921	Medical Research Council muscle power score of elbow extension (observable entity)	4180186
44807923	Medical Research Council muscle power score of elbow supination (observable entity)	4180186
44807924	Open high anterior resection	4180186
44807924	Open high anterior resection of rectum (procedure)	4180186
44807925	Laparoscopically assisted high anterior resection	4180186
44807925	Laparoscopically assisted high anterior resection of rectum (procedure)	4180186
44807926	Medical Research Council muscle power score of elbow pronation (observable entity)	4180186
44807927	Laparoscopically assisted low anterior resection	4180186
44807927	Laparoscopically assisted low anterior resection of rectum (procedure)	4180186
44807929	Laparoscopic high anterior resection	4180186
44807929	Laparoscopic high anterior resection of rectum (procedure)	4180186
44807930	Laparoscopic low anterior resection	4180186
44807930	Laparoscopic low anterior resection of rectum (procedure)	4180186
44807932	Medical Research Council muscle power score of ankle eversion (observable entity)	4180186
44807933	Laparoscopic high anterior resection converted to open	4180186
44807933	Laparoscopic high anterior resection of rectum converted to open (procedure)	4180186
44807938	Laparoscopic abdominoperineal resection (procedure)	4180186
44807940	Has chronic obstructive pulmonary disease care plan (finding)	4180186
44807942	Acute medicine (qualifier value)	4180186
44807944	Emergency ambulance service (qualifier value)	4180186
44807946	Cardiac rehabilitation service (qualifier value)	4180186
44807948	Community midwifery (qualifier value)	4180186
44807949	Community psychiatric nursing (qualifier value)	4180186
44807951	ECG - electrocardiograph	4180186
44807951	Electrocardiograph (record artifact)	4180186
44807952	Urodynamics record (record artifact)	4180186
44807956	Medical Research Council muscle power score of wrist adduction (observable entity)	4180186
44807957	Medical Research Council muscle power score of wrist extension (observable entity)	4180186
44807958	Medical Research Council muscle power score of wrist pronation (observable entity)	4180186
44807960	Assessment using Clarke hypoglycaemia awareness questionnaire (procedure)	4180186
44807961	Determination of nMAD.nNMT (product of normalised metadrenaline and normalised normetadrenaline)	4180186
44807961	Determination of product of metanephrine and normetanephrine values normalised for age and sex (procedure)	4180186
44807961	Normalised metadrenaline product	4180186
44807962	Education about risk of breast cancer (procedure)	4180186
44807963	Skin disorder of perineum (disorder)	4180186
44807964	Skin disorder of genitalia (disorder)	4180186
44807965	Setting health objective (procedure)	4180186
44807966	Verification of completion of HSA1 therapeutic termination of pregnancy form (procedure)	4180186
44807967	Unable to maintain own airway (finding)	4180186
44807969	Closed wound care (regime/therapy)	4180186
44807970	Absence of signs and symptoms of wound cross infection (situation)	4180186
44807971	At risk of institutional abuse (finding)	4180186
44807976	Percutaneous transluminal drug eluting balloon angioplasty using fluoroscopic guidance (procedure)	4180186
44807977	Human papillomavirus vaccination invitation (procedure)	4180186
44807978	Human papillomavirus vaccination invitation first letter (procedure)	4180186
44807981	Measles mumps rubella catch-up vaccination invitation (procedure)	4180186
44807983	Good response to treatment (situation)	4180186
44807986	EQ-5D (EuroQol five dimension) self-report questionnaire score	4180186
44807986	EuroQol five dimension self-report questionnaire score (observable entity)	4180186
44807987	At risk of blood-borne virus infection (finding)	4180186
44807988	Not aware of referral (finding)	4180186
44807991	Endotracheal aspirate (specimen)	4180186
44807991	ETA - endotracheal aspirate	4180186
44807992	Measurement of foscarnet sodium (procedure)	4180186
44807997	Cutting balloon dilatation of trachea using fluoroscopic guidance (procedure)	4180186
44807998	Amyloid of stomach	4180186
44807998	Amyloidosis of stomach (disorder)	4180186
44808002	QRISK2 cardiovascular disease risk assessment declined (situation)	4180186
44808003	Rheumatoid arthritis annual review (regime/therapy)	4180186
44808004	Biventricular pacing	4180186
44808004	Cardiac resynchronisation therapy (procedure)	4180186
44808004	CRT - cardiac resynchronisation therapy	4180186
44808005	Denosumab contraindicated (situation)	4180186
44808009	Electrocardiogram rhythm strip monitoring	4180186
44808009	Electrocardiogram rhythm strip monitoring (procedure)	4180186
44808011	Fluoroscopy guided insertion of nontunnelled central venous catheter via external jugular vein	4180186
44808011	Insertion of non-tunnelled central venous catheter via external jugular vein using fluoroscopic guidance (procedure)	4180186
44808012	Fluoroscopy guided nontunnelled central venous catheter via subclavian vein	4180186
44808012	Insertion of non-tunnelled central venous catheter via subclavian vein using fluoroscopic guidance (procedure)	4180186
44808013	Fluoroscopy guided insertion of nontunnelled central venous catheter via common femoral vein	4180186
44808013	Insertion of non-tunnelled central venous catheter via common femoral vein using fluoroscopic guidance (procedure)	4180186
44808014	Fluoroscopy guided insertion of nontunnelled central venous catheter	4180186
44808014	Insertion of non-tunnelled central venous catheter using fluoroscopic guidance (procedure)	4180186
44808015	Follicular lymphoma grade 1 (disorder)	4180186
44808016	Insertion of non-tunnelled central venous catheter using ultrasonography guidance (procedure)	4180186
44808016	Ultrasound guided insertion of nontunnelled central venous catheter	4180186
44808019	Insertion of non-tunnelled central venous catheter via femoral vein using ultrasonography guidance (procedure)	4180186
44808019	Ultrasound guided insertion of nontunnelled central venous catheter via femoral vein	4180186
44808023	Low back pain clinical pathway (regime/therapy)	4180186
44808024	Intra-arterial injection of chemotherapy agent into ophthalmic artery using fluoroscopic guidance with contrast	4180186
44808024	Intra-arterial injection of antineoplastic agent into ophthalmic artery using fluoroscopic guidance with contrast (procedure)	4180186
44808025	Constipation in children clinical pathway (regime/therapy)	4180186
44808029	Medical Research Council muscle power score of hip adduction (observable entity)	4180186
44808031	Medical Research Council muscle power score of hip internal rotation (observable entity)	4180186
44808032	Medical Research Council muscle power score of hip flexion (observable entity)	4180186
44808034	Rehabilitation - intent (qualifier value)	4180186
44808037	Gene expression assay (procedure)	4180186
44808038	Paediatric audiological medicine (qualifier value)	4180186
44808043	Perinatal psychiatry (qualifier value)	4180186
44808045	Paediatric gastrointestinal surgery (qualifier value)	4180186
44808048	BAAF (British Association for Adoption and Fostering) B1 fee paid	4180186
44808048	British Association for Adoption and Fostering B1 fee paid (finding)	4180186
44808051	Paediatric plastic surgery (qualifier value)	4180186
44808052	Paediatric urology (qualifier value)	4180186
44808056	Community sexual and reproductive health (qualifier value)	4180186
44808058	Paediatric thoracic surgery (qualifier value)	4180186
44808059	Paediatric trauma and orthopaedics (qualifier value)	4180186
44808060	Oral pathology (qualifier value)	4180186
44808064	Health visiting (qualifier value)	4180186
44808065	Homeopathy service (qualifier value)	4180186
44808069	Well man service (qualifier value)	4180186
44808070	Referral to community audiology clinic (procedure)	4180186
44808074	Plasma specimen with lithium heparin (specimen)	4180186
44808076	Whole blood specimen with heparin (specimen)	4180186
44808078	Whole blood specimen with perchlorate (specimen)	4180186
44808082	Sample from rested subject (finding)	4180186
44808084	Carer has complex care needs (finding)	4180186
44808085	Endoscopic radical excision of inguinal lymph nodes (procedure)	4180186
44808086	BAAF (British Association for Adoption and Fostering) form C/D fee unpaid	4180186
44808086	British Association for Adoption and Fostering form C/D fee unpaid (finding)	4180186
44808088	Referral to community rheumatology clinic (procedure)	4180186
44808090	Referral to community neurology clinic (procedure)	4180186
44808091	Collection of catheter tip as specimen (procedure)	4180186
44808092	Referral to community leg ulcer clinic (procedure)	4180186
44808094	Endoscopic wide local excision of breast lesion (procedure)	4180186
44808097	Collection of water	4180186
44808097	Collection of water specimen (procedure)	4180186
44808101	Measurement of emtricitabine (procedure)	4180186
44808102	Provision of information on services for carers (procedure)	4180186
44808105	Measurement of tenofovir disoproxil (procedure)	4180186
44808108	Measurement of darunavir (procedure)	4180186
44808111	Collection of specimen by lumbar puncture (procedure)	4180186
44808115	Biopsy of sentinel lymph node of breast (procedure)	4180186
44808116	Sampling of sentinel lymph node of breast (procedure)	4180186
44808117	Follicular lymphoma grade 3a (disorder)	4180186
44808118	Follicular lymphoma grade 3b (disorder)	4180186
44808120	Fluoroscopy guided insertion of portacath	4180186
44808120	Insertion of implantable venous access port using fluoroscopic guidance (procedure)	4180186
44808123	Reduction mastopexy (procedure)	4180186
44808125	End of life care pathway (regime/therapy)	4180186
44808126	Rupture of artery of transplanted kidney (disorder)	4180186
44808129	Stenosis of vein of transplanted kidney (disorder)	4180186
44808132	EPUAP (European pressure ulcer advisory panel) grade of pressure ulcer of right knee	4180186
44808132	European pressure ulcer advisory panel grade of pressure ulcer of right knee (observable entity)	4180186
44808135	EPUAP (European pressure ulcer advisory panel) grade of pressure ulcer of left hip	4180186
44808135	European pressure ulcer advisory panel grade of pressure ulcer of left hip (observable entity)	4180186
44808136	QFracture risk calculator score (observable entity)	4180186
44808137	Assessment using QFracture risk calculator (procedure)	4180186
44808138	Admit anticoagulation emergency (procedure)	4180186
44808139	Shortage of level 3 beds	4180186
44808139	Shortage of beds in intensive therapy unit (finding)	4180186
44808139	Shortage of beds in ITU (intensive therapy unit)	4180186
44808144	Well woman service (qualifier value)	4180186
44808147	Children's nursing (qualifier value)	4180186
44808148	Respiratory physiology (qualifier value)	4180186
44808150	Paediatric pain management (qualifier value)	4180186
44808151	Psychiatric intensive care (qualifier value)	4180186
44808155	National Health Service 24 (qualifier value)	4180186
44808157	Nursery nursing (qualifier value)	4180186
44808159	Obstetrics - postnatal (qualifier value)	4180186
44808160	Transfer profile form completed (finding)	4180186
44808161	Medical Research Council muscle power score of left ankle inversion (observable entity)	4180186
44808164	Discussion about out of hours care management plan (procedure)	4180186
44808165	Medical Research Council muscle power score of right hip extension (observable entity)	4180186
44808169	Medical Research Council muscle power score of left knee extension (observable entity)	4180186
44808173	Not eligible for adult social care package (finding)	4180186
44808174	National Health Service 111 Final Ambulance Request (record artifact)	4180186
44808178	General practice obstetrics (qualifier value)	4180186
44808180	Surgical podiatry (qualifier value)	4180186
44808181	Therapeutic radiography (qualifier value)	4180186
44808182	Virology (qualifier value)	4180186
44808183	Collection of post mortem specimen (procedure)	4180186
44808186	Measurement of ritonavir (procedure)	4180186
44808188	Consultation for complex sexual health need (procedure)	4180186
44808189	Measurement of saquinavir (procedure)	4180186
44808190	Visceral fat percentage of total body composition (observable entity)	4180186
44808192	Collection of specimen by smear (procedure)	4180186
44808193	Blood test declined (situation)	4180186
44808194	Snip biopsy sample	4180186
44808194	Specimen obtained by snip biopsy (specimen)	4180186
44808195	Collection of specimen by trephination (procedure)	4180186
44808198	Collection of prosthesis as specimen (procedure)	4180186
44808199	Hepatitis B vaccination not offered (situation)	4180186
44808201	Discharge from in-house dermatology (procedure)	4180186
44808202	Discharge from in-house ear, nose and throat service (procedure)	4180186
44808202	In-house ENT (ear, nose, throat) discharge	4180186
44808204	Discharge from in-house orthopaedic service (procedure)	4180186
44808205	Computed tomography arthrography of cervical facet joint with contrast (procedure)	4180186
44808205	Computed tomography arthrography of cervical zygapophyseal joint with contrast	4180186
44808205	CT arthrogram of cervical facet joint with contrast	4180186
44808208	Diabetic retinopathy screening declined (situation)	4180186
44808211	Falls risk assessment tool score (observable entity)	4180186
44808211	FRAT (falls risk assessment tool) score	4180186
44808215	Computed tomography arthrography of hip with contrast (procedure)	4180186
44808215	CT arthrogram of hip with contrast	4180186
44808223	Fluoroscopic arthrogram of interphalangeal joint with contrast	4180186
44808223	Fluoroscopic arthrography of interphalangeal joint with contrast (procedure)	4180186
44808227	Ibandronic acid not tolerated (situation)	4180186
44808228	Zoledronic acid monohydrate not tolerated (situation)	4180186
44808230	Adverse incident probably preventable within current resource (finding)	4180186
44808231	Calcitonin not tolerated (situation)	4180186
44808234	Falls care pathway (regime/therapy)	4180186
44808237	Calcitonin not indicated (situation)	4180186
44808239	History of ibandronic acid allergy (situation)	4180186
44808243	Adverse incident not obviously preventable by any change of practice (finding)	4180186
44808244	History of calcitonin allergy (situation)	4180186
44808248	Measurement of recombinant Ara h3 Arachis hypogaea specific immunoglobulin E antibody (procedure)	4180186
44808248	Measurement of recombinant Ara h3 peanut specific immunoglobulin E antibody (procedure)	4180186
44808248	Recombinant Ara h3 peanut specific IgE antibody level	4180186
44808250	Intravenous infusion of iron (procedure)	4180186
44808253	QCancer gastro-oesophageal cancer risk calculator (assessment scale)	4180186
44808255	QCancer renal cancer risk calculator (assessment scale)	4180186
44808256	QCancer ovarian cancer risk calculator (assessment scale)	4180186
44808257	QCancer pancreatic cancer risk calculator (assessment scale)	4180186
44808261	Seen in chronic obstructive pulmonary disease clinic (finding)	4180186
44808261	Seen in COPD (chronic obstructive pulmonary disease) clinic	4180186
44808262	School visit note (record artifact)	4180186
44808265	High risk of TIA (transient ischaemic attack)	4180186
44808265	High risk of transient ischaemic attack (finding)	4180186
44808266	Chronic obstructive pulmonary disease rescue pack declined (situation)	4180186
44808266	COPD (chronic obstructive pulmonary disease) rescue pack declined	4180186
44808269	Provision of oxygen alert card (procedure)	4180186
44808270	Provision of written information about tobacco use cessation (procedure)	4180186
44808271	Management of complementary therapy (procedure)	4180186
44808273	Provision of written information about tobacco use (procedure)	4180186
44808274	Community care plan (record artifact)	4180186
44808275	Education about hallucinations (procedure)	4180186
44808276	Optimal cognitive function (finding)	4180186
44808277	Provision of written information about diabetes and driving (procedure)	4180186
44808278	Liaison with school nurse (procedure)	4180186
44808279	eGFR (estimated glomerular filtration rate) using CKD-Epi (Chronic Kidney Disease Epidemiology Collaboration) formula	4180186
44808279	Estimated glomerular filtration rate using Chronic Kidney Disease Epidemiology Collaboration formula (observable entity)	4180186
44808282	Paediatric neurodisability (qualifier value)	4180186
44808284	4-hydroxy-2-oxoglutarate aldolase deficiency	4180186
44808284	Oxalosis type 3	4180186
44808284	Primary hyperoxaluria, type III (disorder)	4180186
44808285	Injury of tendon of ankle (disorder)	4180186
44808287	Nutrition and Diet Resources United Kingdom stage 1 thickened fluid diet (finding)	4180186
44808291	Adheres to medication regimen (finding)	4180186
44808295	Paediatric metabolic medicine (qualifier value)	4180186
44808297	Discussion about medication regimen adherence (procedure)	4180186
44808299	Ultrasonics	4180186
44808299	Ultrasound diagnostic imaging - specialty (qualifier value)	4180186
44808301	CART (cocaine and amphetamine regulated transcript) level	4180186
44808301	CART (cocaine and amphetamine regulated transcript) measurement	4180186
44808301	Cocaine and amphetamine regulated transcript level	4180186
44808301	Cocaine and amphetamine regulated transcript peptide level	4180186
44808301	Measurement of cocaine and amphetamine regulated transcript (procedure)	4180186
44808302	12 week virologic response to hepatitis C treatment (situation)	4180186
44808304	Professional narrative (record artifact)	4180186
44808307	Application of hydrogel dressing (procedure)	4180186
44808308	Application of vapour-permeable dressing (procedure)	4180186
44808313	Application of protease modulating matrix dressing (procedure)	4180186
44808315	Fluoroscopic arthrogram of midtarsal joint with contrast	4180186
44808315	Fluoroscopic arthrography of midtarsal joint with contrast (procedure)	4180186
44808317	Fluoroscopic arthrogram of metatarsophalangeal joint with contrast	4180186
44808317	Fluoroscopic arthrography of metatarsophalangeal joint with contrast (procedure)	4180186
44808319	Radionuclide thyroid uptake study using Tc-99 (technetium 99m) MIBI (methoxyisobutylisonitrile)	4180186
44808319	Radionuclide thyroid uptake study using technetium 99m methoxyisobutylisonitrile (procedure)	4180186
44808320	Planned treatment (record artifact)	4180186
44808321	Planned palliative oncology treatment (record artifact)	4180186
44808324	Acute secondary care intervention on development of symptoms (record artifact)	4180186
44808328	Acute intervention on development of symptoms (record artifact)	4180186
44808330	Heart Manual programme started (situation)	4180186
44808331	Heart Manual programme completed (situation)	4180186
44808332	Heart Manual programme declined (situation)	4180186
44808333	Epilepsy management plan given (situation)	4180186
44808337	Current supportive care for terminal illness (record artifact)	4180186
44808339	Duplicate patient record (finding)	4180186
44808340	Acute renal failure induced by cyclosporin A (disorder)	4180186
44808343	Assessment using QCancer lung cancer risk calculator (procedure)	4180186
44808345	Assessment using QCancer gastro-oesophageal cancer risk calculator (procedure)	4180186
44808349	QCancer risk (observable entity)	4180186
44808351	QCancer gastro-oesophageal cancer risk (observable entity)	4180186
44808354	QCancer pancreatic cancer risk (observable entity)	4180186
44808357	QKidney disease risk calculator (assessment scale)	4180186
44808359	Assessment using QKidney disease risk calculator (procedure)	4180186
44808364	Measurement of vegetables mix specific immunoglobulin E antibody (procedure)	4180186
44808364	Vegetables mix RAST test	4180186
44808365	Assessment of risk for deprivation of liberty in accordance with Mental Capacity Act 2005 deprivation of liberty safeguards Code of Practice (procedure)	4180186
44808365	Assessment of risk for deprivation of liberty in accordance with Mental Capacity Act 2005 Deprivation of liberty safeguards Code of Practice (procedure)	4180186
44808366	At risk of deprivation of liberty under Mental Capacity Act 2005 (finding)	4180186
44808368	Standard authorisation for deprivation of liberty under Mental Capacity Act 2005 given (finding)	4180186
44808369	Staff member under pressure to proceed (finding)	4180186
44808370	Standard authorisation for deprivation of liberty under Mental Capacity Act 2005 declined (finding)	4180186
44808372	Measurement of thiopurine methyltransferase activity (procedure)	4180186
44808373	Impaired glucose regulation (disorder)	4180186
44808373	Non-diabetic hyperglycaemia	4180186
44808374	Warfarin daily dose (observable entity)	4180186
44808376	Alendronic acid declined (situation)	4180186
44808378	Antimalarial drug prophylaxis stopped (situation)	4180186
44808383	Computed tomography of entire skeleton (procedure)	4180186
44808386	Positron emission tomography with computed tomography fluorodeoxyglucose imaging of head and neck (procedure)	4180186
44808388	Discussion about lung transplantation (procedure)	4180186
44808389	Discussion about kidney transplantation (procedure)	4180186
44808391	Oral steroid prophylaxis (procedure)	4180186
44808393	Referral to dementia service (procedure)	4180186
44808394	Post vasectomy special clearance to stop contraception given (situation)	4180186
44808397	Metal-on-metal hip replacement annual review (regime/therapy)	4180186
44808400	Nisonger child behaviour rating form (assessment scale)	4180186
44808402	Use of foot impulse device (procedure)	4180186
44808403	Use of intermittent pneumatic compression device (procedure)	4180186
44808404	Detection of Varicella zoster virus using polymerase chain reaction technique (procedure)	4180186
44808408	Life insurance report (record artifact)	4180186
44808410	Percutaneous atherectomy of femoropopliteal artery using fluoroscopic guidance (procedure)	4180186
44808411	Medical Research Council muscle power score of shoulder adduction (observable entity)	4180186
44808414	Computed tomography cystography (procedure)	4180186
44808414	CT cystogram	4180186
44808419	Insertion of fiducial marker into pancreas using computed tomography guidance (procedure)	4180186
44808420	Forced expired volume in 3 seconds (observable entity)	4180186
44808425	Insertion of fiducial marker into liver using ultrasonography guidance (procedure)	4180186
44808425	Ultrasound guided insertion of fiducial marker into liver	4180186
44808426	Insertion of fiducial marker into pancreas using ultrasonography guidance (procedure)	4180186
44808426	Ultrasound guided insertion of fiducial marker into pancreas	4180186
44808427	Insertion of fiducial marker into spine using ultrasonography guidance (procedure)	4180186
44808427	Ultrasound guided insertion of fiducial marker into spine	4180186
44808429	Industrial therapy service (qualifier value)	4180186
44808431	Community child health service (qualifier value)	4180186
44808433	Local anaesthetic block of transversus abdominis plane (procedure)	4180186
44808433	TAP (transversus abdominis plane) block	4180186
44808438	Laparoscopic repair of abdominal aortic aneurysm (procedure)	4180186
44808439	Endoscopic harvesting of long saphenous vein (procedure)	4180186
44808444	Random sample - last ingestion of food or drink unknown (finding)	4180186
44808451	Measurement of raltegravir (procedure)	4180186
44808452	Measurement of adefovir dipivoxil (procedure)	4180186
44808454	Measurement of telbivudine (procedure)	4180186
44808455	Collection of specimen by lavage (procedure)	4180186
44808455	Washings specimen collection	4180186
44808456	Measurement of daclatasvir (procedure)	4180186
44808457	Measurement of asunaprevir (procedure)	4180186
44808461	Sample precondition (finding)	4180186
44808462	Measurement of ribavirin (procedure)	4180186
44808464	Serial transverse enteroplasty (procedure)	4180186
44808464	STEP - serial transverse enteroplasty	4180186
44808465	Intravesical microwave hyperthermia (procedure)	4180186
44808466	Radionuclide electrocardiography gated myocardial perfusion stress and redistribution study using thallium 201 (procedure)	4180186
44808467	Aware of referral (finding)	4180186
44808472	Percutaneous implantation of pulmonary valve (procedure)	4180186
44808473	Trabeculotomy ab interno (procedure)	4180186
44808474	Radiofrequency ablation assisted liver resection (procedure)	4180186
44808475	Assessment of airway (procedure)	4180186
44808476	Assessment of wandering behaviour (procedure)	4180186
44808477	Cystoscopy of fetus (procedure)	4180186
44808482	Error by staff member (finding)	4180186
44808483	Alendronic acid not tolerated (situation)	4180186
44808486	Alendronic acid not indicated (situation)	4180186
44808487	Risedronate sodium not indicated (situation)	4180186
44808493	Alendronic acid contraindicated (situation)	4180186
44808496	Functional gastrointestinal tract disorder (disorder)	4180186
44808498	Percutaneous transluminal coil embolisation occlusion of major systemic to pulmonary collateral artery using fluoroscopic guidance with contrast (procedure)	4180186
44808498	Percutaneous transluminal coil embolisation occlusion of major systemic to pulmonary collateral artery using fluoroscopic guidance with contrast	4180186
44808499	Gastric ulcer with obstruction (disorder)	4180186
44808503	Gastrojejunal ulcer with obstruction (disorder)	4180186
44808504	Congenital absence of digestive system (disorder)	4180186
44808507	Open extra-articular fracture of distal radius (disorder)	4180186
44808510	Endoscopic ultrasonography of duodenal ampulla (procedure)	4180186
44808512	Upper gastrointestinal surgery inpatient care plan (record artifact)	4180186
44808514	Endoscopic fine needle aspiration biopsy of oesophagus using ultrasonography guidance (procedure)	4180186
44808514	Endoscopic ultrasound guided fine needle aspiration of oesophagus	4180186
44808515	Obtaining consent using form 1 (patient agreement to investigation or treatment) (procedure)	4180186
44808517	Provision of written information about eating disorder (procedure)	4180186
44808519	Developmental disabilities modification of children's global assessment scale	4180186
44808519	Developmental disabilities modification of children's global assessment scale (assessment scale)	4180186
44808521	Declines to state current alcohol consumption (finding)	4180186
44808525	Therapeutic endoscopic operation for twin-twin transfusion (navigational concept)	4180186
44808527	Liaison with mental health care coordinator (procedure)	4180186
44808528	Critical care pre-discharge assessment (procedure)	4180186
44808530	Provision of written information about depression (procedure)	4180186
44808532	Exacerbation of cystic fibrosis (disorder)	4180186
44808533	Provision of information about visual impairment (procedure)	4180186
44808534	Assessment of competence with colostomy care (procedure)	4180186
44808535	Assessment of competence with ileostomy care (procedure)	4180186
44808536	Sending of outpatient summary to general practitioner (procedure)	4180186
44808538	Assessment of quality of life (procedure)	4180186
44808539	Assessment using alert voice pain unresponsive scale (procedure)	4180186
44808540	Alert voice pain unresponsive scale score (observable entity)	4180186
44808541	Radionuclide Tc99m MAA (technetium 99m macroaggregated albumin) perfusion scan of liver	4180186
44808541	Radionuclide technetium 99m macroaggregated albumin perfusion study of liver (procedure)	4180186
44808542	Single photon emission computed tomography of liver using technetium 99m macroaggregated albumin (procedure)	4180186
44808542	SPECT of liver using Tc99m MAA (technetium 99m macroaggregated albumin)	4180186
44808548	First assessment using National Audit of Cardiac Rehabilitation questionnaire (procedure)	4180186
44808549	Ultrasonography of small intestine (procedure)	4180186
44808549	Ultrasound scan of small bowel	4180186
44808553	Changing infusion set (procedure)	4180186
44808555	Provision of mechanical ventilator (procedure)	4180186
44808556	Measurement of limb volume using perometer (procedure)	4180186
44808559	BAAF (British Association for Adoption and Fostering) B2 neonatal report sent	4180186
44808559	British Association for Adoption and Fostering B2 neonatal report sent (finding)	4180186
44808560	Measurement of Streptococcus pneumoniae serotype 17 immunoglobulin G antibody (procedure)	4180186
44808560	Pneumococcal serotype 17 IgG antibody measurement	4180186
44808561	Measurement of Western equine encephalitis virus immunoglobulin G antibody (procedure)	4180186
44808561	WEE (Western equine encephalitis) virus IgG antibody measurement	4180186
44808564	JC polyoma virus DNA (deoxyribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44808564	Measurement of JC polyoma virus deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44808565	Adenovirus DNA (deoxyribonucleic acid) by NAAT (nucleic acid amplification test)	4180186
44808565	Measurement of adenovirus deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44808566	CMV (cytomegalovirus) DNA (deoxyribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44808566	Measurement of cytomegalovirus deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44808568	Measurement of oxalate output (procedure)	4180186
44808568	Oxalate output	4180186
44808571	Adrenaline output	4180186
44808571	Measurement of adrenaline output (procedure)	4180186
44808572	Measurement of potassium output (procedure)	4180186
44808572	Potassium output	4180186
44808574	Measurement of beta-mannosidase activity (procedure)	4180186
44808575	Measurement of beta-N-acetylhexosaminidase activity (procedure)	4180186
44808576	Measurement of alpha-N-acetylgalactosaminidase activity (procedure)	4180186
44808579	Measurement of aldolase activity (procedure)	4180186
44808581	Measurement of dihydropteridine reductase activity (procedure)	4180186
44808583	Measurement of chitotriosidase activity (procedure)	4180186
44808584	Measurement of porphobilinogen deaminase activity (procedure)	4180186
44808586	Measurement of biotinidase activity (procedure)	4180186
44808587	Measurement of alpha-fucosidase activity (procedure)	4180186
44808588	Measurement of alpha-galactosidase activity (procedure)	4180186
44808589	Measurement of pneumococcal serotype 2 immunoglobulin G antibody (procedure)	4180186
44808590	Measurement of gamma-glutamyl transferase activity (procedure)	4180186
44808590	Measurement of GTT (gamma-glutamyl transferase) activity	4180186
44808593	Paraprotein typing (procedure)	4180186
44808595	Measurement of creatine kinase activity (procedure)	4180186
44808598	Measurement of Aspergillus nidulans specific immunoglobulin E antibody (procedure)	4180186
44808599	Measurement of Aspergillus versicolor specific immunoglobulin E antibody (procedure)	4180186
44808600	Subacute ischaemic heart disease (disorder)	4180186
44808608	Thoracoscopic approach (qualifier value)	4180186
44808610	History of medical intervention in high risk country for blood-borne virus (situation)	4180186
44808612	Procurement of drugs for chemotherapy for neoplasm for regimens in band 1 (procedure)	4180186
44808616	Procurement of drugs for chemotherapy for neoplasm for regimens in band 5 (procedure)	4180186
44808619	Procurement of drugs for chemotherapy for neoplasm for regimens in band 8 (procedure)	4180186
44808620	Procurement of drugs for chemotherapy for neoplasm for regimens in band 9 (procedure)	4180186
44808621	Procurement of drugs for chemotherapy for neoplasm for regimens in band 10 (procedure)	4180186
44808622	Measurement of Paracoccidioides brasiliensis immunoglobulin G antibody (procedure)	4180186
44808623	Measurement of Blastomyces dermatiditis immunoglobulin G antibody (procedure)	4180186
44808624	Measurement of Cryptococcus neoformans antigen (procedure)	4180186
44808625	Suspected arrhythmia (situation)	4180186
44808626	Measurement of Cryptococcus neoformans immunoglobulin G antibody (procedure)	4180186
44808627	Injection of bulking agent to rectum (procedure)	4180186
44808630	Obtaining consent using form 3 (patient or parental agreement to investigation or treatment) (procedure)	4180186
44808632	Endoscopic core needle biopsy of oesophagus using ultrasonography guidance (procedure)	4180186
44808632	Endoscopic ultrasound guided core biopsy of oesophagus	4180186
44808638	Respecting cultural and spiritual wishes (procedure)	4180186
44808648	Provision of written information about local anaesthesia (procedure)	4180186
44808652	Endoscopic drainage using ultrasonography guidance (procedure)	4180186
44808652	Endoscopic ultrasound guided drainage	4180186
44808655	Provision of written information about erectile dysfunction (procedure)	4180186
44808656	Endoscopic transbronchial fine needle aspiration biopsy using ultrasonography guidance (procedure)	4180186
44808656	Endoscopic transbronchial ultrasound guided fine needle aspiration	4180186
44808657	Endoscopic transbronchial biopsy using ultrasonography guidance (procedure)	4180186
44808657	Endoscopic transbronchial ultrasound guided biopsy	4180186
44808659	Pelvic organ prolapse symptom score (observable entity)	4180186
44808659	POP-SS - pelvic organ prolapse symptom score	4180186
44808662	Referral to podiatric surgery service (procedure)	4180186
44808663	Epilepsy annual review (regime/therapy)	4180186
44808664	Endoscopic retrograde cholangiopancreatography with insertion of nasobiliary drain using fluoroscopic guidance (procedure)	4180186
44808665	Modification of wheelchair (regime/therapy)	4180186
44808671	Referral for family therapy (procedure)	4180186
44808675	Absence of signs and symptoms of phlebitis (situation)	4180186
44808677	Group cognitive behavioural therapy (regime/therapy)	4180186
44808679	Herpes zoster vaccination (procedure)	4180186
44808679	Shingles vaccination	4180186
44808680	Pansynostosis (disorder)	4180186
44808681	Suspected sepsis (situation)	4180186
44808682	Lives with adoptive parents (finding)	4180186
44808683	Telehealth Clinician Response (record artifact)	4180186
44808684	National early warning score	4180186
44808684	RCP (Royal College of Physicians) NEWS (national early warning score)	4180186
44808684	Royal College of Physicians national early warning score (observable entity)	4180186
44808685	Cardiac output within target range (finding)	4180186
44808693	Education about urinary elimination care (procedure)	4180186
44808695	Measurement of lipase activity (procedure)	4180186
44808696	Measurement of hepatitis B virus surface antigen immunoglobulin G antibody (procedure)	4180186
44808697	Measurement of sphingomyelinase activity (procedure)	4180186
44808699	Neonatal blood group typing (procedure)	4180186
44808701	HIV (human immunodeficiency virus) 1 proviral DNA (deoxyribonucleic acid) measurement by NAAT (nucleic acid amplification test)	4180186
44808701	Measurement of human immunodeficiency virus 1 proviral deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44808702	Extractable nuclear antigen typing (procedure)	4180186
44808704	Measurement of alpha-n-acetylglucosaminidase activity (procedure)	4180186
44808705	Measurement of galactosyl transferase activity (procedure)	4180186
44808706	Measurement of phosphoglucomutase activity (procedure)	4180186
44808707	Measurement of galactose-1-phosphate uridyltransferase activity (procedure)	4180186
44808709	Measurement of galactokinase activity (procedure)	4180186
44808710	Measurement of phosphorylase b kinase activity (procedure)	4180186
44808711	Measurement of fructose-1,6-bisphosphatase activity (procedure)	4180186
44808713	Measurement of lactate dehydrogenase activity (procedure)	4180186
44808714	Measurement of phosphorylase A activity (procedure)	4180186
44808715	Measurement of alpha glucosidase activity (procedure)	4180186
44808716	Measurement of alpha-neuraminidase activity (procedure)	4180186
44808717	Measurement of beta-glucosidase activity (procedure)	4180186
44808721	Date insulin pump therapy started (observable entity)	4180186
44808722	Date insulin pump therapy stopped (observable entity)	4180186
44808726	Provision of wig (procedure)	4180186
44808731	Pulsed radiofrequency to occipital nerve (procedure)	4180186
44808733	Coccidioides immitis DNA (deoxyribonucleic acid) detection by NAAT (nucleic acid amplification test)	4180186
44808733	Detection of Coccidioides immitis deoxyribonucleic acid by nucleic acid amplification test (procedure)	4180186
44808737	Approach to organ under video control (qualifier value)	4180186
44808739	Management of care following best interest decision made on behalf of patient (Mental Capacity Act 2005) (procedure)	4180186
44808740	Management of wandering behaviour (procedure)	4180186
44808743	Streptococcal peritonitis (disorder)	4180186
44808744	Acute renal failure due to non-traumatic rhabdomyolysis (disorder)	4180186
44808745	Occlusion of brachial artery (disorder)	4180186
44808747	Occlusion of dorsalis pedis artery (disorder)	4180186
44808748	Able to wander safely (finding)	4180186
44808749	Endoscopic retrograde cholangiopancreatography with removal of biliary stent using fluoroscopic guidance (procedure)	4180186
44808750	Referral to paediatric ear, nose and throat service (procedure)	4180186
44808752	Education about dementia (procedure)	4180186
44808753	Education about glaucoma (procedure)	4180186
44808754	Referral to paediatric orthopaedic service (procedure)	4180186
44808756	Epilepsy care management (procedure)	4180186
44808758	Smoking cessation 12 week follow-up (procedure)	4180186
44808761	Endoscopic retrograde cholangiopancreatography with removal of pancreatic stent using fluoroscopic guidance (procedure)	4180186
44808764	Sexual health inventory for men score (observable entity)	4180186
44808766	Endoscopic insertion of metallic stent into pylorus using fluoroscopic guidance (procedure)	4180186
44808767	Endoscopic balloon dilatation of duodenum using fluoroscopic guidance (procedure)	4180186
44808768	History of being victim of domestic violence (situation)	4180186
44808770	Thoracic surgery inpatient care plan (record artifact)	4180186
44808771	Referral for carpal tunnel injection (procedure)	4180186
44808773	Provision of information about splint (procedure)	4180186
44808777	High risk of diabetes mellitus annual review (regime/therapy)	4180186
44808778	Lloyd George record used for consultation (finding)	4180186
44808780	Percentage count of lymphocytes positive for CD11a antigen (procedure)	4180186
44808784	On examination - symmetrical thigh creases (finding)	4180186
44808785	Date of entry to United Kingdom (observable entity)	4180186
44808789	Seen by consultant psychiatrist (finding)	4180186
44808790	Influenza vaccination first verbal invitation (procedure)	4180186
44808791	Influenza vaccination second verbal invitation (procedure)	4180186
44808792	Influenza vaccination first telephone invitation (finding)	4180186
44808794	Provision of written information about Affordable Warmth programme (procedure)	4180186
44808796	Influenza vaccination third verbal invitation (procedure)	4180186
44808798	Removal of glue from skin (procedure)	4180186
44808799	Barium meal report received (finding)	4180186
44808803	Assessment using Commission for Health Improvement experience of service questionnaire (procedure)	4180186
44808805	Assessment using CGAS (children's global assessment scale)	4180186
44808805	Assessment using children's global assessment scale (procedure)	4180186
44808808	Application for urgent authorisation of deprivation of liberty under Mental Capacity Act 2005 (procedure)	4180186
44808810	Assessment of Year of Care action confidence (procedure)	4180186
44808811	Aspiration biopsy sample	4180186
44808811	Specimen obtained by aspiration biopsy (specimen)	4180186
44808813	Education about management of wandering behaviour (procedure)	4180186
44808814	Acute stroke management plan agreed (finding)	4180186
44808816	Provision of written information about stroke (procedure)	4180186
44808817	Education about thrombolytic therapy (procedure)	4180186
44808819	Sterile defibrinated blood specimen (specimen)	4180186
44808821	Acute renal failure induced by animal toxin (disorder)	4180186
44808823	Acute renal failure induced by heavy metal (disorder)	4180186
44808825	Referral to improving access to psychological therapies programme declined (situation)	4180186
44808826	Screening test for chylomicrons (procedure)	4180186
44808827	MEMS - modified elderly mobility scale	4180186
44808827	Modified elderly mobility scale (assessment scale)	4180186
44808836	Post-exposure diphtheria, tetanus, acellular pertussis and inactivated polio vaccination programme enhanced services administration (procedure)	4180186
44808837	Did not attend post exposure diphtheria, tetanus, acellular pertussis and inactivated polio vaccination (finding)	4180186
44808837	Did not attend post exposure DTaP/IPV (diphtheria, tetanus, acellular pertussis and inactivated polio vaccination)	4180186
44808838	Post exposure diphtheria, tetanus, acellular pertussis and inactivated polio vaccination invitation (procedure)	4180186
44808839	Measurement of recombinant Pru p 3 Prunus persica specific immunoglobulin E antibody (procedure)	4180186
44808839	Recombinant Pru p3 peach specific IgE antibody level	4180186
44808842	Sample from subject of unknown posture (finding)	4180186
44808843	Ear care initial assessment (procedure)	4180186
44808845	Osteoarthritis of talonavicular joint (disorder)	4180186
44808849	Endoscopic fine needle aspiration biopsy of pancreas using ultrasonography guidance (procedure)	4180186
44808849	Endoscopic ultrasound guided fine needle aspiration biopsy of pancreas	4180186
44808850	History of acute hypercapnic respiratory failure (situation)	4180186
44808850	History of acute type II respiratory failure	4180186
44808852	Combined Predictive Model risk score (observable entity)	4180186
44808852	CPM (Combined Predictive Model) risk score	4180186
44808854	Under care of palliative care specialist nurse (finding)	4180186
44808855	Reduction mastopexy by horizontal pedicle technique (procedure)	4180186
44808857	Triglyceride level (observable entity)	4180186
44808858	Carboxyhaemoglobin level (observable entity)	4180186
44808859	Assessment of mood (procedure)	4180186
44808860	Endoscopic examination of pancreatic duct using ultrasonography guidance (procedure)	4180186
44808860	Endoscopic ultrasound guided examination of pancreatic duct	4180186
44808861	Endoscopic retrograde cholangiopancreatography with balloon dilatation of sphincter of Oddi and basket extraction of calculus using fluoroscopic guidance (procedure)	4180186
44808863	Management of erectile dysfunction (procedure)	4180186
44808864	Reduction mastopexy by central pedicle technique (procedure)	4180186
44808866	Reduction mastopexy by inferior pedicle technique (procedure)	4180186
44808867	Reduction mastopexy by free nipple graft technique (procedure)	4180186
44808868	Provision of information about cervical screening programme (procedure)	4180186
44808870	Assessment using DBC (developmental behaviour checklist)	4180186
44808870	Assessment using developmental behaviour checklist (procedure)	4180186
44808874	Sheffield learning disabilities outcome measure score (observable entity)	4180186
44808874	SLDOM (Sheffield learning disabilities outcome measure) score	4180186
44808877	NCBRF (Nisonger child behaviour rating form) score	4180186
44808877	Nisonger child behaviour rating form score (observable entity)	4180186
44808878	DD-CGAS (developmental disabilities - children's global assessment scale) score	4180186
44808878	Developmental disabilities - children's global assessment scale score (observable entity)	4180186
44808879	Assessment using DD-CGAS (developmental disabilities - children's global assessment scale)	4180186
44808879	Assessment using developmental disabilities - children's global assessment scale (procedure)	4180186
44808883	Pale green sputum (finding)	4180186
44808885	Moderate sensorineural hearing loss (disorder)	4180186
44808886	Severe sensorineural hearing loss (disorder)	4180186
44808889	Profound sensorineural hearing loss (disorder)	4180186
44808890	Mild sensorineural hearing loss (disorder)	4180186
44808891	Satisfied with contraception method (finding)	4180186
44808894	Posteromedial corner of knee joint (body structure)	4180186
44808898	Tuberculosis screening questionnaire sent (finding)	4180186
44808900	Provision of written information about weight gain diet (procedure)	4180186
44808904	Patient failed to arrange appointment (finding)	4180186
44808907	Post exposure diphtheria, tetanus, acellular pertussis and inactivated polio vaccination declined (situation)	4180186
44808909	Multidisciplinary cancer case management (procedure)	4180186
44808912	Marking of skin over small saphenous vein using ultrasonography guidance (procedure)	4180186
44808912	Ultrasound guided marking of skin over short saphenous vein	4180186
44808913	Annual school medical examination (procedure)	4180186
44808914	Thyroid disease monitoring not indicated (situation)	4180186
44808915	Computed tomography checking of post-endovascular aneurysm repair (procedure)	4180186
44808915	CT surveillance post-EVAR (endovascular aneurysm repair)	4180186
44808917	Drug addiction notification local SMR22 (procedure)	4180186
44808918	Compensation for liver failure (navigational concept)	4180186
44808919	Percutaneous transluminal balloon test occlusion of internal carotid artery using fluoroscopic guidance with contrast (procedure)	4180186
44808921	Critical care neurological support management (procedure)	4180186
44808924	Oral typhoid vaccination (procedure)	4180186
44808925	Therapeutic percutaneous operation for twin-twin transfusion syndrome (procedure)	4180186
44808927	Obtaining consent for clinical photography (procedure)	4180186
44808927	Obtaining consent for medical photography	4180186
44808930	Education about compression therapy for ulcer healing (procedure)	4180186
44808932	Re-excision of local recurrence of breast cancer	4180186
44808932	Re-excision of local recurrence of breast tumour (procedure)	4180186
44808934	Assessment of sedation level (procedure)	4180186
44808935	Wide excision of local recurrence of breast cancer	4180186
44808935	Wide re-excision of local recurrence of breast tumour (procedure)	4180186
44808936	Hip fracture care (regime/therapy)	4180186
44808937	Haemodialysis care management (procedure)	4180186
44808940	Application for National Health Service continuing healthcare (procedure)	4180186
44808944	Acute exacerbation of chronic obstructive pulmonary disease care plan (record artifact)	4180186
44808944	Acute exacerbation of COPD (chronic obstructive pulmonary disease) care plan	4180186
44808945	Burn inpatient care plan (record artifact)	4180186
44808946	Cardiology inpatient care plan (record artifact)	4180186
44808948	Colorectal surgery inpatient care plan (record artifact)	4180186
44808950	Minor thoracic surgery inpatient care plan (record artifact)	4180186
44808951	Respiratory disorder inpatient care plan (record artifact)	4180186
44808952	Rehabilitation care plan (record artifact)	4180186
44808953	Radiotherapy care plan (record artifact)	4180186
44808954	History of care from relative (situation)	4180186
44808955	Audiology clinical pathway (regime/therapy)	4180186
44808958	Endoscopic retrograde cholangiopancreatography with biopsy of lesion of ampulla of Vater using fluoroscopic guidance (procedure)	4180186
44808959	Catheter care equipment available at home (finding)	4180186
44808961	Colposcopy care plan (record artifact)	4180186
44808962	Cystoscopy care plan (record artifact)	4180186
44808963	Haemodialysis care plan (record artifact)	4180186
44808964	Major head and neck surgery inpatient care plan (record artifact)	4180186
44808965	Hip fracture inpatient care plan (record artifact)	4180186
44808966	Hysteroscopy care plan (record artifact)	4180186
44808967	Plastic surgery inpatient care plan (record artifact)	4180186
44808968	Paediatric surgery inpatient care plan (record artifact)	4180186
44808969	Day case care plan (record artifact)	4180186
44808970	Assessment of colostomy (regime/therapy)	4180186
44808974	Provision of written information about seizure (procedure)	4180186
44808976	Subcutaneous contraceptive implant not palpable (finding)	4180186
44808977	Ambulatory blood pressure recording declined (situation)	4180186
44808979	Antenatal 22 week examination (procedure)	4180186
44808980	Antenatal 25 week examination (procedure)	4180186
44808983	Mental health care and treatment planning (procedure)	4180186
44808985	Application for emergency protection order under section 44 Children Act 1989 (procedure)	4180186
44808987	End of Life Care Document (record artifact)	4180186
44808988	End of Life Care Coordination Summary (record artifact)	4180186
44808989	Duplication of chromosome 17p11.2 (disorder)	4180186
44808989	Potocki-Lupski syndrome	4180186
44808990	Application for disabled driver blue badge	4180186
44808990	Application for disabled driver parking permit (procedure)	4180186
44808993	Diabetic foot screening invitation second letter (procedure)	4180186
44808994	Documenting operation note (procedure)	4180186
44808995	Documenting procedure note (procedure)	4180186
44808998	Education about seizure (procedure)	4180186
44808999	Provision of written information about bereavement service (procedure)	4180186
44809001	Destruction of lesion of Bartholin gland by incision and insertion of balloon catheter	4180186
44809001	Destruction of lesion of Bartholin's gland by incision and insertion of balloon catheter (procedure)	4180186
44809002	Primary repair of epigastric hernia with sutures (procedure)	4180186
44809003	Repair of recurrent epigastric hernia with prosthesis (procedure)	4180186
44809004	BAAF (British Association for Adoption and Fostering) B2 fee unpaid	4180186
44809004	British Association for Adoption and Fostering B2 fee unpaid (finding)	4180186
44809010	Core needle biopsy of chest wall using ultrasonography guidance (procedure)	4180186
44809010	Ultrasound guided core needle biopsy of chest wall	4180186
44809011	Loose corneal suture (disorder)	4180186
44809012	Severe mental illness enhanced services administration (procedure)	4180186
44809013	Electrochemotherapy (procedure)	4180186
44809013	Electroporation therapy	4180186
44809018	Assessment of venous ulcer of lower limb (procedure)	4180186
44809019	Assessment of venous lower leg ulcer (procedure)	4180186
44809023	Assessment of lower leg ulcer (procedure)	4180186
44809024	Assessment of diabetic ulcer of lower limb (procedure)	4180186
44809028	Allogeneic transplantation of pancreatic islet cells (procedure)	4180186
44809031	Thoracoscopic aortopexy (procedure)	4180186
44809034	Butterfly Scheme for dementia declined (situation)	4180186
44809036	Laser assisted non-occlusive cerebral vascular anastomosis (procedure)	4180186
44809037	Education about risk of venous thromboembolism (procedure)	4180186
44809038	EBUS-TBNA - Endobronchial ultrasound - transbronchial needle aspiration	4180186
44809038	Endobronchial ultrasound guided transbronchial needle aspiration	4180186
44809038	Transbronchial needle aspiration using endobronchial ultrasonography guidance (procedure)	4180186
44809040	Able to manage colostomy (finding)	4180186
44809043	Orthopaedic surgery inpatient care plan (record artifact)	4180186
44809045	Major orthopaedic surgery inpatient care plan (record artifact)	4180186
44809046	Ophthalmic surgery inpatient care plan (record artifact)	4180186
44809048	Neurosurgery inpatient care plan (record artifact)	4180186
44809053	Minor plastic surgery inpatient care plan (record artifact)	4180186
44809055	Able to perform all activities of daily living (finding)	4180186
44809057	Percutaneous endoscopic gastrostomy insertion care plan (record artifact)	4180186
44809058	Obesity and weight loss quality of life questionnaire (assessment scale)	4180186
44809058	OWLQOL (obesity and weight loss quality of life) questionnaire	4180186
44809059	Assessment using obesity and weight loss quality of life questionnaire (procedure)	4180186
44809059	Assessment using OWLQOL (obesity and weight loss quality of life) questionnaire	4180186
44809061	Acute kidney injury stage 1 (disorder)	4180186
44809063	Acute kidney injury stage 3 (disorder)	4180186
44809064	ACP - advance care planning	4180186
44809064	Advance care planning (procedure)	4180186
44809069	Agreed needs met (finding)	4180186
44809071	Hepatobiliary and pancreatic surgery inpatient care plan (record artifact)	4180186
44809072	Member of military family (finding)	4180186
44809074	Conversion from extra-articular arthrodesis (procedure)	4180186
44809075	Measurement of recombinant Ara h2 Arachis hypogaea specific immunoglobulin E antibody (procedure)	4180186
44809075	Recombinant Ara h2 peanut specific IgE antibody level	4180186
44809078	Weight-related symptom measure (assessment scale)	4180186
44809078	WRSM - weight-related symptom measure	4180186
44809079	Percutaneous amniotic septostomy using ultrasonography guidance (procedure)	4180186
44809079	Ultrasound guided percutaneous amniotic septostomy	4180186
44809080	Assessment using weight-related symptom measure (procedure)	4180186
44809080	Assessment using WRSM (weight-related symptom measure)	4180186
44809082	Percutaneous amniotic septostomy with reduction of amniotic fluid using ultrasonography guidance (procedure)	4180186
44809082	Ultrasound guided percutaneous amniotic septostomy with amnioreduction	4180186
44809084	Laparoscopic repair of epigastric hernia with sutures (procedure)	4180186
44809087	Legal status under Children (Scotland) Act 1995 (observable entity)	4180186
44809093	Education about Care Programme Approach (procedure)	4180186
44809093	Education about CPA (Care Programme Approach)	4180186
44809096	No safeguarding issues identified (finding)	4180186
44809098	History of epididymitis (situation)	4180186
44809099	History of orchitis (situation)	4180186
44809101	Palliative care not indicated (situation)	4180186
44809102	Bowel cancer screening programme telephone invitation (procedure)	4180186
44809103	Bowel cancer screening programme invitation letter sent (finding)	4180186
44809105	Referral to Parkinson's service (procedure)	4180186
44809106	Video analysis of gait (procedure)	4180186
44809108	Fluoroscopic gastrointestinal transit study (procedure)	4180186
44809108	Fluoroscopic GI (gastrointestinal) transit study	4180186
44809111	Surgery inpatient care plan (record artifact)	4180186
44809114	[X]Angiotensin II receptor antagonists causing adverse effects in therapeutic use (disorder)	4180186
44809116	Referred by hospital outpatient department (finding)	4180186
44809117	Referred by hospital ward (finding)	4180186
44809120	Modified Rankin scale (assessment scale)	4180186
44809121	Assessment using modified Rankin scale (procedure)	4180186
44809123	Referral to Single Point of Access service (procedure)	4180186
44809123	Referral to SPA (Single Point of Access) service	4180186
44809124	History of malignant hyperthermia due to anaesthesia (situation)	4180186
44809127	[V]Personal history of severe cervical dysplasia (situation)	4180186
44809128	Referred by community matron (finding)	4180186
44809130	Did not attend Bacillus Calmette-Guerin vaccination	4180186
44809130	Did not attend Bacillus Calmette-Guerin vaccination (finding)	4180186
44809134	Referral to community phlebotomist (procedure)	4180186
44809138	Care management of venous ulcer of lower limb (procedure)	4180186
44809139	Management of lower limb ulcer (procedure)	4180186
44809143	Infracoccygeal sacropexy using mesh (procedure)	4180186
44809144	Assessment for thrombolytic therapy (procedure)	4180186
44809146	Education for care of arterial ulcer of limb (procedure)	4180186
44809147	Referral to leg ulcer service (procedure)	4180186
44809149	Able to manage ileostomy (finding)	4180186
44809151	Healed lower leg ulcer (finding)	4180186
44809152	Healthy eye (finding)	4180186
44809153	Management of complex patient discharge (procedure)	4180186
44809154	Referral for respite care (procedure)	4180186
44809155	Able to use assistive device (finding)	4180186
44809160	Patient reported disability (finding)	4180186
44809164	Measurement of Saccharomyces cerevisiae specific immunoglobulin G antibody (procedure)	4180186
44809164	Saccharomyces cerevisiae IgG antibody specificity	4180186
44809166	Lindop Parkinson's assessment scale (assessment scale)	4180186
44809167	Agreeing on health professional actions in care plan (procedure)	4180186
44809171	OCT (optical coherence tomography) assessment of airway wall using fluoroscopic guidance	4180186
44809171	Optical coherence tomography assessment of thickness of airway wall using fluoroscopic guidance (procedure)	4180186
44809172	Vascular complication of renal transplant (disorder)	4180186
44809173	Acute renal failure induced by radiographic contrast media (disorder)	4180186
44809178	Percutaneous laser ablation of placental arterio-venous anastomosis using ultrasonography guidance (procedure)	4180186
44809178	Ultrasound guided percutaneous laser ablation of placental arterio-venous anastomosis	4180186
44809181	Target mean blood pressure (observable entity)	4180186
44809182	Maximum mean blood pressure (observable entity)	4180186
44809183	Minimum mean blood pressure (observable entity)	4180186
44809185	Maximum weight (observable entity)	4180186
44809187	Maximum pulse rate (observable entity)	4180186
44809189	Target carboxyhaemoglobin level (observable entity)	4180186
44809190	Maximum carboxyhaemoglobin level (observable entity)	4180186
44809194	Target triglyceride level (observable entity)	4180186
44809195	Maximum triglyceride level (observable entity)	4180186
44809196	Minimum triglyceride level (observable entity)	4180186
44809197	Maximum BMI (body mass index)	4180186
44809197	Maximum body mass index (observable entity)	4180186
44809198	Minimum BMI (body mass index)	4180186
44809198	Minimum body mass index (observable entity)	4180186
44809199	Prothrombin time (observable entity)	4180186
44809200	Target prothrombin time (observable entity)	4180186
44809201	Maximum prothrombin time (observable entity)	4180186
44809204	Minimum activated partial thromboplastin time (observable entity)	4180186
44809206	Minimum forced expired volume in 1 second (observable entity)	4180186
44809207	Target body temperature (observable entity)	4180186
44809210	Maximum blood glucose concentration (observable entity)	4180186
44809214	Target peak flow rate (observable entity)	4180186
44809215	Maximum peak flow rate (observable entity)	4180186
44809216	Surgical biopsy of prepuce (procedure)	4180186
44809217	Assessment for complementary therapy (procedure)	4180186
44809223	Computed tomography of internal auditory meatus with air contrast (procedure)	4180186
44809224	Cementoplasty using computed tomography and fluoroscopic guidance (procedure)	4180186
44809232	Consent form (record artifact)	4180186
44809233	Hepatitis C genotype 1 (disorder)	4180186
44809235	Ambulance service patient report form (record artifact)	4180186
44809238	Hepatitis C genotype 5 (disorder)	4180186
44809239	Hepatitis C genotype 6 (disorder)	4180186
44809242	Carer declined consent for carer details in clinical record (finding)	4180186
44809243	Traumatic dislocation of joint of toe (disorder)	4180186
44809244	Traumatic dislocation of interphalangeal joint of toe (disorder)	4180186
44809247	Traumatic dislocation of metatarsal joint (disorder)	4180186
44809249	Traumatic dislocation of tarsal joint (disorder)	4180186
44809250	Traumatic dislocation of midtarsal joint (disorder)	4180186
44809253	Discussion about human immunodeficiency virus post exposure prophylaxis (procedure)	4180186
44809254	Drainage tube in situ (finding)	4180186
44809255	Referral to literacy service (procedure)	4180186
44809256	Oral penicillin challenge test (procedure)	4180186
44809259	Keep Well health check (procedure)	4180186
44809260	Keep Well health check review (procedure)	4180186
44809263	Employment and support allowance 113 form completed (finding)	4180186
44809264	Employment and support allowance 113 form sent (finding)	4180186
44809265	Employment and support allowance 113 form received (finding)	4180186
44809267	Using inhaled steroids - low dose (finding)	4180186
44809268	Hepatitis B vaccination invitation (procedure)	4180186
44809269	Hepatitis B vaccination invitation first letter (procedure)	4180186
44809270	Hepatitis B vaccination invitation second letter (procedure)	4180186
44809272	Hepatitis B vaccination verbal invitation (procedure)	4180186
44809273	Epidural device in situ (finding)	4180186
44809275	On enteral feeding diet (finding)	4180186
44809276	Peripherally inserted central catheter in situ (finding)	4180186
44809276	PICC (peripherally inserted central catheter) in situ	4180186
44809277	National Health Service continuing healthcare assessment in progress (finding)	4180186
44809278	Eligible for aftercare under Section 117 of Mental Health Act 1983 (England and Wales) (finding)	4180186
44809279	Rehabilitation for heart failure (regime/therapy)	4180186
44809281	Waterpipe tobacco consumption (observable entity)	4180186
44809282	Private referral to psychologist (procedure)	4180186
44809283	Private referral to spinal surgeon (procedure)	4180186
44809286	Acute renal failure induced by solvent (disorder)	4180186
44809288	Magnetic resonance imaging of temporomandibular joint with contrast (procedure)	4180186
44809292	Letter received from solicitor (finding)	4180186
44809295	Totally implantable venous access device (physical object)	4180186
44809298	Influenza vaccination invitation second email (procedure)	4180186
44809299	Influenza vaccination invitation third email (procedure)	4180186
44809302	Measurement of Toxoplasma species immunoglobulin M antibody by biotin antigen M enzyme-linked immunosorbent assay (procedure)	4180186
44809302	Toxoplasma BAM ELISA (biotin antigen M enzyme-linked immunosorbent assay) IgM antibody level	4180186
44809304	Education for psoriasis care (procedure)	4180186
44809311	Measurement of recombinant Ara h8 peanut specific immunoglobulin E antibody (procedure)	4180186
44809311	Recombinant Ara h8 peanut specific IgE antibody level	4180186
44809312	6-TGN (6-thioguanine) nucleotide level	4180186
44809312	Measurement of 6-thioguanine nucleotide (procedure)	4180186
44809313	6-methylmercaptopurine nucleotide level	4180186
44809313	6-MMP (6-methylmercaptopurine) nucleotide level	4180186
44809313	Measurement of 6-methylmercaptopurine nucleotide (procedure)	4180186
44809314	Assessment using DOSE (dyspnoea, airflow obstruction, smoking status, exacerbation frequency) index	4180186
44809314	Assessment using dyspnoea, airflow obstruction, smoking status, exacerbation frequency index (procedure)	4180186
44809317	Maximum forced vital capacity (observable entity)	4180186
44809318	Minimum forced vital capacity (observable entity)	4180186
44809319	Personal Health Plan offered (situation)	4180186
44809319	PHP (Personal Health Plan) offered	4180186
44809321	Adult cystinosis (disorder)	4180186
44809325	Transluminal occlusion of Fontan fenestration using fluoroscopic guidance (procedure)	4180186
44809326	Left upper limb total volume (observable entity)	4180186
44809329	Right upper limb proximal segment volume (observable entity)	4180186
44809330	Left upper limb distal segment volume (observable entity)	4180186
44809332	Personal care after death (regime/therapy)	4180186
44809333	Total excision of breast duct	4180186
44809333	Total excision of lactiferous duct (procedure)	4180186
44809333	Total excision of mammary duct	4180186
44809334	Quantitative volume difference between proximal segments of upper limbs (observable entity)	4180186
44809335	Quantitative volume difference between distal segments of upper limbs (observable entity)	4180186
44809337	Percentage volume difference between proximal segments of upper limbs (observable entity)	4180186
44809339	Liposuction for gynaecomastia (procedure)	4180186
44809340	Aneurysm of artery of transplanted kidney (disorder)	4180186
44809342	Left upper limb volume proximal to distal segment ratio (observable entity)	4180186
44809346	Right lower limb proximal segment volume (observable entity)	4180186
44809347	Revision of mastopexy (procedure)	4180186
44809348	Left lower limb distal segment volume (observable entity)	4180186
44809350	Implantation of neurostimulator in stomach (procedure)	4180186
44809353	Right lower limb total volume (observable entity)	4180186
44809354	Lipofilling of defect of reconstructed breast (procedure)	4180186
44809356	Medical Research Council muscle power score of left shoulder extension (observable entity)	4180186
44809357	Medical Research Council muscle power score of right shoulder flexion (observable entity)	4180186
44809358	Medical Research Council muscle power score of right shoulder internal rotation (observable entity)	4180186
44809360	Active range of right wrist flexion (observable entity)	4180186
44809364	Active range of right shoulder abduction (observable entity)	4180186
44809365	Active range of right elbow flexion (observable entity)	4180186
44809366	Medical Research Council muscle power score of left elbow extension (observable entity)	4180186
44809371	Medical Research Council muscle power score of left elbow pronation (observable entity)	4180186
44809372	Medical Research Council muscle power score of left shoulder flexion (observable entity)	4180186
44809373	Medical Research Council muscle power score of right elbow pronation (observable entity)	4180186
44809374	Medical Research Council muscle power score of left hip internal rotation (observable entity)	4180186
44809375	Medical Research Council muscle power score of right hip internal rotation (observable entity)	4180186
44809376	Medical Research Council muscle power score of left hip external rotation (observable entity)	4180186
44809381	Medical Research Council muscle power score of left wrist pronation (observable entity)	4180186
44809383	Medical Research Council muscle power score of right ankle inversion (observable entity)	4180186
44809384	Medical Research Council muscle power score of right ankle plantar flexion (observable entity)	4180186
44809385	Medical Research Council muscle power score of left ankle plantar flexion (observable entity)	4180186
44809386	Medical Research Council muscle power score of left ankle eversion (observable entity)	4180186
44809387	Medical Research Council muscle power score of right wrist adduction (observable entity)	4180186
44809393	Subject of comprehensive geriatric assessment plan (finding)	4180186
44809398	Percutaneous insertion of plastic stent using fluoroscopic guidance (procedure)	4180186
44809401	Percutaneous insertion of branched tube stent graft using fluoroscopic guidance (procedure)	4180186
44809402	Percutaneous insertion of branched tapered stent graft using fluoroscopic guidance (procedure)	4180186
44809403	Percutaneous insertion of fenestrated stent graft using fluoroscopic guidance (procedure)	4180186
44809405	History of long term condition (situation)	4180186
44809406	Optimal wound healing environment (finding)	4180186
44809408	Insertion of marker into breast using X-ray guidance (procedure)	4180186
44809408	Insertion of marker into breast using X-ray guidance	4180186
44809410	Cervical smear screening invitation short message service text (procedure)	4180186
44809410	Cervical smear screening invitation SMS (short message service) text	4180186
44809410	Cervical smear screening invitation text message	4180186
44809411	Cervical smear screening invitation first short message service text (procedure)	4180186
44809411	Cervical smear screening invitation first SMS (short message service) text	4180186
44809411	Cervical smear screening invitation first text message	4180186
44809413	Patient health questionnaire 2	4180186
44809413	Patient health questionnaire 2 (assessment scale)	4180186
44809414	Assessment using patient health questionnaire 2 (procedure)	4180186
44809418	DOSE (dyspnoea, airflow obstruction, smoking status, exacerbation frequency) index score	4180186
44809418	Dyspnoea, airflow obstruction, smoking status, exacerbation frequency index score (observable entity)	4180186
44809420	Amiodarone monitoring (regime/therapy)	4180186
44809422	Epiploic appendagitis (disorder)	4180186
44809425	Referral to spinal orthopaedic triage service (procedure)	4180186
44809427	Right atrial catheter in situ (finding)	4180186
44809429	3D (three dimensional) rotational fluoroscopic angiogram	4180186
44809429	Three dimensional rotational fluoroscopic angiography (procedure)	4180186
44809433	Waist to height ratio (observable entity)	4180186
44809434	Chronic sialosis of parotid gland (disorder)	4180186
44809435	Three dimensional rotational fluoroscopic angiography of thorax with contrast (procedure)	4180186
44809435	3D (three dimensional) rotational fluoroscopic angiogram of chest with contrast	4180186
44809437	Three dimensional rotational fluoroscopic angiography of upper limb with contrast (procedure)	4180186
44809437	3D (three dimensional) rotational fluoroscopic angiogram of arm with contrast	4180186
44809438	Gold standards framework prognostic indicator (assessment scale)	4180186
44809440	Three dimensional rotational fluoroscopic angiography of lower limb with contrast (procedure)	4180186
44809440	3D (three dimensional) rotational fluoroscopic angiogram of leg with contrast	4180186
44809442	Three dimensional rotational fluoroscopic angiography of neck with contrast (procedure)	4180186
44809442	3D (three dimensional) rotational fluoroscopic angiogram of neck with contrast	4180186
44809444	History of ovarian cyst (situation)	4180186
44809445	Gold standards framework prognostic indicator stage C (yellow) - weeks prognosis (finding)	4180186
44809446	Black fracture index (assessment scale)	4180186
44809447	Black fracture index score (observable entity)	4180186
44809448	Assessment using Black fracture index (procedure)	4180186
44809451	Lipofilling of defect of wider local excision of breast (procedure)	4180186
44809455	Stereotactic focused gamma radiosurgery of trigeminal nerve (procedure)	4180186
44809456	Reconstruction of breast with extended latissimus dorsi flap (procedure)	4180186
44809458	Quantitative volume difference between proximal segments of lower limbs (observable entity)	4180186
44809459	Quantitative volume difference between distal segments of lower limbs (observable entity)	4180186
44809460	Immediate reconstruction of breast with extended latissimus dorsi flap and insertion of prosthesis (procedure)	4180186
44809461	Reconstruction of breast with local muscle flap and insertion of prosthesis (procedure)	4180186
44809462	Immediate reconstruction of breast with local muscle flap and insertion of prosthesis (procedure)	4180186
44809465	Reconstruction of breast with myocutaneous flap of latissimus dorsi muscle and pectoralis major muscle and insertion of prosthesis (procedure)	4180186
44809467	Left lower limb volume proximal to distal segment ratio (observable entity)	4180186
44809470	Immediate reconstruction of breast with pedicled TRAM (transverse rectus abdominis myocutaneous) flap and insertion of prosthesis	4180186
44809470	Immediate reconstruction of breast with pedicled transverse rectus abdominis myocutaneous flap and insertion of prosthesis (procedure)	4180186
44809471	Endoscopic supraorbital craniotomy with clipping of intracranial aneurysm (procedure)	4180186
44809471	Supraorbital minicraniotomy for intracranial aneurysm	4180186
44809472	Edmonton symptom assessment system score (observable entity)	4180186
44809476	Referral to Angina Plan self-management programme declined (situation)	4180186
44809480	Does monitor blood glucose level before driving (finding)	4180186
44809485	Medical Research Council muscle power score of right wrist extension (observable entity)	4180186
44809486	Medical Research Council muscle power score of left wrist flexion (observable entity)	4180186
44809488	Active range of left shoulder flexion (observable entity)	4180186
44809489	Medical Research Council muscle power score of left hip abduction (observable entity)	4180186
44809490	Medical Research Council muscle power score of right hip abduction (observable entity)	4180186
44809495	Active range of left elbow flexion (observable entity)	4180186
44809496	Medical Research Council muscle power score of right hip flexion (observable entity)	4180186
44809500	Active range of right wrist pronation (observable entity)	4180186
44809501	Active range of left wrist pronation (observable entity)	4180186
44809502	Nucleated red blood cell count result (observable entity)	4180186
44809503	Active range of left shoulder internal rotation (observable entity)	4180186
44809505	Medical Research Council muscle power score of right shoulder external rotation (observable entity)	4180186
44809507	Medical Research Council muscle power score of right shoulder extension (observable entity)	4180186
44809510	Carbapenemase producing Enterobacteriacea (organism)	4180186
44809512	No apparent risk of suicide (situation)	4180186
44809514	On chronic obstructive pulmonary disease supportive care pathway (finding)	4180186
44809514	On COPD (chronic obstructive pulmonary disease) supportive care pathway	4180186
44809517	Admission to acute assessment unit (procedure)	4180186
44809518	Patient mobile telephone number unknown (finding)	4180186
44809520	Discharged from acute assessment unit (finding)	4180186
44809525	Edmonton frail scale (assessment scale)	4180186
44809527	Edmonton frail scale score (observable entity)	4180186
44809529	Child is cause for safeguarding concern (finding)	4180186
44809530	Referral to safeguarding coordinator (procedure)	4180186
44809531	Subject of child in need plan (finding)	4180186
44809532	Provision of written information about blood-borne virus transmission risk (procedure)	4180186
44809533	Cardiac resynchronisation therapy not indicated (situation)	4180186
44809535	Assessment for cardiac resynchronisation therapy (procedure)	4180186
44809536	Parenteral nutrition at 10 days (finding)	4180186
44809537	Parenteral nutrition at birth (finding)	4180186
44809541	Referral to residential weight management programme (procedure)	4180186
44809544	Referral to weight management GPwSI (general practitioner with special interest)	4180186
44809544	Referral to weight management special interest general practitioner (procedure)	4180186
44809547	LFQ (lung function questionnaire) score	4180186
44809547	Lung function questionnaire score (observable entity)	4180186
44809548	Hypertension resistant to drug therapy (disorder)	4180186
44809548	Resistant hypertension	4180186
44809549	Discharge from voluntary service (procedure)	4180186
44809552	Consent given for carpal tunnel injection (finding)	4180186
44809554	Post-operative care in primary care (procedure)	4180186
44809555	Discharge from community respiratory team (procedure)	4180186
44809556	Declined consent for Electronic Prescription Service (finding)	4180186
44809557	Provision of splint (procedure)	4180186
44809561	Dabigatran contraindicated (situation)	4180186
44809564	Referral for retinal photography (procedure)	4180186
44809565	Provision of working splint wrist brace (procedure)	4180186
44809567	Burn healed (finding)	4180186
44809569	Stage 2 hypertension	4180186
44809569	Stage 2 hypertension (National Institute for Health and Clinical Excellence 2011) (disorder)	4180186
44809570	Education about burn care (procedure)	4180186
44809571	Discharge by Macmillan nurse (procedure)	4180186
44809573	Child protection medical examination (procedure)	4180186
44809574	Dietary education for eating out (procedure)	4180186
44809575	Ruptured aneurysm of dialysis vascular access (disorder)	4180186
44809576	Assessment using Edmonton symptom assessment system (procedure)	4180186
44809578	Provision of burn compression garment (procedure)	4180186
44809579	Provision of written information about nerve block anaesthesia (procedure)	4180186
44809580	Total cholesterol level (observable entity)	4180186
44809581	Count of percentage of lymphocytes positive for major histocompatibility class I (procedure)	4180186
44809581	MHC (major histocompatibility) class I percentage of lymphocytes	4180186
44809582	Has direct care worker (finding)	4180186
44809584	Live donor liver transplant	4180186
44809584	Living donor liver transplantation (procedure)	4180186
44809587	Endoscopic insertion of pH monitoring capsule to oesophagus (procedure)	4180186
44809594	Three dimensional ultrasonography (procedure)	4180186
44809596	Endoscopic transsphenoidal removal of pituitary lesion (procedure)	4180186
44809601	Open cryoablation of atrioventricular node (procedure)	4180186
44809602	Laparoscopic excision of lesion of liver (procedure)	4180186
44809604	Radiofrequency tonsillectomy (procedure)	4180186
44809605	Amyloid of intestine	4180186
44809605	Amyloidosis of intestine (disorder)	4180186
44809606	Amyloid of small intestine	4180186
44809606	Amyloidosis of small intestine (disorder)	4180186
44809607	Amyloid of large intestine	4180186
44809607	Amyloidosis of large intestine (disorder)	4180186
44809609	EQ-5D-5L (EuroQol five dimension five level) index value	4180186
44809609	EuroQol five dimension five level index value (observable entity)	4180186
44809610	Anaphylactoid reaction due to haemodialysis (disorder)	4180186
44809613	Delayed reconstruction of breast with latissimus dorsi mini-flap and insertion of prosthesis (procedure)	4180186
44809614	Admission profile form completed (situation)	4180186
44809615	Open left hemicolectomy (procedure)	4180186
44809627	Magnetic resonance imaging of urinary bladder with contrast (procedure)	4180186
44809628	Power of attorney and legal guardianship record (record artifact)	4180186
44809629	Magnetic resonance imaging of wrist with contrast (procedure)	4180186
44809633	Legal notice (record artifact)	4180186
44809635	Recanalisation of gastrostomy tube using fluoroscopic guidance (procedure)	4180186
44809637	Guide wire recanalisation of tunnelled central venous catheter using fluoroscopic guidance (procedure)	4180186
44809642	Laparoscopic right hemicolectomy (procedure)	4180186
44809643	Laparoscopic right hemicolectomy converted to open (procedure)	4180186
44809644	Laparoscopically assisted extended right hemicolectomy (procedure)	4180186
44809645	Laparoscopic extended right hemicolectomy (procedure)	4180186
44809646	Carer annual health check declined (situation)	4180186
44809647	At risk of unwanted pregnancy (finding)	4180186
44809648	LFQ - lung function questionnaire	4180186
44809648	Lung function questionnaire (assessment scale)	4180186
44809650	Uses Personal Communication Passport (finding)	4180186
44809651	Discussion about risks of combined oral contraception (procedure)	4180186
44809652	CAF (common assessment framework) for children and young people action plan started	4180186
44809652	Common assessment framework for children and young people action plan started (finding)	4180186
44809653	CAF (common assessment framework) for children and young people action plan completed	4180186
44809653	Common assessment framework for children and young people action plan completed (finding)	4180186
44809657	Life expectancy limiting condition (finding)	4180186
44809660	Proctoscopy abnormal (finding)	4180186
44809665	Personal care plan-based care started (situation)	4180186
44809667	Under care of health visiting service (finding)	4180186
44809668	Assessment using hypoglycaemia fear survey (procedure)	4180186
44809671	Provision of written information about eye care (procedure)	4180186
44809673	Provision of written information about gestational diabetes (procedure)	4180186
44809674	Provision of written information about insulin (procedure)	4180186
44809675	Provision of written information about alcohol (procedure)	4180186
44809676	Provision of written information about alcohol misuse (procedure)	4180186
44809677	Provision of written information about high blood pressure	4180186
44809677	Provision of written information about hypertension (procedure)	4180186
44809678	Paediatric clinical haematology service (qualifier value)	4180186
44809679	Paediatric urology service (qualifier value)	4180186
44809684	Defibulation of vulva to facilitate delivery (procedure)	4180186
44809684	Deinfibulation of vulva to facilitate delivery	4180186
44809686	Paediatric rheumatology service (qualifier value)	4180186
44809687	Paediatric respiratory medicine service (qualifier value)	4180186
44809690	Paediatric ophthalmology service (qualifier value)	4180186
44809692	Electrocauterisation of lesion of organ NOC (procedure)	4180186
44809693	Paediatric neurosurgery service (qualifier value)	4180186
44809695	Paediatric nephrology service (qualifier value)	4180186
44809696	Paediatric maxillofacial surgery service (qualifier value)	4180186
44809701	Paediatric endocrinology service (qualifier value)	4180186
44809704	Paediatric cardiac surgery service (qualifier value)	4180186
44809706	Insertion of diagnostic device into subcutaneous tissue (procedure)	4180186
44809707	Seen in primary care travel clinic (finding)	4180186
44809709	Urodynamic study using suprapubic tube (procedure)	4180186
44809710	Injection of radiocontrast substance into arteriovenous fistula (procedure)	4180186
44809711	Referral to wheelchair service (procedure)	4180186
44809713	Magnetic resonance imaging of small intestine with contrast (procedure)	4180186
44809713	MRI of small bowel with contrast	4180186
44809715	Has child subject of child protection plan (situation)	4180186
44809719	Recommendation to have child immunised against diphtheria (procedure)	4180186
44809721	Recommendation to have child immunised against pertussis (procedure)	4180186
44809722	Sri Lankan - ethnic category 2001 census (finding)	4180186
44809723	Recommendation to have child immunised against measles, mumps and rubella (procedure)	4180186
44809724	Recommendation to have child immunised against pneumococcal infection (procedure)	4180186
44809725	Declines to give urine specimen (finding)	4180186
44809726	Pain control care plan (record artifact)	4180186
44809727	Intravenous administration of analgesia with antiemetic (procedure)	4180186
44809733	111 contact disposition to community service (finding)	4180186
44809734	111 contact disposition to Social Services (finding)	4180186
44809736	111 contact disposition to accident and emergency department (finding)	4180186
44809738	Giving information to carer	4180186
44809738	Informing carer (procedure)	4180186
44809741	Change of nephrostomy catheter over guide wire	4180186
44809741	Change of nephrostomy tube over guide wire (procedure)	4180186
44809742	Time since last hyperglycaemic episode (observable entity)	4180186
44809744	QCancer prostate cancer risk (observable entity)	4180186
44809746	QCancer cervical cancer risk (observable entity)	4180186
44809747	QCancer blood cancer risk (observable entity)	4180186
44809749	ICP (integrated care priorities) for end of life	4180186
44809749	Integrated care priorities for end of life (regime/therapy)	4180186
44809750	Provision of written information about Marie Curie service (procedure)	4180186
44809752	Change of urethral catheter over guide wire (procedure)	4180186
44809753	Measurement of thiopurine methyltransferase in red blood cell specimen (procedure)	4180186
44809753	Red cell thiopurine methyltransferase level	4180186
44809753	Red cell TPMT (thiopurine methyltransferase) level	4180186
44809754	Direct bonding of gold chain to unerupted tooth (procedure)	4180186
44809755	Tuberculosis test by ELISA interferon-gamma release assay	4180186
44809755	Tuberculosis test using enzyme-linked immunosorbent assay interferon-gamma release assay (procedure)	4180186
44809756	Radium 223 therapy (procedure)	4180186
44809760	National Health Service Health Check not appropriate (finding)	4180186
44809762	Child aware of parent diagnosis (finding)	4180186
44809764	Femoral bruit absent (situation)	4180186
44809766	Aortic bruit absent (situation)	4180186
44809769	Patient perception of problem (record artifact)	4180186
44809770	Continence treatment plan given (finding)	4180186
44809772	Diagnostic history (record artifact)	4180186
44809775	Bowel scope (flexible sigmoidoscopy) screen: normal - no further action (finding)	4180186
44809780	Aortic bruit present (situation)	4180186
44809786	Excision of gonad (procedure)	4180186
44809788	Excision of gonad from pelvis (procedure)	4180186
44809790	Planned duration of foreign travel (observable entity)	4180186
44809794	Therapeutic endoscopic operation on nasal cavity (procedure)	4180186
44809795	Missed review appointment letter sent (procedure)	4180186
44809797	Erosive gastritis (disorder)	4180186
44809798	Live human leucocyte antigen matched related donor (person)	4180186
44809798	Live matched related donor	4180186
44809799	Live human leucocyte antigen unmatched related donor (person)	4180186
44809799	Live unmatched related donor	4180186
44809800	Biopsy of ganglion cyst (procedure)	4180186
44809802	Human immunodeficiency virus infection monitoring invitation (procedure)	4180186
44809803	Human immunodeficiency virus infection monitoring telephone invitation (procedure)	4180186
44809806	Active on kidney transplant waiting list (finding)	4180186
44809807	Dietary advice for wound healing	4180186
44809807	Dietary education for wound healing (procedure)	4180186
44809808	Frequent non-attender (finding)	4180186
44809809	Hypoglycaemic warning absent (disorder)	4180186
44809812	Percutaneous transluminal repair of mitral valve leaflet using transoesophageal echocardiographic and fluoroscopic guidance (procedure)	4180186
44809815	Mental Health Act 1983 (England and Wales) form 2 completed (finding)	4180186
44809816	Third hepatitis B junior vaccination (procedure)	4180186
44809820	Second combined paediatric hepatitis A and B vaccination (procedure)	4180186
44809821	Third combined paediatric hepatitis A and B vaccination (procedure)	4180186
44809822	Intramuscular injection of gonadorelin analogue (procedure)	4180186
44809826	Provision of information about vitamin D supplementation (procedure)	4180186
44809827	Uses dispensed dosette box	4180186
44809827	Uses dispensed monitored dosage system (finding)	4180186
44809829	Transfers medication to own dosette box	4180186
44809829	Transfers medication to own monitored dosage system (finding)	4180186
44809830	Computed tomography report received (finding)	4180186
44809831	No H/O epilepsy	4180186
44809831	No history of epilepsy (situation)	4180186
44809832	No peripheral vascular disease symptoms (situation)	4180186
44809833	Thoracoscopic assisted repair of mitral valve (procedure)	4180186
44809834	Thoracoscopic assisted replacement of mitral valve (procedure)	4180186
44809836	External valvuloplasty of vein (procedure)	4180186
44809838	Endoscopic retrograde cold knife pyelotomy and insertion of stent using fluoroscopic guidance (procedure)	4180186
44809839	Endoscopic retrograde laser pyelotomy and insertion of stent using fluoroscopic guidance (procedure)	4180186
44809842	Bowel scope (flexible-sigmoidoscopy) screening invitation declined (finding)	4180186
44809848	Administration of first intranasal pandemic influenza vaccination (procedure)	4180186
44809851	Administration of second intranasal seasonal influenza vaccination (procedure)	4180186
44809855	First intranasal seasonal influenza vaccination given by other healthcare provider (finding)	4180186
44809857	School entrant hearing screening incomplete (situation)	4180186
44809858	School entrant hearing screening right ear - clear response (situation)	4180186
44809859	School entrant hearing screening left ear - clear response (situation)	4180186
44809860	School entrant hearing screening right ear - no clear response (situation)	4180186
44809862	Child and Adolescent Mental Health Service appointment cancelled by patient (finding)	4180186
44809864	Child and Adolescent Mental Health Service choice appointment cancelled by patient (finding)	4180186
44809866	Child and Adolescent Mental Health Service return appointment cancelled by patient (finding)	4180186
44809868	Child and Adolescent Mental Health Service choice appointment cancelled by clinician (finding)	4180186
44809869	Child and Adolescent Mental Health Service partnership appointment cancelled by clinician (finding)	4180186
44809870	Human immunodeficiency virus infection monitoring third telephone invitation (procedure)	4180186
44809871	Spirometry screening invitation (procedure)	4180186
44809872	Spirometry reversibility test invitation (procedure)	4180186
44809873	Panton-Valentine leukocidin toxin level	4180186
44809873	Panton-Valentine leukocidin toxin measurement (procedure)	4180186
44809874	Admission to observation ward (procedure)	4180186
44809876	Normal capillary refill time (finding)	4180186
44809880	Soft tissue disorder drugs Band 1 (procedure)	4180186
44809881	Macular oedema drugs Band 1 (procedure)	4180186
44809885	Hypofractionated stereotactic radiotherapy using megavoltage radiation (procedure)	4180186
44809886	Police domestic incident report received (finding)	4180186
44809887	Meets National Institute of Health and Care Excellence clinical guideline 164 familial breast cancer referral criteria for assessment and management in secondary care (finding)	4180186
44809888	Health of the Nation Outcome Scale for Children and Adolescents item 1 - disruptive, antisocial or aggressive behaviour (observable entity)	4180186
44809890	Health of the Nation Outcome Scale for Children and Adolescents item 3 - non-accidental self injury (observable entity)	4180186
44809898	Unicompartmental interposition arthroplasty of knee with custom-made implant (procedure)	4180186
44809899	Endoscopic retrograde cholangiopancreatography with brush biopsy of pancreas using fluoroscopic guidance (procedure)	4180186
44809900	Low-intensity pulsed ultrasound therapy (regime/therapy)	4180186
44809901	Thoracoscopic repair of congenital diaphragmatic hernia (procedure)	4180186
44809907	Rupture of dialysis vascular access (disorder)	4180186
44809914	Thrombosis of dialysis arteriovenous graft (disorder)	4180186
44809916	Thrombosis of dialysis arteriovenous shunt (disorder)	4180186
44809918	Occlusion of dialysis arteriovenous fistula (disorder)	4180186
44809919	Occlusion of dialysis arteriovenous shunt (disorder)	4180186
44809920	School nurse report received (finding)	4180186
44809921	Frequency of vomiting (observable entity)	4180186
44809923	Celtic Christian	4180186
44809923	Celtic Christian, follower of religion (person)	4180186
44809924	Pelvic girdle pain (disorder)	4180186
44809924	PGP - pelvic girdle pain	4180186
44809924	SPD - symphysis pubis dysfunction	4180186
44809928	Call-Fleming syndrome	4180186
44809928	Reversible cerebral vasoconstriction syndrome (disorder)	4180186
44809929	No family history of epilepsy (situation)	4180186
44809930	Requires course of tick-borne encephalitis vaccination (finding)	4180186
44809933	Natural killer (dim) cell absolute count (procedure)	4180186
44809933	NK (natural killer) (dim) cell absolute count	4180186
44809935	Count of natural killer (dim) cells as a percentage of total lymphocytes (procedure)	4180186
44809935	NK (natural killer) (dim) cell percentage of lymphocytes	4180186
44809936	Count of natural killer (bright) cells as a percentage of total lymphocytes (procedure)	4180186
44809936	NK (natural killer) (bright) cell percentage of lymphocytes	4180186
44809937	Left knee reflex normal (finding)	4180186
44809938	Right knee reflex normal (finding)	4180186
44809939	No history of malignancy (situation)	4180186
44809940	Private referral to hand surgeon (procedure)	4180186
44809941	Private referral to pain management service (procedure)	4180186
44809943	Idiopathic intracranial hypotension (disorder)	4180186
44809944	Referral to paediatric gynaecology service (procedure)	4180186
44809945	Dementia screening questionnaire sent to patient (finding)	4180186
44809948	No history of malignant tumour of breast (situation)	4180186
44809950	No history of ovarian cyst (situation)	4180186
44809952	Medication review with patient (procedure)	4180186
44809954	No history of depression (situation)	4180186
44809955	Warwick-Edinburgh Mental Well-being Scale score (observable entity)	4180186
44809956	Giving information to parent	4180186
44809956	Informing parent (procedure)	4180186
44809958	Measurement of capillary blood ketone (procedure)	4180186
44809960	Frequency of blood ketone self-monitoring (observable entity)	4180186
44809962	Emergency health care plan agreed (finding)	4180186
44809964	Health of the Nation Outcome Scale for Children and Adolescents item 7 - hallucinations and delusions (observable entity)	4180186
44809966	Health of the Nation Outcome Scale for Children and Adolescents item 9 - emotional and related symptoms (observable entity)	4180186
44809967	Health of the Nation Outcome Scale for Children and Adolescents item 10 - peer relationships (observable entity)	4180186
44809969	Health of the Nation Outcome Scale for Children and Adolescents item 12 - family life and relationships (observable entity)	4180186
44809970	Health of the Nation Outcome Scale for Children and Adolescents item 13 - poor school attendance (observable entity)	4180186
44809972	Health of the Nation Outcome Scale for Children and Adolescents item 15 - lack of information - services/management (observable entity)	4180186
44809978	Cannulation site infection (disorder)	4180186
44809982	Measurement of recombinant Api m 1 Apis mellifera venom specific immunoglobulin E antibody (procedure)	4180186
44809982	Recombinant Api m 1 honey bee specific IgE antibody level	4180186
44809984	Measurement of recombinant Pru p 1 Prunus persica specific immunoglobulin E antibody (procedure)	4180186
44809984	Recombinant Pru p 1 peach specific IgE antibody level	4180186
44809985	Did not attend asthma clinic (finding)	4180186
44809985	DNA (did not attend) asthma clinic	4180186
44809987	Measurement of prolactin in serum specimen using polyethylene glycol recovery (procedure)	4180186
44809987	Serum prolactin polyethylene glycol recovery level	4180186
44809989	Measurement of recombinant Bet v 1 Betula verrucosa specific immunoglobulin E antibody level (procedure)	4180186
44809989	Recombinant Bet v 1 birch specific IgE antibody level	4180186
44809991	Health visitor report received (finding)	4180186
44809991	Report from health visitor	4180186
44809992	Pertussis vaccination in pregnancy invitation second letter (procedure)	4180186
44809994	Time since last episode of vomiting (observable entity)	4180186
44809995	Pertussis vaccination in pregnancy invitation third letter (procedure)	4180186
44809998	Assessment using PASI (psoriasis area and severity index)	4180186
44809998	Assessment using psoriasis area and severity index (procedure)	4180186
44809999	PASI (psoriasis area and severity index) score	4180186
44809999	Psoriasis area and severity index score (observable entity)	4180186
44810001	Child Screening Report (record artifact)	4180186
44810008	Number of hours oxygen therapy prescribed per day (observable entity)	4180186
44810010	Supplier reported volume of supplemental oxygen used per day (observable entity)	4180186
44810011	Supplier reported volume variance between prescribed and used supplemental oxygen per day (observable entity)	4180186
44810012	Single Assessment Process care planning (procedure)	4180186
44810016	Peripheral blood oxygen saturation on supplemental oxygen at rest (observable entity)	4180186
44810017	Peripheral blood oxygen saturation on supplemental oxygen on exertion (observable entity)	4180186
44810018	Cone beam computed tomography (procedure)	4180186
44810021	Cone beam computed tomography of mandible (procedure)	4180186
44810022	Left knee reflex reduced (finding)	4180186
44810025	Right knee reflex absent (finding)	4180186
44810027	Right biceps reflex normal (finding)	4180186
44810028	Left biceps reflex absent (finding)	4180186
44810029	Right biceps reflex absent (finding)	4180186
44810030	Left triceps reflex normal (finding)	4180186
44810032	Left triceps reflex absent (finding)	4180186
44810034	Plantar reflex normal (finding)	4180186
44810036	Right plantar reflex normal (finding)	4180186
44810037	Paediatric energy requirement (observable entity)	4180186
44810039	Insertion of anal seton (procedure)	4180186
44810042	MeCP2 (methyl-cytosine-phosphate-guanine-binding protein-2) duplication syndrome	4180186
44810042	Methyl-cytosine-phosphate-guanine-binding protein-2 duplication syndrome (disorder)	4180186
44810043	Referred by Social Services (finding)	4180186
44810045	Bilateral congenital sensorineural hearing loss (disorder)	4180186
44810047	Right Hoffman reflex equivocal (finding)	4180186
44810047	Right Hoffman's reflex equivocal	4180186
44810050	Teledermatology report received (finding)	4180186
44810052	Neonatal critical care plan (record artifact)	4180186
44810055	Liver transplant recipient (finding)	4180186
44810056	Heart transplant recipient (finding)	4180186
44810059	History of rotavirus vaccine allergy (situation)	4180186
44810060	Did not attend hyperthyroidism clinic (finding)	4180186
44810060	DNA (did not attend) hyperthyroidism clinic	4180186
44810063	Fowler syndrome (disorder)	4180186
44810064	Enteropathy induced by NSAID (non-steroidal anti-inflammatory drug)	4180186
44810064	Non-steroidal anti-inflammatory drug-induced enteropathy (disorder)	4180186
44810066	First intranasal pandemic influenza vaccination declined (situation)	4180186
44810070	Occupational Circumstances Assessment Interview and Rating Scale version 4.0 (assessment scale)	4180186
44810074	Mineral advice	4180186
44810074	Mineral education (procedure)	4180186
44810084	Non-union of joint of ankle with infection (disorder)	4180186
44810085	GULP (gauge, urine, look, plan) Dehydration Risk Screening Tool (assessment scale)	4180186
44810086	Assessment using GULP (gauge, urine, look, plan) Dehydration Risk Screening Tool (procedure)	4180186
44810089	Herpes zoster vaccination invitation (procedure)	4180186
44810089	Shingles vaccination invitation	4180186
44810094	Herpes zoster vaccination invitation second letter (procedure)	4180186
44810094	Shingles vaccination invitation second letter	4180186
44810095	Herpes zoster vaccination invitation third letter (procedure)	4180186
44810095	Shingles vaccination invitation third letter	4180186
44810096	Herpes zoster vaccination invitation short message service text message	4180186
44810096	Herpes zoster vaccination invitation short message service text message (procedure)	4180186
44810096	Shingles vaccination invitation SMS (short message service) text message	4180186
44810097	Herpes zoster vaccination invitation email (procedure)	4180186
44810097	Shingles vaccination invitation email	4180186
44810107	Attention to total prosthetic replacement of ankle joint (procedure)	4180186
44810108	Advice to apply for free prescription	4180186
44810108	Recommendation to apply for free prescription (procedure)	4180186
44810109	Revision of component of total prosthetic replacement of ankle joint (procedure)	4180186
44810110	Advised to apply for prescription prepayment certificate (situation)	4180186
44810115	Cone beam computed tomography of mastoid (procedure)	4180186
44810117	Chronic asthma with fixed airflow obstruction (disorder)	4180186
44810118	Eosinophilic bronchitis (disorder)	4180186
44810119	O/E right leg pulses all absent	4180186
44810119	On examination right lower limb pulses all absent (finding)	4180186
44810120	Infection of dialysis arteriovenous shunt (disorder)	4180186
44810121	O/E left leg pulses all absent	4180186
44810121	On examination left lower limb pulses all absent (finding)	4180186
44810123	Haemorrhage of dialysis arteriovenous fistula (disorder)	4180186
44810124	Haemorrhage of dialysis arteriovenous shunt (disorder)	4180186
44810125	Rupture of dialysis arteriovenous graft (disorder)	4180186
44810126	Rupture of dialysis arteriovenous fistula (disorder)	4180186
44810127	Rupture of dialysis arteriovenous shunt (disorder)	4180186
44810128	Mental Health Act 1983 (England and Wales) form 2 passed to nearest relative (finding)	4180186
44810129	Provision of written information about information sharing (procedure)	4180186
44810132	Assessment using Dutch Lipid Clinic Network diagnostic criteria for familial hypercholesterolaemia (procedure)	4180186
44810133	Administration of drug or medicament via sublingual route (procedure)	4180186
44810136	Antimalarial drug prophylaxis started (situation)	4180186
44810140	Child immunisation invitation first short message service text message (procedure)	4180186
44810140	Child immunisation invitation first SMS (short message service) text message	4180186
44810144	Excessive dietary intake of pantothenic acid (finding)	4180186
44810147	Inadequate dietary intake of copper (finding)	4180186
44810150	Inadequate dietary intake of selenium (finding)	4180186
44810152	Inadequate dietary intake of molybdenum (finding)	4180186
44810153	Family history of squamous cell carcinoma of skin (situation)	4180186
44810155	Cervical smear repeat at 24 months (situation)	4180186
44810158	Photograph certified as true likeness (finding)	4180186
44810161	Excessive dietary intake of manganese (finding)	4180186
44810164	Excessive dietary intake of molybdenum (finding)	4180186
44810165	Pharyngeal lymphogranuloma venereum (disorder)	4180186
44810167	Unable to swallow tablets (finding)	4180186
44810170	Mitochondrial 1555 A to G mutation positive (finding)	4180186
44810171	Family history of congenital hip dysplasia (situation)	4180186
44810172	On drug therapy for attention deficit hyperactivity disorder (situation)	4180186
44810173	On stimulant drug therapy for attention deficit hyperactivity disorder (situation)	4180186
44810174	Beta blocker target dose achieved (finding)	4180186
44810177	Assessment of cause of psychotic and behavioural symptoms (procedure)	4180186
44810178	Vitamin D deficiency monitoring administration (record artifact)	4180186
44810182	Vitamin D deficiency monitoring third letter (procedure)	4180186
44810183	Vitamin D deficiency monitoring verbal invitation (procedure)	4180186
44810188	Vitamin D deficiency monitoring (regime/therapy)	4180186
44810189	Vitamin D deficiency annual review (regime/therapy)	4180186
44810192	General practitioner practice (record artifact)	4180186
44810192	GP practice	4180186
44810196	Participation in research (record artifact)	4180186
44810201	Relevant clinical risk factors (record artifact)	4180186
44810202	Risk mitigation (record artifact)	4180186
44810203	Reason for admission (record artifact)	4180186
44810204	Reason for handover (record artifact)	4180186
44810208	Medical devices (record artifact)	4180186
44810211	Imbalanced dietary intake of protein (finding)	4180186
44810213	Allotransplantation of stomach (procedure)	4180186
44810215	Qualitative detection test for tramadol in urine specimen (procedure)	4180186
44810215	Urine tramadol detection test	4180186
44810217	Child BMI (body mass index) centile	4180186
44810217	Child body mass index centile (observable entity)	4180186
44810219	Patient asked to make telephone consultation appointment (finding)	4180186
44810220	Seen in Child and Adolescent Mental Health Service community drop in clinic	4180186
44810220	Seen in Child and Adolescent Mental Health Service community drop in clinic (finding)	4180186
44810221	Measurement of ratio of histidine to creatinine in urine specimen (procedure)	4180186
44810221	Urine histidine:creatinine ratio	4180186
44810225	Urine glycine:creatinine ratio	4180186
44810225	Measurement of ratio of glycine to creatinine in urine specimen (procedure)	4180186
44810229	Measurement of ratio of lysine to creatinine in urine specimen (procedure)	4180186
44810229	Urine lysine:creatinine ratio	4180186
44810231	Measurement of ratio of ornithine to creatinine in urine specimen (procedure)	4180186
44810231	Urine ornithine:creatinine ratio	4180186
44810234	Measurement of ratio of threonine to creatinine in urine specimen (procedure)	4180186
44810234	Urine threonine:creatinine ratio	4180186
44810235	Measurement of ratio of tryptophan to creatinine in urine specimen (procedure)	4180186
44810235	Urine tryptophan:creatinine ratio	4180186
44810243	Grass mix specific IgE antibody level	4180186
44810243	Measurement of grass mix specific immunoglobulin E antibody (procedure)	4180186
44810244	Child immunisation invitation second short message service text message (procedure)	4180186
44810244	Child immunisation invitation second SMS (short message service) text message	4180186
44810247	Length of stay, acuity of admission, comorbidities and emergency department visits index score (observable entity)	4180186
44810248	Local anaesthetic nerve block for fitting of intrauterine contraceptive device offered (situation)	4180186
44810250	First primary immunisation invitation first letter (procedure)	4180186
44810251	First primary immunisation invitation second letter (procedure)	4180186
44810254	Second primary immunisation invitation second letter (procedure)	4180186
44810256	Third primary immunisation invitation first letter (procedure)	4180186
44810257	Third primary immunisation invitation second letter (procedure)	4180186
44810262	Internal referral for injection (procedure)	4180186
44810264	12-13 month immunisation invitation second letter (procedure)	4180186
44810265	12-13 month immunisation invitation third letter (procedure)	4180186
44810267	Second measles mumps rubella immunisation invitation second letter (procedure)	4180186
44810268	Second measles mumps rubella immunisation invitation third letter (procedure)	4180186
44810269	Mental Health Act 1983 (England and Wales) form 2 fee paid (finding)	4180186
44810273	Contraceptive implant clinical management plan (record artifact)	4180186
44810275	Paediatric complex community care plan (record artifact)	4180186
44810276	Requires rubella vaccination (finding)	4180186
44810278	Coronavirus contact	4180186
44810278	Exposure to coronavirus infection (event)	4180186
44810279	Predicted inadequate nutrient intake (finding)	4180186
44810283	Paediatric care (regime/therapy)	4180186
44810285	Management of hysteroscopy (procedure)	4180186
44810287	Management of colposcopy (procedure)	4180186
44810288	No family history of malignant tumour of prostate (situation)	4180186
44810290	No family history of non-Hodgkin lymphoma (situation)	4180186
44810291	QAdmissions risk of emergency hospital admission in next 12 months (observable entity)	4180186
44810297	Allergies and adverse reaction	4180186
44810297	Allergies and adverse reaction (record artifact)	4180186
44810298	Safety alerts (record artifact)	4180186
44810299	Risks to self (record artifact)	4180186
44810301	Legal information (record artifact)	4180186
44810302	Consent for treatment record (record artifact)	4180186
44810304	Advance decisions about treatment (record artifact)	4180186
44810306	Lasting or enduring power of attorney or similar (record artifact)	4180186
44810307	Consent relating to child (record artifact)	4180186
44810308	Consent to information sharing	4180186
44810308	Consent for information sharing (record artifact)	4180186
44810310	Social context (record artifact)	4180186
44810312	Type 2 Bartter syndrome (disorder)	4180186
44810314	Type 4 Bartter syndrome (disorder)	4180186
44810315	Epilepsy, ataxia, sensorineural deafness and tubulopathy syndrome	4180186
44810315	Epilepsy, ataxia, sensorineural deafness and tubulopathy syndrome (disorder)	4180186
44810317	Review of systems (record artifact)	4180186
44810318	Patient and carer concerns (record artifact)	4180186
44810319	Assessment scales (record artifact)	4180186
44810320	Problems and issues (record artifact)	4180186
44810324	Investigations and results (record artifact)	4180186
44810326	Outstanding issues (record artifact)	4180186
44810327	Information given (record artifact)	4180186
44810329	Person handing over (record artifact)	4180186
44810331	Distribution list (record artifact)	4180186
44810332	Most senior healthcare professional present (record artifact)	4180186
44810333	Fibrous corn (disorder)	4180186
44810334	Routine enquiry about domestic abuse (procedure)	4180186
44810335	Routine enquiry about domestic abuse not made (situation)	4180186
44810336	Routine enquiry about domestic abuse declined (situation)	4180186
44810337	Carcinoembryonic antigen monitoring (regime/therapy)	4180186
44810337	CEA (carcinoembryonic antigen) monitoring	4180186
44810339	Patient requests non-blood medical management (finding)	4180186
44810342	Westley Croup Score (assessment scale)	4180186
44810343	Assessment using Westley Croup Score (procedure)	4180186
44810344	Westley Croup Score (observable entity)	4180186
44810347	Measurement of ratio of cadmium to creatinine in urine specimen (procedure)	4180186
44810347	Urine cadmium:creatinine ratio	4180186
44810349	Duodenal gastric metaplasia (disorder)	4180186
44810350	Iatrogenic intestinal disorder (disorder)	4180186
44810351	H/O: clopidogrel allergy	4180186
44810351	History of clopidogrel allergy (situation)	4180186
44810357	Measurement of ratio of lead to creatinine in urine specimen (procedure)	4180186
44810357	Urine lead:creatinine ratio	4180186
44810358	Measurement of ratio of manganese to creatinine in urine specimen (procedure)	4180186
44810358	Urine manganese:creatinine ratio	4180186
44810359	Measurement of ratio of mercury to creatinine in urine specimen (procedure)	4180186
44810359	Urine mercury:creatinine ratio	4180186
44810361	Cone beam computed tomography of temporomandibular joint (procedure)	4180186
44810362	Prescription of orthotic device (procedure)	4180186
44810363	Preferred place of death: community hospital (finding)	4180186
44810368	High cost chemotherapy drugs (procedure)	4180186
44810372	Faecal coproporphyrin II content	4180186
44810372	Measurement of coproporphyrin II content in faeces specimen (procedure)	4180186
44810373	Pre-school booster immunisation invitation first letter (procedure)	4180186
44810374	Pre-school booster immunisation invitation second letter (procedure)	4180186
44810377	Administration of intranasal influenza vaccination (procedure)	4180186
44810380	Transfers using slide sheet (finding)	4180186
44810381	Unsuccessful direct current cardioversion (situation)	4180186
44810381	Unsuccessful electrical cardioversion	4180186
44810384	Did not wait for clinical investigation (finding)	4180186
44810387	Herpes zoster vaccination contraindicated (situation)	4180186
44810389	Education about end of life care (procedure)	4180186
44810390	Second rotavirus vaccination (procedure)	4180186
44810393	Cone beam computed tomography of neck (procedure)	4180186
44810394	Cone beam computed tomography of head (procedure)	4180186
44810395	Cone beam computed tomography of abdomen (procedure)	4180186
44810396	Timed collection: specimen collection, 180 minutes (finding)	4180186
44810397	Measurement of recombinant Cor a 1 Corylus avellana specific immunoglobulin E antibody (procedure)	4180186
44810399	Liverpool care pathway for the dying discontinued (situation)	4180186
44810402	Thrombophilia screening negative (finding)	4180186
44810404	Retinocochleocerebral vasculopathy (disorder)	4180186
44810404	Susac's syndrome	4180186
44810405	Extra large (qualifier value)	4180186
44810406	Extra extra large (qualifier value)	4180186
44810408	CD138+ percentage of nucleated cells	4180186
44810408	Percentage count of nucleated cells positive for CD138 antigen (procedure)	4180186
44810409	Anti-amphiphysin IgG antibody level	4180186
44810409	Measurement of amphiphysin specific immunoglobulin G antibody (procedure)	4180186
44810411	Harvesting of lobe of lung from living donor (procedure)	4180186
44810412	Percutaneous endoscopic laser excision of lumbar intervertebral disc (procedure)	4180186
44810415	No evidence of child sexual abuse (situation)	4180186
44810422	Primary osteoarthritis of talonavicular joint (disorder)	4180186
44810425	Cervical smear - high grade dyskaryosis with features of invasive squamous carcinoma (finding)	4180186
44810426	Framework for the Assessment of Children in Need and their Families (regime/therapy)	4180186
44810427	Activated partial thromboplastin time ratio using Actin FSL and phospholipid correction (procedure)	4180186
44810427	APTR (activated partial thromboplastin time ratio) using Actin FSL and phospholipid correction	4180186
44810430	Cervical smear - features of non-cervical type glandular neoplasia (finding)	4180186
44810432	Key contact informed in advance of discharge (situation)	4180186
44810433	Eligible for Care of Next Infant programme (finding)	4180186
44810434	Emergency health care plan (record artifact)	4180186
44810442	On melatonin for sleep disorder (situation)	4180186
44810443	Kapandji clinical opposition and reposition test of thumb score (observable entity)	4180186
44810445	Parent/guardian not aware of any contraindication to immunisation (finding)	4180186
44810446	No response to dementia screening invitation (finding)	4180186
44810449	PET CT using 11C-metomidate	4180186
44810449	Positron emission tomography with computed tomography using 11C-metomidate (procedure)	4180186
44810451	Plasma porphyrin screening test (procedure)	4180186
44810452	Free erythrocyte protoporphyrin concentration measurement	4180186
44810452	Measurement of red blood cell free protoporphyrin concentration (procedure)	4180186
44810452	Red blood cell free protoporphyrin concentration	4180186
44810456	Implantation of subcutaneous cardioverter defibrillator (procedure)	4180186
44810458	Renewal of subcutaneous cardioverter defibrillator	4180186
44810458	Replacement of subcutaneous cardioverter defibrillator (procedure)	4180186
44810459	Removal of subcutaneous cardioverter defibrillator (procedure)	4180186
44810460	Remote care monitoring commenced (situation)	4180186
44810462	Partial meal replacement programme commenced (situation)	4180186
44810467	Speech and language developmental delay (disorder)	4180186
44810468	Bilateral severe sensorineural hearing loss (disorder)	4180186
44810468	Severe BSNHL (bilateral sensorineural hearing loss)	4180186
44810469	Bilateral moderate sensorineural hearing loss (disorder)	4180186
44810469	Moderate BSNHL (bilateral sensorineural hearing loss)	4180186
44810471	Organic acidaemia (disorder)	4180186
44810471	Organic aciduria	4180186
44810472	Ten year hip fracture probability score using QFracture risk calculator (observable entity)	4180186
44810473	Measurement of ratio of leucine to creatinine in urine specimen (procedure)	4180186
44810473	Urine leucine:creatinine ratio	4180186
44810474	Repositioning of colostomy (procedure)	4180186
44810474	Resiting of colostomy	4180186
44810477	Completion of newborn blood spot screening card (procedure)	4180186
44810478	Diphtheria, tetanus, acellular pertussis, inactivated polio vaccine, Haemophilus influenzae type b vaccination contraindicated (situation)	4180186
44810478	DTaP/IPV/Hib (Diphtheria, tetanus, acellular pertussis, inactivated polio vaccine, Haemophilus influenzae type b) vaccination contraindicated	4180186
44810479	Tube feeding commenced (situation)	4180186
44810481	Cone beam computed tomography of upper limb (procedure)	4180186
44810481	Cone beam CT of arm	4180186
44810482	Cone beam computed tomography of lower limb (procedure)	4180186
44810482	Cone beam CT of leg	4180186
44810483	Cone beam computed tomography of spine (procedure)	4180186
44810484	Biopsy using cone beam computed tomography guidance (procedure)	4180186
44810486	Aspiration using cone beam computed tomography guidance (procedure)	4180186
44810487	Biopsy of neck using cone beam computed tomography guidance (procedure)	4180186
44810489	Biopsy of chest using cone beam computed tomography guidance (procedure)	4180186
44810489	Cone beam CT guided biopsy of thorax	4180186
44810491	Biopsy of pelvis using cone beam computed tomography guidance (procedure)	4180186
44810494	Aspiration of neck using cone beam computed tomography guidance (procedure)	4180186
44810495	Aspiration of head using cone beam computed tomography guidance (procedure)	4180186
44810496	Aspiration of chest using cone beam computed tomography (procedure)	4180186
44810496	Cone beam CT guided aspiration of thorax	4180186
44810498	Aspiration of pelvis using cone beam computed tomography guidance (procedure)	4180186
44810499	Aspiration of upper limb using cone beam computed tomography guidance (procedure)	4180186
44810499	Cone beam CT guided aspiration of arm	4180186
44810504	Insertion of drain into head using cone beam computed tomography guidance (procedure)	4180186
44810509	Insertion of drain into pelvis using cone beam computed tomography guidance (procedure)	4180186
44810510	Did not attend herpes zoster vaccination (finding)	4180186
44810512	Cone beam CT guided insertion of drain into arm	4180186
44810512	Insertion of drain into upper limb using cone beam computed tomography guidance (procedure)	4180186
44810516	Hysteroscopic bipolar electrosurgical excision of uterine polyp (procedure)	4180186
44810517	Insertion of stent into patent ductus arteriosus using fluoroscopic guidance with contrast (procedure)	4180186
44810517	Fluoroscopy guided insertion of stent into PDA (patent ductus arteriosus) with contrast	4180186
44810519	Percutaneous embolisation of lesion of thorax using fluoroscopic guidance with contrast (procedure)	4180186
44810519	Fluoroscopy guided percutaneous embolisation of chest lesion with contrast	4180186
44810521	Secondary osteoarthritis of talonavicular joint (disorder)	4180186
44810522	Osteoarthritis of talonavicular joint secondary to inflammatory arthritis (disorder)	4180186
44810523	Osteoarthritis of talonavicular joint secondary to trauma (disorder)	4180186
44810524	Primary osteoarthritis of subtalar joint (disorder)	4180186
44810525	Secondary osteoarthritis of subtalar joint (disorder)	4180186
44810527	Osteoarthritis of subtalar joint secondary to trauma (disorder)	4180186
44810528	Osteoarthritis of calcaneocuboid joint (disorder)	4180186
44810529	Primary osteoarthritis of calcaneocuboid joint (disorder)	4180186
44810531	Osteoarthritis of calcaneocuboid joint secondary to inflammatory arthritis (disorder)	4180186
44810536	Secondary osteoarthritis of midfoot (disorder)	4180186
44810537	Osteoarthritis of midfoot secondary to inflammatory arthritis (disorder)	4180186
44810538	Osteoarthritis of midfoot secondary to trauma (disorder)	4180186
44810540	Secondary osteoarthritis of first metatarsophalangeal joint (disorder)	4180186
44810540	Secondary osteoarthritis of first MTPJ (metatarsophalangeal joint)	4180186
44810541	Osteoarthritis of first metatarsophalangeal joint secondary to inflammatory arthritis (disorder)	4180186
44810541	Osteoarthritis of first MTPJ (metatarsophalangeal joint) secondary to inflammatory arthritis	4180186
44810547	Charcot arthropathy of ankle (disorder)	4180186
44810549	Chronic rupture of Achilles tendon (disorder)	4180186
44810552	Insertional Achilles tendinopathy (disorder)	4180186
44810553	Non-insertional Achilles tendinopathy (disorder)	4180186
44810554	Tendinopathy of tibialis posterior tendon (disorder)	4180186
44810555	Assessment for preconception care (procedure)	4180186
44810556	No neurodisabling condition detected on examination (finding)	4180186
44810557	No neurodevelopmental condition detected on examination (finding)	4180186
44810559	Cervical smear - human papillomavirus positive (finding)	4180186
44810560	Breathlessness causing difficulty eating (finding)	4180186
44810561	Carditis due to rheumatic fever (disorder)	4180186
44810561	Rheumatic carditis	4180186
44810562	Diabetes mellitus in remission (disorder)	4180186
44810564	Transfer of care to a medium secure health care provider (procedure)	4180186
44810565	Type 2 diabetes mellitus in remission	4180186
44810565	Type II diabetes mellitus in remission (disorder)	4180186
44810566	Secondary care service currently unavailable (situation)	4180186
44810567	Community service currently unavailable (situation)	4180186
44810568	Mild cognitive impairment (finding)	4180186
44810577	Has statement of special educational needs (finding)	4180186
44810580	Ibandronic acid therapy (procedure)	4180186
44810581	Zoledronic acid therapy (procedure)	4180186
44810582	Parathyroid hormone therapy (procedure)	4180186
44810583	Left Hoffman reflex negative (finding)	4180186
44810586	Discharge from care against professional advice (procedure)	4180186
44810588	Partial compliance with food fortification regimen (finding)	4180186
44810589	Compliant with food fortification regimen (finding)	4180186
44810590	Review of tube feeding regimen (procedure)	4180186
44810595	Enteral nutrition not optimised to requirements (finding)	4180186
44810597	Consent given for video recording for assessment (finding)	4180186
44810600	Referral for ambulatory care (procedure)	4180186
44810601	Discharge from homeless advocacy service (procedure)	4180186
44810603	Assessment using Glamorgan paediatric pressure ulcer risk assessment scale (procedure)	4180186
44810610	Absence of signs and symptoms of urinary tract infection (situation)	4180186
44810613	Right toe brachial pressure index (procedure)	4180186
44810615	Verification of parental access rights to child (procedure)	4180186
44810617	Verification of parental responsibility (procedure)	4180186
44810618	Provision of accommodation under section 20 of Children Act 1989 (procedure)	4180186
44810619	Education about peripheral venous cannula care (procedure)	4180186
44810624	Assessment for dementia (procedure)	4180186
44810626	On anticoagulation care pathway (situation)	4180186
44810627	On deep vein thrombosis care pathway (situation)	4180186
44810628	On community cardiac care pathway (situation)	4180186
44810630	On gallstone care pathway (situation)	4180186
44810632	Deep vein thrombosis care pathway (regime/therapy)	4180186
44810634	Ear microsuction care pathway (regime/therapy)	4180186
44810638	Discharge by psychologist (procedure)	4180186
44810640	Agreeing on care plan with legitimate patient representative (procedure)	4180186
44810642	Discharge from community care service (procedure)	4180186
44810643	Education about swallowing (procedure)	4180186
44810645	Discharge letter offered to patient (finding)	4180186
44810647	SAP (Single Assessment Process) care plan	4180186
44810647	Single Assessment Process care plan (record artifact)	4180186
44810649	MCS - minimally conscious state	4180186
44810649	Minimally conscious state (finding)	4180186
44810650	Dysexecutive syndrome (disorder)	4180186
44810650	Executive dysfunction	4180186
44810651	Endoscopy care (regime/therapy)	4180186
44810653	Management of IBD (inflammatory bowel disease)	4180186
44810653	Management of inflammatory bowel disease (procedure)	4180186
44810654	Triple P - Positive Parenting Programme (regime/therapy)	4180186
44810655	Percutaneous transluminal angioplasty of pulmonary vein using fluoroscopic guidance (procedure)	4180186
44810659	Acute instability of ankle (finding)	4180186
44810661	Global instability of ankle (finding)	4180186
44810662	Acute disruption of syndesmosis of ankle (disorder)	4180186
44810663	Chronic instability of syndesmosis of ankle (disorder)	4180186
44810666	Tibial osteochondral defect of ankle (disorder)	4180186
44810667	Fibular osteochondral defect of ankle (disorder)	4180186
44810671	Hallux valgus interphalangeus (finding)	4180186
44810674	Osteomyelitis of midfoot (disorder)	4180186
44810676	SIS (Stroke Impact Scale) version 3.0	4180186
44810676	Stroke Impact Scale version 3.0 (assessment scale)	4180186
44810677	Assessment using SIS (Stroke Impact Scale) version 3.0	4180186
44810677	Assessment using Stroke Impact Scale version 3.0 (procedure)	4180186
44810680	SIS (Stroke Impact Scale) version 3.0 hand function score	4180186
44810680	Stroke Impact Scale version 3.0 hand function score (observable entity)	4180186
44810681	SIS (Stroke Impact Scale) version 3.0 mobility score	4180186
44810681	Stroke Impact Scale version 3.0 mobility score (observable entity)	4180186
44810687	Planned discharge destination (observable entity)	4180186
44810689	Offering of Child and Adolescent Mental Health Service choice appointment (procedure)	4180186
44810690	Informing patient of outcome of Child and Adolescent Mental Health Service choice appointment (procedure)	4180186
44810691	ASSIGN2 cardiovascular disease risk assessment declined (situation)	4180186
44810693	Patient consent given to contact carer about care (finding)	4180186
44810694	PCDH19 (protocadherin 19) mutation analysis	4180186
44810694	Protocadherin 19 mutation analysis (procedure)	4180186
44810696	Heterozygous PCDH19 (protocadherin 19) gene mutation positive	4180186
44810696	Heterozygous protocadherin 19 gene mutation positive (finding)	4180186
44810699	Initial memory assessment declined (situation)	4180186
44810700	Initial memory assessment (procedure)	4180186
44810701	Single Assessment Process completed (situation)	4180186
44810704	Suspected victim of sexual grooming (situation)	4180186
44810706	Screening for child non-accidental injury (procedure)	4180186
44810707	Hypomania checklist 32 item revised (assessment scale)	4180186
44810708	Non-accidental traumatic head injury to child (disorder)	4180186
44810710	Consent given to share Summary Care Record (finding)	4180186
44810711	Dissent to share Summary Care Record (finding)	4180186
44810712	Brachial-cephalic fistula	4180186
44810712	Postoperative brachiocephalic arteriovenous fistula (morphologic abnormality)	4180186
44810713	Dietetics intervention declined (situation)	4180186
44810714	Inadequate self monitoring of dietetic intervention (finding)	4180186
44810716	Measurement of concentration of carbamazepine 10,11 epoxide in serum specimen (procedure)	4180186
44810716	Serum carbamazepine 10,11 epoxide concentration	4180186
44810718	Health Plan Indicator (National Health Service Scotland) - core (finding)	4180186
44810719	Retroorbital radiotherapy (procedure)	4180186
44810720	Health Plan Indicator (National Health Service Scotland) - additional (finding)	4180186
44810722	Health Plan Indicator (National Health Service Scotland) - category unknown (finding)	4180186
44810725	Did not attend first rotavirus vaccination (finding)	4180186
44810727	Did not attend second rotavirus vaccination (finding)	4180186
44810738	SIS (Stroke Impact Scale) version 3.0 communication score	4180186
44810738	Stroke Impact Scale version 3.0 communication score (observable entity)	4180186
44810741	Under care of mental health in-reach team (finding)	4180186
44810749	Management of upper gastrointestinal tract endoscopy (procedure)	4180186
44810752	Supervision required for wheelchair transfer (finding)	4180186
44810753	Postnatal examination second invitation (procedure)	4180186
44810755	Dementia screening declined (situation)	4180186
44810761	School entrant hearing screening no clear response - bilateral referral (situation)	4180186
44810762	School entrant hearing screening incomplete - absent from school (situation)	4180186
44810763	School entrant hearing screening incomplete - screening contraindicated (situation)	4180186
44810765	School entrant hearing screening incomplete - deceased (situation)	4180186
44810771	Patient offered choice of Any Qualified Provider (finding)	4180186
44810771	Patient offered choice of AQP (Any Qualified Provider)	4180186
44810774	Nuclear medicine bremsstrahlung imaging post therapy (procedure)	4180186
44810777	Specific learning difficulty	4180186
44810777	Specific learning disability (disorder)	4180186
44810781	Antipsychotic drug therapy for dementia (procedure)	4180186
44810784	Care home visit (procedure)	4180186
44810786	Care home visit for follow-up patient review (procedure)	4180186
44810787	Acetylcholinesterase activity	4180186
44810787	Measurement of acetylcholinesterase activity (procedure)	4180186
44810791	Polish - ethnic category 2001 census (finding)	4180186
44810794	Arylsulphatase A activity	4180186
44810794	Measurement of arylsulphatase A activity (procedure)	4180186
44810797	Butyrylcholinesterase activity	4180186
44810797	Measurement of butyrylcholinesterase activity (procedure)	4180186
44810800	Acid-fast bacillus sputum smear positive (finding)	4180186
44810801	Baltic States (Estonian or Latvian or Lithuanian) - ethnic category 2001 census (finding)	4180186
44810803	Glycogen debrancher enzyme activity	4180186
44810803	Measurement of glycogen debranching enzyme activity (procedure)	4180186
44810806	Adverse reaction to rotavirus vaccine (disorder)	4180186
44810807	Measurement of propionyl-CoA carboxylase activity (procedure)	4180186
44810807	Propionyl-CoA carboxylase activity	4180186
44810809	QStroke 10 year risk of stroke calculator (assessment scale)	4180186
44810811	Polypharmacy medication review (procedure)	4180186
44810812	In-house diabetic foot screening (procedure)	4180186
44810813	In-house diabetic foot screening first appointment (procedure)	4180186
44810816	Discharge from in-house diabetic foot screening (procedure)	4180186
44810819	Eron severity classification system for skin and soft tissue infections (assessment scale)	4180186
44810823	Arterial cannula care (regime/therapy)	4180186
44810824	Prescription of palliative care anticipatory medication (procedure)	4180186
44810827	Eron class 2 skin and soft tissue infection	4180186
44810827	Eron class II skin and soft tissue infection (finding)	4180186
44810828	Eron class 3 skin and soft tissue infection	4180186
44810828	Eron class III skin and soft tissue infection (finding)	4180186
44810829	Unable to complete EuroQol five dimension self-report questionnaire (finding)	4180186
44810830	Health Plan Indicator (National Health Service Scotland) - additional, low risk (finding)	4180186
44810835	FFT - Functional Family Therapy	4180186
44810835	Functional Family Therapy (regime/therapy)	4180186
44810839	Problem with metalwork of foot and ankle (finding)	4180186
44810842	Abnormality of toenail (finding)	4180186
44810843	Family Nurse Partnership programme (regime/therapy)	4180186
44810844	Cervical smear - borderline change in squamous cells (finding)	4180186
44810845	Cervical smear - borderline change in endocervical cells (finding)	4180186
44810847	Freiberg's disease	4180186
44810847	Osteochondrosis of second metatarsal head (disorder)	4180186
44810850	Upper gastrointestinal tract endoscopy care plan (record artifact)	4180186
44810852	Domestic abuse victim in household (finding)	4180186
44810853	Attachment-based therapy (regime/therapy)	4180186
44810854	Cognitive rehabilitation therapy (regime/therapy)	4180186
44810855	Request for individual funding declined (situation)	4180186
44810858	Right triceps reflex reduced (finding)	4180186
44810867	Timed collection: specimen collection, 30 minutes (finding)	4180186
44810868	Commonwealth of (Russian) Independent States - ethnic category 2001 census (finding)	4180186
44810870	Measurement of tripeptidyl-peptidase I activity (procedure)	4180186
44810870	Tripeptidyl-peptidase I activity	4180186
44810873	Antithrombin III activity	4180186
44810873	Measurement of antithrombin III activity (procedure)	4180186
44810874	Measurement of pyruvate kinase activity (procedure)	4180186
44810874	Pyruvate kinase activity	4180186
44810876	Implantation of extra-articular partial load absorber device to knee joint (procedure)	4180186
44810879	Acid-fast bacillus sputum smear negative (finding)	4180186
44810880	Measurement of salivary gland duct immunoglobulin G antibody (procedure)	4180186
44810881	Multiple and complex disability without physical disability (finding)	4180186
44810883	Referred by police (finding)	4180186
44810887	Scot-PASQ (Scottish Physical Activity Screening Questions) score	4180186
44810887	Scottish Physical Activity Screening Questions score (observable entity)	4180186
44810888	Vision examination not completed (situation)	4180186
44810890	Advice on risks of harm to mother from maternal medication during pregnancy (procedure)	4180186
44810903	Magnetic resonance imaging of thoracic outlet with contrast (procedure)	4180186
44810904	Ultrasonography of kidney with contrast (procedure)	4180186
44810904	Ultrasound scan of kidney with contrast	4180186
44810908	Measurement of concentration of doxepin in serum specimen (procedure)	4180186
44810908	Serum doxepin concentration	4180186
44810909	Measurement of concentration of efavirenz in serum specimen (procedure)	4180186
44810909	Serum efavirenz concentration	4180186
44810911	Measurement of concentration of flucytosine in serum specimen (procedure)	4180186
44810911	Serum flucytosine concentration	4180186
44810912	Measurement of concentration of fluoxetine in serum specimen (procedure)	4180186
44810912	Serum fluoxetine concentration	4180186
44810913	Measurement of concentration of ethylene glycol in serum specimen (procedure)	4180186
44810913	Serum ethylene glycol concentration	4180186
44810915	Referral for participation in research study (procedure)	4180186
44810916	Salicylate/paracetamol/ibuprofen screen (procedure)	4180186
44810919	Declined invitation to participate in research study (finding)	4180186
44810921	Research study follow-up (procedure)	4180186
44810924	Behenic acid level	4180186
44810924	Measurement of behenic acid (procedure)	4180186
44810925	First intranasal influenza vaccination declined (situation)	4180186
44810927	Assessment using Scottish patients at risk of readmission and admission algorithm (procedure)	4180186
44810928	Assessment of arterial cannula site (procedure)	4180186
44810929	Discussion about DS1500 Disability living allowance report (procedure)	4180186
44810933	Social prescribing offered (finding)	4180186
44810935	Referral to social prescribing service (procedure)	4180186
44810936	Administration of first intranasal influenza vaccination (procedure)	4180186
44810937	Liquid contaminant in eye (finding)	4180186
44810939	Possibly eligible for participation in research study (finding)	4180186
44810942	Left thigh circumference (observable entity)	4180186
44810945	Victim of child sexual abuse (finding)	4180186
44810946	Extracorporeal shockwave lithotripsy for calcific tendinopathy of shoulder (procedure)	4180186
44810951	GMFCS (Gross Motor Function Classification System) for Cerebral Palsy level II	4180186
44810951	GMFCS (Gross Motor Function Classification System) level II	4180186
44810951	Gross Motor Function Classification System for Cerebral Palsy level II (finding)	4180186
44810952	Dissent from disclosure of personal confidential data by Health and Social Care Information Centre (finding)	4180186
44810952	Dissent from disclosure of personal confidential data by HSCIC (Health and Social Care Information Centre)	4180186
44810954	Power of myotome of eighth cervical nerve (observable entity)	4180186
44810955	Amended record entry to correct message mapping error (finding)	4180186
44810956	Power of myotome of fifth cervical nerve (observable entity)	4180186
44810957	Power of myotome of fifth lumbar nerve (observable entity)	4180186
44810958	Power of myotome of first sacral nerve (observable entity)	4180186
44810961	Power of myotome of fourth lumbar nerve (observable entity)	4180186
44810962	Power of myotome of second cervical nerve (observable entity)	4180186
44810965	Power of myotome of seventh cervical nerve (observable entity)	4180186
44810967	Power of myotome of sixth cervical nerve (observable entity)	4180186
44810969	Power of myotome of third lumbar nerve (observable entity)	4180186
44810970	Power of left myotome of eighth cervical nerve (observable entity)	4180186
44810972	Power of right myotome of fifth cervical nerve (observable entity)	4180186
44810973	Power of left myotome of fifth lumbar nerve (observable entity)	4180186
44810975	Warfarin not tolerated (situation)	4180186
44810976	Power of left myotome of first thoracic nerve (observable entity)	4180186
44810977	Recovery of kidney function	4180186
44810977	Recovery of renal function (finding)	4180186
44810983	Iranian - ethnic category 2001 census (finding)	4180186
44810985	Patient aware of their named nurse (finding)	4180186
44810988	Muslim - ethnic category 2001 census (finding)	4180186
44810989	Facial lipoatrophy associated with human immunodeficiency virus (disorder)	4180186
44810992	Second assessment using National Audit of Cardiac Rehabilitation questionnaire (procedure)	4180186
44810993	Third assessment using National Audit of Cardiac Rehabilitation questionnaire (procedure)	4180186
44810994	Day case surgery care plan (record artifact)	4180186
44810995	Child and Adolescent Mental Health Services Outcome Research Consortium goal based outcome measure (assessment scale)	4180186
44810996	Discharge from high dependency unit (procedure)	4180186
44810998	Provision of written information about anticoagulant therapy (procedure)	4180186
44811001	Barium enema report received (finding)	4180186
44811002	Assessment using confusion, urea, respiratory rate, blood pressure criteria	4180186
44811002	Assessment using confusion, urea, respiratory rate, blood pressure criteria (procedure)	4180186
44811003	Assessment using confusion, urea, respiratory rate, blood pressure, 65 years of age or older criteria	4180186
44811003	Assessment using confusion, urea, respiratory rate, blood pressure, 65 years of age or older criteria (procedure)	4180186
44811007	Marking of skin over carotid artery using ultrasonography guidance (procedure)	4180186
44811007	Ultrasound guided marking of skin over carotid artery	4180186
44811014	Education about speech and language therapy (procedure)	4180186
44811018	On examination right radial pulse present (finding)	4180186
44811019	On examination left radial pulse absent (finding)	4180186
44811020	On examination right radial pulse absent (finding)	4180186
44811021	Discussion about electronic record sharing (procedure)	4180186
44811022	O/E left arm pulses all present	4180186
44811022	On examination left upper limb pulses all present (finding)	4180186
44811024	Frequency of hyperglycaemic episodes (observable entity)	4180186
44811028	O/E left arm pulses all absent	4180186
44811028	On examination left upper limb pulses all absent (finding)	4180186
44811030	No history of deep vein thrombosis (situation)	4180186
44811039	Assessment using Wagner ulcer classification system (procedure)	4180186
44811040	Giving warm drink (regime/therapy)	4180186
44811043	Power of right myotome of fourth lumbar nerve (observable entity)	4180186
44811044	Power of left myotome of second cervical nerve (observable entity)	4180186
44811045	Power of right myotome of second cervical nerve (observable entity)	4180186
44811046	Power of left myotome of second lumbar nerve (observable entity)	4180186
44811047	Clopidogrel not tolerated (situation)	4180186
44811050	Power of right myotome of second sacral nerve (observable entity)	4180186
44811052	Power of right myotome of seventh cervical nerve (observable entity)	4180186
44811054	Power of right myotome of sixth cervical nerve (observable entity)	4180186
44811057	Power of left myotome of third lumbar nerve (observable entity)	4180186
44811058	Beta blocker not tolerated (situation)	4180186
44811059	Power of right myotome of third lumbar nerve (observable entity)	4180186
44811064	Provision of written information about pressure ulcers (procedure)	4180186
44811066	Nipple abnormality (finding)	4180186
44811067	Did not attend first intranasal seasonal influenza vaccination (finding)	4180186
44811068	Second rotavirus vaccination declined (situation)	4180186
44811069	Non-union of joint of foot without infection (disorder)	4180186
44811071	Pigmented villonodular synovitis of foot and ankle (disorder)	4180186
44811072	Benign neoplasm of soft tissue of foot and ankle (disorder)	4180186
44811072	Benign tumour of soft tissue of foot and ankle	4180186
44811073	Rheumatoid arthritis monitoring invitation (procedure)	4180186
44811075	Benign neoplasm of foot and ankle (disorder)	4180186
44811075	Benign tumour of foot and ankle	4180186
44811076	Postnatal listening visits offered (finding)	4180186
44811078	Timed collection: specimen collection, 20 minutes (finding)	4180186
44811079	[V]Personal history of betablocker allergy (situation)	4180186
44811080	Sacrospinous cervicopexy (procedure)	4180186
44811082	Fourth rabies vaccination (procedure)	4180186
44811083	Fifth rabies vaccination (procedure)	4180186
44811084	[V]Heart donor (situation)	4180186
44811085	Paediatric Early Warning Score (observable entity)	4180186
44811085	PEWS - Paediatric Early Warning Score	4180186
44811086	Forced vital capacity after change of bronchodilator (observable entity)	4180186
44811087	Forced vital capacity post bronchodilator percentage change (observable entity)	4180186
44811088	Regional nerve block using ultrasonography guidance (procedure)	4180186
44811088	Ultrasound guided regional nerve block	4180186
44811092	Forced expiratory volume in 1 second after change of bronchodilator (observable entity)	4180186
44811093	Education about peripheral arterial embolism care (procedure)	4180186
44811094	POCS - podiatry objective clinical score	4180186
44811094	Podiatry objective clinical score (assessment scale)	4180186
44811095	Sure Start visit (regime/therapy)	4180186
44811097	POCS - podiatry objective clinical score	4180186
44811097	Podiatry objective clinical score (observable entity)	4180186
44811098	Speech and language therapy assessment (procedure)	4180186
44811101	Education about health screening (procedure)	4180186
44811102	Adhesive product bonded to skin (finding)	4180186
44811104	Verification of appropriate transport for discharge (procedure)	4180186
44811107	Peripheral vascular disease monitoring third letter (procedure)	4180186
44811109	Peripheral vascular disease monitoring telephone invitation (procedure)	4180186
44811111	Inadequate dietary intake of vitamin B6 (finding)	4180186
44811112	Inadequate dietary intake of vitamin B12 (finding)	4180186
44811113	Magnetic resonance imaging elastography (procedure)	4180186
44811114	Declined consent to leave message on telephone answering machine (finding)	4180186
44811115	Excessive dietary intake of vitamin B12 (finding)	4180186
44811116	Aneurysm of dialysis vascular access (disorder)	4180186
44811117	Transfer to high dependency unit (procedure)	4180186
44811117	Transfer to HDU (high dependency unit)	4180186
44811122	Wagner ulcer classification grade 4 foot ulcer (disorder)	4180186
44811123	Wagner ulcer classification grade 5 foot ulcer (disorder)	4180186
44811124	Stenosis of arterial side of dialysis arteriovenous shunt (disorder)	4180186
44811127	Application of external fixator on bone of lower limb using fluoroscopic guidance (procedure)	4180186
44811128	Dutch Lipid Clinic Network diagnostic criteria for familial hypercholesterolaemia (assessment scale)	4180186
44811129	Dutch Lipid Clinic Network diagnostic criteria for familial hypercholesterolaemia score (observable entity)	4180186
44811133	Insertion of marker into breast using magnetic resonance imaging guidance (procedure)	4180186
44811135	Insertion of marker into breast using stereotactic mammography guidance (procedure)	4180186
44811137	Scottish patients at risk of readmission and admission algorithm score (observable entity)	4180186
44811140	Emodin level	4180186
44811140	Emodin measurement (procedure)	4180186
44811143	Aloe emodin level	4180186
44811143	Measurement of aloe emodin (procedure)	4180186
44811146	Unfit to go on holiday (finding)	4180186
44811147	Computed tomography arthrography of sacroiliac joint with contrast (procedure)	4180186
44811149	Heptacosanoic acid (substance)	4180186
44811149	Heptacosylic acid	4180186
44811150	Lignoceric acid level	4180186
44811150	Lignoceric acid measurement	4180186
44811150	Measurement of tetracosanoic acid (procedure)	4180186
44811151	Rheumatoid arthritis monitoring invitation first letter (procedure)	4180186
44811153	Rheumatoid arthritis monitoring invitation third letter (procedure)	4180186
44811155	Rheumatoid arthritis monitoring telephone invitation (procedure)	4180186
44811158	Magnetic resonance imaging of lower limb for arthroplasty planning (procedure)	4180186
44811160	Obstetric ultrasonography of ductus venosus (procedure)	4180186
44811160	Obstetric ultrasound scan of ductus venosus	4180186
44811161	PET CT of liver using yttrium-90 microspheres	4180186
44811161	Positron emission tomography with computed tomography of liver using yttrium-90 microspheres (procedure)	4180186
44811163	Incretin mimetic treatment started (situation)	4180186
44811164	Airway alert form received (finding)	4180186
44811166	Postoperative intraperitoneal chemotherapy (procedure)	4180186
44811167	National Health Service continuing healthcare fast track funding withdrawn (finding)	4180186
44811168	Booster meningitis C vaccination (procedure)	4180186
44811169	Booster meningitis C vaccination declined (situation)	4180186
44811172	Did not attend booster meningitis C vaccination (finding)	4180186
44811173	Booster meningitis C vaccination given by other healthcare provider (finding)	4180186
44811175	Malignant neoplasm of foot and ankle (disorder)	4180186
44811175	Malignant tumour of foot and ankle	4180186
44811176	Inguinal cystocele (disorder)	4180186
44811181	Has ADRT (Advance Decision to Refuse Treatment) - Refuses all blood transfusion and administration of primary blood components and minor fractions	4180186
44811181	Has Advance Decision to Refuse Treatment (Mental Capacity Act 2005) - Refuses all blood transfusion and administration of primary blood components and minor fractions (finding)	4180186
44811183	Referral to sickle cell and thalassaemia service (procedure)	4180186
44811187	Excessive oral nutrition intake for physiological needs	4180186
44811187	Excessive oral nutrition intake for physiological needs (finding)	4180186
44811188	Referral to feeding and swallowing service (procedure)	4180186
44811189	Internal practice dermatology referral (procedure)	4180186
44811190	Referral to epilepsy service (procedure)	4180186
44811193	Loan equipment returned (finding)	4180186
44811199	Insertion of biodegradable stent into organ NOC (procedure)	4180186
44811202	Pulmonary arterial hypertension drugs Band 4 (procedure)	4180186
44811203	Electrophysiologic evaluation of cardioverter defibrillator (procedure)	4180186
44811203	Evaluation of cardioverter defibrillator	4180186
44811204	Diagnostic endoscopic examination of nasal cavity (procedure)	4180186
44811205	Medical ophthalmology service (qualifier value)	4180186
44811206	Learning disability service (qualifier value)	4180186
44811213	QDiabetes risk calculator score (observable entity)	4180186
44811214	Assessment using QDiabetes risk calculator (procedure)	4180186
44811216	Victim of human trafficking (finding)	4180186
44811217	Provision of written information about advance care planning (procedure)	4180186
44811219	Provision of weighted vaginal cones (procedure)	4180186
44811220	Hydration care (regime/therapy)	4180186
44811222	Transfers using lateral transfer device (finding)	4180186
44811223	Accepted by psychological talking therapy service (finding)	4180186
44811224	Provision of written information about skin cancer (procedure)	4180186
44811230	No history of liver disease (situation)	4180186
44811231	Provision of information about Healthy Start vitamins (procedure)	4180186
44811232	Sending of opt-in appointment letter (procedure)	4180186
44811233	Cognitive linguistic quick test language domain (assessment scale)	4180186
44811234	Cognitive linguistic quick test executive functions domain (assessment scale)	4180186
44811238	Montanic acid	4180186
44811238	Octacosanoic acid (substance)	4180186
44811239	Emergency contraception contraindicated (situation)	4180186
44811241	Measurement of pentacosanoic acid (procedure)	4180186
44811241	Pentacosanoic acid level	4180186
44811242	Unhealthy relationship with food (finding)	4180186
44811245	Eligible for participation in research study (finding)	4180186
44811248	Goal achievement status unknown (finding)	4180186
44811251	Bedtime blood sugar	4180186
44811251	Bedtime blood sugar level	4180186
44811251	Blood glucose level at bedtime (observable entity)	4180186
44811252	Blood glucose level before evening meal (observable entity)	4180186
44811253	Blood glucose level after lunch (observable entity)	4180186
44811254	Blood glucose level before lunch (observable entity)	4180186
44811257	Discussion about resuscitation with carer (situation)	4180186
44811259	Care pathway (regime/therapy)	4180186
44811261	Excessive oral fluid intake for physiological needs (finding)	4180186
44811263	Excessive bioactive substance intake (finding)	4180186
44811264	Measurement of ratio of pregnanediol to creatinine (procedure)	4180186
44811264	Pregnanediol/creatinine ratio	4180186
44811266	Consent given by legitimate patient representative for sharing end of life care coordination record (finding)	4180186
44811268	Repeat prescription managed by pharmacy (finding)	4180186
44811272	Discussion about Liverpool care pathway for the dying with patient (procedure)	4180186
44811275	Not on integrated care pathway (finding)	4180186
44811277	Declined invitation to join patient participation group (finding)	4180186
44811278	Preferred place of care - care home (finding)	4180186
44811278	Preferred place of care - residential home	4180186
44811280	Assessment using DoloTest (procedure)	4180186
44811281	DoloTest (assessment scale)	4180186
44811282	Drug therapy for attention deficit hyperactivity disorder (procedure)	4180186
44811283	Tibialis posterior tendon disorder (disorder)	4180186
44811284	Disorder of peroneal tendon (disorder)	4180186
44811285	Disorder of flexor hallucis longus tendon (disorder)	4180186
44811287	Disorder of tibialis anterior tendon (disorder)	4180186
44811289	Assessment using Leeds Revised Acne Grading System (procedure)	4180186
44811294	Intermediate care service (qualifier value)	4180186
44811295	Hepatology service (qualifier value)	4180186
44811297	In-house alcohol detoxification (procedure)	4180186
44811298	Subcutaneous injection of gonadorelin analogue (procedure)	4180186
44811302	Diagnostic imaging service (qualifier value)	4180186
44811305	Clinical immunology and allergy service (qualifier value)	4180186
44811310	Audiological medicine service (qualifier value)	4180186
44811311	Adult mental health service (qualifier value)	4180186
44811311	Adult mental illness service	4180186
44811312	Critical care medicine service (qualifier value)	4180186
44811316	Recession of lower eyelid (procedure)	4180186
44811318	Gastroenterology service (qualifier value)	4180186
44811319	Endocrinology service (qualifier value)	4180186
44811327	Dermatology service (qualifier value)	4180186
44811328	Respiratory medicine service (qualifier value)	4180186
44811334	Successful trial without catheter (situation)	4180186
44811334	Successful TWOC (trial without catheter)	4180186
44811336	Intrathecal drug delivery device in situ (finding)	4180186
44811337	Seen by forensic psychologist (finding)	4180186
44811338	Seen by specialist health visitor (finding)	4180186
44811340	Mental Health Act 1983 (England and Wales) section 2 compulsory admission for assessment form (record artifact)	4180186
44811343	Living in refuge (finding)	4180186
44811345	Medically unfit for court appearance (finding)	4180186
44811348	Thrombosis of external jugular vein (disorder)	4180186
44811349	Failed encounter - short message service text message delivery failure (finding)	4180186
44811349	Failed encounter - SMS (short message service) text message delivery failure	4180186
44811351	Thrombosis of artery of transplanted kidney (disorder)	4180186
44811357	Assessment using Bupa Health Dialog risk stratification tool (procedure)	4180186
44811358	Johns Hopkins ACG (adjusted clinical groups) system score	4180186
44811358	Johns Hopkins adjusted clinical groups system score (observable entity)	4180186
44811360	On examination - epididymis abnormal (finding)	4180186
44811361	Measurement of ratio of pregnanetriol to creatinine (procedure)	4180186
44811361	Pregnanetriol/creatinine ratio	4180186
44811370	Provision of information about seasonal influenza vaccination (procedure)	4180186
44811374	Not eligible for participation in research study (finding)	4180186
44811375	Consent given to participate in research study (finding)	4180186
44811376	Consent given to review medical record in research study (finding)	4180186
44811377	Consent given to review medical record in clinical trial (finding)	4180186
44811379	Referral to rapid access heart failure clinic (procedure)	4180186
44811382	Benzodiazepine dependence detoxification (regime/therapy)	4180186
44811383	Eron class 4 skin and soft tissue infection	4180186
44811383	Eron class IV skin and soft tissue infection (finding)	4180186
44811384	Measurement of ratio of methyl malonic acid to creatinine (procedure)	4180186
44811384	Methyl malonic acid/creatinine ratio	4180186
44811386	Copy of clinical record sent to Defence Medical Services (finding)	4180186
44811388	Seen by core psychiatry trainee doctor (finding)	4180186
44811391	Non-stimulant drug therapy for attention deficit hyperactivity disorder (procedure)	4180186
44811393	Number of hours short-burst oxygen therapy prescribed per day (observable entity)	4180186
44811394	Number of hours ambulatory oxygen therapy prescribed per day (observable entity)	4180186
44811397	Seasonal influenza vaccination given while hospital inpatient (finding)	4180186
44811400	No consent for 2nd HIB (haemophilus influenzae type B) booster	4180186
44811400	No consent for second Haemophilus influenzae type B booster (finding)	4180186
44811403	Lymphoedema Quality of Life Tool - arm (assessment scale)	4180186
44811405	Lymphoedema Quality of Life Tool score - arm (observable entity)	4180186
44811406	Thrombolysis In Myocardial Infarction risk score for unstable angina or non-ST-segment-elevation myocardial infarction (assessment scale)	4180186
44811406	TIMI (Thrombolysis In Myocardial Infarction) risk score for UA (unstable angina) or NSTEMI (non-ST-segment-elevation myocardial infarction)	4180186
44811408	Low risk environment for patient discharge (finding)	4180186
44811409	At low risk of harm from others (finding)	4180186
44811410	Advice about diabetes and driving	4180186
44811410	Education about diabetes and driving (procedure)	4180186
44811414	Nephrology service (qualifier value)	4180186
44811415	Nuclear medicine service (qualifier value)	4180186
44811417	Clinical neurophysiology service (qualifier value)	4180186
44811418	Rheumatology service (qualifier value)	4180186
44811419	Geriatric medicine service	4180186
44811419	Care of the elderly service (qualifier value)	4180186
44811420	Sport and exercise medicine service (qualifier value)	4180186
44811422	Specialist rehabilitation service (qualifier value)	4180186
44811424	Midwifery service (qualifier value)	4180186
44811425	Mental health recovery and rehabilitation service (qualifier value)	4180186
44811431	Diabetic education service (qualifier value)	4180186
44811433	Congenital heart disease service (qualifier value)	4180186
44811435	Clinical psychology service (qualifier value)	4180186
44811436	Adult cystic fibrosis service (qualifier value)	4180186
44811437	Left hemicolectomy and end to side anastomosis (procedure)	4180186
44811442	Colectomy and end to side anastomosis (procedure)	4180186
44811443	Excision of ejaculatory duct	4180186
44811443	Excision of ejaculatory duct (procedure)	4180186
44811444	Psychiatric intensive care service (qualifier value)	4180186
44811445	Prosthetics service (qualifier value)	4180186
44811447	Well baby service (qualifier value)	4180186
44811448	Paediatric medical oncology service (qualifier value)	4180186
44811449	Paediatric ear nose and throat service (qualifier value)	4180186
44811456	Measurement of concentration of benzoylecgonine in urine specimen (procedure)	4180186
44811456	Urine benzoylecgonine concentration	4180186
44811457	Measurement of concentration of cocaine in urine specimen (procedure)	4180186
44811457	Urine cocaine concentration	4180186
44811458	Insertion of stent suture into Baerveldt tube (procedure)	4180186
44811459	Removal of stent suture from Baerveldt tube (procedure)	4180186
44811462	Uhthoff phenomenon (disorder)	4180186
44811462	Uhthoff's syndrome	4180186
44811463	Measurement of concentration of imipramine in urine specimen (procedure)	4180186
44811463	Urine imipramine concentration	4180186
44811467	Weight loss importance score (finding)	4180186
44811468	Touch sensation of left dermatome of second sacral nerve exaggerated (finding)	4180186
44811469	Health of the Nation Outcome Scale-secure: Rating scale E - need for escort on leave (assessment scale)	4180186
44811469	HoNOS (Health of the Nation Outcome Scale)-secure: Rating scale E - need for escort on leave	4180186
44811470	Touch sensation of right dermatome of second sacral nerve exaggerated (finding)	4180186
44811471	Plasma rivaroxaban level	4180186
44811471	Measurement of rivaroxaban in plasma specimen (procedure)	4180186
44811474	Percutaneous transluminal temporary balloon occlusion of aorta using fluoroscopic guidance (procedure)	4180186
44811476	Cerebrospinal fluid ammonia level	4180186
44811476	Measurement of ammonia in cerebrospinal fluid specimen (procedure)	4180186
44811477	Health of the Nation Outcome Scale-secure: Rating scale F - potential harm to individual from others (assessment scale)	4180186
44811477	HoNOS (Health of the Nation Outcome Scale)-secure: Rating scale F - potential harm to individual	4180186
44811480	NOAC (novel oral anticoagulant) declined	4180186
44811480	Novel oral anticoagulant declined (situation)	4180186
44811483	Health of the Nation Outcome Scale-secure: Rating scale G - need for specialist clinical procedures (assessment scale)	4180186
44811483	HoNOS (Health of the Nation Outcome Scale)-secure: Rating scale G - need for specialist clinical procedures	4180186
44811484	Long term condition care planning invitation second letter (procedure)	4180186
44811485	Dementia advance care plan declined (situation)	4180186
44811486	Long term condition care planning invitation third letter (procedure)	4180186
44811487	Dementia advance care plan agreed (finding)	4180186
44811488	Review of dementia advance care plan (procedure)	4180186
44811489	Health of the Nation Outcome Scale for working age adults (assessment scale)	4180186
44811492	NOAC (novel oral anticoagulant) not tolerated	4180186
44811492	Novel oral anticoagulant not tolerated (situation)	4180186
44811493	Ultrasound guided barbotage of shoulder	4180186
44811493	Barbotage of shoulder using ultrasonography guidance (procedure)	4180186
44811496	Health of the Nation Outcome Scale score (observable entity)	4180186
44811499	Has contact with criminal justice system (finding)	4180186
44811502	Other White background - ethnic category 2001 census (finding)	4180186
44811508	Weight loss confidence score (finding)	4180186
44811509	Measurement of concentration of paracetamol in urine specimen (procedure)	4180186
44811509	Urine paracetamol concentration	4180186
44811511	Continuous enteral tube feeding (regime/therapy)	4180186
44811512	Planned duration of tube feeding (observable entity)	4180186
44811513	BASFI - Bath Ankylosing Spondylitis Functional Index	4180186
44811513	Bath Ankylosing Spondylitis Functional Index (assessment scale)	4180186
44811516	Measurement of ratio of amylase to creatinine in urine specimen (procedure)	4180186
44811518	Measurement of ratio of catecholamine to creatinine in urine specimen (procedure)	4180186
44811518	Urine catecholamine:creatinine ratio	4180186
44811519	National Health Service Health Check follow up (finding)	4180186
44811520	BASMI - Bath Ankylosing Spondylitis Metrology Index	4180186
44811520	Bath Ankylosing Spondylitis Metrology Index (assessment scale)	4180186
44811521	Bilateral spastic cerebral palsy (disorder)	4180186
44811523	Seen in lymphoedema clinic (finding)	4180186
44811525	Subcranial repair of craniofacial cleft and reconstruction of cranial and facial bones (procedure)	4180186
44811526	Transcranial repair of craniofacial cleft and reconstruction of cranial and facial bones (procedure)	4180186
44811527	Measurement of concentration of tetrahydrocannabinolic acid in urine specimen (procedure)	4180186
44811527	Urine tetrahydrocannabinolic acid concentration	4180186
44811528	Measurement of ratio of citrate to creatinine in urine specimen (procedure)	4180186
44811528	Urine citrate:creatinine ratio	4180186
44811529	Measurement of ratio of glutamic acid to creatinine in urine specimen (procedure)	4180186
44811529	Urine glutamic acid:creatinine ratio	4180186
44811530	Measurement of ratio of phosphate to creatinine in urine specimen (procedure)	4180186
44811532	Assessment using SSLM (Sure Start Language Measure)	4180186
44811532	Assessment using Sure Start Language Measure (procedure)	4180186
44811533	Assessment using Sure Start Language Measure, revised (procedure)	4180186
44811533	Assessment using SSLM-R (Sure Start Language Measure, revised)	4180186
44811536	Second measles mumps rubella immunisation second telephone invitation (procedure)	4180186
44811538	Radioisotope hepatobiliary function study with stimulation post transplant (procedure)	4180186
44811539	Cholangiogram of explanted liver (procedure)	4180186
44811541	Magnetic resonance imaging of transplanted small intestine (procedure)	4180186
44811543	Magnetic resonance imaging angiography of transplanted small intestine (procedure)	4180186
44811543	MRI angiogram of transplanted small intestine	4180186
44811546	Insertion of retropubic midurethral sling (procedure)	4180186
44811547	Insertion of transobturator midurethral sling (procedure)	4180186
44811548	Abdominal sacrohysteropexy (procedure)	4180186
44811549	Fluoroscopy of transplanted small intestine with contrast (procedure)	4180186
44811552	Health of the Nation Outcome Scale score 2: mild problem but definitely present (finding)	4180186
44811553	Injection of bulking agent to female bladder neck (procedure)	4180186
44811554	Fluoroscopic angiogram of transplanted small intestine with contrast	4180186
44811554	Fluoroscopic angiography of transplanted small intestine with contrast (procedure)	4180186
44811555	Incident details (record artifact)	4180186
44811556	Disposition details (record artifact)	4180186
44811557	Life extinct details (record artifact)	4180186
44811560	Fluoroscopic percutaneous venography of orbit with contrast	4180186
44811560	Fluoroscopic percutaneous venogram of orbit using contrast	4180186
44811560	Fluoroscopic percutaneous venography of orbit using contrast (procedure)	4180186
44811561	Health of the Nation Outcome Scale score 3: moderately severe problem (finding)	4180186
44811562	Fluoroscopic direct puncture venogram of orbit using contrast	4180186
44811562	Fluoroscopic direct puncture venography of orbit using contrast (procedure)	4180186
44811563	Femoral nerve tension test (procedure)	4180186
44811565	Percutaneous transluminal embolisation of inferior vena caval collateral vein using fluoroscopic guidance with contrast (procedure)	4180186
44811566	Measurement of cardiolipin antibody in serum specimen (procedure)	4180186
44811566	Serum cardiolipin IgA antibody level	4180186
44811567	Endoscopic retrieval of intravascular foreign body using fluoroscopic guidance (procedure)	4180186
44811568	Health of the Nation Outcome Scale score 4: severe to very severe problem (finding)	4180186
44811571	Bangladeshi or British Bangladeshi - ethnic category 2001 census (finding)	4180186
44811574	Other Black background - ethnic category 2001 census (finding)	4180186
44811575	Chinese - ethnic category 2001 census (finding)	4180186
44811578	Maternity booking after 31 weeks (procedure)	4180186
44811580	Minor surgery done - cryotherapy (finding)	4180186
44811581	Rate of administration of tube feed (observable entity)	4180186
44811582	Agreeing on needs to be met by care plan (procedure)	4180186
44811588	Measurement of ratio of tetrahydrocortisol to creatinine in urine specimen (procedure)	4180186
44811588	Urine tetrahydrocortisol:creatinine ratio	4180186
44811590	Measurement of ratio of tetrahydrocorticosterone to creatinine in urine specimen (procedure)	4180186
44811590	Urine tetrahydrocorticosterone:creatinine ratio	4180186
44811591	Measurement of ratio of tetrahydro-11-deoxycortisol to creatinine in urine specimen (procedure)	4180186
44811591	Urine tetrahydro-11-deoxycortisol:creatinine ratio	4180186
44811594	Need not agreed (finding)	4180186
44811596	Patient actions in care plan agreed	4180186
44811596	Service user actions in care plan agreed	4180186
44811596	Subject actions in care plan agreed (finding)	4180186
44811602	Imbalanced dietary intake of fibre (finding)	4180186
44811605	Childhood Asthma Control Test (assessment scale)	4180186
44811611	Myositis of unknown aetiology (disorder)	4180186
44811612	Polymyositis/scleroderma overlap syndrome (disorder)	4180186
44811613	Transfer ribonucleic acid synthetase associated overlap syndrome (disorder)	4180186
44811614	Pseudo-neuropathic pyrophosphate arthropathy (disorder)	4180186
44811617	Measurement of anti-viral citrullinated peptide antibody in serum specimen (procedure)	4180186
44811617	Serum anti-viral citrullinated peptide antibody level	4180186
44811619	Tricyclic antidepressant contraindicated (situation)	4180186
44811624	Personal Independence Payment (qualifier value)	4180186
44811628	Prescription of respiratory disease rescue medication (procedure)	4180186
44811629	Child protection core group meeting (procedure)	4180186
44811630	Vision examination - no abnormality detected (finding)	4180186
44811634	Pulmonary rehabilitation offered (situation)	4180186
44811635	Percutaneous injection of sclerosing agent into long saphenous vein using ultrasonography guidance (procedure)	4180186
44811635	Ultrasound guided injection of sclerosing agent into long saphenous vein	4180186
44811638	Hearing examination - no abnormality detected (finding)	4180186
44811640	Lumbar puncture using computed tomography guidance (procedure)	4180186
44811641	Measurement of concentration of homovanillic acid in plasma specimen (procedure)	4180186
44811641	Plasma homovanillic acid concentration	4180186
44811642	Discussion about preferred priorities for care (procedure)	4180186
44811642	Discussion about PPC (preferred priorities for care)	4180186
44811644	Ethnic category not stated - 2001 census (finding)	4180186
44811650	Timed collection: specimen collection, after food (finding)	4180186
44811652	Ulster Scots - ethnic category 2001 census (finding)	4180186
44811654	Greek Cypriot - ethnic category 2001 census (finding)	4180186
44811655	Italian - ethnic category 2001 census (finding)	4180186
44811656	Reactive arthritis after campylobacter infection (disorder)	4180186
44811660	Reactive arthritis after salmonella infection (disorder)	4180186
44811663	Reactive arthritis after yersinia infection (disorder)	4180186
44811665	Agreeing on needs not to be met by care plan (procedure)	4180186
44811666	Disease modification - intent (qualifier value)	4180186
44811667	Special patient note (record artifact)	4180186
44811670	Reconstruction of skull (procedure)	4180186
44811673	Compliant with oral nutritional supplement regimen (finding)	4180186
44811675	Noncompliance with oral nutritional supplement regimen (finding)	4180186
44811679	Distraction osteogenesis of bones of skull (procedure)	4180186
44811680	Application of external distraction device to skull (procedure)	4180186
44811681	Insertion of nephrostomy tube into transplanted kidney using ultrasonography guidance (procedure)	4180186
44811681	Ultrasound guided insertion of nephrostomy tube into transplanted kidney	4180186
44811682	Insertion of nephrostomy tube into transplanted kidney using fluoroscopic guidance (procedure)	4180186
44811683	Cone beam computed tomography of teeth (procedure)	4180186
44811684	Attention to internal distraction device of skull (procedure)	4180186
44811686	Excision of sincipital encephalocele (procedure)	4180186
44811686	Excision of syncipital encephalocele	4180186
44811687	Measurement of concentration of tetrahydrocorticosterone in plasma specimen (procedure)	4180186
44811687	Plasma tetrahydrocorticosterone concentration	4180186
44811689	Percutaneous microwave ablation of lesion of pelvis using computed tomography guidance (procedure)	4180186
44811691	Obtaining consent to share CAF (Common Assessment Framework) for children and young people record	4180186
44811691	Obtaining consent to share Common Assessment Framework for children and young people record (procedure)	4180186
44811692	Primary percutaneous coronary intervention using fluoroscopic guidance (procedure)	4180186
44811693	Iatrogenic complication of gastrointestinal tract endoscopy (disorder)	4180186
44811696	Measurement of concentration of cortisol in serum specimen at midday (procedure)	4180186
44811696	Serum midday cortisol concentration	4180186
44811698	Measurement of concentration of cortisol in serum specimen at midnight (procedure)	4180186
44811698	Serum midnight cortisol concentration	4180186
44811699	Measurement of concentration of cortisol in plasma specimen at midnight (procedure)	4180186
44811699	Plasma midnight cortisol concentration	4180186
44811702	Finding of SCPE (Surveillance of Cerebral Palsy in Europe) classification for neonatal neuroimaging results for children with cerebral palsy	4180186
44811702	Finding of Surveillance of Cerebral Palsy in Europe classification for neonatal neuroimaging results for children with cerebral palsy (finding)	4180186
44811703	SCPE (Surveillance of Cerebral Palsy in Europe) predominant pattern classification A - maldevelopment	4180186
44811703	Surveillance of Cerebral Palsy in Europe classification - predominant pattern A - maldevelopment (finding)	4180186
44811704	SCPE (Surveillance of Cerebral Palsy in Europe) predominant pattern classification B - predominant white matter injury	4180186
44811704	Surveillance of Cerebral Palsy in Europe classification - predominant pattern B - predominant white matter injury (finding)	4180186
44811705	SCPE (Surveillance of Cerebral Palsy in Europe) predominant pattern classification C - predominant grey matter injury	4180186
44811705	Surveillance of Cerebral Palsy in Europe classification - predominant pattern C - predominant grey matter injury (finding)	4180186
44811706	SCPE (Surveillance of Cerebral Palsy in Europe) predominant pattern classification D - unspecified	4180186
44811706	Surveillance of Cerebral Palsy in Europe classification - predominant pattern D - unspecified (finding)	4180186
44811708	SCPE (Surveillance of Cerebral Palsy in Europe) predominant pattern classification A.1.1 - disorder of proliferation	4180186
44811708	Surveillance of Cerebral Palsy in Europe classification - predominant pattern A.1.1 - disorder of proliferation (finding)	4180186
44811709	SCPE (Surveillance of Cerebral Palsy in Europe) predominant pattern classification A.1.2 - disorder of migration	4180186
44811709	Surveillance of Cerebral Palsy in Europe classification - predominant pattern A.1.2 - disorder of migration (finding)	4180186
44811714	Other Mixed or Mixed unspecified - ethnic category 2001 census (finding)	4180186
44811715	Mixed Asian - ethnic category 2001 census (finding)	4180186
44811717	Kashmiri - ethnic category 2001 census (finding)	4180186
44811719	Tamil - ethnic category 2001 census (finding)	4180186
44811720	British Asian - ethnic category 2001 census (finding)	4180186
44811722	Kosovan - ethnic category 2001 census (finding)	4180186
44811724	Croatian - ethnic category 2001 census (finding)	4180186
44811725	HSA1 form eligible (finding)	4180186
44811727	Mixed Irish and other White - ethnic category 2001 census (finding)	4180186
44811735	Attends parent support group (finding)	4180186
44811738	Percutaneous insertion of artificial tricuspid valve using fluoroscopic guidance (procedure)	4180186
44811741	Acute vascular insufficiency of large intestine (disorder)	4180186
44811743	No longer subject to vulnerable adult care plan (finding)	4180186
44811745	Arbovirus nucleic acid detection assay (procedure)	4180186
44811747	BK polyomavirus nucleic acid detection assay (procedure)	4180186
44811748	Inadequate growth rate (finding)	4180186
44811750	Herpes simplex virus type 1 nucleic acid detection assay (procedure)	4180186
44811752	Adenovirus nucleic acid detection assay (procedure)	4180186
44811756	Molluscum contagiosum nucleic acid detection assay (procedure)	4180186
44811757	Obese class III (body mass index equal to or greater than 40.0) (finding)	4180186
44811758	SCPE (Surveillance of Cerebral Palsy in Europe) predominant pattern classification A.2 - unspecified maldevelopment	4180186
44811758	Surveillance of Cerebral Palsy in Europe classification - predominant pattern A.2 - unspecified maldevelopment (finding)	4180186
44811760	Change to tube feeding regimen (situation)	4180186
44811765	Ambulatory electrocardiographic monitoring report	4180186
44811765	Ambulatory electrocardiographic monitoring report (record artifact)	4180186
44811766	Exercise tolerance test report	4180186
44811766	Exercise tolerance test report (record artifact)	4180186
44811767	SCPE (Surveillance of Cerebral Palsy in Europe) predominant pattern classification B.1 - periventricular leucomalacia	4180186
44811767	Surveillance of Cerebral Palsy in Europe classification - predominant pattern B.1 - periventricular leucomalacia (finding)	4180186
44811769	SCPE (Surveillance of Cerebral Palsy in Europe) predominant pattern classification B.3 - combination of periventricular leucomalacia and intraventricular haemorrhage sequelae	4180186
44811769	Surveillance of Cerebral Palsy in Europe classification - predominant pattern B.3 - combination of periventricular leucomalacia and intraventricular haemorrhage sequelae (finding)	4180186
44811770	SCPE (Surveillance of Cerebral Palsy in Europe) predominant pattern classification E - normal	4180186
44811770	Surveillance of Cerebral Palsy in Europe classification - predominant pattern E - normal (finding)	4180186
44811771	SCPE (Surveillance of Cerebral Palsy in Europe) predominant pattern classification C.1 - basal ganglia and thalamus lesions	4180186
44811771	Surveillance of Cerebral Palsy in Europe classification - predominant pattern C.1 - basal ganglia and thalamus lesions (finding)	4180186
44811772	SCPE (Surveillance of Cerebral Palsy in Europe) predominant pattern classification C.2 - parasagittal lesions	4180186
44811772	Surveillance of Cerebral Palsy in Europe classification - predominant pattern C.2 - parasagittal lesions (finding)	4180186
44811774	Schedule of Growing Skills II (assessment scale)	4180186
44811774	SOGS II - Schedule of Growing Skills II	4180186
44811776	Schedule of Growing Skills II score (observable entity)	4180186
44811776	SOGS II - Schedule of Growing Skills II score	4180186
44811778	Fluid requirements partially supplied through enteral tube feed (finding)	4180186
44811780	Consent given to receive test results by telephone answer machine message (finding)	4180186
44811781	Education about fermentable oligosaccharides, disaccharides, monosaccharides and polyols exclusion diet (procedure)	4180186
44811786	Somali - ethnic category 2001 census (finding)	4180186
44811792	Other White or White unspecified - ethnic category 2001 census (finding)	4180186
44811795	Israeli - ethnic category 2001 census (finding)	4180186
44811796	Kurdish - ethnic category 2001 census (finding)	4180186
44811799	Timed collection: specimen collection, 2 hour post-dose (finding)	4180186
44811800	GMS4 claim - immunisation (Rate B) signed (finding)	4180186
44811801	Moroccan - ethnic category 2001 census (finding)	4180186
44811805	Coronavirus nucleic acid detection assay (procedure)	4180186
44811811	Strengths and Difficulties Questionnaire - prosocial score (observable entity)	4180186
44811812	Strengths and Difficulties Questionnaire - total difficulties score (observable entity)	4180186
44811814	Haemorrhagic fever nucleic acid detection assay (procedure)	4180186
44811815	Hepatitis A nucleic acid detection assay (procedure)	4180186
44811816	Hepatitis D nucleic acid detection assay (procedure)	4180186
44811817	Hepatitis E nucleic acid detection assay (procedure)	4180186
44811822	Human herpes virus 8 nucleic acid detection assay (procedure)	4180186
44811825	Right dorsalis pedis pulse impalpable (finding)	4180186
44811828	Treatment of comorbid condition (procedure)	4180186
44811830	Wire guided localisation of lesion using ultrasonography guidance (procedure)	4180186
44811832	Redaction of patient record not required (finding)	4180186
44811833	Discussed with healthcare professional (situation)	4180186
44811834	Getting It Right For Every Child assessment (assessment scale)	4180186
44811834	GIRFEC (Getting It Right For Every Child) assessment	4180186
44811835	Assessment using Getting It Right For Every Child assessment (procedure)	4180186
44811835	Assessment using GIRFEC (Getting It Right For Every Child) assessment	4180186
44811837	Gold Standards Framework After Death Analysis Audit (procedure)	4180186
44811838	Assessment using Wright and Ayre Stuttering Self-rating Profile (procedure)	4180186
44811845	Japanese - ethnic category 2001 census (finding)	4180186
44811847	Malaysian - ethnic category 2001 census (finding)	4180186
44811849	HSA1 form signed (finding)	4180186
44811851	Multi-ethnic islands: Mauritian or Seychellois or Maldivian or St Helena - ethnic category 2001 census (finding)	4180186
44811853	Sikh - ethnic category 2001 census (finding)	4180186
44811859	JC virus nucleic acid detection assay (procedure)	4180186
44811861	Measles virus nucleic acid detection assay (procedure)	4180186
44811864	Mumps virus nucleic acid detection assay (procedure)	4180186
44811865	Mycobacteria nucleic acid detection assay (procedure)	4180186
44811867	Mycoplasma nucleic acid detection assay (procedure)	4180186
44811869	Nipah virus nucleic acid detection assay (procedure)	4180186
44811871	Norovirus nucleic acid detection assay (procedure)	4180186
44811873	Sterile supplies bar code (observable entity)	4180186
44811874	Measurement of cobalt in serum specimen (procedure)	4180186
44811874	Serum cobalt level	4180186
44811877	Finding of pin prick sensation of dermatome (finding)	4180186
44811877	Observation of pin prick sensation of dermatome	4180186
44811880	Serum thallium level	4180186
44811880	Measurement of thallium in serum specimen (procedure)	4180186
44811884	Measurement of silver in serum specimen (procedure)	4180186
44811884	Serum silver level	4180186
44811885	Pin prick sensation of left dermatome of first thoracic nerve exaggerated (finding)	4180186
44811886	Pin prick sensation of right dermatome of first thoracic nerve normal (finding)	4180186
44811887	FP24A maternity claim checked by staff (finding)	4180186
44811888	HSA1 form refused to sign (finding)	4180186
44811889	Pin prick sensation of right dermatome of first thoracic nerve reduced (finding)	4180186
44811890	Pin prick sensation of right dermatome of first thoracic nerve absent (finding)	4180186
44811891	Pin prick sensation of right dermatome of first thoracic nerve exaggerated (finding)	4180186
44811892	Measurement of transcobalamin in serum specimen (procedure)	4180186
44811892	Serum transcobalamin level	4180186
44811893	Liaison with person with parental responsibility (procedure)	4180186
44811896	Accident prevention education (procedure)	4180186
44811898	Dementia assessment not indicated (situation)	4180186
44811901	Concerned about appearance of fingernails (finding)	4180186
44811907	Parainfluenza type 2 nucleic acid detection assay (procedure)	4180186
44811909	Parainfluenza type 3 nucleic acid detection assay (procedure)	4180186
44811910	Parainfluenza type 4 nucleic acid detection assay (procedure)	4180186
44811911	Poliovirus type 1 nucleic acid detection assay (procedure)	4180186
44811912	Timed collection: specimen collection, 900 minutes (finding)	4180186
44811913	Poliovirus type 2 nucleic acid detection assay (procedure)	4180186
44811916	Rabies virus nucleic acid detection assay (procedure)	4180186
44811917	Rhinovirus nucleic acid detection assay (procedure)	4180186
44811919	Sure Start postnatal visit (regime/therapy)	4180186
44811921	Respiratory syncytial virus nucleic acid detection assay (procedure)	4180186
44811922	Sapovirus nucleic acid detection assay (procedure)	4180186
44811924	Informing patient of named accountable general practitioner (procedure)	4180186
44811927	Anxiety screening using questions (procedure)	4180186
44811928	Patient given advice about management of anxiety (situation)	4180186
44811930	Bone sparing agent therapy not indicated (situation)	4180186
44811931	End of life care report (record artifact)	4180186
44811932	Stage 1 hypertension (National Institute for Health and Clinical Excellence 2011) without evidence of end organ damage (disorder)	4180186
44811933	Stage 1 hypertension (National Institute for Health and Clinical Excellence 2011) with evidence of end organ damage (disorder)	4180186
44811934	Pertussis vaccination given by other healthcare provider (finding)	4180186
44811940	University of Washington Quality of Life questionnaire version 4 (assessment scale)	4180186
44811940	UW-QOL (University of Washington - Quality of Life) questionnaire v4	4180186
44811942	University of Washington Quality of Life questionnaire version 4 score (observable entity)	4180186
44811942	UW-QOL (University of Washington - Quality of Life) questionnaire version 4 score	4180186
44811943	Ex user of electronic cigarette (finding)	4180186
44811943	Ex vaper of electronic cigarette	4180186
44811947	Respiratory system examination abnormal (finding)	4180186
44811948	Touch sensation of left dermatome of first thoracic nerve absent (finding)	4180186
44811949	Touch sensation of right dermatome of first thoracic nerve absent (finding)	4180186
44811950	Community health services medical - specialty (qualifier value)	4180186
44811951	Touch sensation of right dermatome of first sacral nerve absent (finding)	4180186
44811955	Touch sensation of left dermatome of first sacral nerve normal (finding)	4180186
44811956	Touch sensation of right dermatome of first sacral nerve normal (finding)	4180186
44811957	Measurement of carcinoembryonic antigen in serum specimen (procedure)	4180186
44811957	Serum CEA (carcinoembryonic antigen) level	4180186
44811958	Remote triage and advice service (qualifier value)	4180186
44811959	Parents Evaluation of Developmental Status: Developmental Milestones (assessment scale)	4180186
44811959	PEDS:DM - Parents Evaluation of Developmental Status: Developmental Milestones	4180186
44811960	Community health services dental - specialty (qualifier value)	4180186
44811962	Safeguarding report (record artifact)	4180186
44811963	Adult safeguarding report (record artifact)	4180186
44811967	Measurement of tetrahydrocortisol in urine specimen (procedure)	4180186
44811967	Urine tetrahydrocortisol level	4180186
44811970	Measurement of ratio of glycolate to creatinine in urine specimen (procedure)	4180186
44811970	Urine glycolate:creatinine ratio	4180186
44811973	Measurement of ratio of 11 betahydroxy androsterone to creatinine in urine specimen (procedure)	4180186
44811973	Urine 11 betahydroxy androsterone:creatinine ratio	4180186
44811974	Measurement of ratio of 11 oxo-pregnanetriol to creatinine in urine specimen (procedure)	4180186
44811974	Urine 11 oxo-pregnanetriol:creatinine ratio	4180186
44811975	Measurement of ratio of aetiocholanolone to creatinine in urine specimen (procedure)	4180186
44811975	Urine aetiocholanolone:creatinine ratio	4180186
44811976	Measurement of ratio of androsterone to creatinine in urine specimen (procedure)	4180186
44811976	Urine androsterone:creatinine ratio	4180186
44811979	Measurement of cancer antigen 19-9 in serum specimen (procedure)	4180186
44811979	Serum CA 19-9 (cancer antigen 19-9) level	4180186
44811980	Measurement of prostate specific antigen in serum specimen (procedure)	4180186
44811980	Serum prostate specific antigen level	4180186
44811984	Care Programme Approach care co-ordinator (occupation)	4180186
44811984	CPA (care programme approach) care co-ordinator	4180186
44811987	Admission to regional secure unit (procedure)	4180186
44811991	DDS2 - Diabetes Distress Scale 2	4180186
44811991	Diabetes Distress Scale 2 item (assessment scale)	4180186
44811992	DDS2 (Diabetes Distress Scale 2) score	4180186
44811992	Diabetes Distress Scale 2 item score (observable entity)	4180186
44811993	Assessment using DDS2 (Diabetes Distress Scale 2)	4180186
44811993	Assessment using Diabetes Distress Scale 2 item (procedure)	4180186
44811994	DDS17 - Diabetes Distress Scale 17	4180186
44811994	Diabetes Distress Scale 17 item (assessment scale)	4180186
44811995	Measurement of unsaturated iron binding capacity in serum specimen (procedure)	4180186
44811995	Serum unsaturated iron binding capacity	4180186
44811996	Newborn hearing screening not done (situation)	4180186
44811997	Hospice community lodge (environment)	4180186
44811998	Measurement of pancreolauryl T/K ratio in urine specimen (procedure)	4180186
44811998	Urine pancreolauryl T/K ratio	4180186
44812000	Measurement of butyrylcholinesterase in serum specimen (procedure)	4180186
44812000	Serum butyrylcholinesterase level	4180186
44812001	BAAF (British Association for Adoption and Fostering) adult health report form received	4180186
44812001	British Association for Adoption and Fostering adult health report form received (finding)	4180186
44812003	Unilateral spastic cerebral palsy (situation)	4180186
44812004	Dystonic cerebral palsy (disorder)	4180186
44812006	Faltering growth rate (finding)	4180186
44812008	Measurement of amino-terminal pro B-type natriuretic peptide concentration in serum specimen (procedure)	4180186
44812008	Serum N-terminal pro B-type natriuretic peptide concentration	4180186
44812009	Measurement of amino-terminal pro B-type natriuretic peptide concentration in plasma specimen (procedure)	4180186
44812009	Plasma N-terminal pro B-type natriuretic peptide concentration	4180186
44812010	Measurement of B-type natriuretic peptide concentration in serum specimen (procedure)	4180186
44812010	Serum B-type natriuretic peptide concentration	4180186
44812011	Measurement of holotranscobalamin concentration in serum specimen (procedure)	4180186
44812011	Serum holotranscobalamin concentration	4180186
44812013	Touch sensation of left dermatome of first sacral nerve reduced (finding)	4180186
44812015	Measurement of retinol binding protein in serum specimen (procedure)	4180186
44812015	Serum retinol binding protein level	4180186
44812019	Histocompatibility and immunogenetics (record artifact)	4180186
44812021	Measurement of red blood cell 6-methylmercaptopurine (procedure)	4180186
44812021	Red blood cell 6-methylmercaptopurine level	4180186
44812026	Copy of care programme approach care plan with carer (finding)	4180186
44812027	Copy of care programme approach care plan with friend (finding)	4180186
44812030	Epilepsy does not limit activities (finding)	4180186
44812033	Measurement of ratio of kappa to lambda light chains in serum specimen (procedure)	4180186
44812033	Serum kappa:lambda light chain ratio	4180186
44812035	Personal Independence Payment claim form completed (finding)	4180186
44812036	Measurement of kappa light chains in serum specimen (procedure)	4180186
44812036	Serum kappa light chain level	4180186
44812037	Measurement of lambda light chains in serum specimen (procedure)	4180186
44812037	Serum lambda light chain level	4180186
44812038	Mixed strength methotrexate prescribing warning (finding)	4180186
44812039	Mixed strength methotrexate prescribing appropriate (finding)	4180186
44812041	Date expected to leave United Kingdom (observable entity)	4180186
44812043	GAS (Goal Attainment Scaling) score	4180186
44812043	Goal Attainment Scaling score (observable entity)	4180186
44812044	First language not English (finding)	4180186
44812047	Assessment using National Obesity Observatory Standard Evaluation Framework for weight management interventions - participant satisfaction with intervention (procedure)	4180186
44812049	Central heating in home (finding)	4180186
44812051	24 hour ECG (electrocardiogram) enhanced services administration	4180186
44812051	24 hour electrocardiogram enhanced services administration (procedure)	4180186
44812052	SAS - Symptom Assessment Scale	4180186
44812052	Symptom Assessment Scale (assessment scale)	4180186
44812054	Education about salmonella precautions during pregnancy (procedure)	4180186
44812055	Liaison with safeguarding children health team (procedure)	4180186
44812059	Referral to maternal fetal medicine service (procedure)	4180186
44812060	Transfer to maternal fetal medicine service (procedure)	4180186
44812061	Copy of care programme approach care plan with neighbour (finding)	4180186
44812065	Uighur language interpreter needed (finding)	4180186
44812066	Advice to general practitioner to change patient medication (regime/therapy)	4180186
44812069	Incomplete food and nutrition knowledge (finding)	4180186
44812070	Noncompliance with dietetic intervention (finding)	4180186
44812072	Internal practice gynaecology referral (procedure)	4180186
44812076	Measurement of alpha carotene in serum specimen (procedure)	4180186
44812076	Serum alpha carotene level	4180186
44812077	Verification parent held PCHR (Personal Child Health Record) given	4180186
44812077	Verification parent held Personal Child Health Record given (procedure)	4180186
44812078	Diffusion weighted magnetic resonance imaging of prostate (procedure)	4180186
44812079	Diffusion weighted magnetic resonance imaging of breast (procedure)	4180186
44812082	Measurement of cannabinoids in serum specimen (procedure)	4180186
44812082	Serum cannabinoid level	4180186
44812087	Touch sensation of right dermatome of second cervical nerve exaggerated (finding)	4180186
44812088	Touch sensation of left dermatome of second cervical nerve exaggerated (finding)	4180186
44812092	Measurement of ubiquinone in serum specimen (procedure)	4180186
44812092	Serum ubiquinone level	4180186
44812093	Measurement of norclozapine in serum specimen (procedure)	4180186
44812093	Serum norclozapine level	4180186
44812094	Removal of biliary stent using fluoroscopic guidance (procedure)	4180186
44812097	Ultrasonography of perineum (procedure)	4180186
44812097	Ultrasound scan of perineum	4180186
44812099	Measurement of aciclovir in serum specimen (procedure)	4180186
44812099	Serum aciclovir level	4180186
44812103	Measurement of valaciclovir in serum specimen (procedure)	4180186
44812103	Serum valaciclovir level	4180186
44812106	Measurement of norclomipramine in serum specimen (procedure)	4180186
44812106	Serum norclomipramine level	4180186
44812107	Measurement of felbamate in serum specimen (procedure)	4180186
44812107	Serum felbamate level	4180186
44812108	Measurement of saquinavir in serum specimen (procedure)	4180186
44812108	Serum saquinavir level	4180186
44812109	Tswana language interpreter needed (finding)	4180186
44812113	Full Health of the Nation Outcome Scale score (observable entity)	4180186
44812113	Full HoNOS (Health of the Nation Outcome Scale) score	4180186
44812114	Transfer from child and adolescent mental health services (procedure)	4180186
44812115	Mental health home treatment team (qualifier value)	4180186
44812117	Transfer from other mental health care provider (procedure)	4180186
44812118	Did not attend cancer clinic (finding)	4180186
44812118	DNA (did not attend) cancer clinic	4180186
44812121	Transposed brachial-basilic arteriovenous fistula (morphologic abnormality)	4180186
44812122	Limited access to nutrition related supplies (finding)	4180186
44812126	AKPS (Australia-modified Karnofsky Performance Status) scale	4180186
44812126	Australia-modified Karnofsky Performance Status scale (assessment scale)	4180186
44812128	Emotional eating (finding)	4180186
44812129	Assessment using AKPS (Australia-modified Karnofsky Performance Status) scale	4180186
44812129	Assessment using Australia-modified Karnofsky Performance Status scale (procedure)	4180186
44812130	Measurement of concentration of pentazocine in serum specimen (procedure)	4180186
44812130	Serum pentazocine concentration	4180186
44812132	Measurement of concentration of pethidine in serum specimen (procedure)	4180186
44812132	Serum pethidine concentration	4180186
44812133	AKPS (Australia-modified Karnofsky Performance Status) scale score	4180186
44812133	Australia-modified Karnofsky Performance Status scale score (observable entity)	4180186
44812134	Assessment of fitness for work (procedure)	4180186
44812135	Echocardiography not indicated (situation)	4180186
44812136	Measurement of concentration of haloperidol in serum specimen (procedure)	4180186
44812136	Serum haloperidol concentration	4180186
44812137	Palliative Care Outcomes Collaboration Assessment Toolkit (assessment scale)	4180186
44812137	PCOC (Palliative Care Outcomes Collaboration) Assessment Toolkit	4180186
44812140	Measurement of concentration of kanamycin in serum specimen (procedure)	4180186
44812140	Serum kanamycin concentration	4180186
44812141	Measurement of concentration of lidocaine in serum specimen (procedure)	4180186
44812141	Serum lidocaine concentration	4180186
44812142	Measurement of concentration of mycophenolic acid in serum specimen (procedure)	4180186
44812142	Serum mycophenolic acid concentration	4180186
44812143	Measurement of concentration of N-acetylprocainamide in serum specimen (procedure)	4180186
44812143	Serum N-acetylprocainamide concentration	4180186
44812146	Screening test for benzoylecgonine in urine specimen (procedure)	4180186
44812147	History of disturbance of consciousness (situation)	4180186
44812152	Insertion of permanent pacemaker lead using fluoroscopic guidance (procedure)	4180186
44812153	Insertion of permanent pacemaker atrial lead using fluoroscopic guidance (procedure)	4180186
44812156	History of collapse (situation)	4180186
44812157	Measurement of concentration of neurokinin A in plasma specimen (procedure)	4180186
44812157	Plasma neurokinin A concentration	4180186
44812159	Remote health monitoring service	4180186
44812159	Remote health monitoring service (qualifier value)	4180186
44812160	Measurement of amino-terminal glucagon in plasma specimen (procedure)	4180186
44812160	Plasma N-terminal glucagon level	4180186
44812161	Communication of paediatric advice line guidance by general practitioner (procedure)	4180186
44812162	Measurement of concentration of cortisol in plasma specimen at 09.00 hours (procedure)	4180186
44812165	Measurement of concentration of thyroid stimulating antibody in serum specimen (procedure)	4180186
44812165	Serum thyroid stimulating antibody concentration	4180186
44812168	Fluoroscopic angiography of transplanted liver with contrast (procedure)	4180186
44812168	Fluoroscopic angiogram of transplanted liver with contrast	4180186
44812170	Advice about use of elastic compression hosiery	4180186
44812170	Education about use of elastic compression hosiery (procedure)	4180186
44812171	Measurement of free testosterone in serum specimen (procedure)	4180186
44812171	Serum free testosterone level	4180186
44812172	Measurement of free testosterone in serum specimen, calculated (procedure)	4180186
44812172	Serum calculated free testosterone	4180186
44812174	Measurement of concentration of human chorionic gonadotrophin in plasma specimen (procedure)	4180186
44812174	Plasma human chorionic gonadotrophin concentration	4180186
44812175	Doppler ultrasonography of transplanted liver (procedure)	4180186
44812175	Doppler ultrasound scan of transplanted liver	4180186
44812176	Measurement of renin activity in plasma specimen, ambulant (procedure)	4180186
44812176	Plasma renin activity ambulant	4180186
44812177	Provision of information about opting out of SCR (Summary Care Record)	4180186
44812177	Provision of information about opting out of Summary Care Record (procedure)	4180186
44812182	Referral to mental health early intervention service (procedure)	4180186
44812182	Referral to mental health early intervention team	4180186
44812183	Referral by non-health worker (procedure)	4180186
44812185	Referral by education service (procedure)	4180186
44812187	Multi-professional risk assessment done (situation)	4180186
44812197	Resource Utilisation Groups - Activities of Daily Living score (observable entity)	4180186
44812197	RUG-ADL (Resource Utilisation Groups - Activities of Daily Living) score	4180186
44812198	Strip craniectomy with remodelling of cranial bones (procedure)	4180186
44812199	Assessment using Resource Utilisation Groups - Activities of Daily Living scale (procedure)	4180186
44812199	Assessment using RUG-ADL (Resource Utilisation Groups - Activities of Daily Living) scale	4180186
44812203	Advancement and remodelling of cranium and facial bones (procedure)	4180186
44812206	Resource Utilisation Groups - Activities of Daily Living Transfer score (observable entity)	4180186
44812206	RUG-ADL (Resource Utilisation Groups - Activities of Daily Living) Transfer score	4180186
44812208	Measurement of concentration of posaconazole in serum specimen (procedure)	4180186
44812208	Serum posaconazole concentration	4180186
44812211	Assessment using PCPSS (Palliative Care Problem Severity Score)	4180186
44812211	Assessment using Palliative Care Problem Severity Score (procedure)	4180186
44812212	Deist	4180186
44812212	Deist, follower of religion (person)	4180186
44812214	Palliative Care Problem Severity Score - pain (observable entity)	4180186
44812214	PCPSS (Palliative Care Problem Severity Score) - pain	4180186
44812217	Osteotomy of bones of face and translocation of orbit (procedure)	4180186
44812222	Percutaneous thrombolysis of transplanted portal vein using fluoroscopic guidance (procedure)	4180186
44812223	Percutaneous transluminal angioplasty of transplanted hepatic artery using fluoroscopic guidance (procedure)	4180186
44812226	Magnetic resonance angiography of transplanted liver (procedure)	4180186
44812226	MRI angiogram of transplanted liver	4180186
44812227	Health of the Nation Outcome Scale for 65+	4180186
44812227	Health of the Nation Outcome Scale for older adults (assessment scale)	4180186
44812233	Percutaneous transjugular biopsy of transplanted liver using fluoroscopic guidance (procedure)	4180186
44812235	Magnetic resonance imaging of transplanted liver (procedure)	4180186
44812237	Wire guided localisation of breast lesion using magnetic resonance imaging guidance (procedure)	4180186
44812238	Four dimensional computed tomography angiography of cerebrum (procedure)	4180186
44812241	Measurement of concentration of insulin-like growth factor binding protein 3 in serum specimen (procedure)	4180186
44812241	Serum insulin-like growth factor binding protein 3 concentration	4180186
44812242	Measurement of concentration of insulin-like growth factor binding protein 3 in plasma specimen (procedure)	4180186
44812242	Plasma insulin-like growth factor binding protein 3 concentration	4180186
44812251	Pseudoaneurysm of arteriovenous fistula (disorder)	4180186
44812252	Referral by private agency (procedure)	4180186
44812255	Measurement of concentration of ritonavir in serum specimen (procedure)	4180186
44812255	Serum ritonavir concentration	4180186
44812259	Number of days absent from school due to wheeze in past 6 months (observable entity)	4180186
44812260	Measurement of concentration of voriconazole in serum specimen (procedure)	4180186
44812260	Serum voriconazole concentration	4180186
44812263	Measurement of concentration of lithium in urine specimen (procedure)	4180186
44812263	Urine lithium concentration	4180186
44812264	Family history of female genital mutilation (situation)	4180186
44812270	Female genital mutilation type II - World Health Organisation classification (disorder)	4180186
44812271	Female genital mutilation type III - World Health Organisation classification (disorder)	4180186
44812275	Measurement of macromolecular creatine kinase in serum specimen (procedure)	4180186
44812275	Serum macromolecular creatine kinase level	4180186
44812276	Health of the Nation Outcome Scale-secure: Rating scale A - potential harm to others (assessment scale)	4180186
44812276	HoNOS (Health of the Nation Outcome Scale)-secure: Rating scale A - potential harm to others	4180186
44812278	Measurement of 24 hour urine hexaporphyrin output (procedure)	4180186
44812278	Urine 24 hour hexaporphyrin output	4180186
44812279	SAS (Symptom Assessment Scale) - bowel problems score	4180186
44812279	Symptom Assessment Scale - bowel problems score (observable entity)	4180186
44812281	SAS (Symptom Assessment Scale) - nausea score	4180186
44812281	Symptom Assessment Scale - nausea score (observable entity)	4180186
44812283	SAS (Symptom Assessment Scale) - difficulty sleeping score	4180186
44812283	Symptom Assessment Scale - difficulty sleeping score (observable entity)	4180186
44812291	Health of the Nation Outcome Scale-secure: Rating scale C - need for buildings security to prevent escape (assessment scale)	4180186
44812292	Optical coherence tomography of coronary artery using fluoroscopic guidance	4180186
44812292	OCT (optical coherence tomography) of coronary artery using fluoroscopic guidance	4180186
44812292	Optical coherence tomography of coronary artery using fluoroscopic guidance (procedure)	4180186
44812294	Computed tomography angiography of thorax and abdomen (procedure)	4180186
44812295	Insertion of tunnelled drain into abdomen using fluoroscopic guidance (procedure)	4180186
44812298	Touch sensation of right dermatome of second lumbar nerve reduced (finding)	4180186
44812299	Touch sensation of left dermatome of second lumbar nerve reduced (finding)	4180186
44812301	Health of the Nation Outcome Scale-secure: Rating scale D - need for safely staffed living environment (assessment scale)	4180186
44812301	HoNOS (Health of the Nation Outcome Scale)-secure: Rating scale D - need for safely staffed living environment	4180186
44812304	Touch sensation of right dermatome of second lumbar nerve exaggerated (finding)	4180186
44812305	Touch sensation of left dermatome of second sacral nerve absent (finding)	4180186
44812307	Touch sensation of left dermatome of second sacral nerve normal (finding)	4180186
44812308	Touch sensation of right dermatome of second sacral nerve normal (finding)	4180186
44812311	[X]Contact with plant thorns and spines and sharp leaves, occurrence on street and highway (event)	4180186
44812312	Human adenovirus detected (finding)	4180186
44812313	FP1001 - forgot to claim (finding)	4180186
44812314	Disease modifying antirheumatic drug monitoring referred back to secondary care (finding)	4180186
44812315	Excluded from diabetic retinopathy screening as blind (finding)	4180186
44812316	[X]RTA - Road traffic and other transport accidents	4180186
44812316	[X]Traffic and other transport accidents	4180186
44812316	[X]Transport accidents (event)	4180186
44812317	[X]Obstetric and gynaecological devices associated with adverse incidents, surgical instruments, materials and devices (including sutures) (disorder)	4180186
44812319	FP1001 - returned unpaid (finding)	4180186
44812320	FP1001 paid (finding)	4180186
44812322	FP1002 sent to family practitioner committee (finding)	4180186
44812325	Excluded from diabetic retinopathy screening as physical disorder (finding)	4180186
44812332	[X]Myelodysplastic syndrome, unspecified (disorder)	4180186
44812335	[M]Specialized gonadal neoplasm NOS (morphologic abnormality)	4180186
44812337	GMS2 claim underpaid by health authority (finding)	4180186
44812338	FP73 immunisation claim form (record artifact)	4180186
44812339	FP73 completed and signed (finding)	4180186
44812340	FP73 sent to family practitioner committee (finding)	4180186
44812341	CH7 sent to Family Practitioner Committee (finding)	4180186
44812342	FP74 cervical cytology claim form (record artifact)	4180186
44812345	Diabetic retinopathy screening administrative status (finding)	4180186
44812347	Out of hours non practice note (record artifact)	4180186
44812351	[X]Systemic disorders of connective tissue in other diseases classified elsewhere (disorder)	4180186
44812355	[X]Other obstructive defects of renal pelvis and ureter (disorder)	4180186
44812357	[X]Other neonatal gastrointestinal haemorrhage (disorder)	4180186
44812360	[X]Occupant of three-wheeled motor vehicle injured in collision with pedal cycle, driver injured in traffic accident (event)	4180186
44812361	[D]Coma and stupor NOS (situation)	4180186
44812362	GMS4 claim - immunisation (Rate B) paid (finding)	4180186
44812363	FP74 eligible with next smear (finding)	4180186
44812367	ANC5/6 to Family Practitioner Committee - staff change (finding)	4180186
44812369	HC1 requested from Family Practitioner Committee (finding)	4180186
44812370	HC1 to Family Practitioner Committee - end of June (finding)	4180186
44812371	Rent and rates payment procedure (procedure)	4180186
44812371	Rent and rates payments	4180186
44812372	Peripheral vein site (body structure)	4180186
44812373	Able to eat finger food (finding)	4180186
44812373	Eating finger food	4180186
44812374	Eligible for diabetic retinopathy screening (finding)	4180186
44812375	Comment note (record artifact)	4180186
44812378	[X]Other examinations for administrative purposes (situation)	4180186
44812381	[X]Other congenital malformations of diaphragm (disorder)	4180186
44812385	Prem1 form sent to Family Practitioner Committee (finding)	4180186
44812387	Prem2 form sent to Family Practitioner Committee (finding)	4180186
44812388	IG1/2/3 improvement grant form (record artifact)	4180186
44812389	SNOMED CT UK clinical extension module	4180186
44812389	SNOMED CT United Kingdom clinical extension module (core metadata concept)	4180186
44812391	SNOMED CT United Kingdom Edition module	4180186
44812391	SNOMED CT United Kingdom Edition module (core metadata concept)	4180186
44812393	Care planning activities simple reference set (foundation metadata concept)	4180186
44812398	Care planning goals simple reference set (foundation metadata concept)	4180186
44812399	Care planning health issues simple reference set (foundation metadata concept)	4180186
44812400	Care planning administration of medication simple reference set (foundation metadata concept)	4180186
44812403	Care planning patient discharge simple reference set (foundation metadata concept)	4180186
44812404	Care planning patient outgoing referral simple reference set (foundation metadata concept)	4180186
44812405	Instantiable care record element type simple reference set	4180186
44812405	Instantiable care record element type simple reference set (foundation metadata concept)	4180186
44812406	Navigable or instantiable care record element type simple reference set	4180186
44812406	Navigable or instantiable care record element type simple reference set (foundation metadata concept)	4180186
44812407	Administration of medication simple reference set (foundation metadata concept)	4180186
44812408	Administrative procedure simple reference set (foundation metadata concept)	4180186
44812412	Allergy propensity simple reference set (foundation metadata concept)	4180186
44812414	Health visitor contact details given (situation)	4180186
44812415	[D]Other voice disturbance NOS (situation)	4180186
44812417	[X]Severe vaginal dysplasia, not elsewhere classified (disorder)	4180186
44812418	[M]Germ cell neoplasm NOS (morphologic abnormality)	4180186
44812423	Clinical document architecture encounter type simple reference set	4180186
44812423	Clinical document architecture encounter type simple reference set (foundation metadata concept)	4180186
44812424	Capacity to consent simple reference set (foundation metadata concept)	4180186
44812425	Care support needs simple reference set (foundation metadata concept)	4180186
44812427	Correspondence document type simple reference set (foundation metadata concept)	4180186
44812428	Device type simple reference set (foundation metadata concept)	4180186
44812431	Buddhist religion simple reference set (foundation metadata concept)	4180186
44812436	Jewish religion simple reference set (foundation metadata concept)	4180186
44812437	Muslim religion simple reference set (foundation metadata concept)	4180186
44812440	Pagan religion simple reference set (foundation metadata concept)	4180186
44812441	Religious or other belief system affiliation simple reference set (foundation metadata concept)	4180186
44812442	Sikh religion simple reference set (foundation metadata concept)	4180186
44812445	Baha'i religion language reference set (foundation metadata concept)	4180186
44812446	Buddhist religion language reference set (foundation metadata concept)	4180186
44812450	Jain religion language reference set (foundation metadata concept)	4180186
44812454	Other religion language reference set (foundation metadata concept)	4180186
44812455	Pagan religion language reference set (foundation metadata concept)	4180186
44812456	Religious or other belief system affiliation language reference set (foundation metadata concept)	4180186
44812458	Zoroastrian religion language reference set (foundation metadata concept)	4180186
44812459	Diagnosis simple reference set (foundation metadata concept)	4180186
44812461	Document consent simple reference set (foundation metadata concept)	4180186
44812464	Encounter type simple reference set (foundation metadata concept)	4180186
44812470	Laterality simple reference set (foundation metadata concept)	4180186
44812475	Risk to person simple reference set (foundation metadata concept)	4180186
44812476	Services, care professionals and carers simple reference set (foundation metadata concept)	4180186
44812477	Smoking simple reference set (foundation metadata concept)	4180186
44812483	Temperature simple reference set (foundation metadata concept)	4180186
44812484	Treatments simple reference set (foundation metadata concept)	4180186
44812485	Weight simple reference set (foundation metadata concept)	4180186
44812486	National Health Service continuing healthcare encounter simple reference set (foundation metadata concept)	4180186
44812486	NHS CHC (continuing healthcare) encounter simple reference set	4180186
44812490	[X]Exposure to excessive heat of man-made origin, occurrence on street and highway (event)	4180186
44812491	[X]Injury of unspecified muscle and tendon at wrist and hand level (disorder)	4180186
44812495	Device reading body site simple reference set (foundation metadata concept)	4180186
44812496	Supply medication simple reference set (foundation metadata concept)	4180186
44812497	Supply medication request simple reference set (foundation metadata concept)	4180186
44812498	Endoscopy diagnosis simple reference set (foundation metadata concept)	4180186
44812504	Section 117 of Mental Health Act 1983 (England and Wales) eligibility options simple reference set (foundation metadata concept)	4180186
44812506	Link assertion simple reference set (foundation metadata concept)	4180186
44812508	National Health Service pathology bounded code list simple reference set	4180186
44812508	National Health Service pathology bounded code list simple reference set (foundation metadata concept)	4180186
44812512	National Health Service laboratory isolate simple reference set	4180186
44812512	National Health Service laboratory isolate simple reference set (foundation metadata concept)	4180186
44812513	National Health Service laboratory laterality simple reference set	4180186
44812513	National Health Service laboratory laterality simple reference set (foundation metadata concept)	4180186
44812514	National Health Service laboratory morphology simple reference set	4180186
44812514	National Health Service laboratory morphology simple reference set (foundation metadata concept)	4180186
44812515	National Health Service laboratory precondition simple reference set	4180186
44812515	National Health Service laboratory precondition simple reference set (foundation metadata concept)	4180186
44812516	National Health Service laboratory specimen simple reference set	4180186
44812516	National Health Service laboratory specimen simple reference set (foundation metadata concept)	4180186
44812518	Allergies and adverse reaction causative agent groups simple reference set (foundation metadata concept)	4180186
44812520	National Health Service realm language reference set (clinical part)	4180186
44812520	National Health Service realm language reference set (clinical part) (foundation metadata concept)	4180186
44812521	National Health Service pathology bounded code list language reference set	4180186
44812521	National Health Service pathology bounded code list language reference set (foundation metadata concept)	4180186
44812523	SNOMED CT UK Edition module dependency reference set	4180186
44812523	SNOMED CT United Kingdom Edition module dependency reference set (foundation metadata concept)	4180186
44812525	ICD-10 (International Classification of Diseases, Tenth Revision) 4th Edition UK complex map reference set	4180186
44812525	International Classification of Diseases, Tenth Revision, Fourth Edition United Kingdom complex map reference set (foundation metadata concept)	4180186
44812526	Office of Population Censuses and Surveys Classification of Interventions and Procedures Version 4.6 complex map reference set (foundation metadata concept)	4180186
44812526	OPCS (Office of Population Censuses and Surveys) Classification of Interventions and Procedures Version 4.6 complex map reference set	4180186
44812527	Tenure of accommodation simple reference set (foundation metadata concept)	4180186
44812528	Type of accommodation simple reference set (foundation metadata concept)	4180186
44812531	Allergy or adverse reaction propensity simple reference set (foundation metadata concept)	4180186
44812535	National Health Service continuing healthcare acceptance message type simple reference set (foundation metadata concept)	4180186
44812535	NHS CHC (continuing healthcare) acceptance message type simple reference set	4180186
44812537	Care plan agreement simple reference set (foundation metadata concept)	4180186
44812539	Cognition finding simple reference set (foundation metadata concept)	4180186
44812541	Consciousness finding simple reference set (foundation metadata concept)	4180186
44812542	Employment status simple reference set (foundation metadata concept)	4180186
44812543	Financial circumstances finding simple reference set (foundation metadata concept)	4180186
44812546	Mobility issues simple reference set (foundation metadata concept)	4180186
44812547	Mood or emotional state finding simple reference set (foundation metadata concept)	4180186
44812550	Assessment scale simple reference set (foundation metadata concept)	4180186
44812553	Rehabilitation assessment by unidisciplinary non-specialised team (regime/therapy)	4180186
44812554	Brief intervention for excessive alcohol consumption declined (situation)	4180186
44812555	Preparation for external beam radiotherapy (regime/therapy)	4180186
44812557	[X]Struck by thrown, projected or falling object, occurrence at other specified place (event)	4180186
44812560	[D]Fever NOS (situation)	4180186
44812561	[V]Other digestive problems (situation)	4180186
44812562	[D]Ascites NOS (situation)	4180186
44812564	Skin and wound issues simple reference set (foundation metadata concept)	4180186
44812567	Substance misuse finding simple reference set (foundation metadata concept)	4180186
44812568	Map block (foundation metadata concept)	4180186
44812575	Clinical record headings simple reference set (foundation metadata concept)	4180186
44812576	Rheumatology diagnosis simple reference set (foundation metadata concept)	4180186
44812578	Paediatric neurodisability outpatient diagnosis simple reference set (foundation metadata concept)	4180186
44812578	Pediatric neurodisability outpatient diagnosis simple reference set	4180186
44812579	Ophthalmology diagnosis simple reference set (foundation metadata concept)	4180186
44812582	Ophthalmology cornea diagnosis simple reference set (foundation metadata concept)	4180186
44812584	Ophthalmology glaucoma diagnosis simple reference set (foundation metadata concept)	4180186
44812585	Ophthalmology medical retinal diagnosis simple reference set (foundation metadata concept)	4180186
44812586	Ophthalmology paediatric diagnosis simple reference set (foundation metadata concept)	4180186
44812586	Ophthalmology pediatric diagnosis simple reference set	4180186
44812590	Respiratory medicine diagnosis simple reference set (foundation metadata concept)	4180186
44812591	Gastroenterology outpatient diagnosis language reference set (foundation metadata concept)	4180186
44812592	Paediatric neurodisability outpatient diagnosis language reference set (foundation metadata concept)	4180186
44812592	Pediatric neurodisability outpatient diagnosis language reference set	4180186
44812596	Timed collection: specimen collection, 4 - 6 hours post-treatment (finding)	4180186
44812597	Fast track referral (procedure)	4180186
44812598	Issue of palliative care anticipatory medication box (procedure)	4180186
44812598	Issue of palliative care just in case box	4180186
44812599	Patient clinical record requested (finding)	4180186
44812601	Excluded from national child measurement programme as parent opted out (finding)	4180186
44812602	Bone morphogenetic proteins Band 1 (procedure)	4180186
44812603	First pandemic influenza vaccination given by other healthcare provider (finding)	4180186
44812605	[M]Myomatous neoplasm NOS (morphologic abnormality)	4180186
44812606	[X]Other chronic haematogenous osteomyelitis (disorder)	4180186
44812608	[X]Congenital malformation of great arteries, unspecified (disorder)	4180186
44812611	Timed collection: specimen collection, 660 minutes (finding)	4180186
44812613	Contact with family (finding)	4180186
44812615	[X]Other complications of internal orthopaedic prosthetic devices, implants and grafts (disorder)	4180186
44812616	[X]Other problems related to neglect in upbringing (situation)	4180186
44812617	[M]Malignant lymphoma, lymphocytic, poorly differentiated, nodular (morphologic abnormality)	4180186
44812619	RAN forms requested from health board (finding)	4180186
44812621	[X]Examination and observation for other specified reasons (situation)	4180186
44812623	Problem with sexual function	4180186
44812623	[V]Problem with sexual function (situation)	4180186
44812624	[X]Attention to other artificial openings of urinary tract (situation)	4180186
44812626	FP1001 signed (finding)	4180186
44812627	Vodun	4180186
44812627	Vodun, follower of religion (person)	4180186
44812630	Referral to interventional radiology clinic (procedure)	4180186
44812631	Seen in fast track suspected sarcoma clinic (finding)	4180186
44812632	History of ototoxic medication (situation)	4180186
44812634	[V]Diphtheria-tetanus-pertussis with typhoid-paratyphoid (DTP + TAB) vaccination (situation)	4180186
44812635	[X]Poisoning by other opioids (disorder)	4180186
44812637	[X]Benign neoplasm of other male genital organs (disorder)	4180186
44812639	[X]Predominantly compulsive acts [obsessional rituals] (disorder)	4180186
44812640	[V]Singleton (situation)	4180186
44812643	Rotator cuff tendinitis	4180186
44812643	Tendinitis of rotator cuff (disorder)	4180186
44812644	In-house urology (procedure)	4180186
44812646	GPC claim - temporary resident (more than 15 days) sent to Health Board (finding)	4180186
44812650	West Glamorgan health authority (environment)	4180186
44812651	Highland health board (environment)	4180186
44812653	FP1001 up to date (finding)	4180186
44812655	Bowel cancer screening programme finding (finding)	4180186
44812656	Insertion of Implanon (procedure)	4180186
44812660	Antenatal screening shows iron deficiency or possible non significant alpha thalassaemia (finding)	4180186
44812662	Belief affiliation (observable entity)	4180186
44812663	French Protestant	4180186
44812663	French Protestant, follower of religion (person)	4180186
44812667	Seen by counsellor for alcohol misuse (finding)	4180186
44812670	FP1001 claim cancelled (finding)	4180186
44812671	Negative virology findings (finding)	4180186
44812672	No respiratory virus detected (finding)	4180186
44812673	GPC claim - contraception not claimed (finding)	4180186
44812675	Bowel cancer screening programme faecal occult blood test abnormal (finding)	4180186
44812676	GMS2 claim sent to health authority (finding)	4180186
44812677	FP1001 - not claimed (finding)	4180186
44812679	Prisoner assessment for in-possession medication completed (situation)	4180186
44812681	[M]Pancreatic adenomas and carcinomas (morphologic abnormality)	4180186
44812683	[X]Other hookworm diseases (disorder)	4180186
44812684	[X]Ascariasis with other complications (disorder)	4180186
44812686	[X]Other specified special examinations (situation)	4180186
44812691	Crewman driver armoured fighting vehicle - Royal Armoured Corps (occupation)	4180186
44812693	[X]Other specified disorders of lens (disorder)	4180186
44812695	[V]Family history of skin conditions (situation)	4180186
44812696	[X]Acquired absence of other parts of digestive tract (situation)	4180186
44812697	[V]Bone transplanted (situation)	4180186
44812698	Northern health and social services board (environment)	4180186
44812698	Northern HSSB (Health and Social Services Board)	4180186
44812699	[X]Other effects of air pressure and water pressure (disorder)	4180186
44812704	[X]Poisoning by other and unspecified general anaesthetics (disorder)	4180186
44812707	[V]Other specified prophylactic measure (situation)	4180186
44812708	[V]Prophylactic surgery, unspecified (situation)	4180186
44812709	[V]Other specified combined vaccination (situation)	4180186
44812715	[V]Presence of tooth-root and mandibular implants (situation)	4180186
44812716	[V]Pregnancy not (yet) confirmed (situation)	4180186
44812717	[X]Iridocyclitis in other diseases classified elsewhere (disorder)	4180186
44812718	[X]Disorder of muscle, unspecified (disorder)	4180186
44812720	Subject to restriction order under Section 49 of the Mental Health Act 1983 (England and Wales) (finding)	4180186
44812720	Subject to restriction order under Section 49 of the MHA (Mental Health Act) 1983 (England and Wales)	4180186
44812727	Care for mentally disordered offenders - Full day: day care (procedure)	4180186
44812728	Unit light aircraft observer - Royal Marines (occupation)	4180186
44812730	[V]Lack of learning and play experience (situation)	4180186
44812731	[V]Gonorrhea carrier (situation)	4180186
44812732	[V]Special sense and other special function problems (situation)	4180186
44812733	[X]Other viral pneumonia (disorder)	4180186
44812734	[X]Malignant neoplasm of peripheral nerves of trunk, unspecified (disorder)	4180186
44812736	[X]Glomerular disorders in diabetes mellitus (disorder)	4180186
44812738	[X]Additional endocrine, nutritional, metabolic and immunity disease classification terms (disorder)	4180186
44812740	Forth Valley health board (environment)	4180186
44812741	[V]Other unwanted pregnancy (situation)	4180186
44812742	[V]Atypical parenting situation (situation)	4180186
44812743	[V]Problems with communication, including speech (situation)	4180186
44812743	[V]Problems with speech	4180186
44812744	[X]Other complications of genitourinary prosthetic devices, implants and grafts (disorder)	4180186
44812745	[X]Other disorders of eye and adnexa (disorder)	4180186
44812749	[X]Cardiovascular disease, unspecified (disorder)	4180186
44812751	[M]Papillary neoplasms (morphologic abnormality)	4180186
44812756	[M]Chondrosarcoma NOS (morphologic abnormality)	4180186
44812757	[X]Penetrating wound of orbit with or without foreign body (disorder)	4180186
44812761	[V]Inadequate family support (situation)	4180186
44812761	[V]No support from wider family	4180186
44812764	RAF (Royal Air Force) air electronics officer, general duties	4180186
44812764	Royal Air Force air electronics officer, general duties (occupation)	4180186
44812765	[Q] Pre-ganglionic (qualifier value)	4180186
44812767	[X]Myocarditis in viral diseases classified elsewhere (disorder)	4180186
44812769	[V]Fitting or adjustment of hearing aid (situation)	4180186
44812770	[V]Screening for chronic bronchitis	4180186
44812770	[V]Screening for chronic bronchitis or emphysema (situation)	4180186
44812770	[V]Screening for emphysema	4180186
44812772	Healthcare assistant - Royal Army Nursing Corps (occupation)	4180186
44812773	[X]Other injuries of unspecified body region (disorder)	4180186
44812774	[X]Other multiple births, all liveborn (situation)	4180186
44812778	[M]Other monocytic leukaemia NOS (morphologic abnormality)	4180186
44812779	[V]Counselling related to patient's sexual behaviour and orientation (situation)	4180186
44812780	[V]Examination of eyes and vision (situation)	4180186
44812784	[X]Other and unspecified injuries of cervical spinal cord (disorder)	4180186
44812787	[V]Measles vaccination (situation)	4180186
44812789	[V]Healthy liveborn infants according to type of birth (situation)	4180186
44812795	[V]Drug rehabilitation (situation)	4180186
44812798	[V]Other genital problems (situation)	4180186
44812800	[X]Congenital malformation of larynx, unspecified (disorder)	4180186
44812801	[V]Other venereal disease carrier (situation)	4180186
44812803	[X]Occupant of heavy transport vehicle injured in collision with two or three-wheeled motor vehicle, person on outside of vehicle injured in traffic accident (event)	4180186
44812805	[X]Accidental poisoning by and exposure to antiepileptics, occurrence at unspecified place (event)	4180186
44812806	[X]Fall on same level from slipping, tripping and stumbling (event)	4180186
44812811	[X]Other hyperaldosteronism (disorder)	4180186
44812817	[V]Carrier of human T-lymphotropic virus type-1 infect (situation)	4180186
44812818	[V]Problems in relationship with parents and in-laws (situation)	4180186
44812820	[V]Family history of diabetes mellitus (DM)	4180186
44812820	[V]Family history of diabetes mellitus (situation)	4180186
44812821	[X]Need for immunisation against other specified single viral diseases (situation)	4180186
44812822	[X]Other and unspecified oedema specific to fetus and newborn (disorder)	4180186
44812824	[X]Hernia (disorder)	4180186
44812825	[M]Rhabdomyomatous neoplasm NOS (morphologic abnormality)	4180186
44812826	[X]Sepsis of newborn due to other and unspecified staphylococcus (disorder)	4180186
44812828	[X]Family history of malignant neoplasm of other respiratory and intrathoracic organs (situation)	4180186
44812832	[X]Other appendicitis (disorder)	4180186
44812835	[X]Unspecified systemic antibiotic causing adverse effects in therapeutic use (disorder)	4180186
44812837	[V]Fitting or adjustment of unspecified device (situation)	4180186
44812838	[V]Immunization not carried out for unspecified reason (situation)	4180186
44812842	[X]Poisoning by and exposure to other and unspecified drug, medicament and biological substance, occurrence on street and highway, undetermined intent (event)	4180186
44812843	[X]Other deletions from the autosomes (disorder)	4180186
44812844	[X]Other seropositive rheumatoid arthritis (disorder)	4180186
44812845	[M]Mesonephroma NOS (morphologic abnormality)	4180186
44812846	[X]Seropositive rheumatoid arthritis, unspecified (disorder)	4180186
44812847	[V]Fitting or adjustment of auditory substitution device	4180186
44812847	[V]Fitting or adjustment of device related to nervous system or special senses (situation)	4180186
44812847	[V]Fitting or adjustment of nervous system device	4180186
44812847	[V]Fitting or adjustment of neuropacemaker device	4180186
44812847	[V]Fitting or adjustment of visual substitution device	4180186
44812848	[X]Mental and behavioural disorders due to psychoactive substance use (disorder)	4180186
44812856	Non National Health Service registered nursing home mental health care for older adults (regime/therapy)	4180186
44812857	[X]Intentional self poisoning by and exposure to hallucinogens, occurrence at industrial and construction area (event)	4180186
44812858	[V]Special screening examination for human immunodeficiency virus (situation)	4180186
44812859	[V]Screening for measles (situation)	4180186
44812862	[X]Passenger injured in collision with other and unspecified motor vehicles in traffic accident (event)	4180186
44812864	[M]Carcinosarcoma NOS (morphologic abnormality)	4180186
44812865	[M]Chondroblastoma NOS (morphologic abnormality)	4180186
44812866	[V]Occupational exposure to unspecified risk-factor (situation)	4180186
44812867	[V]Plastic surgery used in aftercare (situation)	4180186
44812867	[V]Repair of scarred tissue	4180186
44812868	[V]Follow-up care involving plastic surgery of head and neck (situation)	4180186
44812869	[V]Personal history of self-harm (situation)	4180186
44812870	[X]Contact with hot air and gases, occurrence at school, other institution and public administrative area (event)	4180186
44812872	[X]Inhalation of gastric contents, occurrence at trade and service area (finding)	4180186
44812873	[X]Injury of other nerves at lower leg level (disorder)	4180186
44812875	[V]Contact with and exposure to human immunodeficiency virus (situation)	4180186
44812876	[V]Unspecified vaccination against certain viral disease (situation)	4180186
44812877	[V]Need for prophylactic vaccination and inoculation against other single diseases (situation)	4180186
44812878	[X]Other transient neonatal disorders of coagulation (disorder)	4180186
44812879	[M]Neurofibroma NOS (morphologic abnormality)	4180186
44812881	[X]Reactive arthropathy in other diseases classified elsewhere (disorder)	4180186
44812882	Form A passport application form (record artifact)	4180186
44812883	[V]Aftercare involving peritoneal dialysis	4180186
44812883	[V]Other specified aftercare involving intermittent dialysis (situation)	4180186
44812885	[X]Appetite depressants [anorectics] causing adverse effects in therapeutic use (disorder)	4180186
44812886	[X]Open wound of other and unspecified parts of abdomen, lower back and pelvis (disorder)	4180186
44812888	[X]Other specified noninfective disorders of lymphatic vessels and lymph nodes (disorder)	4180186
44812889	[X]Drowning and submersion whilst in natural water, occurrence at sports and athletics area (event)	4180186
44812890	[M]Adenomatous or adenocarcinomatous polyps of the colon NOS (morphologic abnormality)	4180186
44812892	Patient registered - GP19 (finding)	4180186
44812893	[X]Mosquito-borne viral encephalitis, unspecified (disorder)	4180186
44812894	[V]Other negative life events in childhood (situation)	4180186
44812895	[V]Attention to colostomy (situation)	4180186
44812896	National Health Service (NHS) mental health nursing home/residential care - 24 hour intensive	4180186
44812896	National Health Service (NHS) mental health nursing home/residential care - 24 hour intensive (procedure)	4180186
44812897	[M]Rhabdomyosarcoma NOS (morphologic abnormality)	4180186
44812898	[V]Has cerebrospinal fluid drainage device in situ (situation)	4180186
44812898	[V]Has cerebrospinal fluid shunt in situ	4180186
44812898	[V]Has cerebrospinal fluid valve in situ	4180186
44812899	[V]Screening for senile macular lesion (situation)	4180186
44812900	[X]Unspecified aircraft accident injuring occupant (event)	4180186
44812901	[X]Unintentional cut, puncture, perforation or haemorrhage during unspecified surgical and medical care (disorder)	4180186
44812906	[D]Dysuria NOS (situation)	4180186
44812907	[X]Other specified intervertebral disc degeneration (disorder)	4180186
44812912	[X]Poisoning by and exposure to pesticides, occurrence at industrial and construction area, undetermined intent (event)	4180186
44812914	[X]Unspecified anaesthetics causing adverse effects in therapeutic use (disorder)	4180186
44812915	[X]Unspecified drug or medicament causing adverse effects in therapeutic use (disorder)	4180186
44812917	Nurse of the prescribed class under section 5 (4) of the Mental Health Act 1983 (England and Wales) (occupation)	4180186
44812918	[V]Threat of job loss (situation)	4180186
44812920	[X]Other specified noninflammatory disorders of vagina (disorder)	4180186
44812923	[M]Adrenal cortical tumours NOS (disorder)	4180186
44812926	[V]Illegitimate pregnancy (situation)	4180186
44812927	[X]Unspecified frostbite of thorax, abdomen, lower back and pelvis (disorder)	4180186
44812929	[X]Other eating disorders (disorder)	4180186
44812930	[X]Unspecified frostbite of unspecified site (disorder)	4180186
44812931	[X]Other diseases of intestines (disorder)	4180186
44812932	[X]Inhalation and ingestion of other objects causing obstruction of respiratory tract, occurrence at trade and service area (disorder)	4180186
44812933	[V]Aspirator dependence (situation)	4180186
44812934	[X]Acute bronchiolitis due to other specified organisms (disorder)	4180186
44812935	[X]Other disorders of vestibular function (disorder)	4180186
44812936	[X]Victim of cataclysmic storm, occurrence at home (finding)	4180186
44812937	[X]Unspecified lack of expected normal physiological develop (finding)	4180186
44812937	[X] Unspecified lack of expected normal physiological development	4180186
44812937	[X]Unspecified lack of expected normal physiological development	4180186
44812939	[V]Fitting or adjustment of wheelchair (situation)	4180186
44812940	RAF (Royal Air Force) chaplain	4180186
44812940	Royal Air Force chaplain (occupation)	4180186
44812941	[X]Other cervical disc degeneration (disorder)	4180186
44812942	[X]Mental and behavioral disorders due to use of tobacco: psychotic disorder	4180186
44812942	[X]Mental and behavioural disorders due to use of tobacco: psychotic disorder (disorder)	4180186
44812946	[V]Reproductive and developmental problems NOS (situation)	4180186
44812947	[V]Contact with or exposure to rubella (situation)	4180186
44812948	[X]Other specified abnormal uterine and vaginal bleeding (disorder)	4180186
44812951	[X]Pharmaceutical excipients causing adverse effects in therapeutic use (disorder)	4180186
44812954	[X]Legal execution (event)	4180186
44812955	[X]Unspecified adverse effect of drug or medicament (disorder)	4180186
44812957	[V]Personal history of drug allergy (situation)	4180186
44812959	[V]Screening for other/unspecified cardiovascular disease (situation)	4180186
44812960	[X]Special screening examination for other infectious and parasitic diseases (situation)	4180186
44812964	[X]Injury of other and unspecified nerves of abdomen, lower back and pelvis (disorder)	4180186
44812965	[X]Poisoning by other synthetic narcotics (disorder)	4180186
44812969	[X]Closed multiple fractures unspecified (morphologic abnormality)	4180186
44812970	[V]Personal history of heart or great vessel operation (situation)	4180186
44812971	[X]Other general examinations (situation)	4180186
44812976	[X]Injury of other pelvic organs (disorder)	4180186
44812977	[X]Open wound of thorax, part unspecified (disorder)	4180186
44812978	[X]Dependence on other enabling machines and devices (situation)	4180186
44812979	[V]Person living alone (situation)	4180186
44812982	[X]Poisoning by other and unspecified drugs and biological substances (disorder)	4180186
44812986	[V]Family history of congenital anomalies (situation)	4180186
44812987	[X]Problem related to life-management difficulty, unspecified (situation)	4180186
44812988	[Q] Sequestrated disc prolapse (qualifier value)	4180186
44812989	[Q] Tissue damage qualifying terms (qualifier value)	4180186
44812990	[X]Other congenital malformations of trachea (disorder)	4180186
44812991	[X]Dystonia, unspecified (disorder)	4180186
44812994	[V]Absence of family member (situation)	4180186
44812995	[V]Persons with a condition influencing their health status (situation)	4180186
44812998	Mid Glamorgan health authority (environment)	4180186
44812999	[V]Family history of anaemia (situation)	4180186
44813002	[V]Need for immunisation against leishmaniasis (situation)	4180186
44813004	[X]Foreign body in other and combined sites on external eye (disorder)	4180186
44813007	Abnormal position of thoracoabdominal organ (finding)	4180186
44813008	Boundary data (qualifier value)	4180186
44813013	Very old people (qualifier value)	4180186
44813015	[X]Injury of other blood vessels at abdomen, lower back and pelvis level (disorder)	4180186
44813016	[V]Problems related to medical facilities and other health care (situation)	4180186
44813017	[Q] Post-ganglionic (qualifier value)	4180186
44813018	[V]Personal history of leukaemia (situation)	4180186
44813018	[V]Personal history of leukemia	4180186
44813018	[V]Personal history of lymphoid leukaemia	4180186
44813018	[V]Personal history of lymphoid leukemia	4180186
44813018	[V]Personal history of monocytic leukaemia	4180186
44813018	[V]Personal history of monocytic leukemia	4180186
44813018	[V]Personal history of myeloid leukaemia	4180186
44813018	[V]Personal history of myeloid leukemia	4180186
44813021	[V]Drug abuse counselling and surveillance (situation)	4180186
44813024	Newborn blood spot screening programme - repeat screening with further sample required (finding)	4180186
44813025	ANC1 status (finding)	4180186
44813026	Assessment using health of the nation outcome scale (regime/therapy)	4180186
44813026	Assessment using HoNOS (health of the nation outcome scale)	4180186
44813028	[D]Cervical smear - nonspecific abnormality	4180186
44813028	[D]Nonspecific abnormal Papanicolaou cervical smear (situation)	4180186
44813028	[D]Papanicolaou smear - nonspecific abnormality	4180186
44813029	[D]Koilocytosis - cervical smear (situation)	4180186
44813033	[D]Positive culture findings in wound (situation)	4180186
44813037	Forced expired volume in 1 second percentage change (observable entity)	4180186
44813038	Swelling on flushing of totally implantable venous access device (disorder)	4180186
44813040	[D]Death less than 24 hours from onset of illness (situation)	4180186
44813042	[D]Asphyxia (situation)	4180186
44813044	[D]Cardiorespiratory failure (situation)	4180186
44813046	[D]Other specified symptoms, signs or ill-defined conditions (situation)	4180186
44813048	[D]Overactivity (situation)	4180186
44813052	Administration of medication under patient specific direction (procedure)	4180186
44813054	ADHD (attention deficit hyperactivity disorder) annual review	4180186
44813054	Attention deficit hyperactivity disorder annual review (procedure)	4180186
44813055	Geographical information system (qualifier value)	4180186
44813056	Cohort study (qualifier value)	4180186
44813058	Insertion of subcutaneous contraceptive implant by other healthcare provider (situation)	4180186
44813059	Mental health service (qualifier value)	4180186
44813060	Workplace health promotion (qualifier value)	4180186
44813062	GP/PS3 form sent to Health Board (finding)	4180186
44813064	Metalsmith - Royal Electrical and Mechanical Engineers (occupation)	4180186
44813066	[V]Attention to gastrostomy (situation)	4180186
44813068	Healthy lifestyle maintenance programme declined (situation)	4180186
44813069	Advice about probiotic therapy (procedure)	4180186
44813072	Oxford hip scale (assessment scale)	4180186
44813075	[D]Spasms (situation)	4180186
44813077	[D]Monoplegia, transient (situation)	4180186
44813079	[D]Development, failure in (situation)	4180186
44813080	[D]Heart murmur (situation)	4180186
44813083	[D]Colic (situation)	4180186
44813085	[D]Gastrointestinal X-ray abnormal (situation)	4180186
44813087	Referred for peripheral artery disease assessment (procedure)	4180186
44813088	Education about complications of treatment (procedure)	4180186
44813089	Midwife in attendance at birth (situation)	4180186
44813090	Discharged from diabetes shared care programme (finding)	4180186
44813092	Subject of MAPPA (multi-agency public protection arrangements)	4180186
44813092	Subject of multi-agency public protection arrangements (finding)	4180186
44813094	[D]Choking due to airways obstruction (situation)	4180186
44813095	[D]Culture finding positive (situation)	4180186
44813096	Blood chemistry abnormal [D]	4180186
44813096	[D]Blood chemistry abnormal (situation)	4180186
44813097	[D]Other specified abnormal immunological findings in serum (situation)	4180186
44813099	[D]Left lower quadrant pain (situation)	4180186
44813103	[D]Elevated blood glucose level	4180186
44813103	[D]Hyperglycaemia (situation)	4180186
44813104	[D]Impaired fasting glucose	4180186
44813104	[D]Impaired fasting glycaemia (situation)	4180186
44813105	PULHHEEMS - S7 (finding)	4180186
44813107	GP22 deregistration - correspondence states gone away (finding)	4180186
44813108	Influenza vaccination invitation second short message service text message sent (finding)	4180186
44813108	Influenza vaccination invitation second SMS (short message service) text message sent	4180186
44813108	Influenza vaccination invitation second text message sent	4180186
44813109	Socially isolated parent (finding)	4180186
44813110	National Health Service Continuing Healthcare Fast Track Pathway Tool (record artifact)	4180186
44813112	Consultation with patient and representative encounter type (record artifact)	4180186
44813113	Requires hepatitis B booster (finding)	4180186
44813117	[V]Gambling and betting (situation)	4180186
44813121	[X]Inhalation and ingestion of other objects causing obstruction of respiratory tract, occurrence at school, other institution and public administrative area (disorder)	4180186
44813122	[V]Menstrual extraction (situation)	4180186
44813123	[V]Disappearance and death of family member (situation)	4180186
44813124	[Q] Temporary qualifying terms (qualifier value)	4180186
44813125	[D]Hallucinations, gustatory (situation)	4180186
44813127	[D]Syncope	4180186
44813127	[D]Syncope and collapse (situation)	4180186
44813128	[D]Collapse (situation)	4180186
44813132	[D]Dizziness and giddiness (situation)	4180186
44813134	Deep vein thrombosis enhanced services administration stage 3 service level (finding)	4180186
44813135	Impaired glucose tolerance monitoring invitation first letter (procedure)	4180186
44813136	Impaired glucose tolerance monitoring invitation third letter (procedure)	4180186
44813137	Unable to consent to information sharing (finding)	4180186
44813139	[D]Amnesia (retrograde) (situation)	4180186
44813139	[D]Memory deficit	4180186
44813141	[D]Unhappiness (situation)	4180186
44813142	[D]Irritability and anger (situation)	4180186
44813143	[D]Physical violence (situation)	4180186
44813144	[D]Acute pain (situation)	4180186
44813147	[D]Titubation (situation)	4180186
44813148	[D]Anosmia (situation)	4180186
44813150	[D]Gait abnormality (situation)	4180186
44813151	[D]Paralytic gait (situation)	4180186
44813153	Referral for impaired glucose tolerance management offered (finding)	4180186
44813154	National Health Service Health Check declined (situation)	4180186
44813155	Mammography attended (situation)	4180186
44813158	Insulin/carbohydrate ratio - lunch (observable entity)	4180186
44813160	Frequency of blood glucose self-monitoring (observable entity)	4180186
44813164	Referral to DESMOND (diabetes education and self management for ongoing and newly diagnosed) structured programme declined	4180186
44813164	Referral to diabetes education and self management for ongoing and newly diagnosed structured programme declined (situation)	4180186
44813168	Sound ranging surveyor - Royal Artillery (occupation)	4180186
44813170	[X]Donor of other organ and tissue (situation)	4180186
44813171	[X]Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours, occurrence on farm (event)	4180186
44813174	[D]Meningismus (situation)	4180186
44813176	Histology not indicated (situation)	4180186
44813178	Malposition of heart (disorder)	4180186
44813179	Helicobacter pylori stool test (procedure)	4180186
44813180	[D]Rash on genitals (situation)	4180186
44813181	[D]Swelling, local and superficial (situation)	4180186
44813185	[D]Lump on hand (situation)	4180186
44813187	[D]Lump on shin (situation)	4180186
44813189	[D]Toe lump (situation)	4180186
44813192	Bone sparing drug treatment offered for osteoporosis (situation)	4180186
44813193	Suspected influenza due to Influenza A virus subtype H1N1 (situation)	4180186
44813193	Suspected swine influenza	4180186
44813194	Finding of preferred place of care (finding)	4180186
44813195	Home intravenous antibiotic therapy (procedure)	4180186
44813197	PULHHEEMS - Eul8 (finding)	4180186
44813198	Multiple sclerosis monitoring third letter (procedure)	4180186
44813201	Child in need referral to social services (procedure)	4180186
44813203	History of multiple joint pain (situation)	4180186
44813207	Double chambered right ventricle with VSD (ventricular septal defect) above and below obstruction	4180186
44813207	Two chambered right ventricle with ventricular septal defect above and below obstruction (disorder)	4180186
44813208	Able to use patient controlled analgesia device (finding)	4180186
44813209	Muscle flaccidity improving (finding)	4180186
44813212	[X]Other primarily systemic agents causing adverse effects in therapeutic use, not elsewhere classified (disorder)	4180186
44813214	[D]Physiological development failure (situation)	4180186
44813216	[D]Lack of growth (situation)	4180186
44813217	[D]Physical retardation (situation)	4180186
44813221	[D]Head and neck symptoms (situation)	4180186
44813223	[D]Throat discomfort	4180186
44813223	[D]Throat pain (situation)	4180186
44813225	[D]Intracranial lesion (situation)	4180186
44813229	Health of the nation outcome scale for older adults score (observable entity)	4180186
44813229	HoNOS65+ (health of the nation outcome scale for older adults) score	4180186
44813230	Haemodialysis anticoagulant infusion rate (observable entity)	4180186
44813231	Haemodialysis priming volume (observable entity)	4180186
44813234	[D]Epistaxis (situation)	4180186
44813234	[D]Nosebleed	4180186
44813236	[D]Choking sensation (situation)	4180186
44813237	[D]Mouth breathing (situation)	4180186
44813238	[D]Sneezing (situation)	4180186
44813239	[D]Palpitations (situation)	4180186
44813240	[D]Awareness of heart beat (situation)	4180186
44813241	[D]Functional heart bruit	4180186
44813241	[D]Functional heart murmur	4180186
44813241	[D]Functional systolic bruit	4180186
44813241	[D]Heart murmur, functional (situation)	4180186
44813242	[D]Heart murmur, innocent (situation)	4180186
44813244	[D]Shock without mention of trauma (situation)	4180186
44813245	Influenza A virus H1N1 subtype not detected (finding)	4180186
44813247	Wound dressing requested by accident and emergency service (situation)	4180186
44813248	Brief intervention for physical activity declined (situation)	4180186
44813250	Discussed with pharmacist (situation)	4180186
44813251	Referral to transient ischaemic attack clinic (procedure)	4180186
44813254	Intervention for risk to health associated with overweight and obesity, advice about diet and physical activity, consider drugs (regime/therapy)	4180186
44813255	Meets eligibility criteria for well-being assessment for long term conditions (finding)	4180186
44813258	Patient died in public place (finding)	4180186
44813259	Osmolar gap measurement (procedure)	4180186
44813260	Base excess measurement (procedure)	4180186
44813262	Provision of bariatric transport (procedure)	4180186
44813263	Advice about Healthy Start voucher scheme (procedure)	4180186
44813270	Consent given for influenza A subtype H1N1 vaccination (finding)	4180186
44813271	[D]Respiratory insufficiency (situation)	4180186
44813271	Respiratory insufficiency [D]	4180186
44813276	[D]Cough (situation)	4180186
44813277	[D]Cough with haemorrhage (situation)	4180186
44813278	[D]Abnormal sputum (situation)	4180186
44813280	[D]Precordial pain (situation)	4180186
44813283	[D]Chest tightness (situation)	4180186
44813285	[D]Chest swelling (situation)	4180186
44813286	[D]Chest mass (situation)	4180186
44813287	Vestibular disorders activities of daily living scale (assessment scale)	4180186
44813288	Nephropathy induced by aminoglycoside (disorder)	4180186
44813291	Screening method (record artifact)	4180186
44813297	Removal of permanent cardiac biventricular pacemaker using fluoroscopic guidance (procedure)	4180186
44813298	Thermoactinomyces thalophilus immunoglobulin G antibody level (procedure)	4180186
44813299	Connection of uterus to vagina (procedure)	4180186
44813302	Subject above age for reliable interpretation of test (finding)	4180186
44813303	History of autosomal dominant diabetes mellitus (situation)	4180186
44813305	Intrauterine system contraception leaflet given (situation)	4180186
44813306	Condom contraception leaflet given (situation)	4180186
44813307	CD45 count (procedure)	4180186
44813308	Concerned about heating home (finding)	4180186
44813309	Difficulty cooling home (finding)	4180186
44813313	Difficulty using personal computer (finding)	4180186
44813314	Application for disabled parking permit rejected (finding)	4180186
44813314	Blue Badge permit application rejected	4180186
44813315	Anti-TNF (tumour necrosis factor) drug monitoring	4180186
44813315	Anti-tumour necrosis factor drug monitoring (regime/therapy)	4180186
44813316	[X]Whooping cough, unspecified (disorder)	4180186
44813320	[X]Other preterm infants (disorder)	4180186
44813322	[X]Other single delivery by caesarean section (finding)	4180186
44813323	[X]Other specified disorders of the skin and subcutaneous tissue (disorder)	4180186
44813324	[X]Other manifestations of vitamin A deficiency (disorder)	4180186
44813325	Accident to glider in collision with other aircraft (event)	4180186
44813327	Referral to community ophthalmology service (procedure)	4180186
44813332	History of symptothermal method of contraception usage (situation)	4180186
44813332	H/O: STM (symptothermal method) of contraception usage	4180186
44813332	H/O: temperature method of contraception usage	4180186
44813333	Major complex surgery inpatient care plan (record artifact)	4180186
44813334	Education for care of next infant programme (procedure)	4180186
44813337	Intraocular pressure of right eye (observable entity)	4180186
44813340	Excluded from Summary Care Record (record artifact)	4180186
44813342	Poison management drugs Band 1 (procedure)	4180186
44813344	Target serum LDL (low density lipoprotein) cholesterol level	4180186
44813344	Target serum low density lipoprotein cholesterol level (observable entity)	4180186
44813345	Nonspecific genital infection (disorder)	4180186
44813346	[X]Cervical disc disorder, unspecified (disorder)	4180186
44813348	[V]Fitting or adjustment of artificial leg (situation)	4180186
44813351	[V]Chemoprophylaxis	4180186
44813351	[V]Other prophylactic chemotherapy (situation)	4180186
44813351	[V]Prophylactic antibiotic	4180186
44813352	[V]Birth - type	4180186
44813352	[V]Live birth	4180186
44813352	[V]Outcome of delivery (situation)	4180186
44813352	[V]Stillbirth	4180186
44813353	[M]Thecal cell neoplasm NOS (morphologic abnormality)	4180186
44813354	[X]Other disorders of sexual preference (disorder)	4180186
44813356	[V]Acquired absence of other organs (situation)	4180186
44813358	[V]Normal period	4180186
44813358	[V]Problem was normal state (situation)	4180186
44813359	[X]Other specified neurotic disorders (disorder)	4180186
44813360	[V]Screening for skin condition (situation)	4180186
44813361	[V]Presence of prosthetic heart valve (situation)	4180186
44813362	[V]Loss of love relationship in childhood (situation)	4180186
44813364	[M]Malignant lymphoma, small cell, non-cleaved, diffuse (morphologic abnormality)	4180186
44813365	[M]Cerebellar sarcoma NOS (morphologic abnormality)	4180186
44813367	[D]Incontinence of urine NOS (situation)	4180186
44813368	[Q] Spondyloptosis (qualifier value)	4180186
44813371	[V]Level 1 intensive care (maximal intensive care) administered to neonates (situation)	4180186
44813372	[V]Twin, born before admission to hospital, mate live born (situation)	4180186
44813374	[X]Unspecified occupant of all-terrain or other off-road motor vehicle injured in nontraffic accident (event)	4180186
44813375	[D]Pyrexia of unknown origin NOS (situation)	4180186
44813377	[V]Family history of mental abuse to sibling by family member (situation)	4180186
44813379	FRAX 10 year hip fracture probability score	4180186
44813379	Ten year hip fracture probability score using World Health Organisation FRAX fracture risk assessment tool (observable entity)	4180186
44813380	Weight management programme offered (situation)	4180186
44813383	National Health Service 111 Report (record artifact)	4180186
44813384	Receiving pension credit (finding)	4180186
44813385	Removal of female retropubic device (procedure)	4180186
44813386	High dependency nursing care management (procedure)	4180186
44813388	On examination visual acuity right eye = 6/10 (finding)	4180186
44813391	AHP (allied health professional) assessment record	4180186
44813391	Allied health professional assessment record (record artifact)	4180186
44813392	Common assessment framework assessment record (record artifact)	4180186
44813394	Co-dydramol measurement (procedure)	4180186
44813395	Cannabinoid screening test (procedure)	4180186
44813399	Revision of fusion and external fixation of joint (procedure)	4180186
44813400	Chronic obstructive pulmonary disease self-management plan review (procedure)	4180186
44813400	COPD (chronic obstructive pulmonary disease) self-management plan review	4180186
44813401	Common Assessment Framework for children and young people process completed for unborn child (finding)	4180186
44813403	Outpatient medical note (record artifact)	4180186
44813404	Cytomegalovirus immunoglobulin M antibody positive (finding)	4180186
44813407	Cockatiel faecal specific immunoglobulin G antibody measurement (procedure)	4180186
44813408	Hydroxyproline output measurement (procedure)	4180186
44813409	[V]Problems related to housing and economic circumstances (situation)	4180186
44813410	[X]Other abnormal findings in specimens from male genital organs (finding)	4180186
44813413	[X]Poisoning by other and unspecified hormones and synthetic substitutes (disorder)	4180186
44813416	[X]Additional digestive system disease classification terms (disorder)	4180186
44813418	[V]Pertussis vaccination (situation)	4180186
44813418	[V]Whooping cough vaccination	4180186
44813420	RAF (Royal Air Force) airframes mechanic	4180186
44813420	Royal Air Force airframes mechanic (occupation)	4180186
44813423	[X]Other pneumothorax (disorder)	4180186
44813424	Operator - Royal Artillery intelligence (occupation)	4180186
44813425	[V]Blood transfusion, without reported diagnosis (situation)	4180186
44813428	[X]Rifle, shotgun and larger firearm discharge, occurrence at home (event)	4180186
44813430	[M]Dermatofibrosarcoma NOS (morphologic abnormality)	4180186
44813431	[X]HIV disease resulting in other malignant neoplasms (disorder)	4180186
44813432	[X]Other specified zoonotic bacterial diseases, not elsewhere classified (disorder)	4180186
44813433	Road traffic act claim status (finding)	4180186
44813433	Road Traffic Act claim status (finding)	4180186
44813439	Consent given for follow-up evaluation after smoking cessation intervention (finding)	4180186
44813440	Heating appliance unsuitable for living environment (finding)	4180186
44813441	Insufficient income to heat home (finding)	4180186
44813442	No smoke alarm in home (finding)	4180186
44813443	Manages own finance using electronic banking (finding)	4180186
44813444	Subject of vulnerable adult abuse enquiry (finding)	4180186
44813445	Unable to change stoma bag (finding)	4180186
44813446	Gated computed tomography for complex congenital heart disease with contrast (procedure)	4180186
44813447	Non-invasive ventilation therapy review (regime/therapy)	4180186
44813449	Medical contraindication to ear syringing (situation)	4180186
44813454	Did not attend diabetes foot screening (finding)	4180186
44813454	DNA (did not attend) diabetes foot screening	4180186
44813457	[V]Singleton NOS (situation)	4180186
44813459	[V]Repeat prescription of oral contraceptive (situation)	4180186
44813461	[X]Inhalation and ingestion of other objects causing obstruction of respiratory tract (disorder)	4180186
44813462	[V]Well person screening	4180186
44813462	[V]Well persons examination, investigation and screening (situation)	4180186
44813463	[V]Normal care administered to neonates (situation)	4180186
44813465	[X]Varicose veins of other specified sites (disorder)	4180186
44813467	[X]Secondary parkinsonism, unspecified (disorder)	4180186
44813469	[X]Visual disturbances in diseases classified elsewhere (disorder)	4180186
44813471	[X]Zoonotic bacterial disease, unspecified (disorder)	4180186
44813475	[X]Other specified haemorrhagic conditions (disorder)	4180186
44813475	[X]Other specified hemorrhagic conditions	4180186
44813477	[M]Angiolipomatous neoplasm NOS (morphologic abnormality)	4180186
44813479	[M]Brenner tumors	4180186
44813479	[M]Brenner tumours (morphologic abnormality)	4180186
44813480	Cancellation of intrauterine contraceptive device claim (procedure)	4180186
44813480	Cancellation of IUD (intrauterine device) contraceptive claim	4180186
44813481	[X]Other multiple valve diseases (disorder)	4180186
44813482	[X]Injury of unspecified nerve at wrist and hand level (disorder)	4180186
44813483	[V]High-risk sexual behaviour (situation)	4180186
44813486	[X]Hemorrhage from other sites in respiratory passages (finding)	4180186
44813489	[M]Giant cell tumors	4180186
44813489	[M]Giant cell tumours (morphologic abnormality)	4180186
44813490	[X]Other specified injuries of shoulder and upper arm (disorder)	4180186
44813493	[X]Need for other prophylactic chemotherapy (situation)	4180186
44813494	[X]Bacterial infection, unspecified (disorder)	4180186
44813495	Mobility allowance claim report status (finding)	4180186
44813496	Diabetic dietary review (regime/therapy)	4180186
44813499	Recurrent major depressive episodes, in remission (disorder)	4180186
44813502	On examination - amputated right midfoot (finding)	4180186
44813503	Post exercise systolic blood pressure response abnormal (finding)	4180186
44813504	United Kingdom medical eligibility criteria for contraceptive use 2009 category 2 (finding)	4180186
44813506	Able to manage urostomy (finding)	4180186
44813510	Well driller - Royal Engineers (occupation)	4180186
44813511	Telecommunications technician - Royal Marines (occupation)	4180186
44813512	[X]Other disorders of the musculoskeletal system and connective tissue (disorder)	4180186
44813513	[X]Other specified noninflammatory disorders of vulva and perineum (disorder)	4180186
44813514	[X]Bipolar affective disorder, current episode severe depression without psychotic symptoms (disorder)	4180186
44813515	[X]Other neonatal aspiration syndromes (disorder)	4180186
44813516	[V]Observation for other specified condition (situation)	4180186
44813518	[X]Other androgenic alopecia (disorder)	4180186
44813519	[V]Problems with learning (situation)	4180186
44813520	[X]Unspecified complication of cardiac and vascular prosthetic device, implant and graft (disorder)	4180186
44813521	[V]Supervision of high-risk pregnancy due to social problems (situation)	4180186
44813525	Borders health board (environment)	4180186
44813528	Assertive outreach in mental health care - 1-2 contacts/week (procedure)	4180186
44813531	[X]Exposure to other pollution (situation)	4180186
44813535	[V]Supervision of very young primigravida (situation)	4180186
44813536	[V]Personal history of medical treatment non-compliance (situation)	4180186
44813538	[X]Other osteochondrodysplasia with defects of growth of tubular bones and spine (disorder)	4180186
44813539	[X]Routine general health check-up of other defined subpopulation (situation)	4180186
44813542	Isomaltose measurement (procedure)	4180186
44813544	Percutaneous nephrolithotomy using mobile image intensifier guidance (procedure)	4180186
44813546	BAAF (British Association for Adoption and Fostering) adult 2 fee to referral agency	4180186
44813546	British Association for Adoption and Fostering adult 2 fee to referral agency (finding)	4180186
44813548	Down's syndrome risk level calculation	4180186
44813548	Down syndrome risk level calculation (procedure)	4180186
44813550	TBI - toe brachial index	4180186
44813550	Toe brachial pressure index (observable entity)	4180186
44813553	Has shotgun certificate (finding)	4180186
44813559	Collection of device tip (procedure)	4180186
44813562	Referral for wheelchair assessment (procedure)	4180186
44813563	Breast screening disclaimer sent (finding)	4180186
44813567	Transluminal operation on internal mammary artery	4180186
44813567	Transluminal operation on internal thoracic artery (procedure)	4180186
44813568	[X]Streptococcus, group b, as the cause of diseases classified to other chapters (disorder)	4180186
44813570	[V]Family history of other malignant neoplasm (situation)	4180186
44813575	[X]Toxic effect of other organic solvents (disorder)	4180186
44813578	[X]Arthropathy in hypersensitivity reactions classified elsewhere (disorder)	4180186
44813580	[X]Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate (disorder)	4180186
44813580	[X]Fracture of bone following insertion of orthopedic implant, joint prosthesis, or bone plate	4180186
44813581	[V]Unspecified aftercare (situation)	4180186
44813584	GP31 claim status (finding)	4180186
44813586	[X]Other specified diseases of oesophagus (disorder)	4180186
44813588	[V]Screening for German measles	4180186
44813588	[V]Screening for rubella (situation)	4180186
44813589	[V]Check cystoscopy	4180186
44813589	[V]Cystoscopy normal (situation)	4180186
44813591	[D]Painful respiration NOS (situation)	4180186
44813592	[X]Other specified disorders of tympanic membrane (disorder)	4180186
44813595	[X]Other congenital malformations of renal artery (disorder)	4180186
44813597	[X]Septicemia due to other gram-negative organisms (disorder)	4180186
44813598	[X]Aortic aneurysm of unspecified site, nonruptured (disorder)	4180186
44813601	[V]Screening for depression (situation)	4180186
44813603	[V]Other mental problems (situation)	4180186
44813607	[M]Rhabdomyoma NOS (morphologic abnormality)	4180186
44813614	[D]Sphincter ani incontinence (situation)	4180186
44813615	[D]Stools bulky (situation)	4180186
44813616	[D]Change in bowel habit (situation)	4180186
44813618	[D]Urinary system symptoms (situation)	4180186
44813619	[D]Renal colic, unspecified (situation)	4180186
44813620	Procurator Fiscal report status (finding)	4180186
44813622	Mat B1 certificate due (finding)	4180186
44813623	Immunisation summary certificate fee paid (finding)	4180186
44813624	Mat B1 signed (finding)	4180186
44813625	[X]Other specified disorders of conjunctiva (disorder)	4180186
44813626	[V]Family history of deafness	4180186
44813626	[V]Family history of deafness or hearing loss (situation)	4180186
44813626	[V]Family history of hearing loss	4180186
44813627	[X]Other enthesopathy of foot (disorder)	4180186
44813628	[X]Other haemolytic diseases of fetus and newborn (disorder)	4180186
44813631	[V]Other multiple birth, mates stillborn, NOS (situation)	4180186
44813632	[X]Other problems related to care provider dependency (situation)	4180186
44813636	[D]Painful urination (situation)	4180186
44813637	[D]Retention of urine (situation)	4180186
44813638	[D]Clot retention of urine (situation)	4180186
44813641	Bisoprolol not indicated (situation)	4180186
44813644	Informing of patient care status (procedure)	4180186
44813645	Oral intake restriction (regime/therapy)	4180186
44813647	[D]Vesical pain (situation)	4180186
44813651	[D]Umbilical pain (situation)	4180186
44813652	[D]Suprapubic pain (situation)	4180186
44813654	[D]Groin pain (situation)	4180186
44813655	[D]Hepatomegaly (situation)	4180186
44813656	[D]Liver enlargement (situation)	4180186
44813659	Adenomatoid endometrial hyperplasia	4180186
44813659	Adenomatous endometrial hyperplasia (disorder)	4180186
44813659	Adenomatous hyperplasia of endometrium	4180186
44813666	Right superior vena cava connecting to coronary sinus and left sided atrium (disorder)	4180186
44813666	Right SVC (superior vena cava) connecting to coronary sinus and left-sided atrium	4180186
44813669	Diabetes clinic administration (record artifact)	4180186
44813670	Asthma clinic administration (record artifact)	4180186
44813672	Intracardiac location of anomalous pulmonary venous connection to midline with isomeric atrium (disorder)	4180186
44813673	Staff administration (record artifact)	4180186
44813674	Seniority payment administration (record artifact)	4180186
44813675	Training/seniority/leave administration (record artifact)	4180186
44813676	Training administration (record artifact)	4180186
44813677	Call administration - general	4180186
44813677	Patient call administration (record artifact)	4180186
44813679	[X]Other congenital malformations of cardiac chambers and connections (disorder)	4180186
44813680	[V]Other behavioural problems (situation)	4180186
44813682	[X]Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours (disorder)	4180186
44813683	[M] Myofibromatosis (morphologic abnormality)	4180186
44813684	[V]Divorce	4180186
44813684	[V]Estrangement	4180186
44813684	[V]Family disruption (situation)	4180186
44813690	[D]Alcohol blood level excessive (situation)	4180186
44813691	[D]Acid phosphatase raised (situation)	4180186
44813692	[D]Amylase, serum level raised (situation)	4180186
44813696	[D]Mineral, blood level abnormal (situation)	4180186
44813698	[D]Abnormality of alpha-fetoprotein (situation)	4180186
44813699	[D]Raised antibody titre (situation)	4180186
44813700	Brief intervention for physical activity offered (situation)	4180186
44813701	New sexual partner (finding)	4180186
44813708	[D]Abnormal cytological findings in cerebrospinal fluid (situation)	4180186
44813709	[D]Fat in stool (situation)	4180186
44813710	[D]Mucus in stool (situation)	4180186
44813713	Referral to minor surgery special interest general practitioner (procedure)	4180186
44813717	PULHHEEMS - L1R (finding)	4180186
44813718	Laser excision of lesion of organ NOC (procedure)	4180186
44813720	Person granted indefinite leave to remain in United Kingdom (person)	4180186
44813720	Person granted United Kingdom residency	4180186
44813721	Seat belt exemption administration (record artifact)	4180186
44813726	Notification administration (record artifact)	4180186
44813727	Factory inspection notification administration (record artifact)	4180186
44813731	Changes since last communication originator and recipient (record artifact)	4180186
44813732	[X]Other specified inflammation of vagina and vulva (disorder)	4180186
44813734	[X]Dissociative [conversion] disorders (disorder)	4180186
44813741	National Health Service Health Check completed (situation)	4180186
44813742	National Health Service Health Check telephone invitation (procedure)	4180186
44813743	Townes-Brocks syndrome (disorder)	4180186
44813744	Arteriovenous graft failure (disorder)	4180186
44813745	Catheter contaminated (finding)	4180186
44813748	Advice on pneumococcal vaccination (procedure)	4180186
44813752	Preferred place of death: residential home (finding)	4180186
44813753	Family history of lymphoedema (situation)	4180186
44813754	Referral to podiatric surgeon (procedure)	4180186
44813755	[D]Other imaging abnormality (situation)	4180186
44813756	[D]Nonspecific abnormal function studies (situation)	4180186
44813757	[D]Echoencephalogram abnormal (situation)	4180186
44813758	[D]Brain scan abnormal (situation)	4180186
44813759	[D]Peripheral nervous system or special sense function abnormal (situation)	4180186
44813762	[D]Auditory function studies abnormal (situation)	4180186
44813766	History (qualifier value)	4180186
44813767	Past actions (record artifact)	4180186
44813768	Excepted from smoking quality indicators - patient unsuitable (finding)	4180186
44813771	Excepted from asthma quality indicators - patient unsuitable (finding)	4180186
44813775	Child psychiatry service (qualifier value)	4180186
44813777	Programmed pulmonary rehabilitation service (qualifier value)	4180186
44813778	Medical physics (qualifier value)	4180186
44813779	Endocrinology and diabetes (qualifier value)	4180186
44813780	Oral microbiology (qualifier value)	4180186
44813781	Fluoroscopy guided trans-arterial hepatic radioembolisation using yttrium-90 microspheres (procedure)	4180186
44813782	Computed tomography arthrography of temporomandibular joint with contrast (procedure)	4180186
44813782	CT arthrogram of temporomandibular joint with contrast	4180186
44813786	Application of antimicrobial dressing (procedure)	4180186
44813788	National Health Service Health Check completed by third party (situation)	4180186
44813790	Acute renal failure induced by non-steroidal anti-inflammatory drug (disorder)	4180186
44813791	Paroxysmal nocturnal haemoglobinuria screening test (procedure)	4180186
44813791	PNH (paroxysmal nocturnal haemoglobinuria) screening test	4180186
44813793	Dust mix RAST test	4180186
44813793	Dust mix specific immunoglobulin E antibody measurement (procedure)	4180186
44813795	Disodium etidronate declined (situation)	4180186
44813796	DBC - Developmental behaviour checklist	4180186
44813796	Developmental behaviour checklist (assessment scale)	4180186
44813797	Sheffield learning disabilities outcome measure (assessment scale)	4180186
44813797	SLDOM - Sheffield learning disabilities outcome measure	4180186
44813802	Thrombosis of stent of renal artery (disorder)	4180186
44813803	Measurement of interferon gamma (procedure)	4180186
44813809	Subcranial U-osteotomy of bones of face and translocation of orbit (procedure)	4180186
44813810	Health of the Nation Outcome Scale-secure: Rating scale (assessment scale)	4180186
44813810	HoNOS (Health of the Nation Outcome Scale)-secure: Rating scale	4180186
44813812	Female genital mutilation type IV - World Health Organisation classification (disorder)	4180186
44813813	Chronic kidney disease laboratory study (procedure)	4180186
44813815	Obtaining consent for clinical photography for publication (procedure)	4180186
44813817	Measurement of glutathione peroxidase activity (procedure)	4180186
44813821	Colonoscopy report received (finding)	4180186
44813822	Lives with biological parents (finding)	4180186
44813823	Occlusion of radial artery (disorder)	4180186
44813824	Timed sample series (finding)	4180186
44813827	Seen by specialty trainee doctor (finding)	4180186
44813828	Under care of oncologist (finding)	4180186
44813829	Referral for fundoscopy (procedure)	4180186
44813830	Endoscopic retrograde cholangiopancreatography with insertion of drain into pseudocyst of pancreas using fluoroscopic guidance (procedure)	4180186
44813832	Referral to dose adjustment for normal eating diabetes structured education programme declined (situation)	4180186
44813833	FP1003 status (finding)	4180186
44813834	Immunisation course (non-Family Practitioner Committee) fee due (finding)	4180186
44813834	Immunisation course non-FPC (family practitioner committee) fee due	4180186
44813835	FP74 sent to family practitioner committee (finding)	4180186
44813837	Posterior tibial tendon insufficiency (disorder)	4180186
44813841	Paediatric inpatient care plan (record artifact)	4180186
44813842	Primary repair epigastric hernia with prosthesis (procedure)	4180186
44813843	Participates in Butterfly Scheme for dementia (finding)	4180186
44813847	Weight-related symptom measure score (observable entity)	4180186
44813847	WRSM (weight-related symptom measure) score	4180186
44813850	Amygdalohippocampectomy (procedure)	4180186
44813851	History of trichomoniasis (situation)	4180186
44813858	Care planning health objectives simple reference set (foundation metadata concept)	4180186
44813859	Care planning record types simple reference set (foundation metadata concept)	4180186
44813861	Ambulance request type simple reference set (foundation metadata concept)	4180186
44813862	National Health Service continuing healthcare respond to document type simple reference set (foundation metadata concept)	4180186
44813862	NHS CHC (continuing healthcare) respond to document type simple reference set	4180186
44813863	Ultrasonography of vocal cord (procedure)	4180186
44813863	Ultrasound scan of vocal cord	4180186
44813867	Target forced expired volume in 1 second (observable entity)	4180186
44813868	Minimum body temperature (observable entity)	4180186
44813869	Maximum peripheral oxygen saturation (observable entity)	4180186
44813870	Minimum peak flow rate (observable entity)	4180186
44813871	Traumatic dislocation of metatarsophalangeal joint (disorder)	4180186
44813872	Traumatic dislocation of navicular bone (disorder)	4180186
44813873	BAAF (British Association for Adoption and Fostering) B1 obstetric report sent	4180186
44813873	British Association for Adoption and Fostering B1 obstetric report sent (finding)	4180186
44813876	Not eligible for National Health Service continuing healthcare (finding)	4180186
44813879	Dabigatran declined (situation)	4180186
44813882	Revision of breast reduction (procedure)	4180186
44813886	Cervical smear screening invitation third short message service text (procedure)	4180186
44813886	Cervical smear screening invitation third SMS (short message service) text	4180186
44813886	Cervical smear screening invitation third text message	4180186
44813891	Discharge from cancer primary healthcare multidisciplinary team (procedure)	4180186
44813893	Active range of right shoulder adduction (observable entity)	4180186
44813894	Medical Research Council muscle power score of left wrist adduction (observable entity)	4180186
44813895	British Association for Adoption and Fostering B1 fee sent to social services (finding)	4180186
44813904	Open extended right hemicolectomy (procedure)	4180186
44813906	Under care of health visiting service - Universal plus (finding)	4180186
44813907	Provision of written information about exercise (procedure)	4180186
44813909	Paediatric audiological medicine service (qualifier value)	4180186
44813912	111 contact disposition to mental health service (finding)	4180186
44813914	Bowel scope (flexible sigmoidoscopy) screen: minor polyps removed - no follow up required (finding)	4180186
44813919	Child and Adolescent Mental Health Service return appointment cancelled by clinician (finding)	4180186
44813922	Postcoital intrauterine contraceptive device offered (finding)	4180186
44813927	Vagal nerve stimulator in situ (finding)	4180186
44813928	Lives on boat (finding)	4180186
44813929	Incorrect treatment due to missed communication (finding)	4180186
44813931	Pertussis vaccination in pregnancy declined (situation)	4180186
44813932	Ultrasonography surveillance check post-endovascular aneurysm repair (procedure)	4180186
44813932	US (ultrasound scan) checking post-EVAR (endovascular aneurysm repair)	4180186
44813933	Cone beam computed tomography of maxilla (procedure)	4180186
44813934	Inadequate oral fluid intake for physiological needs	4180186
44813934	Inadequate oral fluid intake for physiological needs (finding)	4180186
44813937	DoloTest Profile (observable entity)	4180186
44813939	GULP (gauge, urine, look, plan) Dehydration Risk Screening Tool score (observable entity)	4180186
44813940	Advice to apply for prescription prepayment certificate	4180186
44813940	Recommendation to apply for prescription prepayment certificate (procedure)	4180186
44813941	Conversion from total prosthetic replacement of ankle joint (procedure)	4180186
44813944	Vitamin D insufficiency (disorder)	4180186
44813946	Excessive dietary intake of selenium (finding)	4180186
44813947	Referral to falls service declined (situation)	4180186
44813951	Discharge details (record artifact)	4180186
44813952	Clinical risk assessment (record artifact)	4180186
44813955	Substance misuse monitoring 6 month review (regime/therapy)	4180186
44813957	No family history of squamous cell carcinoma of skin (situation)	4180186
44813960	Left ankle reflex exaggerated (finding)	4180186
44813964	Laparoscopic hysterosacropexy (procedure)	4180186
44813967	Herpes zoster vaccination declined (situation)	4180186
44813969	Rotavirus vaccination given by other health care provider (finding)	4180186
44813970	Rotavirus vaccination declined (situation)	4180186
44813975	Osteoarthritis of ankle secondary to inflammatory arthritis (disorder)	4180186
44813977	Administration of glyceryl trinitrate (procedure)	4180186
44813978	Percutaneous embolisation of lesion of abdomen using fluoroscopic guidance with contrast (procedure)	4180186
44813982	Denosumab therapy (procedure)	4180186
44813983	Right Hoffman reflex negative (finding)	4180186
44813988	Assessment using HCL-32-R1(hypomania checklist 32 item revised)	4180186
44813988	Assessment using hypomania checklist 32 item revised (procedure)	4180186
44813990	Bisphosphonate holiday	4180186
44813990	Bisphosphonate prophylaxis suspended (situation)	4180186
44813993	School entrant hearing screening incomplete - out of screening coverage (situation)	4180186
44813994	School entrant hearing screening incomplete - late entry (situation)	4180186
44813995	Health Plan Indicator (National Health Service Scotland) - additional, high risk (finding)	4180186
44813999	Difficulty obtaining water (finding)	4180186
44814001	On examination left brachial pulse absent (finding)	4180186
44814005	Power of right myotome of first thoracic nerve (observable entity)	4180186
44814006	Uses guide dog for the blind (finding)	4180186
44814011	Number of hours respite care allocated per month (observable entity)	4180186
44814012	[V]Liver donor (situation)	4180186
44814013	Shared family assessment completed (finding)	4180186
44814014	Assessment using Paediatric Early Warning Score (procedure)	4180186
44814014	Assessment using PEWS (Paediatric Early Warning Score)	4180186
44814016	Inadequate dietary intake of phosphorus (finding)	4180186
44814017	Declined consent to leave telephone message with specified third party (finding)	4180186
44814023	Pulmonary arterial hypertension drugs Band 3 (procedure)	4180186
44814024	Medical oncology service (qualifier value)	4180186
44814025	Interventional radiology service (qualifier value)	4180186
44814030	Discussion about resuscitation (procedure)	4180186
44814035	Disorder of sesamoid bone of foot (disorder)	4180186
44814038	Suspected victim of child sexual abuse (situation)	4180186
44814040	Clinical genetics service (qualifier value)	4180186
44814043	Bupa Health Dialog risk stratification tool score (observable entity)	4180186
44814046	Computed tomography angiography of vessels of abdominal wall (procedure)	4180186
44814048	Respiratory physiology service (qualifier value)	4180186
44814050	Paediatric epilepsy service (qualifier value)	4180186
44814051	Measurement of ratio of 5-hydroxyindoleacetic acid to creatinine in urine specimen (procedure)	4180186
44814051	Urine 5-hydroxyindoleacetic acid:creatinine ratio	4180186
44814052	Measurement of concentration of morphine in urine specimen (procedure)	4180186
44814052	Urine morphine concentration	4180186
44814053	NOAC (novel oral anticoagulant) not indicated	4180186
44814053	Novel oral anticoagulant not indicated (situation)	4180186
44814055	SSLM - Sure Start Language Measure	4180186
44814055	Sure Start Language Measure (assessment scale)	4180186
44814056	SSLM-R - Sure Start Language Measure, revised	4180186
44814056	Sure Start Language Measure, revised (assessment scale)	4180186
44814057	Irish - ethnic category 2001 census (finding)	4180186
44814059	Referral to cardiac device service (procedure)	4180186
44814061	Predicted excessive dietary vitamin intake (finding)	4180186
44814063	Paraneoplastic arthritis (disorder)	4180186
44814064	Systemic lupus erythematosus/Sjogren's overlap syndrome (disorder)	4180186
44814072	Tendon injury associated with fracture dislocation (disorder)	4180186
44814074	Open repair of obstructed ventral hernia (procedure)	4180186
44814076	Primary repair of paraumbilical hernia with prosthesis (procedure)	4180186
44814077	Displacement of vocal cord with non-biological graft (procedure)	4180186
44814078	Ten year osteoporotic fracture probability score using World Health Organisation FRAX fracture risk assessment tool with body mass index (observable entity)	4180186
44814082	Breastfeeding support declined (situation)	4180186
44814085	Injury of muscle of rotator cuff of shoulder (disorder)	4180186
44814086	Operating theatre patient checklist (record artifact)	4180186
44814087	Discharge letter (record artifact)	4180186
44814088	Referral to general practitioner assessment unit (procedure)	4180186
44814089	Insertion of internal distraction device into skull (procedure)	4180186
44814093	Right posterior tibial pulse palpable (finding)	4180186
44814095	Human T-lymphotropic virus nucleic acid detection assay (procedure)	4180186
44814098	Conversion from total prosthetic replacement of elbow joint (procedure)	4180186
44814099	Health promotion clinic due date (observable entity)	4180186
44814101	Home telephone number of informal carer (observable entity)	4180186
44814103	Passive range of left knee extension (observable entity)	4180186
44814105	Passive range of left ankle flexion (observable entity)	4180186
44814107	Active range of left ankle inversion (observable entity)	4180186
44814108	Cholinesterase immunoglobulin G antibody measurement (procedure)	4180186
44814111	Assessment using safeguarding children and young people toolkit for general practice (2009 revision) (procedure)	4180186
44814115	Reviewed by advanced primary nurse (procedure)	4180186
44814116	Referred by secondary care (finding)	4180186
44814118	FP24A maternity claim sent to family practitioner committee (finding)	4180186
44814120	Perioperative care management (procedure)	4180186
44814122	Right posterior tibial pulse triphasic (finding)	4180186
44814125	GP/UMS payments started (finding)	4180186
44814126	FP81 night visit claim signed (finding)	4180186
44814129	Referral cancelled by general practitioner (finding)	4180186
44814130	Amphetamine screening test (procedure)	4180186
44814134	Cytoplasmic CD71 count (procedure)	4180186
44814136	Lymphocyte antigen CD13 (substance)	4180186
44814143	GMS4 claim - immunisation (Rate A) signed (finding)	4180186
44814146	Absence of signs and symptoms of wound infection (situation)	4180186
44814147	Carrier of Connexin 26 gene mutation (finding)	4180186
44814149	Cavity shave of breast for clearance of tumour margins (procedure)	4180186
44814150	Medical Research Council muscle power score of elbow flexion (observable entity)	4180186
44814152	Referred by nursing home (finding)	4180186
44814157	Percutaneous transluminal embolisation of cerebral aneurysm using fluoroscopic guidance with contrast (procedure)	4180186
44814157	Percutaneous transluminal embolisation of cerebral aneurysm using fluoroscopic guidance with contrast	4180186
44814159	Paediatric transplantation surgery (qualifier value)	4180186
44814160	Stroke medicine (qualifier value)	4180186
44814161	Dispensing optometry service (qualifier value)	4180186
44814163	Measurement of abacavir (procedure)	4180186
44814167	Post-traumatic stress disorder impact of events scale (assessment scale)	4180186
44814168	Ibandronic acid declined (situation)	4180186
44814169	Did not attend letter (record artifact)	4180186
44814169	DNA (did not attend) letter	4180186
44814172	Measurement of concentration of sirolimus in whole blood specimen (procedure)	4180186
44814172	Whole blood sirolimus concentration	4180186
44816524	Chemistry; dimethyl acetal palmitic; DMA 16:0; DMA C16:0; Fib; Fibr; i; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44816524	DMA 16:0 Fib-mCnt	4180186
44816524	1,1-二甲氧基十六烷:质量含量:时间点:成纤维细胞:定量型	4182948
44816525	DMA 16:0 RBC-sCnt	4180186
44816525	Chemistry; dimethyl acetal palmitic; DMA 16:0; DMA C16:0; Erythrocytes; i; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance content	4180186
44816525	1,1-二甲氧基十六烷:物质的量含量:时间点:红细胞:定量型	4182948
44816526	Adipylcarnitine; Blood; C6DC; C6-DC; Chemistry; DBS; Dicarboxylic carnitine; Dried blood spot; Filter paper; FP; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
44816526	Adipoylcarn DBS-sCnc	4180186
44816526	已二酰肉碱 (C6-DC):物质的量浓度:时间点:全血.斑点:定量型	4182948
44816528	Malonyl+3OHbutyrylcarn SerPl-sCnc	4180186
44816528	3-Hydroxy butyrylcarnitine; 3-hydroxybutylcarnitine; 3-hydroxy-butylcarnitine; 3OH-Butyrcarn; C3DC; C3-DC; C3DC+C4OH; C3-DC+C4-OH; C4OH; C4-OH; Chemistry; Dicarboxylic carnitine; III; Level; Malonyl+3OHbutyrylcarn; nonderivatized; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; underivatized	4180186
44816528	丙二酰肉碱 (C3-DC)+3-羟基异丁酰肉碱 (C4-OH):物质的量浓度:时间点:血清/血浆:定量型	4182948
44816529	1 day; 24 hours; 24HR; Chemistry; CR; Crea; Creat; GAG; GAGS; Glycosaminoglycan; MPS; Mucopolysaccharides; Mucopolysach; QNT; Quan; Quant; Quantitative; Ratios; Rto; UA; UCr; UR; Urn	4180186
44816529	GAG/Creat 24h Ur-Rto	4180186
44816529	粘多糖/肌酐:比率:24小时:尿液:定量型	4182948
44816530	GAG 24h Ur Ql	4180186
44816530	1 day; 24 hours; 24HR; Chemistry; GAG; GAGS; Glycosaminoglycan; MPS; Mucopolysaccharides; Mucopolysach; Ordinal; PR; QL; Qual; Qualitative; Screen; UA; UR; Urn	4180186
44816530	粘多糖:存在情况或阈值:24小时:尿液:序数型	4182948
44816531	DMA Pnl Fib	4180186
44816531	Chemistry; Dimethyl acetal; DMA Pnl; Fib; Fibr; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random	4180186
44816531	二甲基乙缩醛组套:-:时间点:成纤维细胞:-	4182948
44816532	Chemistry; Dimethyl acetal; DMA Pnl; Erythrocytes; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Red blood cells; Red blood corpusles	4180186
44816532	DMA Pnl RBC	4180186
44816532	二甲基乙缩醛组套:-:时间点:红细胞:-	4182948
44816535	1 day; 24 hours; 24HR; Bands; bnd; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; II; Kidney; M Protein; M Protein 2; Mass Rate; M-band; Monoclonal band; Monoclonal spike; M-protein; mRate; M-spike; Nephrology; Para protein; Paraprotein; PEUR; PR; Prot; QNT; Quan; Quant; Quantitative; Renal; UA; UPEP; UR; Urn	4180186
44816535	M Protein 2 24h Ur Elph-mRate	4180186
44816535	蛋白质.单克隆型 区带 2:质量速率:24小时:尿液:定量型:电泳	4182948
44816536	AE1 Anion Exchanger; Bands; bnd; Chemistry; Hematology; Heme; Identity or presence; IFE; Ifix; III; Immunofixation electrophoresis; Monoclon Band 3 Obs; Nominal; Point in time; Random; UA; UR; Urn	4180186
44816536	Monoclon Band 3 Obs Ur IFE	4180186
44816536	已观察到的单克隆区带 3:存在与否或特征标识:时间点:尿液:名义型:免疫固定电泳分析法	4182948
44816541	Arom Solvents Ur Ql	4180186
44816541	Arom Solvents; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
44816541	芳香族溶剂:存在情况或阈值:时间点:尿液:序数型	4182948
44816542	Addiction; Anexsia; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dihydrocodeinone; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen; Vicodin	4180186
44816542	HYDROcodone Sal Ql Cfm	4180186
44816542	氢可酮:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816545	Addiction; Blood; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; MDA; Methylenedioxymethamphetamine metabolite; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
44816545	MDA SerPlBld-mCnc	4180186
44816545	亚甲基二氧苯丙胺:质量浓度:时间点:血清/血浆/全血:定量型	4182948
44816549	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; GCMS; Illicit; Level; Mass concentration; MDMA; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
44816549	MDMA Sal Cfm-mCnc	4180186
44816549	亚甲基二氧甲基苯丙胺:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
44816551	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; GCMS; Illicit; MDMA; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
44816551	MDMA Sal Ql Cfm	4180186
44816551	亚甲基二氧甲基苯丙胺:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816554	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Heroin; Illicit; OP; Opi; Opiate; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
44816554	Opiates Sal Ql Cfm	4180186
44816554	阿片制剂:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816555	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Lortab; Oral fluid; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen; Vicodin	4180186
44816555	oxyCODONE Sal Ql Cfm	4180186
44816555	羟考酮:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816556	14-Hydroxydihydromorphinone; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Lortab; Numorphan; Numorphone; Opana; Oral fluid; Ordinal; OxyContin; Percocet; Percodan; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen; Vicodin	4180186
44816556	oxyCODONE+oxyMORphone Sal Ql Cfm	4180186
44816556	羟考酮+羟吗啡酮:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816557	14-Hydroxydihydromorphinone; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Numorphan; Numorphone; Opana; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
44816557	oxyMORphone Sal Ql Cfm	4180186
44816557	羟吗啡酮:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
44816559	Binge drinking; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Peth; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
44816559	Peth Bld-mCnc	4180186
44816559	磷脂酰乙醇:质量浓度:时间点:全血:定量型	4182948
44816561	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonata; Starnoc; UA; UR; Urn	4180186
44816561	Zaleplon Ur-mCnc	4180186
44816561	扎来普隆:质量浓度:时间点:尿液:定量型	4182948
44816565	3 Self-Sustaining Sequence Replication; 3SR SR; A vaginae; A vaginae DNA; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid; Viral load	4180186
44816565	A vaginae DNA Vag NAA+probe-Log#	4180186
44816565	阴道阿托波氏菌 DNA:对数型数量或计数浓度:时间点:阴道:定量型:探针法.基因扩增.靶向	4182948
44816566	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; G vaginalis; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid; Viral load	4180186
44816566	G vaginalis DNA Vag NAA+probe-Log#	4180186
44816566	阴道加德纳菌 DNA:对数型数量或计数浓度:时间点:阴道:定量型:探针法.基因扩增.靶向	4182948
44816567	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; Lacto sp DNA; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid; Viral load	4180186
44816567	Lactobacillus DNA Vag NAA+probe-Log#	4180186
44816567	乳杆菌属单个未知种 DNA:对数型数量或计数浓度:时间点:阴道:定量型:探针法.基因扩增.靶向	4182948
44816570	Addiction; Carisoma; Carisoprodol metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Equanil; Flexartal; Illicit; Isopropylmeprobamate; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Rela; Sanoma; Soma; Somadril; Somalgit; UA; UR; Urn	4180186
44816570	Carisoprodol+Meprob Ur-mCnc	4180186
44816570	异丙基甲丁双脲+氨甲丙二酯:质量浓度:时间点:尿液:定量型	4182948
44816581	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Ethanol metabolite; ethyl hydrogen sulfate; GCMS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SO4; SO4-2; Sulf; Sulfovinate; Sulfovinic acid; UA; UR; Urn	4180186
44816581	Ethyl sulfate Ur Ql Cfm	4180186
44816581	硫酸乙酯:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
44816582	After; Carbonic anhydride; cCO2; Chemistry; CO2; CO2 TOTAL; CO2CT; ctCO2; Dialy; Level; p dialysis; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; tCO2	4180186
44816582	CO2 p dialysis SerPl-sCnc	4180186
44816582	二氧化碳^在透析之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816585	Glucose 12h Ur-sCnc	4180186
44816585	12 hours; 12HR; Chemistry; Glu; Gluc; Glucoseur; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
44816585	葡萄糖:物质的量浓度:12小时:尿液:定量型	4182948
44816594	12 hours; 12HR; Chemistry; Level; MAG; Magnes; Mg; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
44816594	Magnesium 12h Ur-sCnc	4180186
44816594	镁:物质的量浓度:12小时:尿液:定量型	4182948
44816595	Addiction; Campral; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; N-acetyl homotaurine; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816595	Acampro SerPl-mCnc	4180186
44816595	阿坎酸:质量浓度:时间点:血清/血浆:定量型	4182948
44816598	Agency for Healthcare Research and Quality; Nominal; Point in time; Random; Survey; SURVEY.AHRQ; Typ	4180186
44816600	Agency for Healthcare Research and Quality; Nominal; Point in time; Random; Survey; SURVEY.AHRQ; Typ	4180186
44816604	Agency for Healthcare Research and Quality; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.AHRQ	4180186
44816606	Agency for Healthcare Research and Quality; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.AHRQ	4180186
44816607	Agency for Healthcare Research and Quality; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.AHRQ	4180186
44816609	Ident; Identifier; Nominal; Point in time; Random; UDI	4180186
44816609	UDI	4180186
44816609	唯一性装置标识符:标识符:时间点:{装置}:名义型	4182948
44816611	Nominal; Other UDI; Othr; Point in time; Random; Typ	4180186
44816611	Other UDI [Type]	4180186
44816611	其他唯一性产品标识符:类型:时间点:{装置}:名义型	4182948
44816614	Ident; Identifier; Nominal; Point in time; Random	4180186
44816614	厂商固件版本:标识符:时间点:{装置}:名义型	4182948
44816621	Agency for Healthcare Research and Quality; Nominal; Point in time; Pt safety event; Random; Survey; SURVEY.AHRQ; Typ	4180186
44816622	Agency for Healthcare Research and Quality; Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.AHRQ	4180186
44816624	Other UDI	4180186
44816624	Ident; Identifier; Nominal; Other UDI; Othr; Point in time; Random	4180186
44816624	其他唯一性产品标识符:标识符:时间点:{装置}:名义型	4182948
44816626	Vitals+wt+ht+OFC+ox+BMI+BSA Pnl CCDAr1.1	4180186
44816626	CCDA; Consolidated CDA; Girth; HC; Pan; PANEL.VITAL SIGNS; Panl; Pnl; Point in time; Random; Vital sign result value set; Vitals+wt+ht+OFC+ox+BMI+BSA Pnl; Wt	4180186
44816626	生命体征、体重、身高、头围、体质指数及 BSA 组套:-:时间点:^患者:-:HL7.CCDAr1.1	4182948
44816629	Bact; Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; GP bact; GP bact identified; ID; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Isolated; Microbiology; Nominal; Point in time; Pos; Prb Mag; Random; WB; Whole blood	4180186
44816629	Deprecated GP bact Bld Pos Prb Mag-Imp	4180186
44816630	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Listeria sp tuf; Listeriosis; Microbiology; Ordinal; Point in time; PR; Prb Mag; Ql; Qual; Qualitative; Random; Screen; species; spp; WB; Whole blood	4180186
44816630	Deprecated Listeria sp tuf Bld Pos Ql Prb Mag	4180186
44816635	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PR; Prb Mag; Ql; Qual; Qualitative; Random; S pneumo; S pneumoniae; Screen; Spn; Strep; Strept; WB; Whole blood	4180186
44816635	Deprecated S pneumoniae gryB Bld Pos Ql Prb Mag	4180186
44816636	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Prb Mag; Ql; Qual; Qualitative; Random; S anginosus grp; S anginosus gryB; S. anginosus; S. milleri group; Screen; Strep; Strep anginosus; Strept; WB; Whole blood	4180186
44816636	Deprecated S anginosus gryB Bld Pos Ql Prb Mag	4180186
44816637	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; GBS; Gp B Strep; Group B; Group B Strep; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Prb Mag; Ql; Qual; Qualitative; Random; S agalactiae; Screen; Steptococcus Group B; Strep; Strep B; Strep group B; Strept; Streptococci group B; WB; Whole blood	4180186
44816637	Deprecated S agalactiae hsp60 Bld Pos Ql Prb Mag	4180186
44816640	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bld Pos; Blood; c162; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Ordinal; Point in time; PR; Prb Mag; Ql; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; VANC; Vancocin; Vancomycin resistance gene; Vancor; WB; Whole blood	4180186
44816640	Deprecated vanA Bld Pos Ql Prb Mag	4180186
44816642	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Prb Mag; Ql; Qual; Qualitative; Random; Screen; Staph; WB; Whole blood	4180186
44816642	Deprecated S lugdunensis sodA Bld Pos Ql Prb Mag	4180186
44816644	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; Prb Mag; Ql; Qual; Qualitative; Random; S epidermidis; Screen; Staph; Staph epi; WB; Whole blood	4180186
44816644	Deprecated S epidermidis hsp60 Bld Pos Ql Prb Mag	4180186
44816648	Blood; Cleaved; Cleft Lymphs; fissured; HEMATOLOGY/CELL COUNTS; LM; Lymp; Lymph; Lympho; Lymphocyte; Lymphocytes.fissured; Lymphs; Lymphs%; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
44816648	Cleft Lymphs Bld/T Ql Micro	4180186
44816648	淋巴细胞.裂缝:存在情况或阈值:时间点:全血/组织:序数型:显微镜检查.光学	4182948
44816649	Collect Tme Ur	4180186
44816649	Coll; Collect; Collect Tme; Collected; Date and time; Point in time; QNT; Quan; Quant; Quantitative; Random; SPEC; Time stamp; Timestamp; UA; UR; Urn	4180186
44816649	采集时间:时间戳:时间点:尿液:定量型	4182948
44816651	Antigens Present Bld IAT	4180186
44816651	Ag; Antiglob; Blood; BLOOD BANK; IAT; Identity or presence; Ind; Indir; Nominal; Point in time; Random; WB; Whole blood	4180186
44816651	存在血型抗原:存在与否或特征标识:时间点:全血:名义型:间接抗球蛋白试验	4182948
44816653	Chemistry; Fac; Fact; Level; Mass concentration; PIGF; Placent; Placenta; Placntl; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
44816653	PIGF Ser-mCnc	4180186
44816653	胎盘生长因子:质量浓度:时间点:血清:定量型	4182948
44816654	sFlt-1 Ser-mCnc	4180186
44816654	Chemistry; i; Level; Mass concentration; PIGF; Point in time; Preeclampsia; QNT; Quan; Quant; Quantitative; Random; Serum; sFlt-1; SR; Tyr	4180186
44816654	可溶性 fms 样酪氨酸激酶-1:质量浓度:时间点:血清:定量型	4182948
44816655	Chemistry; Fac; Fact; i; PIGF; PIGF d; Placent; Placenta; Placntl; Point in time; Preeclampsia; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Serum; sFlt-1; SR; Tyr	4180186
44816655	sFlt-1/PIGF d Ser-Rto	4180186
44816655	可溶性 fms 样酪氨酸激酶-1/胎盘生长因子:比率:时间点:血清:定量型	4182948
44816657	Gram Stn; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; St; Stains; Stn; To be specified in another part of the message; Unspecified	4180186
44816657	Yeast Spec Ql Gram Stn	4180186
44816657	酵母:存在情况或阈值:时间点:XXX:序数型:革兰氏染色法	4182948
44816658	HYDROcodone + metabs Pnl Ur Cfm	4180186
44816658	Anexsia; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dihydrocodeinone; DRUG/TOXICOLOGY; Drugs; GCMS; HYDROcodone + metabs Pnl; Metabolite; Metb; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UR; Urn; Vicodin	4180186
44816658	氢可酮与代谢产物组套:-:时间点:尿液:-:毒理学确认试验	4182948
44816660	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital vaginal; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vag fld; Vag fluid; Vagina; Vaginal fluid; Viral load	4180186
44816660	Megasphaera sp DNA Vag NAA+probe-Log#	4180186
44816660	巨球形菌属单个未知种 DNA:对数型数量或计数浓度:时间点:阴道:定量型:探针法.基因扩增.靶向	4182948
44816662	sFlt1PIGF Pnl SerPl	4180186
44816662	Chemistry; Fac; Fact; i; Pan; PANEL.CHEMISTRY; Panl; PIGF; Pl; Placent; Placenta; Placntl; Plasma; Plsm; Pnl; Point in time; Preeclampsia; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sFlt-1; sFlt1PIGF Pnl; SR; Tyr	4180186
44816662	可溶性 fms 样酪氨酸激酶-1与胎盘生长因子组套:-:时间点:血清/血浆:-	4182948
44816663	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B pert; B pert.PT; B pert.PT Ab; B pert.PT Ab.IgA; B pertussis; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pertussis; Point in time; PR; PT; QL; Qual; Qualitative; Random; Screen; Serum; SR; Whooping cough	4180186
44816663	B pert.PT IgA Ser Ql Line blot	4180186
44816663	百日咳博德特菌.百日咳毒素 抗体.IgA:存在情况或阈值:时间点:血清:序数型:线点印迹法	4182948
44816665	c244; Chemistry; Level; L-tryptophan; Platelet rich plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Trp	4180186
44816665	Tryptophan PRP-sCnc	4180186
44816665	色氨酸:物质的量浓度:时间点:富血小板血浆:定量型	4182948
44816666	5-HTP; 5-Hydroxy tryptophan; 5OH-Tryptophan; Chemistry; Level; Platelet rich plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
44816666	5OH-Tryptophan PRP-sCnc	4180186
44816666	5-羟色氨酸脱羧醇:物质的量浓度:时间点:富血小板血浆:定量型	4182948
44816667	5OH-indoleacetate PRP-sCnc	4180186
44816667	5HIA; 5HIAA; 5-HIAA; 5-Hydroxy indoleacetate; 5-hydroxyindoleacetic acid; 5OH-indoleacetate; Chemistry; Hydroxyindoacet; Level; Platelet rich plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Serotonin metabolite; Substance concentration; Tumor marker	4180186
44816667	5-羟基吲哚乙酸:物质的量浓度:时间点:富血小板血浆:定量型	4182948
44816668	Agency for Healthcare Research and Quality; AHRQ survey Pnl; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.AHRQ	4180186
44816669	Agency for Healthcare Research and Quality; AHRQ survey Pnl; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.AHRQ	4180186
44816672	Blood; Chemistry; Endocrine; Endocrinology; Glu; Gluc; Glucoseur; Level; LimitedUseLabOrders; Mass Concentration; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
44816672	Glucose SerPlBld-mCnc	4180186
44816672	葡萄糖:质量浓度:时间点:血清/血浆/全血:定量型	4182948
44816673	Platelet # PRP Auto	4180186
44816673	#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Platelet; Platelet count; Platelet rich plasma; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes	4180186
44816673	血小板:计数型浓度:时间点:富血小板血浆:定量型:自动化计数方法	4182948
44816677	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV11; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; Papilloma virus low risk; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load	4180186
44816677	HPV11 DNA # Spec NAA+probe	4180186
44816677	人乳头瘤病毒 11 型 DNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
44816679	Vac dust collection pnl PhenX	4180186
44816679	Coll; Collect; Collected; Pan; PANEL.PHENX; Panl; Pnl; Point in time; Random; Vac dust collection pnl; Vacuum dust contaminant	4180186
44816679	真空吸尘污染物组套:-:时间点:^患者:-:PhenX	4182948
44816681	Malignant cells Fld Ql Micro	4180186
44816681	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cell; Cellularity; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; LM; Malig; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
44816681	恶性肿瘤细胞:存在情况或阈值:时间点:体液:序数型:显微镜检查.光学	4182948
44816682	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUBV lineage; FLUV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
44816682	FLUBV lineage RNA Spec NAA+probe	4180186
44816682	流感病毒 B 型谱系 RNA:存在与否或特征标识:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
44816683	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUBV Vic; FLUBV Victoria; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
44816683	FLUBV Vic RNA Spec Ql NAA+probe	4180186
44816683	流感病毒 B 型 Victoria 谱系 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
44816684	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUBV Yam; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
44816684	FLUBV Yam RNA Spec Ql NAA+probe	4180186
44816684	流感病毒 B 型 Yamagata 谱系 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
44816690	Chemistry; Dose med or substance; Fructose PO; Levulose; Point in time; QNT; Quan; Quant; Quantitative; Random; Revulose	4180186
44816690	Fructose PO Dose Qn	4180186
44816690	果糖.口服:质量:时间点:剂量药物或剂量物质:定量型	4182948
44816692	THBR SerPl	4180186
44816692	Bind; Chemistry; Horm; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; THBR; T-uptake	4180186
44816692	甲状腺激素结合率:相对比率:时间点:血清/血浆:定量型	4182948
44816693	Bind; Chemistry; Endocrine; Endocrinology; Levothyroxine; Levo-thyroxine; L-thyroxine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Tot; Total T4; Total TBC; Totl; TT4; T-uptake	4180186
44816693	Total TBC SerPl	4180186
44816693	总甲状腺素结合力:相对比率:时间点:血清/血浆:定量型	4182948
44816694	Glucose HBT ExG-Imp	4180186
44816694	Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Glu; Glu tol; Gluc; Glucose HBT; Glucose tolerance; Glucoseur; GTT; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random	4180186
44816694	葡萄糖刺激:印象:时间点:呼出的气体:名义型	4182948
44816698	锂^波谷:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816698	Chemistry; Eskalith; Level; Li; Lithane; Lithium, Bld; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816698	Lithium, Bld Trough SerPl-sCnc	4180186
44816699	Chemistry; Ferr; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; SerP; SerPl; SerPlas; Serum; Serum or plasma; Siderophilin; SR; sTfR; Tf; Trf; TRFRN	4180186
44816699	sTfR SerPl	4180186
44816699	转铁蛋白受体.可溶性/Log 铁蛋白指数:质量比率:时间点:血清/血浆:定量型	4182948
44816701	Act/Nor; Activ; Actvty; COAGULATION; Contrl; Control; EIA; ELFA; ELISA; Enzyme immunoassay; Fac; Fact; Hematology; Heme; IAA; MEIA; Movements; Normal; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; SUDS; Von will; Vonwillebrand; vWf; vWf:Ac	4180186
44816701	vWf:Ac Act/Nor PPP Cont IA	4180186
44816701	von Willebrand 因子.活性 实际的/正常的:相对比率:时间点:贫血小板血浆^对照:定量型:免疫测定法	4182948
44816702	Actiq; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethyl fentanyl; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Duragesic; Durogesic; Fenpat; fentanil; GCMS; hydrochloride; Illicit; N- phenyl- N- [1- (2- phenylethyl)- 4- piperidinyl]- acetamide, monohydrochloride; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Sublimaze; UA; UR; Urn	4180186
44816702	Acetyl fentanyl Ur Ql Cfm	4180186
44816702	乙酰芬太尼:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
44816705	Nuc cell # Dial fld Manual	4180186
44816705	#; ABS; absolute; absolutes; Cell; Cellularity; Cnt; Count; Count/volume; CT; Diaf; Dialysate; Dialysis fluid; HEMATOLOGY/CELL COUNTS; Manl; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44816705	有核细胞类:计数型浓度:时间点:透析液:定量型:手工计数方法	4182948
44816706	100WBC; Blood; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Myeloma cells; Number fraction; Percent; Plasmacyte; Plasmacytes; Plms centblst; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
44816706	Plms centblst/leuk NFr Bld Manual	4180186
44816706	浆细胞.中心母细胞/100 个白细胞:计数型分数:时间点:全血:定量型:手工计数方法	4182948
44816707	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; p1; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR; SUDS	4180186
44816707	Ascaris IgG Ser Ql IA	4180186
44816707	蛔线虫属单个未知种 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
44816709	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; crocodile; Dihydrodesoxymorphine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; krokodil; Level; Mass concentration; Permonid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
44816709	Desom Ur Cfm-mCnc	4180186
44816709	二氢去氧吗啡:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
44816710	Addiction; crocodile; Dihydrodesoxymorphine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; krokodil; Ordinal; Permonid; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
44816710	Desom Ur Ql Scn	4180186
44816710	二氢去氧吗啡:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
44816712	Plms centcyts/leuk NFr Bld Manual	4180186
44816712	100WBC; Blood; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Myeloma cells; Number fraction; Percent; Plasmacyte; Plasmacytes; Plms centcyts; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood	4180186
44816712	浆细胞.中心细胞/100 个白细胞:计数型分数:时间点:全血:定量型:手工计数方法	4182948
44816713	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CHIKV; HEMAGGLUTINATION INHIBITION; HI; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
44816713	CHIKV Ab Ser Ql HAI	4180186
44816713	基孔肯亚病毒 抗体:存在情况或阈值:时间点:血清:序数型:红细胞凝集抑制试验法	4182948
44816715	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; JCV; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
44816715	JCV Ab Ser Ql IA	4180186
44816715	詹姆斯敦峡谷病毒 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
44816717	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Enc; Enceph; Encephalomyelitis; Hemagglutination inhibition; HI; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SLE virus; SLEV; SR; St Louis	4180186
44816717	SLEV Ab Ser Ql HAI	4180186
44816717	圣路易型脑炎病毒 抗体:存在情况或阈值:时间点:血清:序数型:红细胞凝集抑制试验法	4182948
44816720	雪鞋野兔病毒 抗体.中和:存在情况或阈值:时间点:血清:序数型:中和试验	4182948
44816720	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; ID; Infectious Disease; InfectiousDisease; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; Serum virus neutralization; SR; SSHV; SVN; Virus neutralization test; VNT	4180186
44816720	SSHV NAb Ser Ql Nt	4180186
44816721	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SSHV; Time Resolved Fluorescence; TRF	4180186
44816721	SSHV IgG Ser Ql IF	4180186
44816721	雪鞋野兔病毒 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
44816722	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; T gondii; Toxo; Toxoplasmosis	4180186
44816722	T gondii IgA Ser Ql IA	4180186
44816722	刚地弓形虫 抗体.IgA:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
44816725	ACAT; acetyl-CoA acetyltransferase 1; Blood; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Identity or presence; Inherited; MAT; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Nominal; Point in time; Random; sequencing of entire coding region; T2; THIL; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
44816725	ACAT1 Full Mut Anl Bld/T Seq	4180186
44816725	ACAT1 基因 全面突变分析:存在与否或特征标识:时间点:全血/组织:名义型:序列测定	4182948
44816728	Trns Typ	4180186
44816728	Anatomy; CLIN; Nominal; Point in time; Random; Trns Typ	4180186
44816728	移植类型:解剖学:时间点:^患者:名义型	4182948
44816732	#; ABS; absolute; absolutes; CD56 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Leu19; Leu-19; Misc; Miscellaneous; NCAM; Neural cell adhesion molecule; NKH1; Number concentration; Number Concentration (count/vol); Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified	4180186
44816732	CD56 Cells # Spec	4180186
44816732	细胞.CD56:计数型浓度:时间点:XXX:定量型	4182948
44816733	CD8 Cells; CD8+CD57+ Cells; CD8-CD57+ Cells; Cell; CELL MARKERS; Cellularity; Gated cells; HNK1; Leu2; Leu-2; Leu7; Leu-7; Lyme disease; Misc; Miscellaneous; Natural killer cells; Number fraction; Other; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Suppressor T cells; T8; T-8; To be specified in another part of the message; Tsuppressor; Unspecified	4180186
44816733	CD8+CD57+ Cells NFr Spec	4180186
44816733	细胞.CD8+CD57+/100 个细胞:计数型分数:时间点:XXX:定量型	4182948
44816734	CD25 Cells # Spec	4180186
44816734	#; ABS; absolute; absolutes; CD25 Cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; IL-2 receptor alpha chain; IL-2R; IL-2R Tac antigen; ILR2; Misc; Miscellaneous; Number concentration; Number Concentration (count/vol); Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Tac antigen; To be specified in another part of the message; Unspecified	4180186
44816734	细胞.CD25:计数型浓度:时间点:XXX:定量型	4182948
44816735	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Baylis sp; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; round worm; Screen; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; SUDS	4180186
44816735	Baylis sp IgG CSF Ql IA	4180186
44816735	贝利蛔线虫属单个未知种 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:免疫测定法	4182948
44816738	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SSHV; Time Resolved Fluorescence; TRF	4180186
44816738	SSHV IgM Ser Ql IF	4180186
44816738	雪鞋野兔病毒 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
44816740	Lymphocytes NFr LN Manual	4180186
44816740	Cell; Cellularity; Gated cells; HEMATOLOGY/CELL COUNTS; LN; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44816740	淋巴细胞/100 个细胞:计数型分数:时间点:淋巴结:定量型:手工计数方法	4182948
44816741	Plasma Cells NFr LN Manual	4180186
44816741	Cell; Cellularity; Gated cells; HEMATOLOGY/CELL COUNTS; LN; Manl; Myeloma cells; Number fraction; Percent; Plasmacyte; Plasmacytes; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44816741	浆细胞类/100 个细胞:计数型分数:时间点:淋巴结:定量型:手工计数方法	4182948
44816745	3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 1; HIV type I; HIV1; HIV1 proviral DNA; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
44816745	HIV 1 pro DNA Spec Ql NAA+probe	4180186
44816745	HIV 1 型 前病毒 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
44816748	3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Donr; HBV; HCV; Hep; Hep B; Hep C; Hepatis; Hepatit; HepB; HIV type 1; HIV type 2; HIV type I; HIV type II; HIV1; HIV1+HIV2+HCV+HBV; Human immunodeficiency virus; i; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
44816748	HIV1+2+HCV+HBV DNA SerPl Donr Ql NAA+pr	4180186
44816748	HIV 1 型 O 组 RNA+HIV 1 型 M 组 RNA+HIV 2 型 RNA+丙型肝炎病毒 RNA+乙型肝炎病毒 DNA:存在情况或阈值:时间点:血清/血浆^供体:序数型:探针法.基因扩增.靶向	4182948
44816749	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Donr; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; WNV	4180186
44816749	WNV RNA SerPl Donr Ql NAA+probe	4180186
44816749	西尼罗河病毒 RNA:存在情况或阈值:时间点:血清/血浆^供体:序数型:探针法.基因扩增.靶向	4182948
44816750	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Donr; Hep; Hep E; Hepatis; Hepatit; Hepatology; HEV; HEV 1+2+3+4; HEV 1-4 RNA; i; ID; II; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
44816750	HEV 1+2+3+4 RNA SerPl Donr Ql NAA+probe	4180186
44816750	戊型肝炎病毒基因型 1+2+3+4 RNA:存在情况或阈值:时间点:血清/血浆^供体:序数型:探针法.基因扩增.靶向	4182948
44816752	ERBB2 copy num/nucleus EntNum Tiss FISH	4180186
44816752	breast cancer; CD340; c-erb B2; Entitic; Entitic number; ErbB-2; ERBB2 copy num; erb-b2 receptor tyrosine kinase 2; Fluorescent in situ hybridization; Genetics; HER2; HER-2; HER2/neu; HER-2/neu; Heredity; Heritable; Inherited; MLN 19; Molecular pathology; MOLPATH; NEU; NGL; No; Num; p185; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; TKR1; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	4180186
44816752	HER2 基因拷贝数/核:实体数量:时间点:组织与涂片:定量型:FISH	4182948
44816753	CEP17; Chr 17 copy num; Chromosom; Chromosome 17 centromere; Chromosome Enumeration Probe 17; Chromosomes; Entitic; Entitic number; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; No; Num; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
44816753	Chr 17 copy num/nucleus EntNum Tiss FISH	4180186
44816753	染色体 17 拷贝数/核:实体数量:时间点:组织与涂片:定量型:FISH	4182948
44816755	Chemistry; heavy chain; IgG lamba; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816755	IgG lamba SerPl-mCnc	4180186
44816755	IgG.lambda:质量浓度:时间点:血清/血浆:定量型	4182948
44816760	Chemistry; G lambda; heavy chain; IgG Kappa; IgG lamba; Immune globulin G; Immunoglobulin G; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816760	IgG Kappa/G lambda SerPl	4180186
44816760	IgG.kappa/IgG.lambda:质量比率:时间点:血清/血浆:定量型	4182948
44816765	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Identity or presence; Metabolic disorder monitored; Nominal; Point in time; Random; WB; Whole blood	4180186
44816765	Metabolic disorder monitored DBS	4180186
44816765	所监测的代谢紊乱:存在与否或特征标识:时间点:全血.斑点:名义型	4182948
44816766	Metabolic disorder therapy Pnl DBS	4180186
44816766	Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Metabolic disorder therapy Pnl; Pan; PANEL.CHALLENGE; Panl; Pnl; Point in time; Random; WB; Whole blood	4180186
44816766	代谢紊乱治疗监测组套:-:时间点:全血.斑点:-	4182948
44816767	After; aIle; alloIle; Allo-isoleucine; Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Level; Maple syrup urine disease; MSUD; MSUD (Maple Syrup Urine Disease); p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; WB; Whole blood	4180186
44816767	Alloisoleucine p diet DBS-sCnc	4180186
44816767	别异亮氨酸^在治疗性饮食之后:物质的量浓度:时间点:全血.斑点:定量型	4182948
44816771	After; Blood; Cerebrose; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; GAL-1-P; Gal1PO4; GAL-1-PO4; Galactose tolerance test; i; i Phos; Inorganic phosphate; Level; Mass concentration; p diet; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Ther; WB; Whole blood	4180186
44816771	Gal1PO4 p diet DBS-mCnc	4180186
44816771	半乳糖-1-磷酸^在治疗性饮食之后:质量浓度:时间点:全血.斑点:定量型	4182948
44816776	After; Blood; CHEMISTRY.CHALLENGE TESTING; DBS; Dried blood spot; Filter paper; FP; Level; p diet; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Ther; Val; WB; Whole blood	4180186
44816776	Valine p diet DBS-sCnc	4180186
44816776	缬氨酸^在治疗性饮食之后:物质的量浓度:时间点:全血.斑点:定量型	4182948
44816777	ERBB2 (HER2) Dup Pnl Tiss FISH	4180186
44816777	Assoc; CD340; c-erb B2; C-ERBB-2; erb; ERB2; ERB-2; ErbB-2; ERBB2 (HER2) Dup Pnl; ERBB2 duplication; erb-b2 receptor tyrosine kinase 2; Fluorescent in situ hybridization; Genetics; HER2; HER-2; HER2 amplification; HER-2/neu; Heredity; Heritable; Inherited; MLN 19; Molecular pathology; MOLPATH; NEU; NGL; Pan; Panel.molpath; Panl; Pnl; Point in time; Random; Tissue; Tissue, unspecified; TKR1; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	4180186
44816777	HER2 组套:-:时间点:组织与涂片:-:FISH	4182948
44816778	Stigmasterol SerPl-sCnc	4180186
44816778	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816778	豆甾醇:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816779	Stigmastanol SerPl-sCnc	4180186
44816779	beta Sitostanol; Chemistry; Fucostanol; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sitostanol; SR; Substance concentration	4180186
44816779	豆甾烷醇:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816781	Phosphate Sal-sCnc	4180186
44816781	Chemistry; i Phos; Inorganic phosphate; Level; Oral fluid; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Substance concentration	4180186
44816781	磷酸盐:物质的量浓度:时间点:唾液:定量型	4182948
44816783	ACAD; AcdA; Acyl CoA dehydrogenase, medium chain; Acyl CoA dehydrogenase.medium chain; Catalytic Content; Chains; Chemistry; Chn; Dehydrog; Dehyrdogenase; Leukocytes; MCAD; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells	4180186
44816783	MCAD WBC-cCnt	4180186
44816783	中链脂酰基 CoA 脱氢酶:催化含量:时间点:白细胞:定量型	4182948
44816784	ACAD; AcdA; Acyl CoA dehydrogenase, medium chain; Acyl CoA dehydrogenase.medium chain; Catalytic Content; Chains; Chemistry; Chn; Dehydrog; Dehyrdogenase; Fib; Fibr; MCAD; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44816784	MCAD Fib-cCnt	4180186
44816784	中链脂酰基 CoA 脱氢酶:催化含量:时间点:成纤维细胞:定量型	4182948
44816785	Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
44816785	Mannose/Creat Ur-sRto	4180186
44816785	甘露糖/肌酐:物质的量比率:时间点:尿液:定量型	4182948
44816786	5 hours; 5.0Hr; 5HR; After; Chemistry; p sug sol; PST; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn	4180186
44816786	Mannitol p sug sol 5h Ur-sRate	4180186
44816786	甘露醇^在口服XXX g糖溶液之后:物质的量速率:5小时:尿液:定量型	4182948
44816787	Maltose/Creat Ur-sRto	4180186
44816787	Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
44816787	麦芽糖/肌酐:物质的量比率:时间点:尿液:定量型	4182948
44816788	Lactate Stl-sCnt	4180186
44816788	2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Lact; Lactic acid; L-lactate; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Content	4180186
44816788	乳酸:物质的量含量:时间点:大便:定量型	4182948
44816790	Lanosterol SerPl-sCnc	4180186
44816790	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816790	羊毛甾醇:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816791	5 hours; 5.0Hr; 5HR; After; Chemistry; p sug sol; PST; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; UA; UR; Urn	4180186
44816791	Lactulose/Mannitol p sug sol 5h Ur-sRto	4180186
44816791	乳果糖/甘露醇^在口服XXX g糖溶液之后:物质的量比率:5小时:尿液:定量型	4182948
44816792	Lactulose/Creat p sug sol 5h Ur-sRto	4180186
44816792	5 hours; 5.0Hr; 5HR; After; Chemistry; CR; Crea; Creat; p sug sol; PST; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
44816792	乳果糖/肌酐^在口服XXX g糖溶液之后:物质的量比率:5小时:尿液:定量型	4182948
44816795	FA 24h Stl-mRate	4180186
44816795	1 day; 24 hours; 24HR; Acd; Acid; Bowel movement; Chemistry; Faecal; Faeces; Fatty acid; Fecal; Feces; Lipid; Mass rate; mRate; QNT; Quan; Quant; Quantitative; Stl; Stool = Fecal	4180186
44816795	脂肪酸类:质量速率:24小时:大便:定量型	4182948
44816800	3-ketoacyl CoA thiolase; 3-ketoacyl-CoA thiolase; ACAT; Catalytic Content; Chemistry; Fib; Fibr; III; MCKAT; MEDIUM CHAIN 3-KETOACYL-CoA THIOLASE DEFICIENCY; Point in time; QNT; Quan; Quant; Quantitative; Random; Thiolase 1; Thiolase I	4180186
44816800	Thiolase I Fib-cCnt	4180186
44816800	3-酮脂酰-CoA 硫解酶:催化含量:时间点:成纤维细胞:定量型	4182948
44816802	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zoloft	4180186
44816802	Sertraline Trough SerPl-mCnc	4180186
44816802	舍曲林^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816804	Cipralex; DRUG/TOXICOLOGY; Drugs; Level; Lexamil; Lexapro; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Seroplex; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816804	Deprecated Escitalopram Trough SerPl-mCn	4180186
44816808	CXCL13 Ag CSF-mCnc	4180186
44816808	Antigen; Antigens; BCA1; BCA-1; B-lymphocyte chemoattractant; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant); Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
44816808	CXCL13 抗原:质量浓度:时间点:脑脊液:定量型	4182948
44816810	CAFFN; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816810	Caffeine Trough SerPl-mCnc	4180186
44816810	咖啡因^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816815	Nortrip Trough SerPl-mCnc	4180186
44816815	Amitriptyline metabolite; Aventyl; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Nortrip; Nortriptylene; Nortriptyln; Pamelor; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816815	去甲阿米替林^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816818	Dipiperon; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; Propitan; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816818	Deprecated Pipamperone Trough SerPl-mCnc	4180186
44816822	Abilify; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816822	ARIPiprazole Trough SerPl-mCnc	4180186
44816822	阿立哌唑^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816826	Catalytic Content; Chemistry; Leukocytes; Point in time; PPT; PR; Prot; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells	4180186
44816826	PPT WBC-cCnt	4180186
44816826	棕榈酰蛋白硫酯酶:催化含量:时间点:白细胞:定量型	4182948
44816827	DRUG/TOXICOLOGY; Drugs; Ketipinor; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Seroquel; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Xeroquel	4180186
44816827	QUEtiapine Trough SerPl-mCnc	4180186
44816827	喹硫平^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816829	c232; c251; CLID; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Xylocaine	4180186
44816829	Deprecated Lidocain Trough SerPl-mCnc	4180186
44816830	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Sabril; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816830	Vigabatrin Trough SerPl-mCnc	4180186
44816830	氨己烯酸^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816831	Moclobemide Trough SerPl-mCnc	4180186
44816831	Aurorix; DRUG/TOXICOLOGY; Drugs; Level; Manerix; Mass concentration; MOC; Moclamine; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816831	吗氯贝胺^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816834	Buspar; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816834	busPIRone Trough SerPl-mCnc	4180186
44816834	丁螺旋酮^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816835	DRUG/TOXICOLOGY; Drugs; Lamictal; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816835	lamoTRIgine Trough SerPl-mCnc	4180186
44816835	拉莫三嗪^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816836	clomiPRAMINE+Nor Trough SerPl-mCnc	4180186
44816836	Anafranil; Anofranil; Clom; Clomip; Clomipramine metabolite; Desmeth; Desmethylclomip; Desmethylclomipramine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816836	氯米帕明+去甲基氯米帕明^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816837	Deprecated Normirtazapine Trough SerPl-m	4180186
44816837	Desmethylmirtazapine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Mirtazapine metabolite; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816840	Perphenazine Trough SerPl-mCnc	4180186
44816840	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Trilafon	4180186
44816840	奋乃静^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816843	Blood; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; LPA; LPT; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; Narrative; PHA; Point in time; Random; Report; Serology; WB; Whole blood	4180186
44816843	Lymphocyte prolif Bld-Imp Nar	4180186
44816843	淋巴细胞增殖:印象:时间点:全血:叙述型	4182948
44816844	Macroprolactin SerPl-aCnc	4180186
44816844	Arbitrary concentration; bbPRL; Big-big prolactin; Chemistry; IgG-bound Prolactin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816844	巨催乳素:任意型浓度:时间点:血清/血浆:定量型	4182948
44816845	Isomaltase TSMI-cCnt	4180186
44816845	Alpha dextrinase; Catalytic Content; Chemistry; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue small intestine	4180186
44816845	异麦芽糖酶:催化含量:时间点:小肠组织:定量型	4182948
44816846	C21H21N; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Periactin; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816846	Deprecated Cyproheptadine Trough SerPl-m	4180186
44816847	Chlordiaz; Chlordiaze; Chlordiazep; DRUG/TOXICOLOGY; Drugs; Level; Librium; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816847	Deprecated Chlordiazep Trough SerPl-mCnc	4180186
44816848	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SA; SUAC; Substance concentration	4180186
44816848	Succinylacetone Plas-sCnc	4180186
44816848	琥珀酰丙酮:物质的量浓度:时间点:血浆:定量型	4182948
44816849	Anafranil; Anofranil; Clom; Clomip; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816849	clomiPRAMINE Trough SerPl-mCnc	4180186
44816849	氯米帕明^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816851	valGANciclovir Trough Plas-mCnc	4180186
44816851	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random	4180186
44816851	缬更昔洛韦^波谷:质量浓度:时间点:血浆:定量型	4182948
44816852	10,11-dihydro-10-hydroxycarbamazepine; 10-Hydroxy carbazepine; 10-hydroxycarbamazepine; 10-Monohydroxyoxcarbazepine; 10-OH-carbazepine; 10OH-Carbazepine; DRUG/TOXICOLOGY; Drugs; Level; Licarbazepine; Mass concentration; Oxcarbazepine metabolite; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816852	Deprecated 10OH-Carbazepine Trough SerPl	4180186
44816854	Deprecated Promethazine Trough SerPl-mCn	4180186
44816854	Atosil; Avomine; DRUG/TOXICOLOGY; Drugs; Fargan; Farganesse; Lergigan; Level; Mass concentration; Phenergan; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; Promethegan; Prothiazine; QNT; Quan; Quant; Quantitative; Random; Receptozine; Romergan; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sominex; SR	4180186
44816855	DRUG/TOXICOLOGY; Drugs; Horizant; Level; Mass concentration; Neurontin; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816855	Gabapentin Trough SerPl-mCnc	4180186
44816855	加巴喷丁^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816857	Deprecated APAP Trough SerPl-mCnc	4180186
44816857	ACET; Acetamidophenol; Acetaminoph; Acetominophen; APAP; c209; C55; DRUG/TOXICOLOGY; Drugs; Hydroxyacetanilide; Level; Mass concentration; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tylenol; u209	4180186
44816858	Adrenal cortex IgG Ser Ql IF	4180186
44816858	ABS; Aby; ACA; ACIF; Adrnl; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
44816858	肾上腺皮质 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
44816859	Deprecated Norsertraline Trough SerPl-mC	4180186
44816859	Desmeth; Desmethylsertraline; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Sertraline metabolite; Serum; Serum or plasma; Setralinemetab; SR	4180186
44816867	Phenytoin Trough SerPl-mCnc	4180186
44816867	DI-HYDAN; Dilantin; Dilj; Diphenylhydantoin; DPH; DRUG/TOXICOLOGY; Drugs; Epanutin; Fenantoin; Lehydan; Level; Mass concentration; Phenhydan; PHYT; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinergina; SR; Zentropil	4180186
44816867	苯妥英^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816868	Transferrin 24h Ur-mRate	4180186
44816868	1 day; 24 hours; 24HR; Chemistry; Mass Rate; mRate; QNT; Quan; Quant; Quantitative; Siderophilin; Tf; Trf; TRFRN; UA; UR; Urn	4180186
44816868	转铁蛋白:质量速率:24小时:尿液:定量型	4182948
44816872	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816872	Pimozide Trough SerPl-mCnc	4180186
44816872	哌迷清^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816874	Phenytoin Free Trough SerPl-mCnc	4180186
44816874	DI-HYDAN; Dilantin; Dilj; Diphenylhydantoin; DPH; DRUG/TOXICOLOGY; Drugs; Epanutin; Fenantoin; FR; Lehydan; Level; Mass concentration; Non-protein bound; Phenhydan; Phenytoin Free; PHYT; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinergina; SR; Zentropil	4180186
44816874	苯妥英.游离型^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816877	DRUG/TOXICOLOGY; Drugs; HCQ; Hydroxy chloroquine; Level; Mass concentration; OH-Chloroquine; Oxichlorochin; Pl; Plaquenil; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Quensyl; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44816877	OH-Chloroquine Trough SerPl-mCnc	4180186
44816877	羟基氯喹^波谷:质量浓度:时间点:血清/血浆:定量型	4182948
44816879	Chemistry; Erythrocytes; Hematology; Heme; Hexacarbox; Hexacarboxyl porphyrin; Hexacarboxylporphyrins; Hexacarboxyporphy; Hexacarboxyporphyrin; Hexa-CP; Hexaporphyrin; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration	4180186
44816879	Hexa-CP RBC-sCnc	4180186
44816879	六羧基卟啉:物质的量浓度:时间点:红细胞:定量型	4182948
44816880	Chemistry; Hematology; Heme; Level; Pentacarboxyl porphyrins; Pentacarboxyporhyrin; Penta-CP; Pentaporphyrins; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816880	Penta-CP SerPl-sCnc	4180186
44816880	五羧基卟啉:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816881	1 day; 24 hours; 24HR; A1; A1A; A1AT; A-1-AT; A1-AT; AAT; Alfa; Alpha-1-antitrypsin.total; Alpha-1-protease inhibitor; Alpha-1-proteinase inhibitor; Alpha-1-trypsin inhibitor; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; Hepatology; i; Liver; Lung; Mass Rate; mRate; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Stl; Stool = Fecal	4180186
44816881	A1AT 24h Stl-mRate	4180186
44816881	Alpha 1 抗胰蛋白酶:质量速率:24小时:大便:定量型	4182948
44816882	AA; Acd; Acid; Amino acid; Amino acids Pnl; Amino acids.total; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UR; Urn	4180186
44816882	Amino acids Pnl Ur-sRto	4180186
44816882	氨基酸组套:物质的量比率:时间点:尿液:定量型	4182948
44816883	Alpha amylase; Ams; Amyl; Catalytic Concentration; Chemistry; Diastase; Gastro; Gastroenterology; GI; k87; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
44816883	Amylase Sal-cCnc	4180186
44816883	淀粉酶:催化浓度:时间点:唾液:定量型	4182948
44816887	Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; ALP Bone; ALP-2; AP; B-ALP; BALPase; BAP; Chemistry; Phos; Phosphtase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Standard score; Z score; Z value; Z-score	4180186
44816887	ALP Bone Z-score SerPl	4180186
44816887	碱性磷酸酶.骨骼型:Z评分:时间点:血清/血浆:定量型	4182948
44816891	1 day; 24 hours; 24HR; Chemistry; Copro; Copro total; Copro3; Coproporph; Coproporphyrin III; Coproporphyrins; Hematology; Heme; III; Percent; QNT; Quan; Quant; Quantitative; Substance Fraction; Tetracarboxyl porphyrin; Tetracarboxylporphyrin; Tetracarboxylporphyrins; Tetracarboxyporphyrin; Tot; Totl; UA; UR; Urn	4180186
44816891	Copro3/Copro total 24h SFr Ur	4180186
44816891	粪卟啉 III/粪卟啉.总计:物质的量分数:24小时:尿液:定量型	4182948
44816892	Bowel movement; Chemistry; Copro; Copro total; Copro3; Coproporph; Coproporphyrin III; Coproporphyrins; Faecal; Faeces; Fecal; Feces; Hematology; Heme; III; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Fraction; Tetracarboxyl porphyrin; Tetracarboxylporphyrin; Tetracarboxylporphyrins; Tetracarboxyporphyrin; Tot; Totl	4180186
44816892	Copro3/Copro total SFr Stl	4180186
44816892	粪卟啉 III/粪卟啉.总计:物质的量分数:时间点:大便:定量型	4182948
44816893	Food Allergen Mix50 IgE Qn	4180186
44816893	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Banana; Chinese gooseberry; f084; f091; f092; f210; f84; f91; f92; Food Allergen Mix50; Food panel 50; FP50; Immune globulin E; Immunoglobulin E; Kiwi fruit; Kiwifruit; Mango; Musa sp; Pineapple; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
44816893	(中华猕猴桃+凤梨+芭蕉属+芒果) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
44816894	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f001; f002; f004; f009; f013; f014; f1; f13; f14; f2; f4; f43; f9; Food Allerg Mix A; Food Allergen Mix7A; FP7; Gly; Immune globulin E; Immunoglobulin E; Largest; Maximal; Maximum; Peak; Peanut; Point in time; QNT; Quan; Quant; Quantitative; Random; Rice; Serum; Soja hispida; Soy bean; Soya bean; Soyabean; Soybean; SR; Triticum sativum; Wheat	4180186
44816894	Food Allergen Mix7A IgE Qn	4180186
44816894	(落花生+牛奶+蛋清+大豆+小麦+水稻) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
44816896	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Brassica aleraceae; Brassica oleracea capitata; Cabbage; f214; f216; f218; f25; Food Allerg Mix14; fx14; Immune globulin E; Immunoglobulin E; Lycopersicon esculatum; Lycopersicon lycopersicon; Paprika; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Spinach; SR; Sweet pepper; Tomato; Vegetable mix	4180186
44816896	Food Allerg Mix14 IgE Qn	4180186
44816896	(卷心菜+菜椒+番茄+菠菜) 抗体.IgE:任意型浓度:时间点:血清:定量型:Multidisk 法	4182948
44816898	A3050; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergillus restrictus (nAsp r) 1; Aspergils; Aspergilus; Autoantibodies; Autoantibody; i; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; Right; Serum; SR	4180186
44816898	Aspergillus restrictus (nAsp r) 1 IgE Qn	4180186
44816898	局限曲霉 原生 (nAsp r) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
44816899	Dog native (nCan f) 1 IgE Qn	4180186
44816899	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Dog native (nCan f) 1; i; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
44816899	犬科 原生 (nCan f) 1 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
44816900	Blood; C/EBP-alpha; CCAAT/enhancer binding protein (C/EBP), alpha; CEBP; Document; Familial AML; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
44816900	CEBPA gene Full Mut Anl Bld/T Seq	4180186
44816900	CEBPA 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
44816902	Acute promyelocytic leukemia; APL; BM; BON; Bone marrow; DNA; gene fusion; gene translocation; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; Myelogenous; MYL; NR1B1; Ordinal; PCR; PML-1; PML-2; PML-3; PML-3B; PML-X; Point in time; PR; Promyelocytic leukemia; QL; Qual; Qualitative; Random; RAR alpha form; RARalpha; Retinoic acid receptor alpha; RNA; Screen; T prime; t(15,17) (PML,RARA) gene translocation; t(15,17)(q22,q11.2-q12); t(15;17)(PML,RARA); translocation	4180186
44816902	t(15;17)(PML,RARA) Mar Ql	4180186
44816902	t(15;17)(q24.1;q21.1)(PML,RARA) 融合转录物:存在情况或阈值:时间点:骨髓:序数型:分子遗传学类实验室方法	4182948
44816904	t(8;21)(RUNX1T1,RUNX1) Mar Ql	4180186
44816904	21q22.3; Acute myelogenous leukemia 1 translocation 1, cyclin-D related; Acute myeloid leukemia; Acute myeloid leukemia 1; AML; AML1; AML1T1L myeloid translocation gene on 8q22; BM; BON; Bone marrow; CBFA2; CBFA2T1; CDR; Core binding factor runt domain alpha subunit 2; DNA; ETO; gene fusion; gene translocation; MAR; Marrow (bone); MGC2796; minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MTG8; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(8,21)(RUNX1T1,RUNX1) gene translocation; t(8;21)(RUNX1T1,RUNX1); translocation; ZMYND2	4180186
44816904	t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) 融合转录物:存在情况或阈值:时间点:骨髓:序数型:分子遗传学类实验室方法	4182948
44816906	ABL; ALL; bcr/abl; BCR1; bcr-abl1; Blood; Breakpoint cluster region; Chronic myeloid leukemia; CML; D22S11; D22S662; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; JTK7; major breakpoints; Mbr; Mcr; minor breakpoints; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; p150; PCR; Ph chromosome; Philadelphia chromosome; PHL; Point in time; PR; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(9,22)(ABL1,BCR) gene translocation; t(9,22)(ABL1,BCR) p210 gene translocation; t(9,22)(ABL1,BCR) Translocation; t(9,22)(q34,q11); t(9,22)(q34.1,q11); t(9;22)(ABL1,BCR); t(ABL1,BCR)b2a2; Tissue; Tissue, unspecified; translocation; v-abl Abelson murine leukemia viral oncogene homolog 1; WB; Whole blood; Whole blood or Tissue	4180186
44816906	t(ABL1,BCR)b2a2 Bld/T Ql	4180186
44816906	t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 融合转录物:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
44816907	ABL; ALL; bcr/abl; BCR1; bcr-abl1; BM; BON; Bone marrow; Breakpoint cluster region; Chronic myeloid leukemia; CML; D22S11; D22S662; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; JTK7; major breakpoints; MAR; Marrow (bone); Mbr; Mcr; minimal angle of resolution; Minimum angle of resolution; minor breakpoints; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; p150; PCR; Ph chromosome; Philadelphia chromosome; PHL; Point in time; PR; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(9,22)(ABL1,BCR) gene translocation; t(9,22)(ABL1,BCR) p210 gene translocation; t(9,22)(ABL1,BCR) Translocation; t(9,22)(q34,q11); t(9,22)(q34.1,q11); t(9;22)(ABL1,BCR); t(ABL1,BCR)b3a2; translocation; v-abl Abelson murine leukemia viral oncogene homolog 1	4180186
44816907	t(ABL1,BCR)b3a2 Mar Ql	4180186
44816907	t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 融合转录物:存在情况或阈值:时间点:骨髓:序数型:分子遗传学类实验室方法	4182948
44816910	ABL; ALL; bcr/abl; BCR1; bcr-abl1; BM; BON; Bone marrow; Breakpoint cluster region; Chronic myeloid leukemia; CML; D22S11; D22S662; DNA; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; JTK7; major breakpoints; MAR; Marrow (bone); Mbr; Mcr; minimal angle of resolution; Minimum angle of resolution; minor breakpoints; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; p150; PCR; Ph chromosome; Philadelphia chromosome; PHL; Point in time; PR; QL; Qual; Qualitative; Random; RNA; Screen; T prime; t(9,22)(ABL1,BCR) gene translocation; t(9,22)(ABL1,BCR) p190 gene translocation; t(9,22)(ABL1,BCR) Translocation; t(9,22)(q34,q11); t(9,22)(q34.1,q11); t(9;22)(ABL1,BCR); t(ABL1,BCR)e1a2; translocation; v-abl Abelson murine leukemia viral oncogene homolog 1	4180186
44816910	t(ABL1,BCR)e1a2 Mar Ql	4180186
44816910	t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 融合转录物:存在情况或阈值:时间点:骨髓:序数型:分子遗传学类实验室方法	4182948
44816913	Kidney; Nephrology; Ordinal; ORO Stn; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Screen; St; Stains; Stn; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	4180186
44816913	Fat UrnS Ql ORO Stn	4180186
44816913	脂肪.显微镜观察:存在情况或阈值:时间点:尿沉渣:序数型:油红 O 染色法	4182948
44816916	Bowel movement; Chemistry; Copro; Copro3; Coproporph; Coproporphyrin III; Coproporphyrins; Faecal; Faeces; Fecal; Feces; Hematology; Heme; III; Percent; Point in time; Porph; Porphyrin; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Fraction; Tetracarboxyl porphyrin; Tetracarboxylporphyrin; Tetracarboxylporphyrins; Tetracarboxyporphyrin; Tot; Totl	4180186
44816916	Copro3 SFr Stl	4180186
44816916	粪卟啉 III/卟啉.总计:物质的量分数:时间点:大便:定量型	4182948
44816918	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Percent; Point in time; Porph; Porphyrin; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Fraction; Tot; Totl	4180186
44816918	Mesopor SFr Stl	4180186
44816918	中卟啉/卟啉.总计:物质的量分数:时间点:大便:定量型	4182948
44816920	ANTIBIOTIC SUSCEPTIBILITIES; AST; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Relenza; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
44816920	Zanamivir Islt Genotyp	4180186
44816920	扎那米韦:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
44816924	BM; BON; Bone marrow; CD110; C-MPL; Gene mut tested; Genetics; Heredity; Heritable; Identity or presence; Inherited; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MPL proto-oncogene, thrombopoietin receptor; MPLV; Mut; Mut Tested; Mutation; Muts; MYELOPROLIFERATIVE LEUKEMIA VIRUS ONCOGENE; Nominal; PCR; Point in time; Random; THCYT2; thrombopoietin receptor mutations; TPOR	4180186
44816924	MPL gene Mut Tested Mar	4180186
44816924	MPL 基因 已测试的突变:存在与否或特征标识:时间点:骨髓:名义型:分子遗传学类实验室方法	4182948
44816927	2-hydroxy-glutarate; 2-hydroxyglutaric acid; 2OH-gluterate; AF; alpha-Hydroxyglutarate; alpha-Hydroxyglutaric acid; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; II; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
44816927	2OH-gluterate Amn-sCnc	4180186
44816927	2-羟基戊二酸:物质的量浓度:时间点:羊水:定量型	4182948
44816934	C8H11NO3; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; Pyridoxol; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration; Vit B6; Vitamin B6	4180186
44816934	Vit B6 CSF-sCnc	4180186
44816934	吡哆醇:物质的量浓度:时间点:脑脊液:定量型	4182948
44816937	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; N-Acetylneuraminic Acid; Point in time; QNT; Quan; Quant; Quantitative; Random; SA; Sialic acid; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44816937	Sialate CSF-sCnc	4180186
44816937	唾液酸:物质的量浓度:时间点:脑脊液:定量型	4182948
44816938	Sialate SerPl-sCnc	4180186
44816938	Chemistry; Level; N-Acetylneuraminic Acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SA; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sialic acid; SR; Substance concentration	4180186
44816938	唾液酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816942	Xylose/Creat Ur-sRto	4180186
44816942	Chemistry; CR; Crea; Creat; D-xylose; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
44816942	木糖/肌酐:物质的量比率:时间点:尿液:定量型	4182948
44816943	Adenosine deaminase DBS-cCnc	4180186
44816943	ADA; ADO; ANED; Blood; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; Medication stress; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
44816943	腺苷脱氨酶:催化浓度:时间点:全血.斑点:定量型	4182948
44816945	Catalytic Content; Chemistry; Dehydrog; Dehyrdogenase; GCDH; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells	4180186
44816945	GCDH WBC-cCnt	4180186
44816945	戊二酸单酰 CoA 脱氢酶:催化含量:时间点:白细胞:定量型	4182948
44816946	GCDH Fib-cCnt	4180186
44816946	Catalytic Content; Chemistry; Dehydrog; Dehyrdogenase; Fib; Fibr; GCDH; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44816946	戊二酸单酰 CoA 脱氢酶:催化含量:时间点:成纤维细胞:定量型	4182948
44816948	Alpha neuraminidase; Catalytic Content; Chemistry; Galactosialidosis; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Sialidosis; WBCs; White blood cells	4180186
44816948	Sialidase WBC-cCnt	4180186
44816948	唾液酸酶:催化含量:时间点:白细胞:定量型	4182948
44816949	ThdPase DBS-cCnc	4180186
44816949	Blood; Catalytic Concentration; Chemistry; DBS; Deoxythymidine; Dried blood spot; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; ThdPase; TP; WB; Whole blood	4180186
44816949	胸苷磷酸化酶:催化浓度:时间点:全血.斑点:定量型	4182948
44816953	Chemistry; Level; Phenylacetic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816953	Phenylacetate SerPl-sCnc	4180186
44816953	苯乙酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816955	VMA SerPl-sCnc	4180186
44816955	香草扁桃酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816955	3-methoxy-4-hydroxymandelate; 3-methyl,4-hydroxy mandelate; 3-methyl,4-oh mandelic acid; Catecholamine metabolite; Chemistry; HMMA; Hydroxy-methoxy-mandelate; Hydroxy-methoxy-mandelic acid; Level; MHMA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker; Vanillylmandelic acid; Vanilmandelate; VMA	4180186
44816956	Benzoic acid; c703; Chemistry; k05; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816956	Benzoate SerPl-sCnc	4180186
44816956	苯甲酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816959	Malate SerPl-sCnc	4180186
44816959	Chemistry; Level; Malic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816959	苹果酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816961	1,2-benzenediol; 1,2-dihydroxybenzene; 2-hydroxyphenol; Benzene, o-dihydroxy-; Chemistry; Level; O-diphenol; Ortho-benzenediol; Ortho-dihydroxybenzene; Ortho-dioxybenzene; Ortho-hydroquinone; Ortho-hydroxyphenol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816961	Catechol SerPl-sCnc	4180186
44816961	儿茶酚:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816963	Chemistry; Level; Mandelic acid; Mandilic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816963	Mandelate SerPl-sCnc	4180186
44816963	扁桃酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816965	4OHBenzoate SerPl-sCnc	4180186
44816965	4-Hydroxy benzoate; 4-Hydroxybenzoic acid; 4OHBenzoate; Chemistry; Hydroxybenzoic acid; Level; para-Hydroxybenzoic acid; p-Hydroxybenzoic acid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816965	4-羟基苯甲酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816967	Quinolinate SerPl-sCnc	4180186
44816967	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tryptophan metabolite	4180186
44816967	喹啉酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816968	3-hydroxy dodecanoate; 3-hydroxydodecanoic acid; 3OH-DDDA; 3OH-dodecanoate; Chemistry; CR; Crea; Creat; III; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
44816968	3OH-dodecanoate/Creat Ur-sRto	4180186
44816968	3-羟基正十二烷酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
44816969	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUAC; Substance concentration	4180186
44816969	Succinylacetone SerPl-sCnc	4180186
44816969	琥珀酰丙酮:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816970	N-Ac-L-Asp SerPl-sCnc	4180186
44816970	Asp; Aspartic acid; Chemistry; Left; Level; Levo; NAA; N-Ac-L-Asp; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816970	N-乙酰-L-天门冬氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816975	Catecholamine pattern Ur-Imp	4180186
44816975	Catecholamine pattern; Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Metabolite; Metb; Narrative; Point in time; Random; Report; UA; UR; Urn	4180186
44816975	儿茶酚胺代谢产物模式:印象:时间点:尿液:叙述型	4182948
44816976	Adipate SerPl-sCnc	4180186
44816976	Adipic acid; Chemistry; Hexanedioate; Hexanedioic acid; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816976	己二酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816977	3-Indolelactate SerPl-sCnc	4180186
44816977	Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816977	3-吲哚乙酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816978	5Oxoproline SerPl-sCnc	4180186
44816978	5Oxoproline; Chemistry; Level; Oxopro; Pidolate; Pidolic acid; Pl; Plasma; Plsm; Point in time; Pyroglutamate; Pyroglutamic acid; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816978	5-羟脯氨酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816979	Isocitrate SerPl-sCnc	4180186
44816979	Chemistry; Isocitric acid; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44816979	异柠檬酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
44816984	DHA EntSub RBC	4180186
44816984	C22:6w3; Cervonate; Cervonic acid; Chemistry; DHA; Docosahexaenoic acid; Entitic substance; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
44816984	二十二碳六烯酸:实体物质的量:时间点:红细胞:定量型	4182948
44816985	Acd; Acid; Aliphatic carboxylate; C26:0; Cerotiate; Cerotic acid; Chains; Chemistry; Chn; Entitic substance; Erythrocytes; Fatty acid; Hexacosanoate; Hexacosanoic acid; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; VLC; VLCF; VLCFA; VLCFA C26:0	4180186
44816985	VLCFA C26:0 EntSub RBC	4180186
44816985	脂肪酸类.极长链型.C26:0:实体物质的量:时间点:红细胞:定量型	4182948
44816987	Nervonate EntSub RBC	4180186
44816987	15-Tetracosenoic acid; C24:1; Chemistry; Entitic substance; Erythrocytes; Nervonic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Tetracosenoate	4180186
44816987	神经酸:实体物质的量:时间点:红细胞:定量型	4182948
44816990	VLCFA C22:0 EntSub RBC	4180186
44816990	Acd; Acid; Aliphatic carboxylate; Behenate; Behenic acid; C22:0; Chains; Chemistry; Chn; Docosanoate; Docosanoic acid; Entitic substance; Erythrocytes; Fatty acid; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; VLC; VLCF; VLCFA; VLCFA C22:0	4180186
44816990	脂肪酸类.极长链型.C22:0:实体物质的量:时间点:红细胞:定量型	4182948
44816993	VLCFA C24:0 EntSub RBC	4180186
44816993	Acd; Acid; Aliphatic carboxylate; C24:0; Chains; Chemistry; Chn; Entitic substance; Erythrocytes; Fatty acid; Lignocerate; Lignoceric acid; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Tetracosanoate; Tetracosanoic acid; VLC; VLCF; VLCFA; VLCFA C24:0	4180186
44816993	脂肪酸类.极长链型.C24:0:实体物质的量:时间点:红细胞:定量型	4182948
44816994	Acd; Acid; Aliphatic carboxylate; C26:1; Chains; Chemistry; Chn; Entitic substance; Erythrocytes; Fatty acid; Hexacosenoate; Hexacosenoic acid; i; Lipid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; VLC; VLCF; VLCFA; VLCFA C26:1	4180186
44816994	VLCFA C26:1 EntSub RBC	4180186
44816994	脂肪酸类.极长链型.C26:1:实体物质的量:时间点:红细胞:定量型	4182948
44816996	Chemistry; Entitic substance; Erythrocytes; Pentadecanoic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
44816996	Pentadecanoate EntSub RBC	4180186
44816996	十五烷酸:实体物质的量:时间点:红细胞:定量型	4182948
44816999	5,8,11,14 Eicosatetraenoic acid; AA; Arachidonic acid; Arch acid; C20:4w6; Chemistry; Eicosatetraenoate; Entitic substance; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
44816999	AA EntSub RBC	4180186
44816999	花生四烯酸:实体物质的量:时间点:红细胞:定量型	4182948
44817000	Palmitoleate EntSub RBC	4180186
44817000	C16:1w7; Chemistry; Entitic substance; Erythrocytes; Palmitoleic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
44817000	棕榈油酸:实体物质的量:时间点:红细胞:定量型	4182948
44817001	Adrenate; Adrenic acid; C22:4w6; Chemistry; Docosatetraenoic acid; DTA; Entitic substance; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
44817001	Docosatetraenoate EntSub RBC	4180186
44817001	二十二碳四烯酸:实体物质的量:时间点:红细胞:定量型	4182948
44817002	Alfa; A-Linolenate; Alpha linolenic acid; C18:3w3; Chemistry; Entitic substance; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
44817002	A-Linolenate EntSub RBC	4180186
44817002	Alpha 亚麻酸:实体物质的量:时间点:红细胞:定量型	4182948
44817003	Fatty acids pattern RBC-Imp	4180186
44817003	Acd; Acid; Chemistry; Erythrocytes; Fatty acid; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lipid; Narrative; Point in time; Random; Red blood cells; Red blood corpusles; Report	4180186
44817003	脂肪酸模式:印象:时间点:红细胞:叙述型	4182948
44817005	C10:0; Caprate; Capric acid; Chemistry; Decanoic acid; Entitic substance; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
44817005	Decanoate EntSub RBC	4180186
44817005	癸酸:实体物质的量:时间点:红细胞:定量型	4182948
44817008	C18:3w6; Chemistry; Entitic substance; Erythrocytes; Gamma linolenic acid; Gamoleic acid; G-Linolenate; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
44817008	G-Linolenate EntSub RBC	4180186
44817008	Gamma 亚麻酸:实体物质的量:时间点:红细胞:定量型	4182948
44817015	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Orotic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44817015	Orotate CSF-sCnc	4180186
44817015	乳清酸:物质的量浓度:时间点:脑脊液:定量型	4182948
44817016	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817016	Deoxyinosine SerPl-sCnc	4180186
44817016	脱氧肌苷:物质的量浓度:时间点:血清/血浆:定量型	4182948
44817018	Xanthine CSF-sCnc	4180186
44817018	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44817018	黄嘌呤:物质的量浓度:时间点:脑脊液:定量型	4182948
44817019	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44817019	Uridine CSF-sCnc	4180186
44817019	尿嘧啶核苷:物质的量浓度:时间点:脑脊液:定量型	4182948
44817021	Oxipurinol/Creat Ur-sRto	4180186
44817021	Allopurinol metabolite; alloxanthine; Chemistry; CR; Crea; Creat; Oxyprim; oxypurinol; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
44817021	奥昔嘌醇/肌酐:物质的量比率:时间点:尿液:定量型	4182948
44817024	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817024	Hypoxanthine SerPl-sCnc	4180186
44817024	次黄嘌呤:物质的量浓度:时间点:血清/血浆:定量型	4182948
44817026	5-amino imidazole carboxamide riboside; AICAR; AICA-riboside; Amino imidazole carboxamide riboside; Aminoimidazole carboxamide riboside; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817026	Acadesine SerPl-sCnc	4180186
44817026	阿卡地新:物质的量浓度:时间点:血清/血浆:定量型	4182948
44817027	Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; SAICAR; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
44817027	SAICAR/Creat Ur-sRto	4180186
44817027	琥珀酰氨基咪唑氨甲酰核苷/肌酐:物质的量比率:时间点:尿液:定量型	4182948
44817041	Uracil SerPl-sCnc	4180186
44817041	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817041	尿嘧啶:物质的量浓度:时间点:血清/血浆:定量型	4182948
44817043	Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Hypoxanthosine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration	4180186
44817043	Inosine CSF-sCnc	4180186
44817043	次黄嘌呤核苷:物质的量浓度:时间点:脑脊液:定量型	4182948
44817047	Allantoine SerPl-sCnc	4180186
44817047	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817047	尿囊素:物质的量浓度:时间点:血清/血浆:定量型	4182948
44817055	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Mat; Maternal; Matnl; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC	4180186
44817062	Mat; Maternal; Matnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC	4180186
44817064	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Mat; Maternal; Matnl; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
44817067	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Mat; Maternal; Matnl; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
44817069	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Gestation; Gestations; Gravida; Mat; Maternal; Matnl; Nominal; Point in time; Pregnancies; Random; Survey; SURVEY.CDC	4180186
44817074	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Mat; Maternal; Matnl; Nominal; Point in time; Random; Survey; SURVEY.CDC; Tx	4180186
44817078	Dilution factor; Dilution Factor (Titer); Point in time; QNT; Quan; Quant; Quantitative; Random; Reac; React; Survey; SURVEY.CDC; Titer; Titered; Titre; Ttr	4180186
44817082	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
44817084	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Cerebral spinal fluid; Cerebrospinal Fl; Dis; Diseases; Dz; Finding; Findings; Nominal; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Survey; SURVEY.CDC	4180186
44817085	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Cerebral spinal fluid; Cerebrospinal Fl; Finding; Findings; Leuc; Leuk; Leukocytes; Lkcs; Nominal; Point in time; PR; Prot; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Survey; SURVEY.CDC; WBC; WBCs; White blood cell; White blood cells	4180186
44817090	Cnt; Count; Gestation; Gestations; Gravida; Mat; Maternal; Matnl; Number; Point in time; Pregnancy; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC	4180186
44817091	Cnt; Count; Mat; Maternal; Matnl; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC	4180186
44817094	Arbitrary; Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC; Wt	4180186
44817095	Arbitrary; Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; GA; Gest; Gestation; Ordinal; Point in time; Prenatal; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC	4180186
44817098	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
44817103	Arg; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Orn; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
44817103	Arginine/Ornithine DBS-sRto	4180186
44817103	精氨酸/鸟氨酸:物质的量比率:时间点:全血.斑点:定量型	4182948
44817104	Blood; Chemistry; CIT; Citr; DBS; Dried blood spot; Filter paper; FP; Orn; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
44817104	Ornithine/Cit DBS-sRto	4180186
44817104	鸟氨酸/瓜氨酸:物质的量比率:时间点:全血.斑点:定量型	4182948
44817105	Glutarylcarn/C3-DC DBS-sRto	4180186
44817105	Blood; C3DC; C3-DC; C5DC; C5-DC; Chemistry; DBS; Dicarboxylic carnitine; Dried blood spot; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood	4180186
44817105	戊二酰肉碱 (C5-DC)/丙二酰肉碱 (C3-DC):物质的量比率:时间点:全血.斑点:定量型	4182948
44817106	Blood; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
44817106	Biotinidase DBS-cCnc	4180186
44817106	生物素化物酶:催化浓度:时间点:全血.斑点:定量型	4182948
44817111	ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn; Throat; Upper respiratory	4180186
44817111	Alberts Stn Throat	4180186
44817111	显微镜观察:存在与否或特征标识:时间点:咽喉:名义型:Albert 染色法	4182948
44817113	Blood; Cell; Cellularity; Ched-hig cells; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
44817113	Ched-hig cells Bld Ql	4180186
44817113	Chediak-Higashi 细胞:存在情况或阈值:时间点:全血:序数型	4182948
44817119	m-CPP Ur Ql	4180186
44817119	1,3 - Chlorophenyl piperazine; DRUG/TOXICOLOGY; Drugs; mCPP; m-CPP; meta-chlorophenylpiperazine; Nefazodone metabolite; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Trazodone metabolite; UA; UR; Urn	4180186
44817119	间氯苯哌嗪:存在情况或阈值:时间点:尿液:序数型	4182948
44817120	DRUG/TOXICOLOGY; Drugs; Nefadar; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serzone; UA; UR; Urn	4180186
44817120	Nefazodone Ur Ql	4180186
44817120	奈法唑酮:存在情况或阈值:时间点:尿液:序数型	4182948
44817121	Norcitalopram Ur Ql	4180186
44817121	Citalopram metabolite; Desmeth; Desmethylcitalopram; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn	4180186
44817121	去甲基西酞普兰:存在情况或阈值:时间点:尿液:序数型	4182948
44817129	Meat Fibers #/area Stl LPF	4180186
44817129	#/area; Bowel movement; Chemistry; creatorrhea; Faecal; Faeces; Fecal; Feces; Fiber; LM; Micro; Micros; Microscopic; Muscle fiber; Muscle fibers; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
44817129	肉类纤维:单位面积数量或计数:时间点:大便:定量型:显微镜检查.光学.低倍视野	4182948
44817130	Procalcitonin SerPl IA-mCnc	4180186
44817130	Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; PCT; Pl; Plasma; Plsm; Point in time; proCT; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
44817130	降钙素原:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
44817132	Norton Scale Pnl; Pan; PANEL.SURVEY.NORTON; Panl; Pnl; Point in time; Random; Survey; SURVEY.NORTON	4180186
44817134	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NORTON	4180186
44817135	Activ; Actvty; Finding; Findings; Movements; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NORTON	4180186
44817137	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.NORTON	4180186
44817138	Norton Scale Total Score; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.NORTON; Tot; Totl	4180186
44817144	Department of Health and Human Services, Affordable Care Act Section 4302; Department of Health and Human Services, Affordable Care Act Section 4302 and Office of the National Coordinator for Health Information Technology (ONC); Finding; Findings; HHS.ACASec4302; HHS.ACASec4302.ONC; Nominal; Point in time; Random; Survey; SURVEY.HHS	4180186
44817145	Department of Health and Human Services, Affordable Care Act Section 4302; Department of Health and Human Services, Affordable Care Act Section 4302 and Office of the National Coordinator for Health Information Technology (ONC); HHS.ACASec4302; HHS.ACASec4302.ONC; Pan; PANEL.SURVEY.HHS; Panl; Pnl; Point in time; Random; Survey; SURVEY.HHS	4180186
44817146	Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Mat; Maternal; Matnl; Nominal; Point in time; Random; Survey; SURVEY.CDC; Typ	4180186
44817148	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
44817151	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
44817153	Ab; Bld gp Ab Scn; BLOOD BANK; Low ionic strength saline; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44817153	Bld gp Ab Scn SerPl Ql LISS	4180186
44817153	血型抗体筛查:存在情况或阈值:时间点:血清/血浆:序数型:低离子强度盐水法	4182948
44817154	Ab; Bld gp Ab Scn; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; Polyethylene Glycol; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
44817154	Bld gp Ab Scn SerPl Ql PEG	4180186
44817154	血型抗体筛查:存在情况或阈值:时间点:血清/血浆:序数型:聚乙二醇分析法	4182948
44817163	Antigen; Antigens; Identity or presence; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; MART-1; Melan-A+Ki67; Nominal; Pathology; Point in time; Random; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
44817163	Melan-A+Ki67 Ag Tiss ImStn	4180186
44817163	黑素-A 与 Ki67 抗原:存在与否或特征标识:时间点:组织与涂片:名义型:免疫染色法	4182948
44817164	PAX5+BCL2 Ag Tiss ImStn	4180186
44817164	Antigen; Antigens; B-cell leukemia/lymphoma 2; BCL-2; Identity or presence; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Nominal; Pathology; PAX5+BCL2; Point in time; Random; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
44817164	PAX5 与 BCL2 抗原:存在与否或特征标识:时间点:组织与涂片:名义型:免疫染色法	4182948
44817166	PAX5+CD43 Ag Tiss ImStn	4180186
44817166	Antigen; Antigens; gpL115; Identity or presence; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Leu22; Leu-22; leukocyte sialoglycoprotein; leukosialin; Nominal; Pathology; PAX5+CD43; Point in time; Random; Sialophorin; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
44817166	PAX5 与 CD43 抗原:存在与否或特征标识:时间点:组织与涂片:名义型:免疫染色法	4182948
44817169	Agency for Healthcare Research and Quality; AHRQ survey Pnl; Form version; Hosp; Pan; Panel; Panl; Pnl; Point in time; Pt safety event; Random; Survey; SURVEY.AHRQ	4180186
44817170	Injury Loc ICD	4180186
44817170	Injury Loc ICD; International Classification of Diseases; Nominal; Place of occurrence of external cause; Point in time; Random; TRAUMA; Typ; Ulcer; Y92; Y92.x	4180186
44817170	损伤位置 ICD 代码:类型:时间点:^患者:名义型	4182948
44817173	Death pronouc; Document; Finding; Findings; Point in time; Random; Survey; SURVEY.CDC	4180186
44817176	Agency for Healthcare Research and Quality; AHRQ survey Pnl; Form version; Hosp; Pan; Panel; Panl; PIF v1.2; Pnl; Point in time; Pt safety event; Random; Survey; SURVEY.AHRQ	4180186
44817178	1 day; 16B,18-diOH-DHEA; 24 hours; 24HR; 3 beta Hydroxysteroid Dehydrogenase; 3-Beta Hydroxysteroid dehydrogenase deficiency; B; Chemistry; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn	4180186
44817178	16B,18-diOH-DHEA 24h Ur-sCnc	4180186
44817178	16-Beta,18-二羟基脱氢表雄甾酮:物质的量浓度:24小时:尿液:定量型	4182948
44817183	3-OH-decanoylcarn SerPl-sCnc	4180186
44817183	3-OH-decanoylcarn; C10OH; C10-OH; Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817183	3-羟癸酰肉碱 (C10-OH):物质的量浓度:时间点:血清/血浆:定量型	4182948
44817188	Amino acids Pnl Ur-sCnc	4180186
44817188	AA; Acd; Acid; Amino acid; Amino acids Pnl; Amino acids.total; Chemistry; Level; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	4180186
44817188	氨基酸组套:物质的量浓度:时间点:尿液:定量型	4182948
44817190	Calcium Sal-sCnc	4180186
44817190	Ca; Cal; Chemistry; Level; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; Substance concentration	4180186
44817190	钙:物质的量浓度:时间点:唾液:定量型	4182948
44817191	Cholest Sulf SerPl-sCnc	4180186
44817191	Chemistry; Chol; Choles; Cholest; Cholest Sulf; Cholesterol total; Cholesterols; CS; Level; Lipid; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Substance concentration; Sulf	4180186
44817191	胆固醇硫酸酯:物质的量浓度:时间点:血清/血浆:定量型	4182948
44817193	Activ; Actvty; Comp; Comp activity Pnl; Complement screening; Complmt; HEMATOLOGY/CELL COUNTS; Movements; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random; Serum; SR	4180186
44817193	Comp activity Pnl Ser	4180186
44817193	补体活性组套:-:时间点:血清:-	4182948
44817194	AH50 Act/Nor Ser IA	4180186
44817194	Act/Nor; AP; APH50; Comp; Complement alternative pathway; Complement total alternate pathway AH50; Complmt; Control; EIA; ELFA; ELISA; Enzyme immunoassay; HEMATOLOGY/CELL COUNTS; IAA; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Serum; SR; SUDS	4180186
44817194	补体备用途径活性 AH50 实际的/正常的:相对任意型浓度:时间点:血清:定量型:免疫测定法	4182948
44817198	Decatrienoylcarn SerPl-sCnc	4180186
44817198	C10:3; Chemistry; III; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817198	癸三烯肉碱 (C10:3):物质的量浓度:时间点:血清/血浆:定量型	4182948
44817201	5-ALA; 5-aminolevulinate; 5-aminolevulinic acid; ALA; Aminolevulinic acid; Amnolev; Amnolevuunc; Chemistry; CR; Crea; Creat; Creat Pnl; D-ALA; D-ALA+PBG+creat Pnl; Delta-ala; Delta-aminolevulinic acid; Pan; PANEL.CHEMISTRY; Panl; PBG; Pnl; Point in time; Porph; Porphobili; Porphoblngn; Porpoblngn; Random; UA; UCr; UR; Urn	4180186
44817201	D-ALA+PBG+creat Pnl Ur	4180186
44817201	Delta 氨基酮戊酸、 胆色素原与肌酐组套:-:时间点:尿液:-	4182948
44817202	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817202	Dicarboxyeicosanoylcarn SerPl-sCnc	4180186
44817202	二羧基二十酰肉碱 (C20-DC):物质的量浓度:时间点:血清/血浆:定量型	4182948
44817208	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N men serogroup; N men sg X; N men sg X DNA; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Neisseria meningitidis group X; Neisseria meningitidis type X; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
44817208	N men sg X DNA Spec Ql NAA+probe	4180186
44817208	脑膜炎奈瑟菌 X 血清群 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
44817212	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N men serogroup; N men sg A; N men sg A DNA; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Neisseria meningitidis group A; Neisseria meningitidis type A; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
44817212	N men sg A DNA Spec Ql NAA+probe	4180186
44817212	脑膜炎奈瑟菌 A 血清群 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
44817213	C6:1; Chemistry; i; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
44817213	Hexenoylcarn SerPl-sCnc	4180186
44817213	己烯酰肉碱 (C6:1):物质的量浓度:时间点:血清/血浆:定量型	4182948
44817215	PK/G6PD RBC-cRto	4180186
44817215	Catalytic Concentration Ratio; Catalytic Ratio; CCrto; Chemistry; Dehydrog; Dehyrdogenase; Enzymatic activity ratio; Erythrocytes; G6PD; G-6-PD; G6PDH; Glu; Gluc; Glucose-6-PD; Glucose-6-PDH; Glucoseur; GPD; i Phos; Inorganic phosphate; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PK; PO4; Point in time; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles	4180186
44817215	丙酮酸激酶/葡萄糖-6-磷酸脱氢酶:催化比率:时间点:红细胞:定量型	4182948
44817217	Tryp-related indole profile pnl PRP	4180186
44817217	c244; Chemistry; L-tryptophan; Pan; PANEL.CHEMISTRY; Panl; Platelet rich plasma; Pnl; Point in time; Random; Trp; Tryp-related indole profile pnl	4180186
44817217	色氨酸相关吲哚分析组套:-:时间点:富血小板血浆:-	4182948
44817218	Nominal; Occupation; Point in time; Random; Survey; SURVEY.AHRQ; Typ; Work	4180186
44817219	Nominal; Point in time; Random; Survey; SURVEY.AHRQ	4180186
44817225	Agency for Healthcare Research and Quality; Finding; Findings; Narrative; Point in time; Pt safety event; Random; Report; Survey; SURVEY.AHRQ	4180186
44817226	Agency for Healthcare Research and Quality; Finding; Findings; Narrative; Point in time; Pt safety event; Random; Report; Survey; SURVEY.AHRQ	4180186
44817227	Date and time; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.AHRQ; Time stamp; Timestamp	4180186
44817229	Agency for Healthcare Research and Quality; Finding; Findings; Len; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.AHRQ	4180186
44817231	Agency for Healthcare Research and Quality; Durat; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.AHRQ	4180186
44817233	Agency for Healthcare Research and Quality; Nominal; Point in time; Random; Survey; SURVEY.AHRQ; Typ	4180186
44817234	Agency for Healthcare Research and Quality; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Rescue intervention attempted; Screen; Survey; SURVEY.AHRQ	4180186
44817235	Agency for Healthcare Research and Quality; Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.AHRQ	4180186
44817236	Agency for Healthcare Research and Quality; Nominal; Point in time; Random; Survey; SURVEY.AHRQ; Typ	4180186
44817238	Agency for Healthcare Research and Quality; Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.AHRQ	4180186
44817240	Agency for Healthcare Research and Quality; Assoc; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.AHRQ	4180186
44817245	Agency for Healthcare Research and Quality; Nominal; Point in time; Pt safety event; Random; Survey; SURVEY.AHRQ; Typ	4180186
44817249	PDC Fib-cCnt	4180186
44817249	Catalytic Content; Chemistry; Compx; Dehydrog; Dehyrdogenase; Fib; Fibr; PDC; PDH; Point in time; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random	4180186
44817249	丙酮酸脱氢酶复合物:催化含量:时间点:成纤维细胞:定量型	4182948
44817250	PDC Tiss-cCnt	4180186
44817250	Catalytic Content; Chemistry; Compx; Dehydrog; Dehyrdogenase; PDC; PDH; Point in time; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
44817250	丙酮酸脱氢酶复合物:催化含量:时间点:组织与涂片:定量型	4182948
44817251	Catalytic Content; Chemistry; Dehydrog; Dehyrdogenase; Fib; Fibr; PDH; PDH E1; Point in time; Pyruvic acid; QNT; Quan; Quant; Quantitative; Random	4180186
44817251	PDH E1 Fib-cCnt	4180186
44817251	丙酮酸脱氢酶 E1:催化含量:时间点:成纤维细胞:定量型	4182948
44817253	Catalytic Content; Chemistry; Fib; Fibr; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817253	Fumarase Fib-cCnt	4180186
44817253	延胡索酸酶:催化含量:时间点:成纤维细胞:定量型	4182948
44817254	VLCFA C26:0/C22:0 Fib	4180186
44817254	Acd; Acid; Aliphatic carboxylate; C26:0; Cerotiate; Cerotic acid; Chains; Chemistry; Chn; Fatty acid; Fib; Fibr; Hexacosanoate; Hexacosanoic acid; Lipid; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; VLC; VLCF; VLCFA; VLCFA C26:0; VLCFA C26:0/C22:0	4180186
44817254	脂肪酸类.极长链型.C26:0/C22:0:质量比率:时间点:成纤维细胞:定量型	4182948
44817256	Catalytic Concentration Ratio; Catalytic Ratio; CCrto; Chemistry; Cit Syn; Citric acid; COX; CyC Oxidase; cyt; Enzymatic activity ratio; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
44817256	CyC Oxidase/Cit Syn Tiss-cRto	4180186
44817256	细胞色素 C 氧化酶/柠檬酸合酶:催化比率:时间点:组织与涂片:定量型	4182948
44817258	CoQ CyC Reduct Tiss-cCnt	4180186
44817258	Catalytic Content; Chemistry; Complex III; CoQ CyC Reduct; cyt; Cytochrome bc1 complex; Cytochrome C reductase; Point in time; Q-cytochrome c oxidoreductase; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
44817258	辅酶 Q 细胞色素 C 还原酶:催化含量:时间点:组织与涂片:定量型	4182948
44817259	Succinate CyC Reduct/Cit Syn Tiss-cRto	4180186
44817259	Butanedioate; Butanedioic acid; Catalytic Concentration Ratio; Catalytic Ratio; CCrto; Chemistry; Cit Syn; Citric acid; cyt; Enzymatic activity ratio; Point in time; QNT; Quan; Quant; Quantitative; Random; Succinate CyC Reduct; Succinic acid; Tissue; Tissue, unspecified	4180186
44817259	琥珀酸细胞色素 C 还原酶/柠檬酸合酶:催化比率:时间点:组织与涂片:定量型	4182948
44817260	Butanedioate; Butanedioic acid; Catalytic Content; Chemistry; cyt; Fib; Fibr; Point in time; QNT; Quan; Quant; Quantitative; Random; Succinate CyC Reduct; Succinic acid	4180186
44817260	Succinate CyC Reduct Fib-cCnt	4180186
44817260	琥珀酸细胞色素 C 还原酶:催化含量:时间点:成纤维细胞:定量型	4182948
44817262	NADH CyC Reduct/Cit Syn Tiss-cRto	4180186
44817262	Catalytic Concentration Ratio; Catalytic Ratio; CCrto; Chemistry; Cit Syn; Citric acid; cyt; Enzymatic activity ratio; NADH CyC Reduct; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
44817262	NADH 细胞色素 C 还原酶/柠檬酸合酶:催化比率:时间点:组织与涂片:定量型	4182948
44817263	C8DC; C8-DC; Catalytic Content; Chemistry; Dicarboxylic carnitine; Fib; Fibr; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817263	Suberylcarn Fib-cCnt	4180186
44817263	环庚基肉碱 (C8-DC):催化含量:时间点:成纤维细胞:定量型	4182948
44817268	Butyrylcarn Fib-cCnt	4180186
44817268	C4; Catalytic Content; Chemistry; Fib; Fibr; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817268	丁酰肉碱 (C4):催化含量:时间点:成纤维细胞:定量型	4182948
44817269	3OH-Palmitoylcarn Fib-cCnt	4180186
44817269	3-hydroxyhexadecanoylcarnitine; 3-hydroxy-hexadecanoylcarnitine; 3-hydroxy-palmitoylcarnitine; 3OH-Palmitoylcarn; C16OH; C16-OH; Catalytic Content; Chemistry; Fib; Fibr; III; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817269	3-羟基棕榈酰肉碱 (C16-OH):催化含量:时间点:成纤维细胞:定量型	4182948
44817270	Dicarboxypalmitoylcarn Fib-cCnt	4180186
44817270	C16DC; C16-DC; Catalytic Content; Chemistry; Fib; Fibr; Hexadecanediolycarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; thapsoyl carnitine	4180186
44817270	二羧基棕榈酰肉碱 (C16-DC):催化含量:时间点:成纤维细胞:定量型	4182948
44817271	3OH-Palmitoleylcarn Fib-cCnt	4180186
44817271	3-Hydroxy palmitoleylcarnitine; 3-hydroxyhexadecenoylcarnitine; 3-hydroxy-hexadecenoylcarnitine; 3OH-Palmitoleylcarn; C16:1OH; C16:1-OH; Catalytic Content; Chemistry; Fib; Fibr; i; III; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817271	3-羟基棕榈烯酰肉碱 (C16:1-OH):催化含量:时间点:成纤维细胞:定量型	4182948
44817273	Palmitoylcarn Fib-cCnt	4180186
44817273	C16; Catalytic Content; Chemistry; Fib; Fibr; Hexadecanoylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817273	棕榈酰肉碱 (C16):催化含量:时间点:成纤维细胞:定量型	4182948
44817275	Tdecadienoylcarn Fib-cCnt	4180186
44817275	C14:2; Catalytic Content; Chemistry; Fib; Fibr; II; Point in time; QNT; Quan; Quant; Quantitative; Random; Tdecadienoylcarn	4180186
44817275	十四烷二烯酰肉碱 (C14:2):催化含量:时间点:成纤维细胞:定量型	4182948
44817276	3-Hydroxy myristoleylcarnitine; 3-Hydroxymyristoleyl carnitine; 3OH-myristoleylcarn; 9-cis-tetradecenylhydroxyl carnitine; 9-cis-tetradecenylhydroxylcarnitine; Catalytic Content; Chemistry; Fib; Fibr; i; III; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817276	3OH-myristoleylcarn Fib-cCnt	4180186
44817276	3-羟基肉豆蔻油酰肉碱 (C14:1-OH):催化含量:时间点:成纤维细胞:定量型	4182948
44817277	Tdecenoylcarn Fib-cCnt	4180186
44817277	C14:1; Catalytic Content; Chemistry; Fib; Fibr; i; Point in time; QNT; Quan; Quant; Quantitative; Random; Tdecenoylcarn	4180186
44817277	十四烯酰肉碱 (C14:1):催化含量:时间点:成纤维细胞:定量型	4182948
44817280	Dodecanoylcarn Fib-cCnt	4180186
44817280	C12; Catalytic Content; Chemistry; Fib; Fibr; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817280	十二烷酰肉碱 (C12):催化含量:时间点:成纤维细胞:定量型	4182948
44817281	Sebacylcarn Fib-cCnt	4180186
44817281	C10DC; C10-DC; Catalytic Content; Chemistry; Dicarboxylic carnitine; Dodecanedioylcarnitine; Fib; Fibr; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817281	癸二酰肉碱 (C10-DC):催化含量:时间点:成纤维细胞:定量型	4182948
44817284	C10; Catalytic Content; Chemistry; Fib; Fibr; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817284	Decanoylcarn Fib-cCnt	4180186
44817284	癸酰肉碱 (C10):催化含量:时间点:成纤维细胞:定量型	4182948
44817285	Acd; Acid; Aliphatic carboxylate; C24:0; Chains; Chemistry; Chn; Fatty acid; Fib; Fibr; Lignocerate; Lignoceric acid; Lipid; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tetracosanoate; Tetracosanoic acid; VLC; VLCF; VLCFA; VLCFA C24:0	4180186
44817285	VLCFA C24:0 Fib-mCnt	4180186
44817285	脂肪酸类.极长链型.C24:0:质量含量:时间点:成纤维细胞:定量型	4182948
44817286	Acd; Acid; Aliphatic carboxylate; C26:0; Cerotiate; Cerotic acid; Chains; Chemistry; Chn; Fatty acid; Fib; Fibr; Hexacosanoate; Hexacosanoic acid; Lipid; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; VLC; VLCF; VLCFA; VLCFA C26:0	4180186
44817286	VLCFA C26:0 Fib-mCnt	4180186
44817286	脂肪酸类.极长链型.C26:0:质量含量:时间点:成纤维细胞:定量型	4182948
44817288	1-Heptadecanecarboxylic acid; C18:0; C18H36O2; Cetylacetic acid; Chemistry; DMA 18:0; DMA C18:0; Elaidate; Fib; Fibr; i; Mass concentration ratio; Mass ratio; MCRto; Octadecanoic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Stearaldehyde, dimethyl acetal; Stearate; Stearic acid	4180186
44817288	DMA 18:0/C18:0 Fib	4180186
44817288	1,1-二甲氧基十八碳烷/十八碳酯:质量比率:时间点:成纤维细胞:定量型	4182948
44817291	Chemistry; DMA 18:0; DMA C18:0; Erythrocytes; i; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Stearaldehyde, dimethyl acetal; Substance content	4180186
44817291	DMA 18:0 RBC-sCnt	4180186
44817291	1,1-二甲氧基十八碳烷:物质的量含量:时间点:红细胞:定量型	4182948
44817293	C18:1w9; Chemistry; dimethyl acetal oleic; DMA 18:1; DMA C18:1; Erythrocytes; i; Oleic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Scrto; Substance concentration ratio; Substance ratio	4180186
44817293	DMA 18:1/Oleate RBC-sRto	4180186
44817293	1,1-二甲氧基-(9Z)十八碳烯/油酸:物质的量比率:时间点:红细胞:定量型	4182948
44817294	Chemistry; dimethyl acetal oleic; DMA 18:1; DMA C18:1; Fib; Fibr; i; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817294	DMA 18:1 Fib-mCnt	4180186
44817294	1,1-二甲氧基-(9Z)十八碳烯:质量含量:时间点:成纤维细胞:定量型	4182948
44817296	DMA 16:0/C16:0 Fib	4180186
44817296	C16:0; Chemistry; dimethyl acetal palmitic; DMA 16:0; DMA C16:0; Fib; Fibr; Hexadecanoate; Hexadecanoic acid; i; Mass concentration ratio; Mass ratio; MCRto; Palmitic acid; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
44817296	1,1-二甲氧基十六烷/棕榈酸:质量比率:时间点:成纤维细胞:定量型	4182948
44817311	Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 E6+E7 mRNA	4180186
44817379	Arachidonate	4180186
44817445	Fatty acids.very long chain.C26:1	4180186
44817648	CD3 & CD20 Ag	4180186
44817649	Plan of care+summary note	4180186
44817656	Palmitoleate	4180186
44817658	Alpha linolenate	4180186
44817660	Nervonate	4180186
44817664	Docosatetraenoate	4180186
44817666	CD34 & Coagulation factor XIII Ag	4180186
44817695	Fatty acids.very long chain.C22:0	4180186
44817696	Inositol.free	4180186
44817704	MT-ND6 gene.m.14459G>A	4180186
44817705	1,1-Dimethoxyhexadecane	4180186
44817707	1,1-Dimethoxy-(9Z)octadecene	4180186
44817708	Adrenoleukodystrophy protein	4180186
44817720	Dimethylacetals	4180186
44818767	Has component (SNOMED)	4180186
44818772	Has property (SNOMED)	4180186
44818773	Has scale type (SNOMED)	4180186
44818792	Associated with (SNOMED)	4180186
44818802	ICD9 procedure to SNOMED equivalent (OMOP)	4180186
44818810	ATC to RxNorm (FDB)	4180186
44818849	Method of (SNOMED)	4180186
44818865	Component of (SNOMED)	4180186
44818870	Property of (SNOMED)	4180186
44818872	Time aspect of (SNOMED)	4180186
44818890	Associated with (SNOMED)	4180186
44818952	RxNorm to Multilex equivalent (OMOP)	4180186
44818953	Multilex to RxNorm equivalent (OMOP)	4180186
44818982	Branded Pack	4180186
44818993	Pharmacologic Drug Class	4180186
44819004	Branded Drug Component	4180186
44819028	Clinical Drug	4180186
44819053	Canonical Unit	4180186
44819063	Branded Drug	4180186
44819064	Clinical Drug Component	4180186
44819096	OMOP Vocabulary v5.0 2014-10-01	4180186
44819097	Systematic Nomenclature of Medicine - Clinical Terms (IHDSTO)	4180186
44819098	International Classification of Diseases, Ninth Revision, Clinical Modification, Volume 1 and 2 (NCHS)	4180186
44819110	Place of Service Codes for Professional Claims (CMS)	4180186
44819124	International Classification of Diseases, 10th Revision, Clinical Modification (NCHS)	4180186
44819141	Generic sequence number (FDB)	4180186
44819170	Endocrine, nutritional and metabolic	4180186
44819188	Certain infectious and parasitic	4180186
44819249	CPT4	4180186
44819254	Genseqno	4180186
44819255	GPI	4180186
44819265	MDC	4180186
44819266	MedDRA	4180186
44819280	ATC 3rd	4180186
44819281	ATC 1st	4180186
44819284	ATC 5th	4180186
45610009	deterlon	4180186
45610009	Dobanic acid 83	4180186
45610009	dodecylbenzenesulfonic acid, potassium salt	4180186
45610009	dodecyl benzene sulfonic acid sodium	4180186
45610009	dodecylbenzenesulfonic acid, sodium salt	4180186
45610009	sodium dodecylbenzenesulfonate	4180186
45610009	sodium dodecyl benzene sulfonate	4180186
45610009	sodium laurylbenzenesulfonate	4180186
45610009	sulfanol	4180186
45610009	sulfanol NP 1	4180186
45610009	sulfonol	4180186
45610016	2-ethylvaleramide	4180186
45610016	Depamide	4180186
45610016	valproic acid amide	4180186
45610016	valpromide	4180186
45610020	benzenemethanol, alpha-((1R)-1-aminoethyl)-, (alphaR)-rel-	4180186
45610020	cathine	4180186
45610020	cathine hydrochloride	4180186
45610020	exponcit	4180186
45610020	fasupond	4180186
45610020	Fugoa Depot	4180186
45610020	(+)-norpseudoephedrine	4180186
45610020	norpseudoephedrine, conjugate monoacid, (R-(R*,S*))-isomer	4180186
45610020	norpseudoephedrine hydrobromide	4180186
45610020	norpseudoephedrine hydrochloride	4180186
45610020	norpseudoephedrine hydrochloride, (+)-isomer	4180186
45610020	norpseudoephedrine hydrochloride, (R-(R*,R*))-isomer	4180186
45610020	norpseudoephedrine hydrochloride, (R*,S*)-isomer	4180186
45610020	norpseudoephedrine hydrochloride, (R*,S*)-(+-)-isomer	4180186
45610020	norpseudoephedrine hydrochloride, (S-(R*,S*))-isomer	4180186
45610020	norpseudoephedrine, (-)-isomer	4180186
45610020	norpseudoephedrine, (R*,R*)-(+-)-isomer	4180186
45610020	norpseudoephedrine, (R-(R*,S*))-isomer	4180186
45610020	norpseudoephedrine, (R*,S*)-isomer	4180186
45610020	norpseudoephedrine, (S-(R*,R*))-isomer	4180186
45610020	norpseudoephedrine, (S-(R*,S*))-isomer	4180186
45610020	norpseudoephedrine sulfate (2:1), (+)-isomer	4180186
45610020	norpseudoephedrine sulfate (2:1), (R-(R*,R*))-isomer	4180186
45610020	norpseudoephedrine sulfate, (R-(R*,S*))-isomer	4180186
45610020	norpseudoephedrine sulfate, (S-(R*,R*))-isomer	4180186
45610020	norpseudoephedrine tartrate, (S-(R*,R*))-(R-(R*,R*))-isomer	4180186
45610020	pseudonorephedrine	4180186
45610023	((4-oxo-2-phenyl-4H-1-benzopyran-7-yl)oxy)acetic acid ethyl ester	4180186
45610023	Recordil	4180186
45610024	2-(1,2,3,4-tetrahydro-1-naphthyl)-2-imidazoline	4180186
45610024	Berberil N	4180186
45610024	Caltheon	4180186
45610024	Collyrium Fresh	4180186
45610024	Diabenyl T	4180186
45610024	Eye-Sine	4180186
45610024	Eye-Zine	4180186
45610024	Murine Plus	4180186
45610024	Murine Sore Eyes	4180186
45610024	Ophtalmin	4180186
45610024	Optazine Fresh	4180186
45610024	Optigene	4180186
45610024	Rhinopront	4180186
45610024	Tetraclear	4180186
45610024	tetrahydrozoline hydrochloride	4180186
45610024	tetrahydrozoline, (-)-isomer	4180186
45610024	tetrahydrozoline, (+-)-isomer	4180186
45610024	tetrahydrozoline monohydrochloride	4180186
45610024	Tetra-Ide	4180186
45610024	Tetrilin	4180186
45610024	tetryzoline	4180186
45610024	Tyzine	4180186
45610024	Vasopos	4180186
45610024	Visine	4180186
45610024	Vispring	4180186
45610024	Yxin	4180186
45610025	1-(4-methoxyphenyl)propene	4180186
45610025	1-methoxy-4-(1-propenyl)benzene	4180186
45610025	anethole, (E)-isomer	4180186
45610025	anethole, (Z)-isomer	4180186
45610025	p-propenylanisole	4180186
45610025	trans-anethole	4180186
45610030	2-(hexahydro-1H-azepin-1-yl)ethyl alpha-cyclohexyl-3-thiopheneacetate citrate (1:1)	4180186
45610030	3-thiopheneacetic acid, alpha-cyclohexyl-, 2-(hexahydro-1H-azepin-1-yl)ethyl ester, hydrochloride (1:1)	4180186
45610030	alpha-cyclohexyl-3-thiopheneacetic acid, 2-(hexahydro-1H-azepin-1-yl)ethyl ester	4180186
45610030	cetiedil citrate	4180186
45610030	cetiedil citrate (1:1)	4180186
45610030	cetiedil hydrochloride	4180186
45610030	cetiedil oxalate	4180186
45610030	Stratene	4180186
45610032	4-chloro-3-cresol	4180186
45610032	4-chloro-3-methylphenol	4180186
45610032	4-chloro-meta-cresol	4180186
45610032	chlorocresol sodium salt	4180186
45610035	1-(2-phenyl-2-ethoxy)ethyl-4-(2-benzyloxy)propylpiperazine	4180186
45610035	1-(2-phenyl-2-ethoxy)ethyl-4-(3-phenyl-2-methyl-3-propanone)piperazine	4180186
45610035	3-(4-(beta-ethoxyphenethyl)-1-piperazinyl)-2-methylpropiophenone	4180186
45610035	746 CE	4180186
45610035	Eftapan	4180186
45610035	eprazinone dihydrochloride	4180186
45610035	eprazinone dihydrochloride, 3-(14)C-labeled	4180186
45610035	eprazinone hydrochloride	4180186
45610036	1 alpha-hydroxycholecalciferol	4180186
45610036	1 alpha-hydroxyvitamin D3	4180186
45610036	1alpha-OHD3	4180186
45610036	1-alpha-oxycholecalciferol	4180186
45610036	1-hydroxycholecalciferol	4180186
45610036	1-hydroxycholecalciferol, (1alpha,3alpha-(5Z,7E))-isomer	4180186
45610036	1-hydroxycholecalciferol, (1beta,3beta-(5E,7E))-isomer	4180186
45610036	1-hydroxycholecalciferol, (1beta)-(5Z)-isomer	4180186
45610036	1-hydroxycholecalciferol, aluminum salt	4180186
45610036	9,10-secocholesta-,7,10(19)-triene-1 alpha,3 beta-diol	4180186
45610036	AlfaD	4180186
45610036	alphacalcidol	4180186
45610036	Bondiol	4180186
45610036	Eenalfadrie	4180186
45610036	EinsAlpha	4180186
45610036	Etalpha	4180186
45610036	Oksidevit	4180186
45610036	One-Alpha	4180186
45610036	Un-Alfa	4180186
45610038	Anacalcit	4180186
45610038	Calcibind	4180186
45610038	Calcisorb	4180186
45610038	cellulose phosphate	4180186
45610038	cellulose polyphosphate	4180186
45610038	potassium cellulose phosphate	4180186
45610038	sodium cellulose phosphate	4180186
45610042	sulfiram	4180186
45610042	tetraethylthiuram monosulfide	4180186
45610043	2-nitroimidazole benznidazole	4180186
45610043	benznidazole	4180186
45610043	N-benzyl-2-nitro-1-imidazoleacetamide	4180186
45610043	Radanil	4180186
45610043	Ro 7-1051	4180186
45610044	eticlordifene	4180186
45610044	etophamide	4180186
45610044	Kitnos	4180186
45610044	N-(2-ethoxyethyl)-N-(p-(p-nitrophenoxy)-benzyl)-di- chloracetamide	4180186
45610045	7-chloro-1,3-dihydro-5-phenyl-1- (2,2,2-trifluoroethyl)-2H-1,4-benzodiazepin-2-one	4180186
45610045	Sch 12041	4180186
45610046	3-(4-biphenylcarbonyl)propionic acid	4180186
45610046	Cinopal	4180186
45610046	gamma-oxo(1,1'-biphenyl)-4-butanoic acid	4180186
45610046	Lederfen	4180186
45610047	colloidal bismuth subnitrate	4180186
45610047	Roter	4180186
45610047	Vicalin	4180186
45610047	Vikalin	4180186
45610047	Vikaline	4180186
45610049	AlCl3	4180186
45610049	aluminum chloride, anhydrous	4180186
45610049	aluminum chloride hexahydrate	4180186
45610049	aluminum trichloride	4180186
45610049	Drysol	4180186
45610052	fluocortinbutyl	4180186
45610052	Vaspit	4180186
45610055	Bronquimucil	4180186
45610055	brovanexine monohydrochloride	4180186
45610055	N-(2-(N'-cyclohexyl-N'-methyl-N'-methylene)-4,6-dibromophenyl)-3-methoxy-4-acetoxybenzamide	4180186
45610055	UR 389	4180186
45610056	1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy- 4-methyl-5H-2,3-benzodiazepine	4180186
45610056	1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine	4180186
45610056	dextofisopam	4180186
45610056	EGYT-341	4180186
45610056	Grandaxin	4180186
45610056	levotofisopam	4180186
45610056	tofizopam	4180186
45610058	Tasto	4180186
45610058	tris(hydroxymethyl)aminomethanegluconate dihydroxyaluminate	4180186
45610058	trometamolgluconate aluminum	4180186
45610059	6,7-dihydro-9-fluoro-5-methyl-1-oxo- 1H,5H-quinolizine-2-carboxylic acid	4180186
45610059	Apurone	4180186
45610059	R 802	4180186
45610059	R-802	4180186
45610060	A-73025	4180186
45610060	glycosaminoglycan polysulfate	4180186
45610060	Adequan	4180186
45610060	glycosaminoglycan polysulfuric acid ester	4180186
45610060	sulfated glycosaminoglycan	4180186
45610060	polysulfated glycosaminoglycan	4180186
45610060	glycosaminoglycan polysulphate	4180186
45610060	PSGAG	4180186
45610060	A 73025	4180186
45610061	Bioparox Spray	4180186
45610061	C29H51N2O8	4180186
45610061	fusafungine	4180186
45610061	Locabiotal	4180186
45610065	dawsonite	4180186
45610065	dihydroxyaluminum sodium carbonate potassium salt	4180186
45610065	dihydroxy sodium aluminum carbonate	4180186
45610065	Kompensan	4180186
45610072	mercuric oxide, (197)mercury-labeled	4180186
45610072	mercuric oxide, (203)mercury-labeled	4180186
45610073	6-(2-chlorophenyl)-2,4-dihydro-2-((4-methyl-1-piperazinyl)methylene)-8-nitro-1H-imidazo(1,2-a) (1,4)benzodiazepin-1-one	4180186
45610073	8-nitro-6-(o-chlorophenyl)-1,2-dihydro-2-(N-methylpiperazin-1-yl)methylene-1H,4H-imidazo (1,2-a)(1,4)benzodiazepin-1-one methanesulfonate	4180186
45610073	HR 158	4180186
45610073	HR 458	4180186
45610073	loprazolam	4180186
45610073	RU 31158	4180186
45610073	triazulenone mesylate	4180186
45610073	triazulenone, (Z)-isomer	4180186
45610076	1-(10-(2-(dimethylamino)propyl)-10H-phenothiazin- 2-yl)ethanone	4180186
45610076	aceprometazine maleate	4180186
45610077	(11 beta,16 beta)-21-(acetyloxy)-11-hydroxy-2'- methyl-5'H-pregna-1,4-dieno(17,16-d)oxazole-3,20- dione	4180186
45610077	Calcort	4180186
45610077	Dezacor	4180186
45610077	Emflaza	4180186
45610077	Zamene	4180186
45610079	1-acetyl-3-(2-bromo-2-ethylbutyryl)urea	4180186
45610079	Abasin	4180186
45610079	acetylcarbobromal	4180186
45610079	Paxarel	4180186
45610080	ammonium hydrogen phosphate	4180186
45610080	ammonium orthophosphate	4180186
45610080	ammonium phosphate, dibasic	4180186
45610080	ammonium phosphate, monobasic	4180186
45610080	ammonium phosphate ((NH4)3PO4)	4180186
45610080	ammonium phosphate, tribasic	4180186
45610080	diammonium hydrogen phosphate	4180186
45610080	diammonium phosphate	4180186
45610080	monoammonium phosphate	4180186
45610080	monobasic ammonium phosphate	4180186
45610080	phosphoric acid, ammonium salt	4180186
45610080	primary ammonum phosphate	4180186
45610080	triammonium phosphate	4180186
45610080	tribasic ammonium phosphate	4180186
45610081	7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-thione	4180186
45610081	Doral	4180186
45610081	Quiedorm	4180186
45610081	Sch 16134	4180186
45610081	Sch-16134	4180186
45610082	sunflower oil	4180186
45610082	sunflower seed oil, potassium salt	4180186
45610087	ammonium dodecyl sulfate	4180186
45610087	ammonium lauryl sulfate	4180186
45610087	dodecyl sulfate, ammonium salt	4180186
45610087	dodecyl sulfate, barium salt	4180186
45610087	dodecyl sulfate, cadmium salt	4180186
45610087	dodecyl sulfate, calcium salt	4180186
45610087	dodecyl sulfate, cesium salt	4180186
45610087	dodecyl sulfate, cobalt (+2) salt	4180186
45610087	dodecyl sulfate, copper (+2) salt	4180186
45610087	dodecyl sulfate, lead (+2) salt	4180186
45610087	dodecyl sulfate, lithium salt	4180186
45610087	dodecyl sulfate, magnesium salt	4180186
45610087	dodecyl sulfate, magnesium, sodium salt (4:1:2)	4180186
45610087	dodecyl sulfate, manganese (+2) salt	4180186
45610087	dodecyl sulfate, manganese salt	4180186
45610087	dodecyl sulfate, nickel (+2) salt	4180186
45610087	dodecyl sulfate, potassium salt	4180186
45610087	dodecyl sulfate, rubidium salt	4180186
45610087	dodecyl sulfate, silver (+1) salt	4180186
45610087	dodecyl sulfate, strontium salt	4180186
45610087	dodecyl sulfate, thallium (+1) salt	4180186
45610087	dodecyl sulfate, zinc salt (2:1)	4180186
45610087	laurylsulfate	4180186
45610087	lauryl sulfate	4180186
45610087	lithium dodecyl sulfate	4180186
45610087	lithium lauryl sulfate	4180186
45610087	magnesium dodecyl sulfate	4180186
45610087	magnesium lauryl sulfate	4180186
45610087	potassium dodecyl sulfate	4180186
45610089	5-nitro-2-thiophenecarboxylic acid-(3-(5-nitro-2-furanyl)-2-propenylidene)hydrazide	4180186
45610089	Ricridène	4180186
45610090	potassium hydroxide, 39K-labeled	4180186
45610090	potassium hydroxide, 41K-labeled	4180186
45610090	potassium hydroxide monohydrate	4180186
45610090	potassium hydroxide tetrahydrate	4180186
45610092	clemizole penicillin G	4180186
45610098	Ethamolin	4180186
45610098	oleic acid, 2-aminoethyl ester	4180186
45610100	1,2-dihydrospirorenone	4180186
45610100	1,2-dihydro-spirorenone	4180186
45610100	6beta,7beta,15beta,16beta-dimethylen-3-oxo-17alpha-pregn-4-en-21,17-carbolacton	4180186
45610100	dihydrospirorenone	4180186
45610100	Spiro(17H-dicyclopropa(6,7:15,16)cyclopenta(a)phenanthrene-17,2'(5'H)-furan)-3,5'(2H)-dione, 1,3',4',6,7,8,9,10,11,12,13,14,15,16,20,21-hexadecahydro-10,13-dimethyl-, (6R-(6alpha,7alpha,8beta,9alpha,10beta,13beta,14alpha,15alpha,16alpha,17beta))-	4180186
45610100	ZK30595	4180186
45610100	ZK 30595	4180186
45610101	4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (((3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-yl)carbonyl)oxy)methyl ester, S,S-dioxide, (2S-(2alpha(2R*,5S*),5alpha,6beta(S*)))-	4180186
45610101	CP 49,952	4180186
45610101	CP 49952	4180186
45610101	Combisid	4180186
45610101	Unasyn	4180186
45610101	ampicillin-sulbactam	4180186
45610104	6-desoxy-6-methylenenaltrexone	4180186
45610104	nalmefene hydrochloride	4180186
45610104	Revex	4180186
45610104	Selincro	4180186
45610106	156-S	4180186
45610106	2-(4-((2-oxocyclopentyl)methyl)phenyl)propionic acid	4180186
45610106	2-OCPPP	4180186
45610106	CS 600	4180186
45610106	CS-600	4180186
45610106	loxoprofen alcohol	4180186
45610106	loxoprofen sodium dihydrate	4180186
45610106	loxoprofen sodium, (R*,S*)-isomer	4180186
45610106	sodium 2-(4-(2-oxocyclopentylmethyl)phenyl)propionate dihydrate	4180186
45610106	sodium loxoprofen	4180186
45610108	taszobactam sodium	4180186
45610108	YTR 830	4180186
45610108	YTR-830	4180186
45610108	YTR 830H	4180186
45610109	Axépim	4180186
45610109	BMY 28142	4180186
45610109	BMY-28142	4180186
45610109	cefepim	4180186
45610109	cefepime hydrochloride	4180186
45610109	Maxipime	4180186
45610109	Pyrrolidinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, hydroxide, inner salt, (6R-(6alpha,7beta(Z)))-	4180186
45610109	Quadrocef	4180186
45610111	1,3-Benzenedicarboxamide, 5,5'-((2-hydroxy-1,3-propanediyl)bis(acetylimino))bis(N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo)-, (16alpha)-	4180186
45610111	contrast media 2-5410-3	4180186
45610111	iodixanol-320	4180186
45610111	Visipaque	4180186
45610111	Visipaque Unique Softpac	4180186
45610112	1H-Indole-3-carboxylic acid, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-	4180186
45610112	(3 alpha-tropanyl)-1H-indole-3-carboxylic acid ester	4180186
45610112	ICS 205-930	4180186
45610112	ICS-205930	4180186
45610112	ICS-205-930	4180186
45610112	indole-3-carboxylic acid tropine ester	4180186
45610112	Navoban	4180186
45610112	tropisetron hydrochloride	4180186
45610113	2(1H)-quinolinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-	4180186
45610113	6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone	4180186
45610113	OPC 13013	4180186
45610113	OPC-13013	4180186
45610113	Pletal	4180186
45610117	chlorothen citrate	4180186
45610119	2,2'-((1,4-dioxobutane-1,4-diyl)bis(oxypropane-3,1-diyl))bis(6,7,8-trimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolinium) dichloride	4180186
45610119	BW A938U	4180186
45610119	BW-A938U	4180186
45610119	BW-A 938U	4180186
45610119	BW-A-938U	4180186
45610119	doxacurium chloride	4180186
45610119	Isoquinolinium, 2,2'-((1,4-dioxo-1,4-butanediyl)bis(oxy-3,1-propanediyl))bis(1,2,3,4-tetrahydro-6,7,8-trimethoxy-2-methyl-1-((3,4,5-trimethoxyphenyl)methyl))-	4180186
45610119	Nuromax	4180186
45610120	Oils, wheat	4180186
45610122	3H-1,2,4-triazol-3-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl))propyl-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-	4180186
45610122	Apo-Nefazodone	4180186
45610122	Dutonin	4180186
45610122	Lin-Nefazodone	4180186
45610122	Menfazona	4180186
45610122	Nefadar	4180186
45610122	nefazodone hydrochloride	4180186
45610122	Rulivan	4180186
45610122	Serzone	4180186
45610123	3-amino-9,13b-dihydro-1H-benz(c,f)imidazo(1,5a)azepine	4180186
45610123	epinastine hydrochloride	4180186
45610123	Flurinol	4180186
45610123	WAL 80	4180186
45610123	WAL 801	4180186
45610123	WAL 801CL	4180186
45610123	WAL 801 CL	4180186
45610123	WAL-80 Cl	4180186
45610127	theaflavine	4180186
45610127	1,8-bis(3-alpha,5,7-trihydroxy-2-alpha-chromanyl)-5H-benzocyclohepten-5-one	4180186
45610127	1,8-bis((2R,3R)-3,5,7-trihydroxy-2H-1-benzopyran-2-yl)-3,4,6-trihydroxy-5H-benzocyclohepten-5-one	4180186
45610128	benzyl paraben	4180186
45610129	Glaxo Wellcome brand of salmeterol xinafoate	4180186
45610129	Serevent	4180186
45610129	salmeterol xinafoate	4180186
45610130	Ronem	4180186
45610130	SM 7338	4180186
45610130	SM-7338	4180186
45610130	Penem	4180186
45610130	1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (4R-(3(3S*,5S*),4alpha,5beta,6beta(R*)))-	4180186
45610130	3-(5-dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid	4180186
45610130	Merrem	4180186
45610137	granule cell differentiation protein	4180186
45610137	Mtpn protein, rat	4180186
45610137	myotrophin protein, human	4180186
45610137	myotrophin protein, mouse	4180186
45610137	MTPN protein, human	4180186
45610137	myotrophin protein, rat	4180186
45610137	V-1 protein	4180186
45610137	Mtpn protein, mouse	4180186
45610140	5,10,15,20-tetra(m-hydroxyphenyl)chlorin	4180186
45610140	Foscan	4180186
45610140	Foslip	4180186
45610140	meso-tetrahydroxyphenylchlorin	4180186
45610140	meso-tetra-(hydroxyphenyl)chlorin	4180186
45610140	meso-tetrahydroxyphenyl chlorin	4180186
45610140	mTHPC	4180186
45610140	m-THPC	4180186
45610142	AC 2993	4180186
45610142	AC 2993 LAR	4180186
45610142	bydureon	4180186
45610142	Byetta	4180186
45610142	Ex4 peptide	4180186
45610142	exendin 4	4180186
45610142	exendin-4	4180186
45610142	Exendin 4	4180186
45610142	ITCA 650	4180186
45610143	(+--)-1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid	4180186
45610143	(+--)-1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid monohydrochloride	4180186
45610143	3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-	4180186
45610143	3-quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-, monohydrochloride, (+--)-	4180186
45610143	grepafloxacin HCl	4180186
45610143	grepafloxacin hydrochloride	4180186
45610143	OPC 17116	4180186
45610143	OPC-17116	4180186
45610143	Raxar	4180186
45610144	(R-)-3-isobutyl GABA	4180186
45610144	(S)-3-(aminomethyl)-5-methylhexanoic acid	4180186
45610144	(S+)-3-isobutyl GABA	4180186
45610144	3-(aminomethyl)-5-methylhexanoic acid	4180186
45610144	3-isobutyl GABA	4180186
45610144	CI 1008	4180186
45610144	CI-1008	4180186
45610144	Lyrica	4180186
45610145	23-L-leucine-colony-stimulating factor 2 (human clone pHG25 protein moiety)	4180186
45610145	Leukine	4180186
45610145	Prokine	4180186
45610145	recombinant human granulocyte-macrophage colony-stimulating factor	4180186
45610145	rhu GM-CSF	4180186
45610147	Aventis brand of valsartan	4180186
45610147	CEPA brand of valsartan	4180186
45610147	CGP 48933	4180186
45610147	Diovan	4180186
45610147	Esteve brand of valsartan	4180186
45610147	Kalpress	4180186
45610147	L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-	4180186
45610147	Lacer brand of valsartan	4180186
45610147	Miten	4180186
45610147	N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine	4180186
45610147	Nisis	4180186
45610147	Novartis brand of valsartan	4180186
45610147	Provas	4180186
45610147	Sanol brand of valsartan	4180186
45610147	Schwarz brand of valsartan	4180186
45610147	Tareg	4180186
45610147	Vals	4180186
45610147	walsartan	4180186
45610148	(1,1'-Biphenyl)-2-carboxylic acid, 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-	4180186
45610148	4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid	4180186
45610148	BIBR 277	4180186
45610148	BIBR-277	4180186
45610148	Micardis	4180186
45610148	Pritor	4180186
45610151	2,4,6(1H,3H,5H)-pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-	4180186
45610151	2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-, monosodium salt	4180186
45610151	butabarbital	4180186
45610151	butabarbital sodium	4180186
45610151	butabarbitone	4180186
45610151	Butisol	4180186
45610151	Butisol Sodium	4180186
45610151	Sarisol	4180186
45610151	secbutabarbital sodium	4180186
45610151	secbutobarbitone	4180186
45610151	secumalum	4180186
45610152	deoxyribonuclease I, human	4180186
45610153	5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide	4180186
45610153	5-((2R)-2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2-methoxy-benzenesulfonamide	4180186
45610153	Flomax	4180186
45610153	LY 253352	4180186
45610153	LY-253352	4180186
45610153	tamsulosin hydrochloride	4180186
45610153	YM 617	4180186
45610153	YM-617	4180186
45610155	1H-pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-	4180186
45610155	2,3,4,5-tetrahydro-5-methyl-2-((5-methylimidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one monohydrochloride	4180186
45610155	alosetron hydrochloride	4180186
45610155	alosetron monohydrochloride	4180186
45610155	GR68755	4180186
45610155	GR 68755	4180186
45610155	Lotronex	4180186
45610156	5-(2-(4-(3-benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one	4180186
45610156	CP 88059	4180186
45610156	CP-88,059	4180186
45610156	CP 88059-01	4180186
45610156	CP-88,059-01	4180186
45610156	CP-88,059-1	4180186
45610156	Geodon	4180186
45610156	ziprasidone hydrochloride	4180186
45610156	ziprasidone hydrochloride, monohydrate	4180186
45610156	ziprazidone	4180186
45610158	Allegra	4180186
45610158	alpha-(4-(1-carboxy-1-methylethyl)phenyl)-4-hydroxydiphenylmethyl-1-piperidinebutanol	4180186
45610158	fexofenadine hydrochloride	4180186
45610158	MDL 16455	4180186
45610158	MDL 16.455	4180186
45610158	MDL-16455	4180186
45610158	MDL 16,455A	4180186
45610158	Telfast	4180186
45610163	phensuccimide	4180186
45610163	phensuximide, (+-)-isomer	4180186
45610164	Tebamide	4180186
45610164	T-Gen	4180186
45610164	Ticon	4180186
45610164	Tigan	4180186
45610164	trimethobenzamide monohydrochloride	4180186
45610166	Capromab	4180186
45610166	CYT 356	4180186
45610166	CYT-356	4180186
45610166	Cytogen 356	4180186
45610166	(III)In-CYT-356	4180186
45610166	Indium-111-CYT-356	4180186
45610166	Prostascint	4180186
45610168	methionyl human stem cell factor	4180186
45610168	Met-stem cell factor	4180186
45610168	recombinant human methionyl stem cell factor	4180186
45610168	r-metHuSCF	4180186
45610168	stem cell factor, Met-	4180186
45610168	stem cell factor, methionyl	4180186
45610168	Stemgen	4180186
45610169	Avicel PH-101	4180186
45610169	cellulose, microcrystalline	4180186
45610169	Cephere	4180186
45610169	Ethispheres250	4180186
45610169	Pharmacel 101	4180186
45610170	AE-941	4180186
45610170	Neovastat	4180186
45610170	shark cartilage extract AE 941	4180186
45610171	(8,11-bis(carboxymethyl)-14-(2-((2-methoxyethyl)amino)-2-oxoethyl)-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(3-)), gadolinium	4180186
45610171	OptiMARK	4180186
45610172	FC-1271a	4180186
45610172	Osphena	4180186
45610172	Senshio	4180186
45610172	Z-2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol	4180186
45610173	Baraclude	4180186
45610173	6H-purin-6-one, 2-amino-1,9-dihydro-9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-	4180186
45610173	9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate	4180186
45610173	anhydrous entecavir	4180186
45610173	BMS 200475	4180186
45610173	BMS-200475	4180186
45610173	BMS-200475-01	4180186
45610173	BMS-20047501	4180186
45610173	BMS20047501	4180186
45610173	entecavir hydrate	4180186
45610173	entecavir monohydrate	4180186
45610173	SQ-34676	4180186
45610173	SQ34676	4180186
45610175	Immunoglobulin G, anti-(human immunoglobulin E Fc region)(human-mouse monoclonal E25 clone pSVIE26 gamma-chain), disulfide with human-mouse monoclonal E25 clone pSVIE26 kappa-chain, dimer	4180186
45610175	Xolair	4180186
45610176	(1-(9-(3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6-aminopurin-2-yl)pyrazol-4-yl)-N-methylcarboxamide	4180186
45610176	CVT3146	4180186
45610176	CVT 3146	4180186
45610176	CVT-3146	4180186
45610176	Lexiscan	4180186
45610178	2,3-dehydrosilybin	4180186
45610178	Alepa-forte	4180186
45610178	Ardeyhepan	4180186
45610178	Cefasilymarin	4180186
45610178	durasilymarin	4180186
45610178	HepaBesch	4180186
45610178	hepa-loges	4180186
45610178	Hepa-Merz Sil	4180186
45610178	Hepar-Pasc	4180186
45610178	Heparsyx	4180186
45610178	Hepatos	4180186
45610178	Heplant	4180186
45610178	Lagosa	4180186
45610178	legalon forte	4180186
45610178	silibin	4180186
45610178	silibinin	4180186
45610178	silybin A	4180186
45610178	silybin B	4180186
45610178	silybinin	4180186
45610181	Antegren	4180186
45610181	Tysabri	4180186
45610183	TD6424	4180186
45610183	TD 6424	4180186
45610183	TD-6424	4180186
45610183	telavancin hydrochloride	4180186
45610183	Vibativ	4180186
45610185	Macugen	4180186
45610185	pegaptanib sodium	4180186
45610186	Rozerem	4180186
45610186	(S)-N-(2-(1,6,7,8-tetrahydro-2H-indeno-(5,4)furan-8-yl)ethyl)propionamide	4180186
45610186	TAK-375	4180186
45610187	ABX-EGF MAb	4180186
45610187	ABX-EGF monoclonal antibody	4180186
45610187	Immunoglobulin, anti-(human epidermal growth factor receptor) (human monoclonal ABX-EGF heavy chain), disulfide with human monoclonal ABX-EGF light chain, dimer	4180186
45610187	panitumumab antibody, human	4180186
45610187	Vectibix	4180186
45610188	3-(7-((2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-(1-3)-triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol	4180186
45610188	AZD6140	4180186
45610188	AZD 6140	4180186
45610188	AZD-6140	4180186
45610188	Brilinta	4180186
45610188	Brilique	4180186
45610190	Isentress	4180186
45610190	MK 0518	4180186
45610190	MK-0518	4180186
45610190	MK0518	4180186
45610193	ISIS301012	4180186
45610193	ISIS 301012	4180186
45610193	ISIS-301012	4180186
45610193	Kynamro	4180186
45610193	mipomersen sodium	4180186
45610195	1-docosanol	4180186
45610195	Abreva	4180186
45610195	behenyl alcohol	4180186
45610195	IK.2	4180186
45610196	interleukin-1 Trap	4180186
45610198	Alopecia Celsi	4180186
45610198	Cazenave's Vitiligo	4180186
45610198	Celsus' Vitiligo	4180186
45610198	Jonston's Alopecia	4180186
45610198	Marginal alopecia	4180186
45610198	Patchy alopecia	4180186
45610199	Anthrax, skin type	4180186
45610199	Skin anthrax	4180186
45610204	Homocarnosinase deficiency	4180186
45610204	Carnosinase Deficiency	4180186
45610204	Carnosinemia	4180186
45610206	Dermochondrocorneal dystrophy	4180186
45610206	Francois syndrome	4180186
45610210	Chromosome 13q deletion	4180186
45610210	Chromosome 13q deletion syndrome	4180186
45610210	Chromosome 13q monosomy	4180186
45610210	Chromosome 13q syndrome	4180186
45610210	Deletion 13q	4180186
45610210	Deletion 13q syndrome	4180186
45610210	Monosomy 13q	4180186
45610210	Monosomy 13q syndrome	4180186
45610210	Orbeli's syndrome	4180186
45610210	Orbeli syndrome	4180186
45610212	Bilateral absence of the tibia	4180186
45610212	Tibia, absence of	4180186
45610212	Tibial hemimelia	4180186
45610213	Autoerythrocyte sensitization	4180186
45610213	Psychogenic purpura	4180186
45610214	Familial hypomagnesemia - hypercalciuria	4180186
45610216	SED Congenita	4180186
45610216	Sed, Congenital Type	4180186
45610216	Spondyloepiphyseal Dysplasia Congenita	4180186
45610216	Spondyloepiphyseal dysplasia, congenital type	4180186
45610218	Leukopenia, benign familial	4180186
45610218	Neutropenia, chronic familial	4180186
45610221	Ectodermal Dysplasia-Exocrine Pancreatic Insufficiency	4180186
45610221	Johanson-Blizzard Syndrome	4180186
45610221	Malabsorption-Ectodermal Dysplasia-Nasal Alar Hypoplasia	4180186
45610221	Nasal Alar Hypoplasia, Hypothyroidism, Pancreatic Achylia, and Congenital Deafness	4180186
45610221	Nasal Alar Hypoplasia, Hypothyroidism, Pancreatic Achylia, Congenital Deafness	4180186
45610225	Acat2 Deficiency	4180186
45610225	Acetocoenzyme A acetyltransferase 2 deficiency	4180186
45610225	Acetyl-coa acetyltransferase 2 deficiency	4180186
45610227	Osteogenesis Imperfecta, Type IV	4180186
45610227	Osteogenesis imperfecta with normal sclerae	4180186
45610229	Hyperostosis Generalisata with Striations	4180186
45610229	Osteopathia Striata with Cranial Sclerosis	4180186
45610233	Alcohol-Responsive Dystonia	4180186
45610233	Dystonia 11	4180186
45610233	Dystonia, Alcohol-Responsive	4180186
45610233	Hereditary essential myoclonus	4180186
45610233	Myoclonus-Dystonia	4180186
45610233	Myoclonus-dystonia syndrome	4180186
45610233	Myoclonus, hereditary essential	4180186
45610236	Meckel-Gruber Syndrome	4180186
45610236	Meckel Syndrome	4180186
45610236	Meckel Gruber syndrome	4180186
45610236	Meckel syndrome type1	4180186
45610236	Dysencephalia Splanchnocystica	4180186
45610236	Dysencephalia splachnocystica	4180186
45610236	Gruber syndrome	4180186
45610236	Meckel Syndrome, Type 1	4180186
45610236	Meckel-Gruber Syndrome, Type 1	4180186
45610240	Erdheim Cystic medial necrosis of aorta	4180186
45610243	6 alpha mercaptopurine sensitivity	4180186
45610243	TPMT deficiency	4180186
45610243	Thiopurine S-Methyltransferase Deficiency	4180186
45610243	Thiopurine methyltransferase deficiency	4180186
45610243	Thiopurines, poor metabolism of	4180186
45610244	Dalpro, Fetal Effects From	4180186
45610244	Epival, Fetal Effects From	4180186
45610244	Fetal valproate syndrome	4180186
45610244	Fetal valproic syndrome	4180186
45610244	Valproic acid embryopathy	4180186
45610250	Cross-McKusick syndrome	4180186
45610250	Spastic paraparesis, childhood onset, with distal muscle wasting	4180186
45610250	Spastic Paraparesis, Childhood-Onset, With Distal Muscle Wasting	4180186
45610250	Spastic paraplegia, autosomal recessive, Troyer type	4180186
45610250	Spastic paraplegia with distal muscle wasting	4180186
45610250	Troyer syndrome	4180186
45610257	Adrenal hyperplasia 1	4180186
45610257	Adrenal Hyperplasia I	4180186
45610257	Lipoid hyperplasia, congenital, of adrenal cortex with male pseudohermaphroditism	4180186
45610261	Coloboma of optic nerve with renal disease	4180186
45610261	Coloboma-Ureteral-Renal Syndrome	4180186
45610261	Optic coloboma, vesicoureteral reflux, and renal anomalies	4180186
45610261	Optic Nerve Coloboma Renal Syndrome	4180186
45610261	Optic nerve coloboma with renal disease	4180186
45610261	Renal-coloboma syndrome	4180186
45610261	Renal Coloboma Syndrome	4180186
45610261	Renal-Coloboma Syndrome With Macular Abnormalities	4180186
45610261	Renal Hypoplasia, Isolated	4180186
45610267	Microphthalmia With Ankyloblepharon And Mental Retardation	4180186
45610267	Microphthalmia, Syndromic 4	4180186
45610267	MCOPS4	4180186
45610267	Lenz Dysmorphogenic Syndrome	4180186
45610267	Lenz dysplasia	4180186
45610267	Lenz microphthalmia syndrome	4180186
45610267	Lenz Syndrome	4180186
45610267	MCOPS1	4180186
45610267	Microphthalmia Or Anophthalmos with Associated Anomalies	4180186
45610267	Microphthalmia or anophthalmos with associated anomalies (formerly)	4180186
45610270	Ring 4, Chromosome	4180186
45610271	Chronic Congenital Idiopathic Hyperphosphatasemia	4180186
45610271	Familial Idiopathic Hyperphosphatasemia	4180186
45610271	Familial Osteoectasia	4180186
45610271	Hyperphosphatasemia, chronic congenital idiopathic	4180186
45610271	Hyperphosphatasemia with Bone Disease	4180186
45610271	Hyperphosphatasia, familial idiopathic	4180186
45610271	Idiopathic Hyperphosphatasia	4180186
45610271	Juvenile Paget Disease	4180186
45610271	Juvenile Paget's Disease	4180186
45610271	Osteochalasia Desmalis Familiaris	4180186
45610271	Osteoectasia, familial	4180186
45610271	Osteoectasia with Hyperphosphatasia	4180186
45610271	Paget disease of bone 5, juvenile-onset	4180186
45610273	Absence of testes	4180186
45610273	Anorchia, Familial	4180186
45610273	Congenital absence of testes	4180186
45610273	Empty scrotum	4180186
45610273	Testicular Regression, Embryonic	4180186
45610273	Testicular regression syndrome	4180186
45610273	Vanishing testes	4180186
45610273	Xy Gonadal Agenesis Syndrome	4180186
45610273	XY gonadal dysgenesis syndrome	4180186
45610280	Histiocytosis X, acute disseminated	4180186
45610283	BoNT-A	4180186
45610283	NT 201	4180186
45610283	NT-201	4180186
45610283	NT201	4180186
45610283	Xeomin	4180186
45610283	bocouture	4180186
45610287	COBI cpd	4180186
45610287	GS 9350	4180186
45610287	GS-9350	4180186
45610287	GS9350	4180186
45610292	Parkinson Disease, Juvenile, Of Hunt	4180186
45610293	Interstitial Lung Disease, Desquamative	4180186
45610293	Pneumonia, Desquamative Interstitial, Familial	4180186
45610293	Pneumonitis, Desquamative Interstitial, Familial	4180186
45610297	OMP Decarboxylase Deficiency	4180186
45610297	Orotidylic Decarboxylase Deficiency	4180186
45610299	Trehalose Intolerance	4180186
45610302	Cutaneous Ossification	4180186
45610302	Ectopic Ossification, Familial	4180186
45610302	Osteodermia	4180186
45610302	Osteoma Cutis	4180186
45610302	Osteosis Cutis	4180186
45610302	Progressive Osseous Heteroplasia	4180186
45610305	Hypothyroidism, Congenital, due to Dyshormonogenesis, 3	4180186
45610305	Thyroid Hormonogenesis, Genetic Defect in, 3	4180186
45610307	Hypophosphatemia, Autosomal Recessive	4180186
45610315	Asplenia, Familial	4180186
45610315	Hyposplenia, Isolated Congenital	4180186
45610319	Urolithiasis, Calcium Oxalate	4180186
45610320	EDS7C	4180186
45610320	Dermatosparaxis	4180186
45610320	Ehlers-Danlos Syndrome, Dermatosparaxis Type	4180186
45610320	EDS VIIC	4180186
45610321	dornase alpha	4180186
45610321	Pulmozyme	4180186
45610321	recombinant human deoxyribonuclease I	4180186
45610321	recombinant human DNase	4180186
45610321	rhDNase	4180186
45610325	acebraus	4180186
45610325	Acemuc	4180186
45610325	Acetabs	4180186
45610325	Acetylcystein AL	4180186
45610325	Acetylcystein Atid	4180186
45610325	Acetylcysteine, (D)-Isomer	4180186
45610325	Acetylcysteine, (DL)-Isomer	4180186
45610325	Acétylcystéine GNR	4180186
45610325	Acetylcysteine Hydrochloride	4180186
45610325	Acetylcysteine, Monoammonium Salt	4180186
45610325	Acetylcysteine, Monosodium Salt	4180186
45610325	Acetylcysteine Sodium	4180186
45610325	Acetylcysteine Zinc	4180186
45610325	Acetylcystein Heumann	4180186
45610325	Acetylcystein, mentopin	4180186
45610325	Acetylcystein Trom	4180186
45610325	Acetylin	4180186
45610325	Acetyst	4180186
45610325	Acid, Mercapturic	4180186
45610325	Airbron	4180186
45610325	Alveolex	4180186
45610325	Azubronchin	4180186
45610325	Bisolvon NAC	4180186
45610325	Bromuc	4180186
45610325	BronchoFips	4180186
45610325	Broncho Fips	4180186
45610325	Broncho-Fips	4180186
45610325	Broncholysin	4180186
45610325	Broncoclar	4180186
45610325	Codotussyl	4180186
45610325	Cystamucil	4180186
45610325	Dampo Mucopect	4180186
45610325	durabronchal	4180186
45610325	Eurespiran	4180186
45610325	Exomuc	4180186
45610325	Fabrol	4180186
45610325	Fluimucil	4180186
45610325	Fluprowit	4180186
45610325	Frekatuss	4180186
45610325	Genac	4180186
45610325	Hoestil	4180186
45610325	Hustengetränk, Optipect	4180186
45610325	Hydrochloride, Acetylcysteine	4180186
45610325	Ilube	4180186
45610325	Jenacystein	4180186
45610325	Jenapharm	4180186
45610325	Lantamed	4180186
45610325	Larylin NAC	4180186
45610325	L-Cysteine, N-acetyl-	4180186
45610325	Lindocetyl	4180186
45610325	mentopin Acetylcystein	4180186
45610325	Mercapturic Acid	4180186
45610325	Monoammonium Salt Acetylcysteine	4180186
45610325	Monosodium Salt Acetylcysteine	4180186
45610325	MPectil	4180186
45610325	M Pectil	4180186
45610325	M-Pectil	4180186
45610325	Muciteran	4180186
45610325	Mucomyst	4180186
45610325	Mucopect, Dampo	4180186
45610325	Muco Sanigen	4180186
45610325	Mucosil	4180186
45610325	Mucosol	4180186
45610325	Mucosolvin	4180186
45610325	NAC AL	4180186
45610325	NAC, Bisolvon	4180186
45610325	N Acetylcysteine	4180186
45610325	N-Acetylcysteine	4180186
45610325	N Acetyl L cysteine	4180186
45610325	N-Acetyl-L-cysteine	4180186
45610325	NAC Zambon	4180186
45610325	Optipect Hustengetränk	4180186
45610325	Sanigen, Muco	4180186
45610325	Siccoral	4180186
45610325	Siran	4180186
45610325	Sodium, Acetylcysteine	4180186
45610325	Solmucol	4180186
45610325	Zambon, NAC	4180186
45610325	Zinc, Acetylcysteine	4180186
45610326	Acquired Immune Deficiency Syndrome	4180186
45610326	Acquired Immuno Deficiency Syndrome	4180186
45610326	Acquired Immuno-Deficiency Syndrome	4180186
45610326	Acquired Immunodeficiency Syndromes	4180186
45610326	Acquired Immuno-Deficiency Syndromes	4180186
45610326	AIDS	4180186
45610326	Immunodeficiency Syndrome, Acquired	4180186
45610326	Immuno-Deficiency Syndrome, Acquired	4180186
45610326	Immunodeficiency Syndromes, Acquired	4180186
45610326	Immuno-Deficiency Syndromes, Acquired	4180186
45610326	Immunologic Deficiency Syndrome, Acquired	4180186
45610326	Syndrome, Acquired Immunodeficiency	4180186
45610326	Syndrome, Acquired Immuno-Deficiency	4180186
45610326	Syndromes, Acquired Immunodeficiency	4180186
45610326	Syndromes, Acquired Immuno-Deficiency	4180186
45610327	Acrocephalosyndactylias	4180186
45610327	Acrocephalosyndactylies, Type 1	4180186
45610327	Acrocephalosyndactylies, Type 3	4180186
45610327	Acrocephalosyndactylies, Type I	4180186
45610327	Acrocephalosyndactylies, Type II	4180186
45610327	Acrocephalosyndactylies, Type III	4180186
45610327	Acrocephalosyndactylies, Type V	4180186
45610327	Acrocephalosyndactyly (Apert)	4180186
45610327	Acrocephalosyndactyly III	4180186
45610327	Acrocephalosyndactyly IIIs	4180186
45610327	Acrocephalosyndactyly, Type 1	4180186
45610327	Acrocephalosyndactyly, Type 3	4180186
45610327	Acrocephalosyndactyly, Type I	4180186
45610327	Acrocephalosyndactyly, Type II	4180186
45610327	Acrocephalosyndactyly, Type III	4180186
45610327	Acrocephalosyndactyly, Type V	4180186
45610327	Acrocephaly, Skull Asymmetry, and Mild Syndactyly	4180186
45610327	Apert Crouzon Disease	4180186
45610327	Apert-Crouzon Disease	4180186
45610327	Apert Syndrome	4180186
45610327	Chotzen Syndrome	4180186
45610327	Craniofacial-Skeletal-Dermatologic Dysplasia	4180186
45610327	Disease, Apert-Crouzon	4180186
45610327	Dysostosis Craniofacialis with Hypertelorism	4180186
45610327	Kurczynski Casperson Syndrome	4180186
45610327	Noack Syndrome	4180186
45610327	Noack Syndromes	4180186
45610327	Pfeiffer Syndrome	4180186
45610327	Saethre Chotzen Syndrome	4180186
45610327	Saethre-Chotzen Syndrome	4180186
45610327	Syndactylic Oxycephalies	4180186
45610327	Syndactylic Oxycephaly	4180186
45610327	Syndrome, Apert	4180186
45610327	Syndrome, Chotzen	4180186
45610327	Syndrome, Kurczynski Casperson	4180186
45610327	Syndrome, Noack	4180186
45610327	Syndrome, Pfeiffer	4180186
45610327	Syndrome, Saethre-Chotzen	4180186
45610327	Syndromes, Noack	4180186
45610327	Type I Acrocephalosyndactylies	4180186
45610327	Type I Acrocephalosyndactyly	4180186
45610327	Type II Acrocephalosyndactylies	4180186
45610327	Type II Acrocephalosyndactyly	4180186
45610327	Type III Acrocephalosyndactyly	4180186
45610327	Type V Acrocephalosyndactylies	4180186
45610327	Type V Acrocephalosyndactyly	4180186
45610329	Actinobacillus Infection	4180186
45610329	Infection, Actinobacillus	4180186
45610329	Infections, Actinobacillus	4180186
45610331	Adenocard	4180186
45610331	Adenoscan	4180186
45610332	Syndrome, Adie's	4180186
45610332	Pupils, Poorly Reacting	4180186
45610332	Syndrome, Adie	4180186
45610332	Poorly Reacting Pupils	4180186
45610332	Holmes-Adie Syndrome	4180186
45610332	Adie's Syndrome	4180186
45610332	Poorly Reacting Pupil	4180186
45610332	Pupil, Poorly Reacting	4180186
45610332	Holmes Adie Syndrome	4180186
45610332	Syndrome, Holmes-Adie	4180186
45610333	Tissue, Adipose	4180186
45610333	Body Fat	4180186
45610333	Fat Pad	4180186
45610333	Pads, Fat	4180186
45610333	Tissue, Fatty	4180186
45610333	Fat Pads	4180186
45610333	Pad, Fat	4180186
45610333	Fatty Tissue	4180186
45610334	Administration, Anal Drug	4180186
45610334	Administration, Rectal Drug	4180186
45610334	Administrations, Anal Drug	4180186
45610334	Administrations, Rectal	4180186
45610334	Administrations, Rectal Drug	4180186
45610334	Anal Drug Administration	4180186
45610334	Anal Drug Administrations	4180186
45610334	Drug Administration, Anal	4180186
45610334	Drug Administration, Rectal	4180186
45610334	Drug Administrations, Anal	4180186
45610334	Drug Administrations, Rectal	4180186
45610334	Instillation, Rectal	4180186
45610334	Instillations, Rectal	4180186
45610334	Rectal Administration	4180186
45610334	Rectal Administrations	4180186
45610334	Rectal Drug Administration	4180186
45610334	Rectal Drug Administrations	4180186
45610334	Rectal Instillation	4180186
45610334	Rectal Instillations	4180186
45610335	Adrenal Hyperplasias, Congenital	4180186
45610335	Congenital Adrenal Hyperplasia	4180186
45610335	Congenital Adrenal Hyperplasias	4180186
45610335	Hyperplasia, Congenital Adrenal	4180186
45610335	Hyperplasias, Congenital Adrenal	4180186
45610341	Intake, Alcohol	4180186
45610341	Drinking, Alcohol	4180186
45610341	Habits, Alcohol Drinking	4180186
45610341	Alcohol Intake	4180186
45610341	Habit, Alcohol Drinking	4180186
45610341	Alcohol Intakes	4180186
45610341	Alcohol Drinking Habit	4180186
45610341	Consumption, Alcohol	4180186
45610341	Alcohol Drinking Habits	4180186
45610341	Alcohol Consumption	4180186
45610341	Drinking Habit, Alcohol	4180186
45610342	Allele	4180186
45610342	Allelomorph	4180186
45610342	Allelomorphs	4180186
45610344	Alopecia Circumscripta	4180186
45610345	Ridge Augmentation, Maxillary	4180186
45610345	Alveolar Ridge Augmentations	4180186
45610345	Augmentation, Alveolar Ridge	4180186
45610345	Augmentation, Mandibular Ridge	4180186
45610345	Augmentation, Maxillary Ridge	4180186
45610345	Augmentations, Alveolar Ridge	4180186
45610345	Augmentations, Mandibular Ridge	4180186
45610345	Augmentations, Maxillary Ridge	4180186
45610345	Mandibular Ridge Augmentation	4180186
45610345	Mandibular Ridge Augmentations	4180186
45610345	Maxillary Ridge Augmentation	4180186
45610345	Maxillary Ridge Augmentations	4180186
45610345	Ridge Augmentation, Alveolar	4180186
45610345	Ridge Augmentation, Mandibular	4180186
45610345	Ridge Augmentations, Alveolar	4180186
45610345	Ridge Augmentations, Mandibular	4180186
45610345	Ridge Augmentations, Maxillary	4180186
45610346	Allergic Alveolitides, Extrinsic	4180186
45610346	Allergic Alveolitis, Extrinsic	4180186
45610346	Alveolitides, Extrinsic Allergic	4180186
45610346	Extrinsic Allergic Alveolitides	4180186
45610346	Extrinsic Allergic Alveolitis	4180186
45610346	Hypersensitivity Pneumonitides	4180186
45610346	Hypersensitivity Pneumonitis	4180186
45610346	Pneumonitides, Hypersensitivity	4180186
45610346	Pneumonitis, Hypersensitivity	4180186
45610348	Abscess, Amebic	4180186
45610348	Abscesses, Amebic	4180186
45610348	Acanthamebiases	4180186
45610348	Acanthamebiasis	4180186
45610348	Acanthamoeba Infection	4180186
45610348	Acanthamoeba Infections	4180186
45610348	Amebiases	4180186
45610348	Amebic Abscess	4180186
45610348	Amebic Abscesses	4180186
45610348	Ameboma	4180186
45610348	Amoebiases	4180186
45610348	Amoebiasis	4180186
45610348	Balamuthia Infection	4180186
45610348	Balamuthia Infections	4180186
45610348	Infection, Acanthamoeba	4180186
45610348	Infection, Balamuthia	4180186
45610348	Iodamoebiases	4180186
45610348	Iodamoebiasis	4180186
45610349	Congenital Enamel Hypoplasia	4180186
45610355	Nitrite, Amyl	4180186
45610358	Leukemia, Smoldering	4180186
45610358	Leukemia, Smouldering	4180186
45610358	Leukemias, Smoldering	4180186
45610358	RAEB	4180186
45610358	RAEM	4180186
45610358	Refractory Anemia with Excess of Blasts	4180186
45610358	Smoldering Leukemia	4180186
45610358	Smoldering Leukemias	4180186
45610358	Smouldering Leukemia	4180186
45610362	Phantosmias	4180186
45610362	Phantosmia	4180186
45610362	Parosmias	4180186
45610362	Parosmia	4180186
45610362	Olfactions, Impaired	4180186
45610362	Olfaction, Impaired	4180186
45610362	Impaired Olfactions	4180186
45610362	Impaired Olfaction	4180186
45610362	Cacosmia	4180186
45610362	Cacosmias	4180186
45610362	Dysfunction, Smell	4180186
45610362	Dysosmia	4180186
45610362	Dysosmias	4180186
45610362	Impairment, Olfactory	4180186
45610362	Olfaction Disorder	4180186
45610362	Olfactory Impairment	4180186
45610362	Paraosmia	4180186
45610362	Paraosmias	4180186
45610362	Smell Disorder	4180186
45610362	Smell Disorders	4180186
45610362	Smell Dysfunction	4180186
45610365	Anxiety Disorder, Separation	4180186
45610365	Separation Anxiety	4180186
45610365	Separation Anxiety Disorder	4180186
45610366	Appetite Disorder	4180186
45610366	Appetite Disorders	4180186
45610366	Eating Disorder	4180186
45610366	Disorders, Feeding	4180186
45610366	Eating and Feeding Disorders	4180186
45610366	Disorders, Eating	4180186
45610366	Feeding Disorder	4180186
45610366	Disorder, Feeding	4180186
45610366	Disorder, Eating	4180186
45610366	Eating Disorders	4180186
45610366	Feeding Disorders	4180186
45610367	1,3-Propanediamine, N-(2,3-dihydro-1H-inden-2-yl)-N',N'-diethyl-N-phenyl-	4180186
45610367	Amidonal	4180186
45610367	Fiboran	4180186
45610368	Arenaviridae Infection	4180186
45610368	Arenavirus Infection	4180186
45610368	Arenavirus Infections	4180186
45610368	Infection, Arenaviridae	4180186
45610368	Infection, Arenavirus	4180186
45610368	Infections, Arenaviridae	4180186
45610368	Infections, Arenavirus	4180186
45610369	Arsenic 75	4180186
45610369	Arsenic-75	4180186
45610370	Obliterans, Arteriosclerosis	4180186
45610371	Arterial Inflammation	4180186
45610371	Arteritides	4180186
45610371	Inflammation, Arterial	4180186
45610372	Articulation Disorder	4180186
45610372	Articulation Disorder, Developmental	4180186
45610372	Articulation Disorder, Speech	4180186
45610372	Articulation Disorders, Developmental	4180186
45610372	Articulation Disorders, Speech	4180186
45610372	Articulation, Unintelligible	4180186
45610372	Articulations, Unintelligible	4180186
45610372	Developmental Articulation Disorder	4180186
45610372	Developmental Articulation Disorders	4180186
45610372	Disarticulation Disorder	4180186
45610372	Disarticulation Disorders	4180186
45610372	Disorder, Disarticulation	4180186
45610372	Disorders, Disarticulation	4180186
45610372	Impairment, Phonological	4180186
45610372	Impairment, Phonology	4180186
45610372	Impairments, Phonological	4180186
45610372	Impairments, Phonology	4180186
45610372	Misarticulation	4180186
45610372	Phonological Impairment	4180186
45610372	Phonological Impairments	4180186
45610372	Phonology Impairment	4180186
45610372	Phonology Impairments	4180186
45610372	Speech Articulation Disorder	4180186
45610372	Speech Articulation Disorders	4180186
45610372	Unintelligible Articulation	4180186
45610372	Unintelligible Articulations	4180186
45610374	Ascorbic Acid Deficiencies	4180186
45610374	Deficiencies, Ascorbic Acid	4180186
45610374	Deficiencies, Vitamin C	4180186
45610374	Deficiency, Ascorbic Acid	4180186
45610374	Deficiency, Vitamin C	4180186
45610374	Vitamin C Deficiencies	4180186
45610374	Vitamin C Deficiency	4180186
45610375	Atelectases	4180186
45610375	Atelectases, Compression	4180186
45610375	Atelectases, Compression Pulmonary	4180186
45610375	Atelectases, Congestive	4180186
45610375	Atelectases, Congestive Pulmonary	4180186
45610375	Atelectases, Contraction Pulmonary	4180186
45610375	Atelectases, Postoperative Pulmonary	4180186
45610375	Atelectases, Pulmonary	4180186
45610375	Atelectases, Resorption	4180186
45610375	Atelectases, Resorption Pulmonary	4180186
45610375	Atelectasis	4180186
45610375	Atelectasis, Compression	4180186
45610375	Atelectasis, Compression Pulmonary	4180186
45610375	Atelectasis, Congestive	4180186
45610375	Atelectasis, Congestive Pulmonary	4180186
45610375	Atelectasis, Contraction Pulmonary	4180186
45610375	Atelectasis, Postoperative Pulmonary	4180186
45610375	Atelectasis, Pulmonary	4180186
45610375	Atelectasis, Resorption	4180186
45610375	Atelectasis, Resorption Pulmonary	4180186
45610375	Collapse, Lung	4180186
45610375	Compression Atelectases	4180186
45610375	Compression Atelectasis	4180186
45610375	Compression Pulmonary Atelectases	4180186
45610375	Compression Pulmonary Atelectasis	4180186
45610375	Congestive Atelectases	4180186
45610375	Congestive Atelectasis	4180186
45610375	Congestive Pulmonary Atelectases	4180186
45610375	Congestive Pulmonary Atelectasis	4180186
45610375	Contraction Pulmonary Atelectases	4180186
45610375	Contraction Pulmonary Atelectasis	4180186
45610375	Lung Collapse	4180186
45610375	Postoperative Pulmonary Atelectases	4180186
45610375	Postoperative Pulmonary Atelectasis	4180186
45610375	Pulmonary Atelectases	4180186
45610375	Pulmonary Atelectases, Compression	4180186
45610375	Pulmonary Atelectases, Congestive	4180186
45610375	Pulmonary Atelectases, Contraction	4180186
45610375	Pulmonary Atelectases, Postoperative	4180186
45610375	Pulmonary Atelectases, Resorption	4180186
45610375	Pulmonary Atelectasis, Compression	4180186
45610375	Pulmonary Atelectasis, Congestive	4180186
45610375	Pulmonary Atelectasis, Contraction	4180186
45610375	Pulmonary Atelectasis, Postoperative	4180186
45610375	Pulmonary Atelectasis, Resorption	4180186
45610375	Resorption Atelectases	4180186
45610375	Resorption Atelectasis	4180186
45610375	Resorption Pulmonary Atelectases	4180186
45610375	Resorption Pulmonary Atelectasis	4180186
45610377	Auscultations	4180186
45610379	Ak Tracin	4180186
45610379	Ak-Tracin	4180186
45610379	Altracin	4180186
45610379	Baciguent	4180186
45610379	Baci IM	4180186
45610379	Baci-IM	4180186
45610379	Baci Rx	4180186
45610379	Baci-Rx	4180186
45610379	Bacitin	4180186
45610379	Bacitracine Martinet	4180186
45610379	Bacitracin Zinc	4180186
45610379	Bacitracin, Zinc	4180186
45610379	Bacitracin Zinc Complex	4180186
45610379	Martinet, Bacitracine	4180186
45610379	OcuTracin	4180186
45610379	Ocu Tracin	4180186
45610379	Ocu-Tracin	4180186
45610379	Topitracin	4180186
45610379	Zeba Rx	4180186
45610379	Zeba-Rx	4180186
45610379	Zinc Bacitracin	4180186
45610379	Zinc, Bacitracin	4180186
45610385	2,4,6(1H,3H,5H)-Pyrimidinetrione, 5,5-diethyl-	4180186
45610385	Barbitone	4180186
45610385	Diemal	4180186
45610385	Diethylmalonylurea	4180186
45610385	Dormileno	4180186
45610385	Ethylbarbital	4180186
45610385	Medinal	4180186
45610385	Veronal	4180186
45610386	Barotraumas	4180186
45610388	Basal Ganglia Disease	4180186
45610388	Basal Ganglia Disorder	4180186
45610388	Basal Ganglia Disorders	4180186
45610388	Extrapyramidal Disorder	4180186
45610388	Extrapyramidal Disorders	4180186
45610388	Lenticulostriate Disorder	4180186
45610388	Lenticulostriate Disorders	4180186
45610389	Battered Child Syndromes	4180186
45610389	Nonaccidental Trauma in Children	4180186
45610389	Syndrome, Battered Child	4180186
45610389	Child Syndrome, Battered	4180186
45610389	Syndromes, Battered Child	4180186
45610389	Child Syndromes, Battered	4180186
45610390	Montmorillonite	4180186
45610390	Montmorrillonite	4180186
45610391	Osvan	4180186
45610391	BTC-2125	4180186
45610391	Alkyldimethylbenzylammonium Chloride	4180186
45610391	Benzalkonium	4180186
45610391	Chloride, Benzalkonium	4180186
45610391	Benzalkonium Chloride	4180186
45610391	Germex	4180186
45610391	Asepsol	4180186
45610391	Compounds, Benzalkonium	4180186
45610391	Zephiran	4180186
45610391	Drapolene	4180186
45610391	BTC2125	4180186
45610391	BTC 2125	4180186
45610391	Chloride, Alkyldimethylbenzylammonium	4180186
45610392	8-Azabicyclo(3.2.1)octane, 3-(diphenylmethoxy)-8-methyl-, endo-	4180186
45610392	Apo Benztropine	4180186
45610392	Apo-Benztropine	4180186
45610392	Bensylate	4180186
45610392	Benzatropine	4180186
45610392	Benzatropine Mesylate	4180186
45610392	Benzatropine Methanesulfonate	4180186
45610392	Benzatropine Methanesulfonate, Hydrobromide	4180186
45610392	Benzatropine Methanesulfonate, Hydrobromide, (endo)-Isomer	4180186
45610392	Benzatropine Methanesulfonate, Hydrochloride, (endo)-Isomer	4180186
45610392	Benztropine Mesylate	4180186
45610392	Cogentin	4180186
45610392	Cogentinol	4180186
45610392	Hydrobromide Benzatropine Methanesulfonate	4180186
45610392	Mesylate, Benzatropine	4180186
45610392	Mesylate, Benztropine	4180186
45610392	Methanesulfonate, Benzatropine	4180186
45610392	Methanesulfonate, Hydrobromide Benzatropine	4180186
45610392	N Methylbenztropine	4180186
45610392	N-Methylbenztropine	4180186
45610392	PMS Benztropine	4180186
45610392	PMS-Benztropine	4180186
45610395	Biliary Tract Disease	4180186
45610395	Disease, Biliary Tract	4180186
45610395	Diseases, Biliary Tract	4180186
45610395	Tract Disease, Biliary	4180186
45610395	Tract Diseases, Biliary	4180186
45610396	Birthweights	4180186
45610396	Birthweight	4180186
45610396	Birth Weights	4180186
45610396	Weight, Birth	4180186
45610396	Weights, Birth	4180186
45610398	Bladder Cancer	4180186
45610398	Bladder Cancers	4180186
45610398	Bladder Neoplasm	4180186
45610398	Bladder Neoplasms	4180186
45610398	Bladder Tumor	4180186
45610398	Bladder Tumors	4180186
45610398	Cancer, Bladder	4180186
45610398	Cancer of Bladder	4180186
45610398	Cancer of the Bladder	4180186
45610398	Cancer, Urinary Bladder	4180186
45610398	Malignant Tumor of Urinary Bladder	4180186
45610398	Neoplasm, Bladder	4180186
45610398	Neoplasms, Bladder	4180186
45610398	Neoplasm, Urinary Bladder	4180186
45610398	Tumor, Bladder	4180186
45610398	Tumors, Bladder	4180186
45610398	Urinary Bladder Cancer	4180186
45610398	Urinary Bladder Neoplasm	4180186
45610399	Blepharospasms	4180186
45610402	Bone Cyst	4180186
45610402	Cyst, Bone	4180186
45610402	Cysts, Bone	4180186
45610402	Cyst, Solitary	4180186
45610402	Cysts, Solitary	4180186
45610402	Cysts, Subchondral	4180186
45610402	Cyst, Subchondral	4180186
45610402	Ganglia, Intraosseous	4180186
45610402	Ganglia, Intra Osseous	4180186
45610402	Ganglia, Intra-Osseous	4180186
45610402	Ganglias, Intraosseous	4180186
45610402	Ganglias, Intra-Osseous	4180186
45610402	Ganglion, Intraosseous	4180186
45610402	Ganglion, Intra Osseous	4180186
45610402	Ganglion, Intra-Osseous	4180186
45610402	Ganglions, Intra-Osseous	4180186
45610402	Intraosseous Ganglia	4180186
45610402	Intra Osseous Ganglia	4180186
45610402	Intra-Osseous Ganglia	4180186
45610402	Intraosseous Ganglias	4180186
45610402	Intra-Osseous Ganglias	4180186
45610402	Intraosseous Ganglion	4180186
45610402	Intra Osseous Ganglion	4180186
45610402	Intra-Osseous Ganglion	4180186
45610402	Intraosseous Ganglions	4180186
45610402	Intra-Osseous Ganglions	4180186
45610402	Solitary Cyst	4180186
45610402	Solitary Cysts	4180186
45610402	Subchondral Cyst	4180186
45610402	Subchondral Cysts	4180186
45610403	Bacterium tussis-convulsivae	4180186
45610403	Haemophilus pertussis	4180186
45610403	Hemophilus pertussis	4180186
45610404	Cerebral Edema, Vasogenic	4180186
45610404	Cerebral Edema, Cytotoxic	4180186
45610404	Cerebral Edema	4180186
45610404	Edema, Intracranial	4180186
45610404	Edema, Cytotoxic Brain	4180186
45610404	Brain Edema, Cytotoxic	4180186
45610404	Edema, Vasogenic Brain	4180186
45610404	Vasogenic Cerebral Edema	4180186
45610404	Edema, Cytotoxic Cerebral	4180186
45610404	Brain Swelling	4180186
45610404	Swelling, Brain	4180186
45610404	Brain Swellings	4180186
45610404	Edema, Brain	4180186
45610404	Cytotoxic Cerebral Edema	4180186
45610404	Brain Edema, Vasogenic	4180186
45610404	Cytotoxic Brain Edema	4180186
45610404	Edema, Cerebral	4180186
45610404	Edema, Vasogenic Cerebral	4180186
45610404	Cerebral Edemas, Vasogenic	4180186
45610404	Intracranial Edema	4180186
45610404	Vasogenic Brain Edema	4180186
45610406	2H-1,4-Benzodiazepin-2-one, 7-bromo-1,3-dihydro-5-(2-pyridinyl)-	4180186
45610406	Anxyrex	4180186
45610406	Apo Bromazepam	4180186
45610406	Apo-Bromazepam	4180186
45610406	Beta, Bromazepam	4180186
45610406	BromaLich	4180186
45610406	Bromaz 1A Pharma	4180186
45610406	Bromazanil	4180186
45610406	Bromazepam AL	4180186
45610406	Bromazepam Beta	4180186
45610406	Bromazepam Heumann	4180186
45610406	Bromazepam Neuraxpharm	4180186
45610406	Bromazepam-Neuraxpharm	4180186
45610406	Bromazepam Ratiopharm	4180186
45610406	Bromazepam-Ratiopharm	4180186
45610406	Bromazep Von Ct	4180186
45610406	Durazanil	4180186
45610406	Gen Bromazepam	4180186
45610406	Gen-Bromazepam	4180186
45610406	Lexatin	4180186
45610406	Lexomil	4180186
45610406	Lexotan	4180186
45610406	Lexotanil	4180186
45610406	Ro 53350	4180186
45610406	Ro 5-3350	4180186
45610406	Von Ct, Bromazep	4180186
45610408	1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide	4180186
45610408	2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-	4180186
45610408	Bupivacaina Braun	4180186
45610408	Bupivacaine Anhydrous	4180186
45610408	Bupivacaine Carbonate	4180186
45610408	Bupivacaine Hydrochloride	4180186
45610408	Bupivacaine Monohydrochloride, Monohydrate	4180186
45610408	Bupivacain Janapharm	4180186
45610408	Bupivacain RPR	4180186
45610408	Bupivacain-RPR	4180186
45610408	Buvacaina	4180186
45610408	Carbostesin	4180186
45610408	Dolanaest	4180186
45610408	Marcain	4180186
45610408	Marcaine	4180186
45610408	Sensorcaine	4180186
45610408	Svedocain Sin Vasoconstr	4180186
45610410	Barany's Test	4180186
45610410	Baranys Test	4180186
45610410	Barany Test	4180186
45610410	Caloric Test	4180186
45610410	Test, Barany	4180186
45610410	Test, Barany's	4180186
45610410	Test, Caloric	4180186
45610410	Tests, Caloric	4180186
45610412	Syndrome, Capgras	4180186
45610414	Carbuncles	4180186
45610416	Low Cardiac Output	4180186
45610416	Low Cardiac Output Syndrome	4180186
45610416	Output, Low Cardiac	4180186
45610417	Cardiac Tamponades	4180186
45610417	Pericardial Tamponade	4180186
45610417	Pericardial Tamponades	4180186
45610417	Tamponade, Cardiac	4180186
45610417	Tamponade, Pericardial	4180186
45610417	Tamponades, Cardiac	4180186
45610417	Tamponades, Pericardial	4180186
45610425	Ceramide	4180186
45610426	Neoplasms, Cerebellar, Benign	4180186
45610426	Benign Cerebellar Neoplasm	4180186
45610426	Benign Cerebellar Neoplasms	4180186
45610426	Cancer, Cerebellar	4180186
45610426	Cerebellar Cancer	4180186
45610426	Cerebellar Cancers	4180186
45610426	Cerebellar Neoplasm	4180186
45610426	Cerebellar Neoplasm, Benign	4180186
45610426	Cerebellar Neoplasm, Malignant	4180186
45610426	Cerebellar Neoplasm, Primary	4180186
45610426	Cerebellar Neoplasms, Benign	4180186
45610426	Cerebellar Neoplasms, Malignant	4180186
45610426	Cerebellar Neoplasms, Primary	4180186
45610426	Cerebellar Tumor	4180186
45610426	Cerebellar Tumors	4180186
45610426	Cerebellum Primary Neoplasm	4180186
45610426	Cerebellum Primary Neoplasms	4180186
45610426	Malignant Cerebellar Neoplasm	4180186
45610426	Malignant Cerebellar Neoplasms	4180186
45610426	Neoplasm, Benign Cerebellar	4180186
45610426	Neoplasm, Cerebellar	4180186
45610426	Neoplasm, Cerebellum Primary	4180186
45610426	Neoplasm, Malignant Cerebellar	4180186
45610426	Neoplasms, Cerebellar	4180186
45610426	Neoplasms, Cerebellar, Malignant	4180186
45610426	Neoplasms, Cerebellar, Primary	4180186
45610426	Primary Cerebellar Neoplasm	4180186
45610426	Primary Cerebellar Neoplasms	4180186
45610426	Primary Neoplasm, Cerebellum	4180186
45610426	Primary Neoplasms, Cerebellum	4180186
45610426	Tumor, Cerebellar	4180186
45610429	Cerebrospinal Fluid Otorrhea, Post Traumatic	4180186
45610429	Cerebrospinal Fluid Otorrhea, Post-Traumatic	4180186
45610429	Cerebrospinal Fluid Otorrheas	4180186
45610429	Cerebrospinal Fluid Otorrhea, Spontaneous	4180186
45610429	Cerebrospinal Fluid Otorrhea, Traumatic	4180186
45610429	Cerebrospinal Otorrhea	4180186
45610429	Otorrhea, Cerebrospinal	4180186
45610429	Otorrhea, Cerebrospinal Fluid	4180186
45610429	Otorrhea, Cerebrospinal Fluid, Post-Traumatic	4180186
45610429	Otorrhea, Cerebrospinal Fluid, Spontaneous	4180186
45610429	Otorrhea, Cerebrospinal Fluid, Traumatic	4180186
45610429	Otorrhea, Post-Traumatic, Cerebrospinal Fluid	4180186
45610429	Otorrhea, Spontaneous, Cerebrospinal Fluid	4180186
45610429	Otorrhea, Traumatic Cerebrospinal Fluid	4180186
45610429	Post Traumatic Cerebrospinal Fluid Otorrhea	4180186
45610429	Post-Traumatic Cerebrospinal Fluid Otorrhea	4180186
45610429	Post Traumatic Otorrhea, Cerebrospinal Fluid	4180186
45610429	Post-Traumatic Otorrhea, Cerebrospinal Fluid	4180186
45610429	Spontaneous Cerebrospinal Fluid Otorrhea	4180186
45610429	Spontaneous Otorrhea, Cerebrospinal Fluid	4180186
45610429	Traumatic Cerebrospinal Fluid Otorrhea	4180186
45610429	Traumatic Otorrhea, Cerebrospinal Fluid	4180186
45610430	Neoplasms, Cervical Intraepithelial	4180186
45610430	Neoplasm, Cervical Intraepithelial	4180186
45610430	Neoplasia, Cervical Intraepithelial	4180186
45610430	Intraepithelial Neoplasms, Cervical	4180186
45610430	Intraepithelial Neoplasm, Cervical	4180186
45610430	Intraepithelial Neoplasia, Cervical	4180186
45610430	Dysplasia of Cervix Uteri	4180186
45610430	Dysplasia, Cervical	4180186
45610430	Cervix Uteri Dysplasias	4180186
45610430	Cervix Uteri Dysplasia	4180186
45610430	Cervical Intraepithelial Neoplasms	4180186
45610430	Cervical Intraepithelial Neoplasm	4180186
45610430	Cervical Intraepithelial Neoplasia, Grade III	4180186
45610430	Cervical Intraepithelial Neoplasia	4180186
45610430	Cervical Dysplasias	4180186
45610430	Cervical Dysplasia	4180186
45610430	Cervical Dysplasia, Uterine	4180186
45610430	Cervix Dysplasia	4180186
45610430	Dysplasia, Cervix	4180186
45610430	Dysplasia, Uterine Cervical	4180186
45610431	Cervical Erosion, Uterine	4180186
45610431	Cervix Erosion	4180186
45610431	Cervix Erosion, Uterine	4180186
45610431	Erosion, Cervix	4180186
45610431	Erosion, Uterine Cervical	4180186
45610431	Erosion, Uterine Cervix	4180186
45610431	Uterine Cervix Erosion	4180186
45610432	Abdominal Deliveries	4180186
45610432	Abdominal Delivery	4180186
45610432	Caesarean Section	4180186
45610432	Caesarean Sections	4180186
45610432	Cesarean Sections	4180186
45610432	C Section (OB)	4180186
45610432	C-Section (OB)	4180186
45610432	C-Sections (OB)	4180186
45610432	Deliveries, Abdominal	4180186
45610432	Delivery, Abdominal	4180186
45610432	Postcesarean Section	4180186
45610434	3H-1,4-Benzodiazepin-2-amine, 7-chloro-N-methyl-5-phenyl-, 4-oxide	4180186
45610434	7 Chloro 2 methylamino 5 phenyl 3H 1,4 benzodiazepine 4 oxide	4180186
45610434	7-Chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine-4-oxide	4180186
45610434	7 Chloro N methyl 5 phenyl 3H 1,4 benzodiazepin 2 amine 4 oxide	4180186
45610434	7-Chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide	4180186
45610434	Chlordiazepoxide Hydrobromide	4180186
45610434	Chlordiazepoxide Hydrochloride	4180186
45610434	Chlordiazepoxide Monohydrochloride	4180186
45610434	Chlordiazepoxide Perchlorate	4180186
45610434	Chlozepid	4180186
45610434	Elenium	4180186
45610434	Hydrobromide, Chlordiazepoxide	4180186
45610434	Hydrochloride, Chlordiazepoxide	4180186
45610434	Librium	4180186
45610434	Methaminodiazepoxide	4180186
45610434	Monohydrochloride, Chlordiazepoxide	4180186
45610434	Perchlorate, Chlordiazepoxide	4180186
45610437	Benzene, 1,1',1''-(1-chloro-1-ethenyl-2-ylidene)tris(4-methoxy)-	4180186
45610438	Adenomas, Bile Duct	4180186
45610438	Bile Duct Adenoma	4180186
45610438	Bile Duct Adenomas	4180186
45610438	Cholangioma	4180186
45610438	Cholangiomas	4180186
45610439	Cholangitides	4180186
45610440	Cholecystographies	4180186
45610442	Bile Duct Obstruction	4180186
45610442	Bile Duct Obstructions	4180186
45610442	Biliary Stases	4180186
45610442	Biliary Stasis	4180186
45610442	Cholestases	4180186
45610442	Duct Obstruction, Bile	4180186
45610442	Duct Obstructions, Bile	4180186
45610442	Obstruction, Bile Duct	4180186
45610442	Obstructions, Bile Duct	4180186
45610442	Stases, Biliary	4180186
45610442	Stasis, Biliary	4180186
45610444	1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine	4180186
45610444	Cinarizina Inkey	4180186
45610444	Cinarizina Ratiopharm	4180186
45610444	Cinarizine	4180186
45610444	Cinazière	4180186
45610444	Cinna	4180186
45610444	Cinnarizin AL	4180186
45610444	Cinnarizine, Dihydrochloride	4180186
45610444	Cinnarizine, (E)-Isomer	4180186
45610444	Cinnarizine L Tartrate	4180186
45610444	Cinnarizine L-Tartrate	4180186
45610444	Cinnarizine L-Tartrate (1:1)	4180186
45610444	Cinnarizin Ratiopharm	4180186
45610444	Cinnarizin-Ratiopharm	4180186
45610444	Cinnarizin Siegfried	4180186
45610444	Cinnarizin Von Ct	4180186
45610444	Cinnipirine	4180186
45610444	Cisaken	4180186
45610444	Dihydrochloride Cinnarizine	4180186
45610444	Dimitronal	4180186
45610444	L-Tartrate, Cinnarizine	4180186
45610444	Piperazine, 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-	4180186
45610444	R516	4180186
45610444	R 516	4180186
45610444	R-516	4180186
45610444	Stugeron	4180186
45610444	Stugeron Forte	4180186
45610444	Von Ct, Cinnarizin	4180186
45610445	(1,3)Dioxolo(4,5-g)cinnoline-3-carboxylic acid, 1-ethyl-1,4-dihydro-4-oxo-	4180186
45610445	Acid, Azolinic	4180186
45610445	Azolinic Acid	4180186
45610445	Cinobac	4180186
45610445	Clinoxacin	4180186
45610445	Compound 64716	4180186
45610447	Benzenemethanol, 4-amino-3,5-dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)-	4180186
45610447	NAB365	4180186
45610447	NAB 365	4180186
45610447	NAB-365	4180186
45610447	Planipart	4180186
45610448	Zuclopenthixol	4180186
45610448	alpha Clopenthixol	4180186
45610448	Cisordinol	4180186
45610448	1-Piperazineethanol, 4-(3-(2-chloro-9H-thioxanthen-9-ylidene)propyl)-	4180186
45610448	alpha-Clopenthixol	4180186
45610452	Solitary Lung Nodules	4180186
45610452	Solitary Lung Nodule	4180186
45610452	Nodule, Solitary Lung	4180186
45610452	Lung Nodule, Solitary	4180186
45610452	Coin Lesion, Pulmonary	4180186
45610452	Coin Lesions, Pulmonary	4180186
45610452	Lesion, Pulmonary Coin	4180186
45610452	Nodule, Solitary Pulmonary	4180186
45610452	Nodules, Solitary Pulmonary	4180186
45610452	Pulmonary Coin Lesion	4180186
45610452	Pulmonary Coin Lesions	4180186
45610452	Pulmonary Nodule, Solitary	4180186
45610452	Pulmonary Nodules, Solitary	4180186
45610452	Solitary Pulmonary Nodules	4180186
45610453	Colonic Polyp	4180186
45610453	Polyp, Colonic	4180186
45610453	Polyps, Colonic	4180186
45610455	Behavior, Compulsive	4180186
45610455	Behaviors, Compulsive	4180186
45610455	Compulsive Behaviors	4180186
45610462	Consumption Test, Antiglobulin	4180186
45610462	Test, Direct Antiglobulin	4180186
45610462	Indirect Antiglobulin Test	4180186
45610462	Tests, Antiglobulin	4180186
45610462	Test, Coombs'	4180186
45610462	Antiglobulin Tests	4180186
45610462	Tests, Indirect Antiglobulin	4180186
45610462	Indirect Coombs Test	4180186
45610462	Test, Coombs	4180186
45610462	Direct Antiglobulin Tests	4180186
45610462	Indirect Antiglobulin Tests	4180186
45610462	Test, Direct Coombs	4180186
45610462	Test, Indirect Coombs	4180186
45610462	Antiglobulin Tests, Direct	4180186
45610462	Consumption Tests, Antiglobulin	4180186
45610462	Tests, Direct Antiglobulin	4180186
45610462	Direct Coombs Test	4180186
45610462	Test, Antiglobulin	4180186
45610462	Coombs Test, Indirect	4180186
45610462	Tests, Antiglobulin Consumption	4180186
45610462	Antiglobulin Test	4180186
45610462	Antiglobulin Tests, Indirect	4180186
45610462	Antiglobulin Test, Indirect	4180186
45610462	Antiglobulin Consumption Tests	4180186
45610462	Coomb's Test	4180186
45610462	Coomb Test	4180186
45610462	Antiglobulin Test, Direct	4180186
45610462	Anti Human Globulin Consumption Test	4180186
45610462	Coombs' Test	4180186
45610462	Anti-Human Globulin Consumption Test	4180186
45610462	Test, Antiglobulin Consumption	4180186
45610462	Antihuman Globulin Consumption Test	4180186
45610462	Test, Indirect Antiglobulin	4180186
45610462	Direct Antiglobulin Test	4180186
45610462	Antiglobulin Consumption Test	4180186
45610462	Coombs Test, Direct	4180186
45610463	Arterioscleroses, Coronary	4180186
45610463	Arteriosclerosis, Coronary	4180186
45610463	Artery Disease, Coronary	4180186
45610463	Artery Diseases, Coronary	4180186
45610463	Atheroscleroses, Coronary	4180186
45610463	Atherosclerosis, Coronary	4180186
45610463	Coronary Arterioscleroses	4180186
45610463	Coronary Arteriosclerosis	4180186
45610463	Coronary Artery Diseases	4180186
45610463	Coronary Atheroscleroses	4180186
45610463	Coronary Atherosclerosis	4180186
45610463	Left Main Coronary Artery Disease	4180186
45610463	Left Main Coronary Disease	4180186
45610463	Left Main Disease	4180186
45610463	Left Main Diseases	4180186
45610464	Spasm, Coronary Artery	4180186
45610464	Coronary Artery Spasms	4180186
45610464	Coronary Artery Spasm	4180186
45610464	Artery Spasm, Coronary	4180186
45610464	Artery Vasospasm, Coronary	4180186
45610464	Coronary Artery Vasospasm	4180186
45610464	Coronary Artery Vasospasms	4180186
45610464	Coronary Vasospasms	4180186
45610464	Vasospasm, Coronary	4180186
45610464	Vasospasm, Coronary Artery	4180186
45610467	Cosmid	4180186
45610468	1-24-ACTH	4180186
45610468	1-24-Corticotropin	4180186
45610468	ACTH (1-24)	4180186
45610468	ACTH 1-24	4180186
45610468	ACTH, Synthetic	4180186
45610468	alpha1-24-Corticotropin	4180186
45610468	Corticotropin (1-24)-Peptide	4180186
45610468	Corticotropin (1-24)-Tetracosapeptide	4180186
45610468	Cortosyn	4180186
45610468	Cortrosyn	4180186
45610468	Synthetic ACTH	4180186
45610468	Tetracosactide	4180186
45610468	Tetracosactrin	4180186
45610468	Tetracosapeptide	4180186
45610469	Countertransference, Psychology	4180186
45610472	Cretinism	4180186
45610472	Cretinism, Endemic	4180186
45610472	Endemic Cretinism	4180186
45610472	Fetal Iodine Deficiency Disorder	4180186
45610472	Hypothyroidism, Congenital	4180186
45610472	Myxedema, Congenital	4180186
45610476	Adenocystic Carcinomas	4180186
45610476	Carcinomas, Adenocystic	4180186
45610476	Carcinomas, Adenoid Cystic	4180186
45610476	Cylindroma	4180186
45610476	Cystic Carcinoma, Adenoid	4180186
45610476	Adenocystic Carcinoma	4180186
45610476	Adenoid Cystic Carcinomas	4180186
45610476	Carcinoma, Adenocystic	4180186
45610476	Adenoid Cystic Carcinoma	4180186
45610476	Cylindromas	4180186
45610476	Cystic Carcinomas, Adenoid	4180186
45610478	Azol	4180186
45610478	Cyclomen	4180186
45610478	Danatrol	4180186
45610478	Danazant	4180186
45610478	Danazol Ratiopharm	4180186
45610478	Danazol-Ratiopharm	4180186
45610478	Danocrine	4180186
45610478	Danol	4180186
45610478	Danoval	4180186
45610478	Ladogal	4180186
45610478	Norciden	4180186
45610478	Panacrine	4180186
45610478	Pregna-2,4-dien-20-yno(2,3-d)isoxazol-17-ol, (17alpha)-	4180186
45610479	Decerebrate Posturing	4180186
45610479	Decerebrate Posturings	4180186
45610479	Decerebrate Rigidity	4180186
45610479	Decerebrate States	4180186
45610479	Decorticate Rigidities	4180186
45610479	Decorticate Rigidity	4180186
45610479	Decorticate State	4180186
45610479	Decorticate States	4180186
45610479	Posturing, Decerebrate	4180186
45610479	Posturings, Decerebrate	4180186
45610479	Rigidities, Decorticate	4180186
45610479	Rigidity, Decerebrate	4180186
45610479	Rigidity, Decorticate	4180186
45610479	State, Decerebrate	4180186
45610479	States, Decerebrate	4180186
45610480	Decholin	4180186
45610480	Trioxocholate	4180186
45610480	Dehydrocholic Acid, Lithium Salt	4180186
45610480	Ketocholanic Acid	4180186
45610480	CholanHMB	4180186
45610480	Cholan-24-oic acid, 3,7,12-trioxo-, (5beta)-	4180186
45610480	(5beta)-3,7,12-Trioxocholan-24-oic Acid	4180186
45610480	Dehydrocholic Acid, Magnesium Salt	4180186
45610480	Dehydrocholate	4180186
45610480	Cholan-HMB	4180186
45610480	Cholan HMB	4180186
45610480	Dehydrocholate, Sodium	4180186
45610480	Dehydrocholic Acid, Potassium Salt	4180186
45610480	Dehydrocholic Acid, Sodium Salt	4180186
45610480	Triketocholanic Acid	4180186
45610480	Atrocholin	4180186
45610480	Chologon	4180186
45610480	Sodium Dehydrocholate	4180186
45610482	Agenesis, Enamel	4180186
45610482	Enamel Ageneses	4180186
45610482	Enamel Agenesis	4180186
45610482	Enamel Hypoplasia	4180186
45610482	Enamel Hypoplasia, Dental	4180186
45610482	Enamel Hypoplasias	4180186
45610482	Enamel, Hypoplastic	4180186
45610482	Hypoplasia, Dental Enamel	4180186
45610482	Hypoplasia, Enamel	4180186
45610482	Hypoplastic Enamel	4180186
45610483	Exposure, Dental Pulp	4180186
45610483	Pulp Exposure, Dental	4180186
45610484	Dentin Dysplasias	4180186
45610484	Dysplasia, Dentin	4180186
45610484	Dysplasias, Dentin	4180186
45610487	Adult Type Dermatomyositis	4180186
45610487	Childhood Type Dermatomyositis	4180186
45610487	Dermatomyositis, Adult Type	4180186
45610487	Dermatomyositis, Childhood Type	4180186
45610487	Dermatomyositis, Juvenile	4180186
45610487	Dermatopolymyositis	4180186
45610487	Juvenile Dermatomyositis	4180186
45610487	Juvenile Myositis	4180186
45610487	Myositis, Juvenile	4180186
45610487	Polymyositis Dermatomyositis	4180186
45610487	Polymyositis-Dermatomyositis	4180186
45610489	Diabetic Comas	4180186
45610489	Comas, Diabetic	4180186
45610489	Coma, Diabetic	4180186
45610490	Oral Diagnoses	4180186
45610490	Oral Diagnosis	4180186
45610490	Examinations, Oral	4180186
45610490	Examination, Oral	4180186
45610490	Oral Examination	4180186
45610490	Oral Examinations	4180186
45610490	Diagnoses, Oral	4180186
45610492	3',4' Dideoxykanamycin B	4180186
45610492	3',4'-Dideoxykanamycin B	4180186
45610492	B, 3',4'-Dideoxykanamycin	4180186
45610492	Dibekacin Sulfate	4180186
45610492	Dibekacin Sulphate	4180186
45610492	Dideoxykanamycin B	4180186
45610492	Dideoxykanamycine	4180186
45610492	D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1-4))-2-deoxy-	4180186
45610492	Orbicin	4180186
45610492	Sulfate, Dibekacin	4180186
45610492	Sulphate, Dibekacin	4180186
45610494	Amfepramone	4180186
45610494	1-Propanone, 2-(diethylamino)-1-phenyl-	4180186
45610494	2-Diethylaminopropiophenone	4180186
45610494	Amfepramon	4180186
45610494	Anorex	4180186
45610494	Delgamer	4180186
45610494	Diethylpropion Hydrochloride	4180186
45610494	Dietilretard	4180186
45610494	Dietil retard	4180186
45610494	Dietil-retard	4180186
45610494	Hydrochloride, Diethylpropion	4180186
45610494	Ifa Norex	4180186
45610494	Lipomin	4180186
45610494	Maruate	4180186
45610494	Modératan	4180186
45610494	Neobes	4180186
45610494	Nobesine	4180186
45610494	Norex, Ifa	4180186
45610494	Phepranon	4180186
45610494	Préfamone	4180186
45610494	Propion	4180186
45610494	Regenon	4180186
45610494	Regibon	4180186
45610494	Tenuate	4180186
45610494	Tepanil	4180186
45610495	Ankylosing Hyperostoses, Vertebral	4180186
45610495	Ankylosing Hyperostosis, Vertebral	4180186
45610495	Ankylosing Vertebral Hyperostosis with Tylosis	4180186
45610495	Diffuse Idiopathic Skeletal Hyperostosis	4180186
45610495	Disease, Forestier	4180186
45610495	Disease, Forestier-Rotes	4180186
45610495	Disease, Forestier's	4180186
45610495	Forestier Disease	4180186
45610495	Forestier Rotes Disease	4180186
45610495	Forestier-Rotes Disease	4180186
45610495	Forestier's Disease	4180186
45610495	Forestiers Disease	4180186
45610495	Hyperostoses, Vertebral Ankylosing	4180186
45610495	Hyperostosis, Vertebral Ankylosing	4180186
45610495	Vertebral Ankylosing Hyperostoses	4180186
45610495	Vertebral Ankylosing Hyperostosis	4180186
45610496	Boehringer, Digoxina	4180186
45610496	Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-	4180186
45610496	Digacin	4180186
45610496	Digitek	4180186
45610496	Digoregen	4180186
45610496	Digoxina Boehringer	4180186
45610496	Digoxine Nativelle	4180186
45610496	Dilanacin	4180186
45610496	Hemigoxine Nativelle	4180186
45610496	Lanacordin	4180186
45610496	Lanicor	4180186
45610496	Lanoxicaps	4180186
45610496	Lanoxin	4180186
45610496	Lanoxin PG	4180186
45610496	Lanoxin-PG	4180186
45610496	Lenoxin	4180186
45610496	Mapluxin	4180186
45610496	Nativelle, Digoxine	4180186
45610496	Nativelle, Hemigoxine	4180186
45610497	Alkaloids, Hydrogenated Ergot	4180186
45610497	Co-Dergocrine	4180186
45610497	Dihydroergotoxin	4180186
45610497	Ergot Alkaloids, Hydrogenated	4180186
45610497	Ergotoxine, dihydro-	4180186
45610497	Hydrogenated Ergot Alkaloids	4180186
45610501	Colonic Diverticulitis	4180186
45610502	Divorced	4180186
45610502	Separations	4180186
45610502	Separated	4180186
45610502	Divorces	4180186
45610502	Separation	4180186
45610503	Autonomous Replication	4180186
45610503	Autonomous Replications	4180186
45610503	DNA Replications	4180186
45610503	Replication, Autonomous	4180186
45610503	Replication, DNA	4180186
45610503	Replications, Autonomous	4180186
45610503	Replications, DNA	4180186
45610504	Drownings	4180186
45610505	Evaluations, Drug	4180186
45610505	Drug Evaluation Studies	4180186
45610505	Drug Evaluation Study	4180186
45610505	Drug Evaluations	4180186
45610505	Evaluation Studies, Drug	4180186
45610505	Evaluation Study, Drug	4180186
45610505	Evaluation, Drug	4180186
45610505	Studies, Drug Evaluation	4180186
45610505	Study, Drug Evaluation	4180186
45610506	Chemotherapies	4180186
45610506	Chemotherapy	4180186
45610506	Drug Therapies	4180186
45610506	Pharmacotherapies	4180186
45610506	Pharmacotherapy	4180186
45610506	Therapies, Drug	4180186
45610506	Therapy, Drug	4180186
45610511	Nanism	4180186
45610512	Drug-Induced Dyskinesia	4180186
45610512	Drug-Induced Dyskinesias	4180186
45610512	Dyskinesia, Drug Induced	4180186
45610512	Dyskinesia, Medication Induced	4180186
45610512	Dyskinesia, Medication-Induced	4180186
45610512	Dyskinesias, Drug-Induced	4180186
45610512	Dyskinesias, Medication-Induced	4180186
45610512	Medication Induced Dyskinesia	4180186
45610512	Medication-Induced Dyskinesia	4180186
45610512	Medication-Induced Dyskinesias	4180186
45610513	Trepopnea	4180186
45610513	Rest Dyspnea	4180186
45610513	Recumbent Dyspnea	4180186
45610513	Platypnea	4180186
45610513	Orthopnea	4180186
45610513	Dyspneas, Rest	4180186
45610513	Dyspnea, Rest	4180186
45610513	Dyspnea, Recumbent	4180186
45610513	Breathlessness	4180186
45610513	Breath Shortness	4180186
45610513	Shortness of Breath	4180186
45610516	Ecchymoses	4180186
45610517	Alveolar Echinococcosis, Hepatic	4180186
45610517	Cyst, Hepatic Hydatid	4180186
45610517	Cysts, Hepatic Hydatid	4180186
45610517	Echinococcosis, Hepatic Alveolar	4180186
45610517	Hepatic Alveolar Echinococcosis	4180186
45610517	Hepatic Echinococcosis	4180186
45610517	Hepatic Hydatid Cyst	4180186
45610517	Hepatic Hydatid Cysts	4180186
45610517	Hepatic Hydatidosis	4180186
45610517	Hydatid Cyst, Hepatic	4180186
45610517	Hydatid Cysts, Hepatic	4180186
45610517	Hydatidosis, Hepatic	4180186
45610524	Electronystagmographies	4180186
45610525	Embolizations, Therapeutic	4180186
45610525	Embolotherapies	4180186
45610525	Embolotherapy	4180186
45610525	Therapeutic Embolization	4180186
45610525	Therapeutic Embolizations	4180186
45610529	California Encephalitis	4180186
45610529	California Encephalitis Virus Infection	4180186
45610529	California Viral Encephalitis	4180186
45610529	Encephalitis, California Viral	4180186
45610529	Encephalitis, California, Viral	4180186
45610529	Encephalitis, La Crosse	4180186
45610529	La Crosse Encephalitis	4180186
45610529	La Crosse Encephalitis Virus Infection	4180186
45610529	Viral Encephalitis, California	4180186
45610531	Endomyocardial Fibroses	4180186
45610531	Fibroses, Endomyocardial	4180186
45610531	Fibrosis, Endomyocardial	4180186
45610538	E coli Infection	4180186
45610538	E. coli Infection	4180186
45610538	E coli Infections	4180186
45610538	E. coli Infections	4180186
45610538	Escherichia coli Infection	4180186
45610538	Infection, E coli	4180186
45610538	Infection, E. coli	4180186
45610538	Infection, Escherichia coli	4180186
45610538	Infections, E coli	4180186
45610538	Infections, Escherichia coli	4180186
45610539	Esophageal Stenoses	4180186
45610539	Esophageal Stricture	4180186
45610539	Stenosis, Esophageal	4180186
45610539	Stricture, Esophageal	4180186
45610540	Delestrogen	4180186
45610540	17 beta Estradiol	4180186
45610540	17 beta-Estradiol	4180186
45610540	17 beta Oestradiol	4180186
45610540	17 beta-Oestradiol	4180186
45610540	Aerodiol	4180186
45610540	Estra-1,3,5(10)-triene-3,17-diol (17beta)-	4180186
45610540	Estrace	4180186
45610540	Estraderm TTS	4180186
45610540	Estradiol, (16 alpha,17 alpha)-Isomer	4180186
45610540	Estradiol, (16 alpha,17 beta)-Isomer	4180186
45610540	Estradiol 17 alpha	4180186
45610540	Estradiol-17 alpha	4180186
45610540	Estradiol, (17-alpha)-Isomer	4180186
45610540	Estradiol 17beta	4180186
45610540	Estradiol 17 beta	4180186
45610540	Estradiol-17beta	4180186
45610540	Estradiol-17 beta	4180186
45610540	Estradiol, (8 alpha,17 beta)-Isomer	4180186
45610540	Estradiol, (8 alpha,17 beta)-(+-)-Isomer	4180186
45610540	Estradiol, (9 beta,17 alpha)-Isomer	4180186
45610540	Estradiol, (9 beta,17 beta)-Isomer	4180186
45610540	Estradiol Anhydrous	4180186
45610540	Estradiol Hemihydrate	4180186
45610540	Estradiol Hemihydrate, (17 alpha)-Isomer	4180186
45610540	Estradiol, (-)-Isomer	4180186
45610540	Estradiol, (+-)-Isomer	4180186
45610540	Estradiol Monohydrate	4180186
45610540	Estradiol, Monosodium Salt	4180186
45610540	Estradiol, Sodium Salt	4180186
45610540	Estradiol Valerate	4180186
45610540	Estradiol Valeriante	4180186
45610540	Oestradiol	4180186
45610540	Ovocyclin	4180186
45610540	Progynon Depot	4180186
45610540	Progynon-Depot	4180186
45610540	Progynova	4180186
45610540	Vivelle	4180186
45610542	1-Penten-4-yn-3-ol, 1-chloro-3-ethyl-	4180186
45610542	Ethchlorovynol	4180186
45610542	Ethchlorvinol	4180186
45610542	Placidyl	4180186
45610543	19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-	4180186
45610543	Estinyl	4180186
45610543	Estradiol, Ethinyl	4180186
45610543	Estradiol, Ethynyl	4180186
45610543	Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer	4180186
45610543	Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer	4180186
45610543	Ethinyl Estradiol, (8 alpha)-Isomer	4180186
45610543	Ethinyl Estradiol, (9 beta,17 alpha)-Isomer	4180186
45610543	Ethinyl Estradiol Hemihydrate	4180186
45610543	Ethinylestradiol Jenapharm	4180186
45610543	Ethinyloestradiol	4180186
45610543	Ethinyl Oestradiol Effik	4180186
45610543	Ethinyl-Oestradiol Effik	4180186
45610543	Ethynyl Estradiol	4180186
45610543	Hemihydrate, Ethinyl Estradiol	4180186
45610543	Jenapharm, Ethinylestradiol	4180186
45610543	Lynoral	4180186
45610543	Microfollin	4180186
45610543	Microfollin Forte	4180186
45610543	Progynon C	4180186
45610546	Killing, Mercy	4180186
45610546	Killings, Mercy	4180186
45610546	Mercy Killing	4180186
45610546	Mercy Killings	4180186
45610548	Disease, Sixth	4180186
45610548	Roseola Infantum	4180186
45610548	Sixth Disease	4180186
45610554	Coagulation Factor 12 Deficiency	4180186
45610554	Deficiencies, Factor 12	4180186
45610554	Deficiencies, Factor Twelve	4180186
45610554	Deficiencies, Factor XII	4180186
45610554	Deficiency, Factor 12	4180186
45610554	Deficiency, Factor Twelve	4180186
45610554	Deficiency, Factor XII	4180186
45610554	Deficiency, Hageman Factor	4180186
45610554	Factor 12 Deficiencies	4180186
45610554	Factor 12 Deficiency	4180186
45610554	Factor Deficiency, Hageman	4180186
45610554	Factor Twelve Deficiencies	4180186
45610554	Factor Twelve Deficiency	4180186
45610554	Factor XII Deficiencies	4180186
45610554	Hageman Factor Deficiency	4180186
45610554	Hageman Trait	4180186
45610558	Femoral Fracture	4180186
45610558	Fracture, Femoral	4180186
45610558	Fractures, Femoral	4180186
45610559	Fenestrations, Labyrinth	4180186
45610559	Labyrinth Fenestration	4180186
45610559	Labyrinth Fenestrations	4180186
45610563	Twin-to-Twin Transfusions	4180186
45610563	Twin-to-Twin Transfusion	4180186
45610563	Twin to Twin Transfusion	4180186
45610563	Transfusion, Twin-to-Twin	4180186
45610563	Transfusion, Fetofetal	4180186
45610563	Syndrome, Twin Transfusion	4180186
45610563	Cross Transfusion, Intrauterine	4180186
45610563	Cross-Transfusion, Intrauterine	4180186
45610563	Fetal Transfusion Syndrome	4180186
45610563	Fetal Transfusion Syndromes	4180186
45610563	Fetofetal Transfusions	4180186
45610563	Fetofetal Transfusion Syndrome	4180186
45610563	Fetofetal Transfusion Syndromes	4180186
45610563	Intrauterine Cross Transfusion	4180186
45610563	Intrauterine Cross-Transfusion	4180186
45610563	Intrauterine Cross-Transfusions	4180186
45610563	Syndrome, Fetal Transfusion	4180186
45610563	Syndrome, Fetofetal Transfusion	4180186
45610563	Syndrome, Twin-to-Twin Transfusion	4180186
45610563	Transfusion Syndrome, Fetal	4180186
45610563	Transfusion Syndrome, Fetofetal	4180186
45610563	Transfusion Syndrome, Twin	4180186
45610563	Transfusion Syndrome, Twin-to-Twin	4180186
45610563	Transfusion, Twin	4180186
45610563	Twin to Twin Transfusion Syndrome	4180186
45610563	Twin-to-Twin Transfusion Syndrome	4180186
45610563	Twin-to-Twin Transfusion Syndromes	4180186
45610563	Twin Transfusion	4180186
45610563	Twin Transfusions	4180186
45610563	Twin Transfusion Syndrome	4180186
45610563	Twin Transfusion Syndromes	4180186
45610563	Twin Twin Transfusion Syndrome	4180186
45610564	Unknown Origin Fever	4180186
45610564	Unknown Origin Fevers	4180186
45610565	Flécaïne	4180186
45610565	Apocard	4180186
45610565	Benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-	4180186
45610565	Flecadura	4180186
45610565	Flecainide, 5-HO-N-(6-oxo)-Derivative	4180186
45610565	Flecainide, 5-HO-N-(6-oxo)-Derivative, (+-)-Isomer	4180186
45610565	Flecainide Acetate	4180186
45610565	Flecainide Monoacetate	4180186
45610565	Flecainide Monoacetate, (+-)-Isomer	4180186
45610565	Flecainide Monoacetate, (R)-Isomer	4180186
45610565	Flecainide Monoacetate, (S)-Isomer	4180186
45610565	Flecainide, (R)-Isomer	4180186
45610565	Flecainide, (S)-Isomer	4180186
45610565	Flecainid Isis	4180186
45610565	Flecainid-Isis	4180186
45610565	Flecatab	4180186
45610565	R818	4180186
45610565	Tambocor	4180186
45610568	Cortisdin	4180186
45610568	Efflumidex	4180186
45610568	Flucon	4180186
45610568	Flucon, Isopto	4180186
45610568	Fluoro Ophtal	4180186
45610568	Fluoro-Ophtal	4180186
45610568	Fluor Op	4180186
45610568	Fluor-Op	4180186
45610568	Fluoropos	4180186
45610568	FML	4180186
45610568	FML Forte	4180186
45610568	FML Liquifilm	4180186
45610568	Isopto Flucon	4180186
45610568	PMS Fluorometholone	4180186
45610568	PMS-Fluorometholone	4180186
45610568	Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-6-methyl-, (6alpha,11beta)-	4180186
45610570	Allergies, Food	4180186
45610570	Allergy, Food	4180186
45610570	Food Allergies	4180186
45610570	Food Allergy	4180186
45610570	Food Hypersensitivities	4180186
45610570	Hypersensitivities, Food	4180186
45610570	Hypersensitivity, Food	4180186
45610571	Forearm Injury	4180186
45610571	Injuries, Forearm	4180186
45610571	Injury, Forearm	4180186
45610572	Bodies, Foreign	4180186
45610572	Body, Foreign	4180186
45610572	Foreign Body	4180186
45610572	Foreign Object	4180186
45610572	Foreign Objects	4180186
45610572	Gossypiboma	4180186
45610572	Gossypibomas	4180186
45610572	Object, Foreign	4180186
45610572	Objects, Foreign	4180186
45610572	Retained Surgical Instrument	4180186
45610572	Retained Surgical Instruments	4180186
45610572	Retained Surgical Item	4180186
45610572	Retained Surgical Items	4180186
45610572	Retained Surgical Needle	4180186
45610572	Retained Surgical Needles	4180186
45610572	Retained Surgical Sponge	4180186
45610572	Retained Surgical Sponges	4180186
45610572	Retained Surgical Tool	4180186
45610572	Retained Surgical Tools	4180186
45610572	Surgical Instrument, Retained	4180186
45610572	Surgical Instruments, Retained	4180186
45610572	Surgical Item, Retained	4180186
45610572	Surgical Items, Retained	4180186
45610572	Surgical Needle, Retained	4180186
45610572	Surgical Needles, Retained	4180186
45610572	Surgical Sponge, Retained	4180186
45610572	Surgical Sponges, Retained	4180186
45610572	Surgical Tool, Retained	4180186
45610572	Surgical Tools, Retained	4180186
45610572	Textiloma	4180186
45610572	Textilomas	4180186
45610574	Fracture Fixations, Intramedullary	4180186
45610574	Nailing, Intramedullary	4180186
45610574	Nailings, Intramedullary	4180186
45610574	Intramedullary Nailings	4180186
45610574	Intramedullary Fracture Fixations	4180186
45610574	Fixation, Intramedullary Fracture	4180186
45610574	Intramedullary Fracture Fixation	4180186
45610574	Osteosynthesis, Fracture, Intramedullary	4180186
45610574	Fixations, Intramedullary Fracture	4180186
45610574	Intramedullary Nailing	4180186
45610576	1-(2-Tetrahydrofuryl)-5-fluorouracil	4180186
45610576	1-(Tetrahydro-2-furanyl)-5-fluorouracil	4180186
45610576	2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-	4180186
45610576	5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione	4180186
45610576	Florafur	4180186
45610576	Fluorofur	4180186
45610576	FT207	4180186
45610576	FT 207	4180186
45610576	FT-207	4180186
45610576	Ftorafur	4180186
45610576	Futraful	4180186
45610576	N1-(2'-Tetrahydrofuryl)-5-fluorouracil	4180186
45610576	Sunfural S	4180186
45610576	Uftoral	4180186
45610576	Utefos	4180186
45610577	Alpha-Fucosidase Deficiency	4180186
45610577	alpha Fucosidase Deficiency Disease	4180186
45610577	alpha-Fucosidase Deficiency Disease	4180186
45610577	alpha-Fucosidase Deficiency Diseases	4180186
45610577	alpha-L-Fucosidase Deficiency	4180186
45610577	alpha L Fucosidase Deficiency Disease	4180186
45610577	alpha-L-Fucosidase Deficiency Disease	4180186
45610577	alpha-L-Fucosidase Deficiency Diseases	4180186
45610577	Deficiency Disease, alpha Fucosidase	4180186
45610577	Deficiency Disease, alpha-Fucosidase	4180186
45610577	Deficiency Disease, alpha L Fucosidase	4180186
45610577	Deficiency Disease, alpha-L-Fucosidase	4180186
45610577	Deficiency Disease, Fucosidase	4180186
45610577	Deficiency Diseases, alpha-Fucosidase	4180186
45610577	Deficiency Diseases, alpha-L-Fucosidase	4180186
45610577	Deficiency Diseases, Fucosidase	4180186
45610577	Disease, alpha-Fucosidase Deficiency	4180186
45610577	Disease, alpha-L-Fucosidase Deficiency	4180186
45610577	Disease, Fucosidase Deficiency	4180186
45610577	Diseases, alpha-Fucosidase Deficiency	4180186
45610577	Diseases, alpha-L-Fucosidase Deficiency	4180186
45610577	Diseases, Fucosidase Deficiency	4180186
45610577	Fucosidase Deficiency	4180186
45610577	Fucosidase Deficiency Disease	4180186
45610577	Fucosidase Deficiency Diseases	4180186
45610577	Fucosidosis, Infantile	4180186
45610577	Fucosidosis, Juvenile	4180186
45610577	Fucosidosis Type 1	4180186
45610577	Fucosidosis Type 1s	4180186
45610577	Fucosidosis Type I	4180186
45610577	Fucosidosis Type II	4180186
45610577	Infantile Fucosidosis	4180186
45610577	Juvenile Fucosidosis	4180186
45610577	Type 1, Fucosidosis	4180186
45610577	Type 1s, Fucosidosis	4180186
45610579	Gingival Pockets	4180186
45610579	Pocket, Gingival	4180186
45610579	Pockets, Gingival	4180186
45610587	Deficiencies, Muscle Phosphorylase	4180186
45610587	deficiencies, Myophosphorylase	4180186
45610587	Deficiencies, PYGM	4180186
45610587	Deficiency, Muscle Phosphorylase	4180186
45610587	deficiency, Myophosphorylase	4180186
45610587	Deficiency, PYGM	4180186
45610587	Disease, McArdle	4180186
45610587	Disease, McArdle's	4180186
45610587	Glycogenosis 5	4180186
45610587	Glycogenosis 5s	4180186
45610587	Glycogen Storage Disease Type 5	4180186
45610587	Glycogen Storage Disease V	4180186
45610587	McArdle Disease	4180186
45610587	McArdle's Disease	4180186
45610587	McArdles Disease	4180186
45610587	Mcardle Syndrome	4180186
45610587	Mcardle Syndromes	4180186
45610587	McArdle Type Glycogen Storage Disease	4180186
45610587	Muscle Glycogen Phosphorylase Deficiency	4180186
45610587	Muscle Phosphorylase Deficiencies	4180186
45610587	Muscle Phosphorylase Deficiency	4180186
45610587	Myophosphorylase deficiencies	4180186
45610587	Myophosphorylase deficiency	4180186
45610587	Phosphorylase Deficiencies, Muscle	4180186
45610587	Phosphorylase Deficiency, Muscle	4180186
45610587	PYGM Deficiencies	4180186
45610587	PYGM Deficiency	4180186
45610587	Syndrome, Mcardle	4180186
45610587	Syndromes, Mcardle	4180186
45610592	Granulation Tissues	4180186
45610592	Tissue, Granulation	4180186
45610592	Tissues, Granulation	4180186
45610594	Habit	4180186
45610594	Habit Disturbance	4180186
45610594	Habit Disturbances	4180186
45610596	Hair Disease	4180186
45610600	Cardiac Hypertrophies	4180186
45610600	Cardiac Hypertrophy	4180186
45610600	Enlarged Heart	4180186
45610600	Enlargement, Heart	4180186
45610600	Heart, Enlarged	4180186
45610600	Heart Enlargement	4180186
45610600	Heart Hypertrophies	4180186
45610600	Heart Hypertrophy	4180186
45610600	Hypertrophies, Cardiac	4180186
45610600	Hypertrophies, Heart	4180186
45610600	Hypertrophy, Cardiac	4180186
45610600	Hypertrophy, Heart	4180186
45610601	Cardiac Ruptures, Traumatic	4180186
45610601	Cardiac Rupture, Traumatic	4180186
45610601	Heart Injury	4180186
45610601	Heart Ruptures, Traumatic	4180186
45610601	Heart Rupture, Traumatic	4180186
45610601	Injuries, Heart	4180186
45610601	Injury, Heart	4180186
45610601	Ruptures, Traumatic Cardiac	4180186
45610601	Ruptures, Traumatic Heart	4180186
45610601	Rupture, Traumatic Cardiac	4180186
45610601	Rupture, Traumatic Heart	4180186
45610601	Traumatic Cardiac Rupture	4180186
45610601	Traumatic Cardiac Ruptures	4180186
45610601	Traumatic Heart Rupture	4180186
45610601	Traumatic Heart Ruptures	4180186
45610603	Collapse, Heat	4180186
45610603	Exhaustion, Heat	4180186
45610603	Heat Collapse	4180186
45610603	Heat Prostration	4180186
45610603	Prostration, Heat	4180186
45610605	Hemagglutination Test	4180186
45610605	Test, Hemagglutination	4180186
45610605	Tests, Hemagglutination	4180186
45610606	Hemedonin	4180186
45610606	Hematoporphyrin	4180186
